data_5woy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5woy _Structure_validation_residue.Date_analyzed 2018-02-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.8 mt -100.79 140.55 34.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.06 136.3 43.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.228 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.8 -138.45 2.52 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -102.19 119.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 111.233 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.54 87.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.95 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.218 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 t -150.28 138.64 12.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.238 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.81 160.67 34.04 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.696 1.597 . . . . 0.0 111.199 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.87 175.16 13.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -125.09 124.6 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 177' ' ' LEU . . . -125.92 132.8 52.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -129.57 127.39 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.31 -153.74 24.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.01 154.71 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.171 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.67 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 31.7 m-85 -121.46 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.59 117.96 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -66.28 124.37 22.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -117.83 131.5 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.96 130.09 50.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.04 135.07 56.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.73 128.2 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.68 93.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.1 m -97.73 112.88 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.48 126.83 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -99.68 103.43 15.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.27 20.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.214 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.16 138.9 47.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.22 139.51 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 pt -118.12 170.28 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.214 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.42 146.19 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -64.03 -20.65 66.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.0 p -73.56 -14.44 61.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -98.42 4.43 48.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.2 -51.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.01 -32.8 74.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.85 -49.26 78.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.196 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.7 -37.3 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.65 -44.6 98.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.27 84.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -64.01 -37.97 89.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -59.28 -49.15 78.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.2 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.49 -36.68 84.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.7 -40.41 92.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.19 -33.49 76.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.65 -40.97 98.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.253 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.64 -42.76 99.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.58 -39.98 85.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.206 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.0 m -63.17 -41.61 99.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -60.97 -44.81 96.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.225 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -59.39 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.58 -55.91 21.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.58 -42.99 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.166 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.95 -49.33 77.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.36 -36.76 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.7 mt -63.03 -45.61 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.17 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.7 -43.72 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -55.35 -52.95 61.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -60.03 -42.85 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -43.11 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.42 -45.02 95.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.21 -31.71 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -97.06 -39.78 9.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.3 -34.91 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.25 -171.91 15.72 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -63.26 -26.13 68.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 111.175 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -45.59 -42.28 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.98 -34.74 10.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.46 -39.21 93.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.9 -32.68 74.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.16 -41.61 91.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.214 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -77.46 -24.09 50.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.36 -41.07 96.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.192 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.79 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -59.64 -41.16 89.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.187 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.73 -43.37 93.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.9 mtm -64.82 -36.09 83.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.86 -45.68 88.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.65 -33.12 74.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.3 m -94.69 1.93 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -65.79 114.17 15.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.86 -33.9 83.48 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.689 1.593 . . . . 0.0 111.216 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -67.94 -43.74 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.198 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.12 -36.69 72.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.96 -51.85 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.19 -35.16 79.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.19 -46.25 91.81 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.29 -46.59 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.37 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.76 -36.39 80.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp -63.68 -40.34 96.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.177 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.88 -50.91 77.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.51 -42.19 71.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.8 m -63.69 -47.37 81.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -99.17 -6.07 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt 59.97 45.05 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.66 -179.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -76.31 163.2 27.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.207 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.66 77.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.19 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.49 -53.17 60.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -59.86 -47.55 85.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -51.24 70.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.247 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.73 -46.1 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -54.84 -47.27 74.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -73.07 -47.86 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.81 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.416 HG23 ' HG ' ' A' ' 130' ' ' LEU . 33.5 mm -65.42 -43.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.43 -44.69 95.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.86 -56.15 25.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.211 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.77 94.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.2 p -67.16 -30.59 70.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.164 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.72 -51.61 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 76.1 mtm -60.3 -35.42 75.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.79 -37.93 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.5 p -70.63 -20.0 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.86 -12.54 61.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.44 32.05 14.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.199 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -105.53 112.45 25.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.176 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.41 -30.67 68.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.38 -50.05 71.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.24 -25.18 62.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.99 -45.23 89.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.218 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.51 -42.13 91.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.93 -33.76 76.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.61 94.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.76 -43.47 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -56.39 -45.82 80.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.416 ' HG ' HG23 ' A' ' 108' ' ' ILE . 57.7 tp -63.06 -45.08 93.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.229 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -58.41 -43.01 88.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.178 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.53 -48.84 79.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.0 -47.16 90.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.06 -45.14 95.69 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -61.69 -41.67 97.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.346 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -69.71 -33.04 71.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.04 -46.08 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.92 -43.02 96.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.31 -35.65 79.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.76 -31.15 64.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.37 -38.93 88.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.193 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.5 -28.09 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.72 38.23 10.84 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.26 120.37 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.208 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.75 161.37 14.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 72.0 p -160.32 169.73 22.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.8 t -72.42 123.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.185 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.74 74.89 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.215 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.37 -25.67 66.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.196 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.1 p -70.45 -14.05 62.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.219 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -96.46 5.5 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.25 137.67 41.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -110.15 41.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -148.38 143.58 26.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.173 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -57.99 104.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.219 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.49 157.03 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.28 134.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.19 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.1 105.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.18 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.3 mm -104.22 124.21 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -157.95 156.86 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -78.51 -39.92 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -159.11 111.17 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.55 151.15 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -108.4 162.06 21.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.04 -32.98 60.85 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.714 1.609 . . . . 0.0 111.194 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.3 p -69.79 -19.02 63.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -94.54 -38.6 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -77.92 -16.93 57.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.212 -175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.45 -2.97 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.209 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.6 p -88.92 -18.28 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 96.0 mmm -77.95 130.49 36.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.1 129.72 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -48.66 -50.12 34.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -82.12 -3.36 54.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.191 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.5 mmt -110.19 10.35 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.182 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -119.86 122.39 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.402 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 79.2 mt -79.78 -36.04 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.22 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.85 -178.68 45.64 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.54 144.25 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 65.5 p -131.41 159.11 38.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.214 -170.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.57 -33.08 64.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.3 m -115.36 163.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -108.93 24.3 21.75 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.46 -21.86 70.9 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.35 31.43 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 111.197 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.6 m -51.99 -48.52 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.7 p -65.37 -30.31 71.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -76.51 -39.16 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.9 p -70.29 -28.12 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -67.61 -52.78 34.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.65 -46.5 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 43.7 ttp -61.65 -55.0 35.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.234 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.19 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.198 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.09 -41.51 97.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -70.93 -22.6 62.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.227 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.1 -2.17 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.23 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.64 35.37 9.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 45.9 pt -132.31 154.26 81.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.234 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.11 160.63 39.58 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.754 1.636 . . . . 0.0 111.166 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 139.33 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 57.3 t -132.64 109.43 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.02 165.41 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.193 -168.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 70.43 39.3 69.71 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.77 -35.37 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 119.53 -53.95 0.66 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -143.95 31.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.54 -25.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -70.57 -22.52 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.21 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.1 p -94.38 -25.82 16.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -94.61 -24.24 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.11 125.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -115.69 164.27 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . . . -61.01 125.37 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.74 -12.38 50.12 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -71.23 144.68 50.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.08 124.26 27.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -132.4 136.77 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.48 124.81 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 80.8 t -97.78 112.6 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -108.91 93.14 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.94 -10.56 83.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.37 -39.5 47.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 111.195 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -93.72 -25.59 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.2 39.36 8.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.7 pt -132.44 160.55 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 111.183 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.12 133.0 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 78.5 mt -113.15 121.39 65.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.89 134.7 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.512 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 87.2 m-20 54.63 61.79 8.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 -171.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 230' ' ' ASN . 50.8 Cg_exo -58.43 145.85 92.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.736 1.624 . . . . 0.0 111.173 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.94 157.74 36.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.186 169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.06 -48.46 61.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.14 -45.22 93.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.224 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.5 m -57.55 -42.6 83.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.225 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.5 -48.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.67 -35.09 74.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.85 -51.92 66.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.198 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -72.58 -26.83 61.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.19 -51.56 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 92.1 p -69.32 -34.48 74.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.2 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.26 -42.85 75.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -53.52 -49.81 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.216 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -35.83 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 72.4 m -58.52 -38.91 78.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.206 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -178.63 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 91.5 mt -79.76 81.75 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.253 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.61 134.84 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.1 -141.19 3.14 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.06 115.06 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 111.174 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.62 133.12 35.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.1 -32.5 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 44.8 t -165.39 137.05 3.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 72.5 Cg_exo -55.82 144.65 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.675 1.583 . . . . 0.0 111.198 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.94 173.14 16.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.3 mt -133.73 120.51 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 111.202 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.08 124.62 49.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.72 115.71 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.97 -157.41 14.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.59 162.75 13.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 111.18 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.02 132.53 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.183 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -121.13 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -102.13 133.0 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.151 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -134.01 114.79 13.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.3 p -105.91 172.13 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -154.42 132.21 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -109.61 157.08 19.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.176 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.27 128.43 34.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.1 t -102.09 132.44 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.183 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -62.59 129.37 40.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.76 133.31 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -74.24 104.24 4.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.212 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.26 21.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.54 -98.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.21 149.15 44.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.03 165.53 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -59.33 137.51 57.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -54.33 -38.07 65.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -68.59 -15.72 63.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.8 0.03 57.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.15 -51.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -65.43 -33.06 75.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.11 -50.03 75.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -69.82 -34.49 73.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.208 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.28 -43.78 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.51 89.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.04 -45.73 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -60.12 -51.18 70.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.06 -42.61 99.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.25 -55.26 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.46 75.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.202 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.11 -47.05 75.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.61 -40.73 88.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.31 -44.89 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -57.62 -45.04 85.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.222 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -60.53 -47.82 84.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -58.31 -47.96 82.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.57 -48.81 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.68 -44.24 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.205 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.04 -49.62 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.85 -45.9 76.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.43 -26.66 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.16 -50.85 72.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.19 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.64 -46.23 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.219 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.22 -48.77 79.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.24 93.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 62' ' ' LEU . 9.8 tt -55.64 -47.35 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.204 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.81 -34.25 34.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -79.88 -42.34 24.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.12 -33.63 4.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.56 168.64 12.62 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.36 -22.05 66.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.164 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.16 -36.85 80.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -85.23 -30.52 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.94 77.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -54.01 -36.26 62.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.206 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.09 -46.9 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -75.61 -28.05 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.211 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -59.53 -49.06 79.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.198 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -69.16 -33.1 72.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.76 -43.25 80.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.99 -40.76 98.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.55 -40.66 97.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.81 70.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.175 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.8 p -91.87 -1.02 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.3 115.95 28.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.38 -17.56 23.89 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.735 1.623 . . . . 0.0 111.228 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -71.62 -41.28 69.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.215 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.71 -38.32 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.224 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.2 -48.87 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.215 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.86 -43.48 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.64 64.15 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.66 -45.97 96.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 111.188 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.91 -38.3 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.71 -33.22 72.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.6 tpp -64.18 -43.0 96.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.204 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.0 mt -58.85 -47.86 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.16 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -73.52 -46.57 46.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -66.51 -48.4 69.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -96.2 -7.55 35.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.233 -174.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.9 64.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.161 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.86 169.0 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.24 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.9 p -76.01 162.4 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.4 81.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.02 -48.52 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.12 -45.68 80.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -47.67 85.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.201 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.48 -48.17 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.225 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.63 -41.14 85.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.203 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -68.47 -50.9 49.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.28 -44.41 91.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -61.76 -44.5 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.227 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -65.29 -42.35 93.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -59.17 -54.91 41.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -66.75 -38.83 87.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.89 93.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.0 p -65.8 -32.24 73.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.14 -51.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 96.7 mtp -57.23 -37.46 72.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -73.07 -37.96 66.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.198 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.2 p -70.21 -19.21 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.05 -11.78 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.211 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.59 32.35 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -105.89 113.01 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.198 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -59.86 -30.33 68.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.73 -50.02 70.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.32 -27.34 65.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.73 -46.55 84.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.77 -43.58 90.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.217 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -69.39 -32.4 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.238 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.9 85.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.248 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.0 t -60.02 -45.83 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.228 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.62 -43.5 84.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -45.53 93.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.95 -41.2 95.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.21 -48.1 83.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.34 -44.34 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.84 -44.44 92.13 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.98 -39.69 95.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.221 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.78 -37.01 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.219 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.99 -45.49 98.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -60.73 -41.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -47.08 77.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.222 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -71.24 -29.44 65.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.68 -40.18 88.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 172.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.07 -26.23 39.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.33 30.62 15.92 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.29 126.32 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.76 163.14 13.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.2 p -148.88 163.1 38.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -118.92 131.04 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.211 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -82.75 114.58 21.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 149' ' ' LEU . 3.6 pp -67.72 -23.11 65.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.4 p -73.12 -13.27 61.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -99.02 8.55 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.23 148.27 35.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -95.87 -21.59 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.55 156.13 30.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -76.32 129.68 36.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.07 167.7 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 93.6 t -98.58 126.53 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.4 t -86.45 113.76 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.59 117.97 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.9 147.31 30.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.217 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.53 -32.94 60.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -126.36 94.93 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.76 109.12 17.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 71.7 p -110.16 164.01 15.83 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.173 -167.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.39 -31.2 66.91 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.682 1.588 . . . . 0.0 111.216 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.9 p -69.37 -16.37 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -91.02 -31.42 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 93.7 m -59.52 -38.03 79.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.36 -29.32 63.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.222 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -109.65 37.21 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 62.4 ttp -93.85 105.19 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -91.45 99.43 12.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.181 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.57 -20.15 64.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.08 -33.75 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 39.1 mmt -92.57 -34.14 14.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.48 122.52 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.209 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.8 -26.38 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.232 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.7 178.1 48.46 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.58 152.66 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -156.88 152.72 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.3 t -159.69 -176.21 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.235 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -120.48 -43.93 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 p -172.73 138.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 174.5 176.77 43.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.27 14.05 65.6 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.33 27.51 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.152 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.2 m -68.74 -46.19 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 96.4 p -64.56 -31.64 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.18 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -64.96 -46.01 83.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 99.1 m -52.54 -45.01 66.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.27 -42.84 99.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.206 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.49 -44.06 95.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.225 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.5 mtp -55.54 -48.3 74.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.39 81.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.69 -33.92 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.234 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.7 p -68.43 -19.99 64.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.2 mt -107.6 1.47 23.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 57.22 47.04 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.206 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.5 pt -127.37 156.89 74.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.46 154.37 31.46 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.673 1.582 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.33 144.79 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.205 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.9 117.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.227 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.8 163.4 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.68 55.95 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.65 -48.87 12.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.24 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.99 -11.9 58.94 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -132.57 -14.51 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -170.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.5 -28.67 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -160.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.0 p -80.31 -11.3 59.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.215 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.6 p -105.61 -30.23 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.222 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -81.11 -34.69 32.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.64 120.42 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.244 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.41 152.02 32.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.22 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 126.65 27.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.82 -16.85 46.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.1 175.25 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 111.191 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -99.23 139.39 34.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 170.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.32 134.7 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.178 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.87 127.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.246 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -105.33 94.5 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.182 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -84.6 82.03 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.187 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.35 73.96 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.39 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -78.18 -40.22 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.28 32.66 5.15 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -131.61 156.19 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.212 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 97.6 t -121.32 135.36 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.54 127.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.38 117.3 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.13 62.48 8.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.55 147.0 63.26 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.731 1.62 . . . . 0.0 111.216 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.91 162.7 28.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 173.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.68 -46.12 58.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -62.32 -43.87 97.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.2 m -59.66 -43.18 94.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.242 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.06 -46.29 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -64.61 -35.24 80.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.63 -46.29 90.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.196 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -73.62 -28.75 61.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -62.61 -45.6 92.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.77 -32.34 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.66 -42.42 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.14 -39.63 87.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.83 -43.31 99.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.2 p -71.06 -27.73 63.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 172.627 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.417 ' HE3' ' HB ' ' A' ' 228' ' ' ILE . 99.6 mtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.48 109.34 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -103.85 138.27 40.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.86 -139.43 2.84 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.88 121.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.363 . . . . 0.0 111.191 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.53 87.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.33 -33.01 72.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.186 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -148.56 135.64 10.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 164.31 31.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.659 1.573 . . . . 0.0 111.177 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.89 -168.02 15.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 tt -158.73 144.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 111.239 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.76 154.95 33.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 219' ' ' ILE . 81.9 mt -122.91 128.16 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.26 -177.06 29.07 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.53 150.6 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 111.204 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.28 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -111.0 120.38 42.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.2 tp -93.44 109.22 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.197 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -64.11 108.24 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -91.44 117.12 29.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.211 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -120.85 108.71 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 139.37 54.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.65 160.07 29.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.55 119.3 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.5 m -119.33 118.02 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 101' ' ' ASP . 97.0 mt -71.4 125.65 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.204 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -78.93 114.64 18.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.65 22.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.57 136.35 52.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.226 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.5 128.98 39.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -102.9 127.25 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -57.98 136.81 57.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.2 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.58 -44.59 26.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.8 p -68.5 -20.82 64.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.18 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.04 2.33 43.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.96 -38.16 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.48 -21.94 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -68.44 -35.42 77.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 171.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.89 -35.45 80.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.56 -46.01 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.91 87.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.239 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.35 -47.34 81.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.98 -49.96 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -59.4 -42.03 90.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.25 -37.68 52.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.47 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.71 -42.3 82.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -50.87 -50.48 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.99 -44.74 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.7 m -52.86 -50.09 64.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.73 -42.9 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.5 -46.11 89.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.2 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -60.96 -42.38 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -61.03 -40.96 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.25 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.51 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -57.19 -47.39 81.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.5 -51.35 67.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.211 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.17 -31.55 70.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.46 93.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.4 tt -63.17 -46.96 84.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.67 -39.22 93.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.221 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -83.32 -34.13 25.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.185 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.12 -58.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.18 -168.26 23.45 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -60.81 -27.5 68.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -43.79 -44.34 6.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.22 -34.35 11.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.205 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.49 -39.11 93.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -176.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.03 -32.7 74.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.22 -43.93 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.168 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -76.81 -19.83 57.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -63.36 -49.1 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.98 81.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.195 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -56.19 -47.24 78.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.214 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -64.33 -44.74 90.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.8 ttp -49.72 -48.4 49.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.171 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.75 -38.61 91.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.0 66.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.5 p -94.56 4.54 53.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -62.55 116.54 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.0 -33.61 73.66 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.733 1.622 . . . . 0.0 111.16 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.39 -35.95 78.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.2 tp -67.55 -46.53 72.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.5 -58.25 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.52 -35.12 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.19 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.59 -48.5 84.19 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.5 t -68.84 -43.88 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.24 -42.7 91.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.265 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -68.89 -36.72 78.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.99 -43.55 98.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.76 -50.78 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.9 -40.86 87.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.5 m -67.07 -47.61 70.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -91.62 -15.89 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.8 mt 64.98 43.75 3.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.223 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.64 -177.59 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -72.1 156.62 38.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.217 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.1 76.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.424 ' HB3' HG23 ' A' ' 26' ' ' ILE . 94.3 m-20 -58.95 -50.49 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.233 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -65.01 -41.31 95.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.95 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -45.36 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.242 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -56.49 -46.81 80.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -68.19 -50.05 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.71 -45.07 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.2 mm -60.0 -43.65 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -64.42 -43.35 94.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.214 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.03 -45.9 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -57.89 -47.62 82.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -50.3 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 93.0 mtp -58.26 -38.56 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.186 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -72.09 -38.58 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.194 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 p -70.01 -20.08 63.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.197 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.38 -15.41 63.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.211 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 62.54 32.31 16.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.248 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -100.33 109.84 22.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -42.4 -44.79 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -62.24 -54.64 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.241 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.46 -31.71 71.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.184 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -46.79 86.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.8 -43.81 94.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.206 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -68.74 -31.38 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.48 87.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -61.48 -44.21 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.196 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.57 -41.99 91.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.247 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.63 -41.66 97.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -58.99 -38.64 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.27 -41.36 89.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -54.55 -46.03 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.04 93.49 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.05 -42.43 99.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.18 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -62.56 -40.59 97.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.206 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.53 -48.06 86.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -60.73 -39.89 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.211 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -56.07 -46.71 78.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -71.38 -29.37 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.4 mt -66.45 -37.23 84.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.246 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.24 -32.18 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.27 31.75 7.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 81.9 t -72.01 123.52 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.19 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -122.49 163.22 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -152.31 165.83 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.1 t -69.88 130.25 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -76.49 108.79 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.56 -3.39 58.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.208 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 84.6 p -90.78 0.18 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -94.82 5.49 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.16 78.25 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -68.76 -30.94 69.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -87.91 151.85 22.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.55 113.08 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.09 170.4 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.44 134.24 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.87 113.27 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.65 116.05 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.235 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -147.57 156.65 43.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -171.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -97.8 -20.97 17.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.212 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -161.7 110.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.19 96.91 8.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.231 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 46.5 p -80.99 165.38 45.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.222 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 93.9 Cg_exo -50.25 -37.44 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.736 1.624 . . . . 0.0 111.166 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.2 p -76.22 -30.41 57.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.65 -35.07 72.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.7 p -80.79 -29.62 36.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.93 86.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.183 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.8 p -95.95 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 58.5 ttp -136.39 133.02 36.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -77.35 89.37 3.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.231 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -54.99 -35.0 63.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.246 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -47.89 -38.56 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.215 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -109.53 31.4 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.201 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 92.0 t -106.72 124.21 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.197 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.9 mt -100.84 -10.78 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.59 170.73 38.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -121.79 141.61 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -143.38 108.84 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.185 169.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 67.9 p -118.82 154.73 32.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.86 -42.11 95.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.1 m -108.07 157.16 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.194 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.76 3.86 45.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.81 73.11 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -108.4 22.8 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.328 . . . . 0.0 111.182 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.6 m -49.14 -45.89 44.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.0 m -58.82 -44.09 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.18 -49.9 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 80.7 p -72.28 -30.7 65.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.74 72.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.22 -49.07 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.8 mtm -64.79 -46.16 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.45 83.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.185 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -59.63 -45.88 90.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 85.7 p -77.89 -23.62 48.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.227 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.81 -16.02 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 60.81 50.09 5.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.243 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.44 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 42.1 pt -128.64 159.84 65.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.186 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 71.8 Cg_endo -72.36 150.27 52.18 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.658 1.572 . . . . 0.0 111.198 177.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.12 126.16 12.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.229 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.17 123.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.67 159.34 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.78 39.98 32.49 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.09 -14.01 58.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.91 -59.82 1.45 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -152.06 45.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.84 -23.55 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.193 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.0 p -75.38 -15.51 60.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.5 p -97.47 -27.22 14.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.2 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.41 -23.46 20.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.15 122.96 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.236 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.86 159.85 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.11 26.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.79 -16.68 36.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.09 163.82 27.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.0 129.59 44.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.186 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.92 136.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.204 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 13' ' ' ILE . 74.7 mt -122.95 126.03 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 175.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.6 t -107.97 112.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -98.54 91.1 4.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.18 -33.73 69.35 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 67.2 tp -57.74 -49.79 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 111.213 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.59 -26.38 30.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.82 10.68 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.2 pt -133.71 149.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.94 135.95 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.417 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 7.9 tp -115.4 140.46 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.39 138.24 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.178 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 89.0 m-20 56.05 52.3 7.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -173.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.3 Cg_endo -71.76 155.28 58.63 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.665 1.576 . . . . 0.0 111.235 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -88.09 -177.88 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.04 -54.37 45.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.238 -172.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.79 -46.56 88.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.243 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.6 m -56.23 -45.55 79.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.62 -45.54 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.59 -35.6 77.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.04 -45.75 90.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -76.15 -26.06 55.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.189 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.181 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 75.3 m -59.16 -41.48 88.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.17 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.55 -49.97 75.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.221 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.64 -40.27 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 73.4 m -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.245 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 177.464 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.845 0.355 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.9 mt -98.08 122.43 41.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.06 136.8 47.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -140.67 2.93 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.36 113.71 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 111.168 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.31 87.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.72 76.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.194 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.9 t -148.33 135.77 10.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.19 162.01 31.78 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.699 1.599 . . . . 0.0 111.239 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 177.59 14.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.94 130.41 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 111.176 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.02 140.11 36.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.65 124.91 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.72 -156.02 7.85 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.24 179.27 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.22 131.2 41.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -121.56 97.66 5.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.84 118.23 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 -170.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -98.72 111.26 23.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 p -104.33 167.82 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.165 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.94 132.19 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.197 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.41 132.68 54.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.191 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.19 131.43 50.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t -83.58 99.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.6 m -97.67 114.11 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -96.24 126.4 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -80.44 115.78 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.65 23.54 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.219 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -83.19 157.57 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -84.3 160.14 20.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.2 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.7 pt -122.64 165.03 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.54 146.26 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -51.27 -39.29 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -69.88 -16.31 63.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.25 -0.13 53.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -58.61 -46.79 90.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.209 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.93 -32.14 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.211 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.55 -42.47 87.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.192 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.81 -37.58 76.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 84.5 mt -63.63 -43.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.47 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.18 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -64.27 -37.92 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.83 -48.48 81.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.99 -35.62 81.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.93 -42.13 99.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.89 85.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.173 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.38 -41.6 97.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.75 -38.33 90.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.15 -46.54 95.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.2 p -68.93 -29.89 68.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.216 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -60.03 -51.26 70.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.218 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -49.93 75.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.18 -55.1 39.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.36 -41.77 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.12 -51.33 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.5 -38.18 83.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.191 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.8 mt -64.55 -41.85 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.02 -49.35 60.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -54.7 -52.94 60.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -60.74 -40.02 90.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.46 99.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.3 tt -57.41 -47.21 82.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.183 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.23 -28.88 57.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.225 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.23 -44.02 9.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.208 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.17 -32.76 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -168.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.89 164.34 11.48 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.9 -34.97 66.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -45.88 -44.51 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -76.56 -34.7 58.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.79 81.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.239 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.51 -35.87 82.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.93 -42.54 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -76.91 -24.25 52.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.209 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -64.59 -41.01 96.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.18 98.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.46 -40.74 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.211 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.97 -43.68 87.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -64.86 -36.81 85.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.9 -44.96 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.63 78.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.2 p -104.57 20.6 18.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.234 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -72.66 114.87 34.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.98 -34.55 77.4 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.69 1.593 . . . . 0.0 111.192 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -69.11 -43.36 74.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.226 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 99.5 mt -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.86 -51.78 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.42 -30.75 69.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.216 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.97 -47.09 91.29 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.11 -43.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.201 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.78 -44.93 90.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -67.68 -34.87 77.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.206 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 tpp -63.71 -43.25 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.79 -48.02 89.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -73.97 -45.91 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.3 m -63.62 -48.83 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.91 -12.07 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.217 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.5 mt 59.05 65.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.246 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 165.61 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.201 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.4 p -66.4 154.78 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.89 97.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.241 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.89 -37.12 85.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.22 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.49 -43.86 84.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.88 94.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.37 -46.5 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.5 -47.07 76.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -69.47 -51.62 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.61 -46.92 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -68.83 -47.13 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.71 -39.77 84.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.201 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -57.19 -54.56 45.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.188 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.84 -38.2 89.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.217 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.07 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.9 p -66.98 -31.19 71.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.47 -49.16 79.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 98.7 mtp -58.5 -37.38 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -74.32 -34.52 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 p -69.98 -17.56 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.251 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.62 -11.29 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.193 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 64.49 32.79 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.14 112.99 25.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.46 -31.37 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -63.34 -51.01 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.39 -25.28 63.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.223 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.48 -47.96 81.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.19 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.84 -39.59 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.48 -33.41 75.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.227 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.89 84.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.46 -43.53 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.173 173.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.01 -48.07 73.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.85 -49.14 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 131' ' ' ARG . 39.7 ttm105 -56.89 -45.18 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.35 -42.91 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.211 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.52 -48.87 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.56 -40.45 99.15 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -59.64 -43.94 93.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.81 -37.23 76.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.219 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.49 -44.87 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.236 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.3 -44.44 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.52 -47.53 85.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.14 -33.3 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.56 77.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.54 -34.38 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.17 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.76 35.09 5.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.84 122.53 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 111.177 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -107.0 163.62 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 71.7 p -158.59 177.71 10.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.4 125.65 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -81.31 105.9 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.199 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.58 -26.78 67.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.242 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -77.53 -9.01 58.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.194 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.68 -3.34 58.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.194 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.08 120.41 16.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.213 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -122.72 30.21 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -145.9 137.61 25.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.82 98.46 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 173.29 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.211 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -89.2 127.24 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.6 125.19 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.87 112.05 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.229 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.92 143.92 43.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -170.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -89.54 -7.73 54.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 172.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -169.27 152.01 4.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.5 tp -173.61 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.8 p -99.99 161.04 25.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.215 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.1 -34.89 59.96 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.744 1.629 . . . . 0.0 111.179 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 p -67.21 -19.98 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -91.92 -34.12 14.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.1 p -63.65 -32.87 74.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.182 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.31 71.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.7 p -113.2 14.14 19.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.4 ttt -77.59 131.79 37.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -67.35 74.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -66.34 -22.42 66.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.86 -25.03 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.03 23.48 14.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.194 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.4 t -110.26 116.13 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.185 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.68 -4.68 33.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.52 169.48 38.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -150.4 132.04 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -141.59 150.17 41.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.3 p -137.0 165.47 25.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -104.87 7.92 34.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.99 153.43 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 139.28 145.42 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.97 -76.41 1.07 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.08 140.78 47.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.226 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.9 p -123.14 25.19 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -60.17 -59.27 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -60.07 -38.89 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 79.8 m -58.25 -47.51 83.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.8 87.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.35 -47.89 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.21 -44.86 94.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.8 82.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.201 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -61.56 -46.48 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 78.5 p -70.58 -25.03 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -22.88 28.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.209 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 60.6 47.43 8.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.203 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.03 155.87 80.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.94 161.6 23.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.664 1.576 . . . . 0.0 111.219 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.88 132.22 8.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.15 112.62 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.224 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.77 169.83 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 -170.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.64 78.68 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.5 mt -80.35 -27.44 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.29 -62.77 4.44 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -93.21 -6.12 48.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.167 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.92 -29.13 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.9 p -79.56 -14.08 59.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.259 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.2 p -102.62 -28.8 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.215 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -92.37 -23.94 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.66 120.8 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.189 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -117.49 157.57 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.23 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.46 127.31 29.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.76 -20.05 32.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.63 163.48 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.767 0.318 . . . . 0.0 111.239 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.86 134.15 36.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.6 t -133.27 128.58 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.233 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.5 mt -113.7 127.51 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.186 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.1 t -106.52 118.89 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.172 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -116.4 96.98 5.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.63 -23.7 66.78 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.66 -38.23 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 111.176 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.36 -27.64 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.187 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.45 36.45 14.32 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.68 157.68 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 111.185 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.59 134.84 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.199 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 mm -103.23 128.85 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 72.4 t -105.2 120.9 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 54.97 58.4 11.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.93 156.17 63.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.748 1.632 . . . . 0.0 111.232 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -86.47 -178.23 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.99 -42.67 99.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -64.06 -44.18 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.6 m -61.6 -44.22 97.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.99 -44.97 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.234 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.89 -35.7 80.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.221 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.02 -50.57 72.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.185 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -72.37 -27.21 62.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -59.56 -45.48 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.198 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.7 p -69.36 -31.45 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.18 -42.96 83.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.86 -44.95 86.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.85 -50.61 73.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.0 p -67.7 -26.57 66.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.228 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.233 174.432 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.759 0.314 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -97.14 99.36 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -87.37 131.31 34.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.31 -150.82 5.45 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.6 119.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.83 87.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.74 -31.84 65.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -148.28 133.98 9.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.6 163.44 31.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.735 1.623 . . . . 0.0 111.171 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.4 179.66 15.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -130.67 121.36 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 111.208 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.01 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.225 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.9 mt -124.11 119.53 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.23 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.81 -161.82 13.66 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.0 157.42 16.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 111.215 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.41 95.15 4.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -105.64 105.23 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.11 140.27 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -85.29 97.94 10.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -120.83 137.89 54.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -123.09 160.18 26.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -68.67 139.46 55.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.215 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.02 115.04 29.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.27 127.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.218 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.0 m -70.66 133.67 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.35 127.26 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -79.82 113.05 17.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.84 16.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -56.96 133.6 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.207 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.44 129.74 43.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.08 125.37 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.03 145.79 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.33 -34.87 61.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.7 p -75.85 -21.69 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.233 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.61 -9.35 41.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 93' ' ' ILE . 42.6 t -54.78 -45.0 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.52 -32.93 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -67.0 -41.83 86.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.65 -36.2 78.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.21 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 173.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.93 90.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.3 -45.82 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.94 -47.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.51 -36.33 83.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.48 -39.69 92.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.77 -35.08 79.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.2 -42.36 99.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.48 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.36 -44.06 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.199 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.3 m -60.21 -48.82 80.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.3 -42.19 99.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.15 -49.81 74.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.31 -45.77 92.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.66 -44.22 93.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.49 -45.76 78.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.36 -41.57 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.86 -40.77 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.195 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -50.58 -47.33 58.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.195 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.68 -49.14 68.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.01 -42.06 98.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.07 85.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.4 tt -62.45 -46.08 90.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.49 -29.96 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.197 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -82.38 -53.83 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -117.36 -34.49 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.38 -168.46 16.51 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.56 -19.0 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.776 0.322 . . . . 0.0 111.208 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -55.92 -52.91 62.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -77.9 -28.99 49.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.211 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.64 76.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.211 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.75 -34.84 79.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.49 -47.2 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -76.38 -26.61 55.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.189 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.0 -45.39 90.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.73 97.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -60.19 -41.36 92.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.172 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.2 tp -64.72 -43.96 91.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.4 mtp -57.2 -45.85 83.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.216 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.77 -40.75 98.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.232 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.75 66.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.234 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 -2.64 37.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.74 113.79 14.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.04 -33.37 83.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.658 1.572 . . . . 0.0 111.199 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -67.67 -44.44 77.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.04 -37.29 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.96 -52.52 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.208 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.27 -35.05 78.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.81 -47.6 87.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.5 -45.29 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 111.17 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -62.09 -38.76 90.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -67.01 -37.88 84.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.151 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.4 tpp -63.01 -42.46 99.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.404 HG22 HG13 ' A' ' 36' ' ' VAL . 96.1 mt -57.25 -48.01 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.49 -43.21 57.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.211 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 m -62.28 -50.33 72.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -172.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.27 -11.35 32.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.0 mt 59.0 63.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.49 158.95 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.22 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.3 t -66.18 150.0 49.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.04 -31.87 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.234 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -54.73 -43.7 72.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -84.82 -31.67 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.91 -45.41 93.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.17 -46.31 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.19 -48.21 71.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.28 -49.41 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 -174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.9 -45.1 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.443 HG23 ' HG ' ' A' ' 130' ' ' LEU . 31.1 mm -64.57 -46.34 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -69.1 -38.28 78.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.73 -54.34 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.82 -31.33 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.72 98.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.5 p -69.42 -29.33 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.19 -48.98 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 66.4 mtt -51.91 -42.65 62.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.234 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.22 -40.46 82.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.0 p -69.34 -19.98 63.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.98 -8.69 57.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 62.62 33.9 15.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -110.73 112.76 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.84 -31.0 69.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.198 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.2 -49.94 75.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.53 -25.69 62.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.195 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.17 -40.49 97.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -67.17 -35.69 80.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 17.2 mmp_? -69.57 -31.6 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.3 96.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.181 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.33 -46.55 96.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.221 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -57.29 -44.0 83.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 108' ' ' ILE . 56.3 tp -62.44 -46.05 90.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 -58.36 -45.28 88.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.12 -42.44 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.205 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.38 -49.69 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.79 98.5 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -60.2 -44.09 95.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 111.183 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -70.0 -36.14 74.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.0 mt -57.56 -46.23 86.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.37 -42.61 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.71 -40.11 91.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.186 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.47 -30.33 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.76 -38.78 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.2 -26.0 36.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.198 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.05 27.31 23.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.51 125.97 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.77 161.74 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -144.96 175.87 9.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.18 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.75 124.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.44 72.51 7.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -21.01 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -67.42 -18.01 64.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.2 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -105.47 20.11 19.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 156' ' ' VAL . 60.3 tp -63.62 130.92 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.28 22.22 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -137.73 140.52 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.54 97.83 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.19 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.407 HG22 HD21 ' A' ' 152' ' ' LEU . 34.8 m -137.72 -168.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.69 132.34 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.8 t -96.41 125.13 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 98.7 mt -122.42 132.08 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.71 170.06 22.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.207 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.401 ' HD2' ' HB2' ' A' ' 182' ' ' ASP . 29.8 tpt180 -66.34 -46.24 77.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.202 175.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.71 173.38 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.202 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.68 84.51 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 51.5 p -78.22 165.25 51.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.174 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 95.3 Cg_exo -50.03 -36.68 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.7 1.6 . . . . 0.0 111.209 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 93.7 p -73.27 -31.06 63.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -45.85 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.6 p -68.74 -27.31 65.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.176 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.56 -1.39 37.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 74.2 p -113.96 5.05 16.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.0 mtp -78.16 126.89 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -67.06 106.48 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.238 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.5 -48.81 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.204 -166.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.21 8.5 44.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 -164.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -123.84 16.81 9.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.4 112.45 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.5 mt -91.03 -13.45 33.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.6 178.41 41.96 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -165.15 162.48 20.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 111.21 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -150.2 144.65 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.244 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.6 p -127.85 154.78 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.227 -170.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.401 ' HB2' ' HD2' ' A' ' 161' ' ' ARG . 99.5 m-20 -63.86 -55.35 23.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.186 172.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.46 129.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 59.1 4.51 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.88 73.89 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -118.0 62.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.3 m -63.18 -40.1 96.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.1 m -52.8 -53.41 48.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -72.73 -33.1 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.258 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -58.42 -48.94 79.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.0 mt -58.31 -46.05 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 tpp -64.3 -46.83 81.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.27 91.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.167 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.1 -36.64 69.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 82.8 p -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -98.59 -14.97 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 60.95 51.03 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.183 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 44.2 pt -125.45 153.21 72.4 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.219 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.55 148.74 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.663 1.576 . . . . 0.0 111.205 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -148.2 122.09 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.44 120.33 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.177 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.86 160.81 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.01 38.75 29.5 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.18 -5.57 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.79 -62.97 4.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -151.94 45.06 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.2 -174.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.9 -23.26 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.7 p -70.66 -17.92 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.8 p -101.01 -27.85 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.189 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -83.18 -17.89 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.79 134.36 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -109.05 149.75 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.89 126.21 26.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.06 -14.99 44.26 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.58 166.21 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 111.195 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.27 133.41 36.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.245 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.94 126.31 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.35 114.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.251 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.67 91.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -85.94 78.91 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.186 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.01 -24.44 73.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 64.1 tp -58.2 -48.31 80.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.186 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -91.79 -17.89 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.12 36.53 14.72 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -132.28 155.16 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 96.1 t -121.64 133.94 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 175.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.7 127.43 66.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.9 122.85 62.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 94.0 m-20 55.71 55.52 9.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.7 Cg_endo -69.64 155.33 66.64 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.7 1.6 . . . . 0.0 111.219 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.39 161.61 29.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.174 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.91 -50.46 63.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -57.72 -46.88 83.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.219 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 99.9 m -54.19 -45.39 72.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.92 -47.55 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.87 -32.37 73.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.209 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -64.47 -41.35 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.43 -28.23 64.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.85 -43.07 99.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 78.6 p -71.03 -30.96 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -68.56 -39.98 80.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.192 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -59.84 -41.57 91.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.51 -49.19 77.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.1 p -67.06 -28.91 68.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.212 172.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.6 mt -91.61 120.18 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.3 129.62 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.17 -150.91 5.31 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.4 t -105.21 124.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 111.177 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.56 87.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.57 96.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.218 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.4 p -149.09 148.84 28.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.64 161.81 24.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.699 1.599 . . . . 0.0 111.236 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.64 177.13 14.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -133.92 117.03 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 219' ' ' ILE . . . -97.81 113.31 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.92 111.56 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.71 -156.75 13.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.5 150.83 22.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 111.224 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 120.72 31.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -119.82 100.42 7.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.3 tp -78.25 113.79 16.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.66 106.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.3 m -92.77 133.66 35.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.58 127.55 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.163 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -67.19 146.35 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.73 125.82 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.49 82.04 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.6 m -85.42 112.22 20.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.201 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -81.57 122.1 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -80.2 109.01 14.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.7 24.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.196 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.12 173.55 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.2 164.83 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 pt -123.24 165.26 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -72.92 142.96 47.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.19 -43.1 66.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.2 p -69.28 -17.88 63.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.31 4.72 46.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.2 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.43 -46.78 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.24 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.74 -36.31 82.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -67.85 -40.38 83.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.171 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.33 -37.89 74.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.217 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.24 -42.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.91 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.211 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.95 -42.86 94.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.214 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.27 -48.3 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.39 -36.91 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.91 -39.37 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.218 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.61 81.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.212 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.68 -40.53 97.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.54 -45.27 94.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.5 t -67.44 -42.67 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.0 m -58.0 -53.83 53.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.24 -39.38 94.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.42 -50.89 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.199 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -65.35 -39.13 91.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.229 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.44 -49.09 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.231 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -67.24 -45.94 75.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.55 -43.94 83.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.224 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.82 -39.88 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -49.24 -47.22 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.73 -51.75 59.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.227 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.42 -40.92 98.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.98 95.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.198 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.17 -44.87 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.16 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.31 -35.78 81.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.214 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -87.04 -67.77 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.09 -31.58 15.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.33 -163.24 13.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.06 -23.4 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.194 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -48.0 -41.0 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -102.04 -32.36 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.159 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -37.99 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -65.66 -33.44 75.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -58.57 -46.57 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.225 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.01 -35.56 78.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.182 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -57.12 -46.7 82.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.61 98.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -67.38 -34.42 77.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.0 -46.04 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.54 -41.97 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.209 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.26 -39.43 93.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.03 79.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.18 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -87.49 -14.85 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.63 113.77 10.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.232 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.32 -28.58 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.683 1.589 . . . . 0.0 111.209 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -63.56 -28.62 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.252 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.55 -35.87 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -53.43 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.31 -35.39 80.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.94 94.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.8 -45.61 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.64 -36.19 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.202 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -65.16 -42.08 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.06 -47.0 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.67 -43.98 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -67.28 -47.27 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -97.4 -8.07 30.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.41 63.71 1.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.48 165.92 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.2 p -65.91 159.53 25.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.41 78.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.215 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -55.39 -51.22 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.201 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.39 -43.68 89.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.68 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.65 -46.28 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.19 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.89 -55.1 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.21 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.75 -52.28 63.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.49 -50.03 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -172.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.9 mt -71.62 -42.95 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.247 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -57.69 -41.58 81.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.83 -52.95 63.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.35 -37.04 81.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.8 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.8 p -68.59 -29.64 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.178 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.68 -49.98 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 60.1 mtt -53.58 -40.77 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.81 -41.12 83.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 73.2 p -69.69 -21.25 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.4 mt -73.65 -13.06 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.94 32.19 17.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -103.83 108.98 20.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.54 -33.45 74.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -169.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.28 -49.28 77.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.236 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.45 -26.08 63.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -42.47 97.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.68 -41.75 91.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.219 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -67.25 -32.91 74.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.01 88.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.217 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.73 -43.05 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.84 -41.35 86.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.07 -43.17 95.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -59.99 -42.32 93.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.95 -46.51 81.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.41 -46.12 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.74 -46.32 93.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.11 -41.77 97.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 111.235 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -62.86 -41.62 99.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.44 -46.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.62 -41.78 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.67 -39.82 85.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -72.66 -31.05 64.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.192 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.06 -38.32 82.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.247 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.43 -33.17 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.56 8.84 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.61 119.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.186 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.81 161.94 13.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.3 p -153.92 165.13 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.73 123.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.213 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -93.54 94.67 8.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.03 -3.25 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.22 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.3 p -74.56 -13.17 60.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -110.93 23.66 13.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.17 132.61 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -101.18 -6.25 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.85 156.87 43.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.16 121.24 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -138.12 170.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.0 t -94.76 133.36 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.44 121.17 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 79.3 mt -122.21 135.34 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.45 24.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.55 -45.58 30.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -168.71 147.21 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.8 mt -135.9 148.89 48.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.6 p -84.26 163.39 47.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.66 -29.63 33.82 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.703 1.602 . . . . 0.0 111.165 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.9 p -84.73 -25.31 28.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -83.5 -34.14 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.6 p -67.01 -18.15 65.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 1.5 56.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.5 p -101.94 36.39 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 77.0 mtm -122.42 143.62 49.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.187 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -81.64 93.77 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.202 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -47.33 -46.69 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.212 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.12 -26.64 68.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.93 27.57 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.2 t -105.83 118.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.23 -29.6 24.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.18 174.82 43.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -122.8 154.49 38.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 0.0 111.226 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -151.51 144.82 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 168.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 -171.43 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -152.1 -0.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.31 152.69 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.72 171.89 26.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 166.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 -6.22 87.91 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -75.24 -1.36 23.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.9 p -66.57 -21.6 66.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 98.8 p -101.48 -35.06 9.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.254 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.06 -47.12 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 53.6 m -49.8 -44.16 48.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.232 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -58.17 -45.45 87.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.7 mt -62.59 -49.28 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.239 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mmm -63.75 -50.04 70.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.63 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.81 -30.84 68.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 81.0 p -79.54 -24.85 41.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.56 -5.36 58.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.207 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 60.32 41.76 15.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 35.7 pt -129.59 155.62 79.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 156.05 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.756 1.637 . . . . 0.0 111.187 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.54 142.55 12.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.78 129.32 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.201 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.56 153.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.229 -173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 73.49 40.75 46.72 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 227' ' ' VAL . 91.3 mt -69.66 -24.43 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.235 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 121.26 -54.7 0.67 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -161.31 27.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 -175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.9 p -51.37 -33.56 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -74.34 -21.12 59.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.0 p -90.33 -20.94 22.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -103.36 23.2 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.19 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.95 149.81 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -139.18 142.06 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.204 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 122.85 12.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 114.01 -19.3 18.17 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.29 -179.26 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.21 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.87 153.46 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.43 141.99 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 89.0 mt -119.72 120.41 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 170.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.92 97.29 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -83.37 80.81 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.79 -33.1 86.34 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 68.7 tp -56.41 -49.21 75.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -80.01 -40.73 27.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 102.06 28.47 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.88 158.57 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 111.218 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 205' ' ' LEU . 99.5 t -133.85 134.69 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.06 127.44 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 130.8 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.37 56.97 9.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.66 153.15 64.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.74 1.627 . . . . 0.0 111.177 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -88.42 -178.48 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.2 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.55 -54.41 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -59.23 -48.37 81.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.4 m -54.14 -46.8 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.216 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 67.6 t -61.13 -46.59 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -68.73 -33.46 73.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.168 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.59 -42.93 99.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.247 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -68.14 -31.83 71.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.47 -44.68 96.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.72 -31.97 69.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.204 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.96 -42.29 76.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -61.88 -37.76 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.183 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.32 -49.77 75.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.7 p -67.94 -28.58 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 64.8 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 172.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.1 mt -74.95 79.84 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.65 130.01 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.28 -153.17 5.8 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.6 136.44 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 111.218 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.7 76.22 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.184 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.82 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 t -149.94 128.67 6.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.232 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 155.38 33.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.636 1.557 . . . . 0.0 111.195 -175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 170.78 12.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.2 mm -113.18 130.36 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.184 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 220' ' ' VAL . . . -126.42 112.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.55 111.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.23 -162.06 18.02 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.27 163.64 15.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.346 . . . . 0.0 111.236 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.44 109.49 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.58 137.56 52.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 168.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.64 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.207 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -88.1 97.56 11.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.208 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -118.1 135.35 54.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -140.79 159.3 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.173 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -58.93 135.17 57.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.55 130.56 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.179 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.15 109.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.4 p -124.15 152.27 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.85 127.48 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.218 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -81.49 105.14 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.91 14.0 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 -171.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 150.08 25.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.73 158.48 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.55 167.27 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 144.81 55.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -52.38 -37.12 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.1 p -69.52 -15.46 63.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.192 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -94.7 0.01 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.47 -50.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.66 -32.0 73.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.219 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.88 -50.73 72.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.15 -34.28 72.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.188 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.14 -43.61 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.212 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.77 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.93 -44.93 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.52 -48.94 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.182 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.45 -36.2 82.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -66.94 -40.09 87.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.209 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.66 80.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.95 -42.5 99.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.56 -50.99 70.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.16 -43.09 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.209 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.5 m -58.0 -53.1 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -64.0 -39.06 93.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.53 -46.72 88.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.88 -39.8 91.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.73 -39.93 87.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.213 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -56.47 -46.95 80.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.27 -40.36 97.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.75 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -52.36 -49.91 63.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.238 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -57.83 -51.56 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.253 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.66 -42.43 92.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.183 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.05 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.4 tt -56.48 -47.32 79.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.85 -32.31 52.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.229 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -84.79 -47.88 9.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.6 -34.55 5.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.52 161.15 9.86 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.32 -37.97 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.189 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.64 -46.34 63.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -65.8 -37.83 87.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.71 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.69 -34.29 77.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.6 mt -59.27 -44.71 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.48 -30.4 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -58.11 -42.36 85.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.7 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -58.13 -41.91 84.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 77' ' ' LEU . 9.3 tt -59.65 -48.93 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -63.62 -34.95 78.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.4 -39.21 91.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.202 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.26 80.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.7 p -85.0 -9.05 58.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.208 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -63.47 115.45 18.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.207 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.52 -31.26 68.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 0.0 111.207 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.82 -33.2 75.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -81.21 -44.29 18.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.224 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -53.53 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -65.93 -34.76 78.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.99 -46.37 93.81 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.52 -45.47 88.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -64.57 -39.07 93.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.208 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -67.64 -34.34 76.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -64.64 -41.79 95.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.52 -47.37 91.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.59 -46.75 36.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.9 m -64.23 -47.53 79.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -172.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.68 -9.53 34.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.1 mt 57.82 63.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.04 -179.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.172 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.4 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 70.4 p -81.11 164.15 22.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.227 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.04 90.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.4 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 35.6 p-10 -68.6 -36.7 79.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.2 -174.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -64.28 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.84 95.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.19 -49.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.227 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -60.89 -43.49 98.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -66.91 -50.39 62.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.199 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.93 -46.28 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.229 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.22 -44.86 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -64.1 -39.38 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -60.39 -52.94 63.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.99 -37.5 87.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.55 96.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.198 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.6 p -65.85 -30.56 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.193 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.35 -51.56 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.212 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 67.1 mtt -54.71 -40.27 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -68.47 -41.56 79.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.4 p -69.96 -22.11 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.17 -13.42 60.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.16 32.97 19.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -103.74 106.67 17.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.193 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.65 -32.84 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -169.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -60.88 -50.16 74.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.14 -30.4 69.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.55 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.89 -41.96 97.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.96 -34.2 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.95 -41.4 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -56.41 -44.37 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.21 -37.58 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.225 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -61.39 -41.74 97.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.5 -41.89 96.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.13 -44.7 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.19 97.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -55.81 -47.91 76.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -61.0 -45.52 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.212 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.75 -48.73 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.67 -43.59 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.32 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.39 -32.84 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.23 -39.35 86.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.21 -36.94 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.22 27.3 10.18 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.41 125.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -109.88 156.22 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.246 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.0 p -143.32 174.59 10.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.35 106.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -83.8 115.75 22.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.72 -16.07 59.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.9 p -69.43 -13.37 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -88.85 -3.68 58.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.212 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.94 149.48 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.241 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.75 28.55 7.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -150.09 141.42 23.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.222 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.54 113.5 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.12 172.59 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.204 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.04 134.13 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.8 t -113.76 129.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.155 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.7 mt -123.42 136.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -162.02 149.66 14.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -50.05 -49.96 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.177 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.56 153.08 31.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -133.58 141.82 47.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.8 p -116.6 163.89 20.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.61 -35.31 67.07 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.729 1.62 . . . . 0.0 111.192 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.7 p -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -87.76 -30.3 20.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.185 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.425 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 69.7 p -78.9 -11.18 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.78 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.5 p -106.91 21.86 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 168' ' ' THR . 60.9 mtt -100.32 150.59 22.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -117.64 107.45 14.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -62.01 -26.42 68.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.98 -22.42 66.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -105.6 5.56 31.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.51 119.38 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.64 -17.38 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.71 173.55 29.43 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.25 165.99 33.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.246 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.31 152.08 36.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.215 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 38.6 p -126.25 161.86 26.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -172.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -76.47 -41.37 47.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.84 167.55 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 -171.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -113.09 15.02 23.44 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -67.67 -16.0 67.23 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -124.62 37.97 4.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -54.98 -40.55 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.232 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.6 p -63.88 -32.57 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.8 -35.22 62.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -70.43 -27.24 64.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.51 76.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.38 -46.28 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 28.4 ttt -60.89 -52.87 63.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.234 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -64.37 -56.56 13.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.2 m -63.42 -42.19 98.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.187 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.65 -17.63 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 63.4 51.79 2.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.169 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.26 157.15 76.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 158.25 56.59 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.73 1.62 . . . . 0.0 111.161 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -154.28 135.55 14.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.09 123.16 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 157.58 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.47 17.7 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.45 -3.02 58.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.233 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.35 -65.43 3.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.36 42.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 111.186 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -24.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.4 p -68.21 -21.59 64.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.2 p -97.08 -25.36 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -85.24 -23.05 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.209 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.92 128.43 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.89 150.97 26.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.45 129.11 40.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.46 -19.06 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.97 159.85 32.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.28 133.29 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.37 132.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.2 117.05 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 171.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 12' ' ' ALA . 67.3 t -104.78 115.27 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.99 98.69 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.7 -39.32 86.22 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.1 -46.76 87.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.771 0.32 . . . . 0.0 111.194 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -73.97 -35.86 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 173.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.36 7.28 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.5 pt -132.67 154.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.218 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.76 134.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.83 130.54 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.11 136.81 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.261 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 90.3 m-20 59.11 51.43 3.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 98.6 Cg_endo -72.25 155.77 55.82 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.683 1.589 . . . . 0.0 111.219 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -91.39 -177.83 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.65 -50.79 72.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.63 -48.78 78.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.6 m -54.41 -46.71 73.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 57.9 t -59.11 -45.02 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -69.26 -34.12 74.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -50.15 73.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.41 -26.88 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.12 -43.66 95.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 80.5 p -72.13 -29.55 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.93 -36.59 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -53.39 -52.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.33 -39.16 93.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.8 m -61.03 -38.77 87.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 178.823 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.63 148.7 24.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.82 134.32 38.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.74 -149.39 5.07 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -97.02 122.7 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.72 88.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.183 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.93 -38.78 76.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.191 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -148.49 141.41 15.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.212 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.07 165.11 24.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.728 1.619 . . . . 0.0 111.203 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.4 -178.51 16.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -131.11 132.04 63.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.64 127.03 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.405 HG12 HG12 ' A' ' 219' ' ' ILE . 69.5 mt -127.87 122.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.57 -147.19 10.01 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.43 149.63 25.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 111.207 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.26 127.49 53.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.66 140.74 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.199 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 tp -106.7 122.93 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.194 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -97.27 90.21 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.1 m -116.5 129.1 56.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -100.8 152.18 20.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.87 127.29 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.176 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -78.8 119.24 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.34 162.2 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.4 p -129.36 171.61 12.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.235 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -118.32 127.75 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.52 114.12 20.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.78 2.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.84 136.16 57.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.33 130.4 46.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.185 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.51 172.98 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.29 143.94 50.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.59 -37.5 63.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.236 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.4 p -69.03 -15.19 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.92 2.89 55.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.76 -49.97 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.15 -32.77 74.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -59.44 -48.85 80.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -68.42 -34.63 76.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.2 -45.12 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.207 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.58 95.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.22 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -58.35 -45.51 88.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.243 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.98 -50.27 74.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.5 -44.01 93.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.174 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.45 -46.64 79.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.9 79.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.9 -45.72 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.23 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.75 -44.97 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -56.95 -43.36 81.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.28 -44.26 88.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.21 -38.4 87.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.249 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -65.59 -40.45 92.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.25 -40.74 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.201 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -63.42 -39.69 95.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.63 -38.76 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.197 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.57 -41.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -55.7 -46.33 77.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.0 -53.08 62.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.21 -36.89 84.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.51 94.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.428 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.5 tt -55.55 -44.46 76.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.13 -43.66 77.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -88.87 -48.02 7.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -91.95 -48.04 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.197 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.83 162.19 10.15 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.21 -37.74 64.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.205 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -49.63 -42.53 45.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.83 -37.8 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.35 80.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.222 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.08 -33.65 76.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.68 -43.03 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.07 -20.56 55.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.41 -40.17 85.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.31 98.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.256 172.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -57.68 -41.72 82.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.48 -44.81 89.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.15 -37.06 85.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.248 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.44 -36.82 85.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.19 65.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -93.82 0.27 56.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.35 117.15 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.54 -32.05 61.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.689 1.593 . . . . 0.0 111.219 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.23 -35.75 78.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.44 -45.38 69.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.66 -56.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.64 -28.24 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.27 -50.02 71.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.4 t -69.06 -41.27 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.249 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -55.02 -49.12 72.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.191 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.03 -32.47 72.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.12 -42.3 94.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.61 -39.16 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.86 -40.35 95.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.1 m -72.13 -55.12 7.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -113.67 124.09 51.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 mp -77.04 75.03 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -126.08 167.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.4 m -58.83 138.48 57.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.81 -44.63 39.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.21 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -56.09 -41.46 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -63.12 -42.28 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.182 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.14 99.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.222 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.98 -47.66 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.54 -45.14 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.59 -48.66 76.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.22 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.11 -47.29 94.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.205 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.6 mt -65.33 -42.74 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -58.48 -43.99 89.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.31 -47.45 79.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.202 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.19 -37.8 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.85 97.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.6 p -65.95 -30.7 71.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.194 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.32 -50.21 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.212 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 68.1 mtt -56.84 -38.51 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.172 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.94 -41.52 82.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.225 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.9 p -69.24 -21.39 63.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.219 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.33 -10.98 59.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 59.67 35.22 22.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -103.69 104.95 15.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.186 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.01 -33.93 76.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -60.04 -50.33 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.65 -30.48 69.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.72 -42.63 93.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.19 -41.88 96.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -68.03 -32.14 72.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.281 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.02 97.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.95 -42.42 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.216 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.87 -38.73 82.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.28 -38.87 85.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.193 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.04 -42.36 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.79 -45.26 92.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.03 -46.58 91.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.64 -43.86 97.36 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.83 -39.76 90.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.156 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -70.04 -38.2 75.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.29 -44.68 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.214 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.34 -45.4 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -60.67 -43.0 98.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -69.48 -39.97 77.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -70.19 -44.4 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.13 -20.0 52.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.24 43.13 8.22 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.33 119.67 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 111.23 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.95 154.09 36.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 94.2 p -147.13 167.4 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.42 127.35 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -81.92 72.06 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.221 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.79 0.69 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.15 -9.88 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 170.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -107.61 23.73 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.93 132.37 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.199 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -109.43 -2.33 17.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.201 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -149.51 158.79 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.61 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.38 161.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.31 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.51 116.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.91 115.53 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.78 145.6 41.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 -170.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -67.22 -33.69 75.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.188 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -154.43 154.52 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -126.76 75.04 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -86.66 159.56 52.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.01 -40.6 67.35 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.733 1.622 . . . . 0.0 111.235 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.1 m -66.96 -39.84 87.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.5 -52.82 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.5 p -77.12 -20.41 55.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.72 67.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.159 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 66.7 p -90.83 -29.73 17.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 68.5 mtt -59.31 133.74 56.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.63 88.41 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.213 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -50.7 -43.39 57.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.64 -13.25 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.87 27.32 9.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.16 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.45 124.23 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.23 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.62 -25.94 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.41 158.9 22.52 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -108.68 148.59 30.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -155.97 150.37 25.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 t -162.27 -177.65 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.222 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.55 -27.48 8.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.231 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.27 126.09 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.201 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.0 166.33 48.42 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.78 -7.75 81.17 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -106.76 9.88 30.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.4 m -65.31 -44.77 86.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.9 p -71.63 -41.43 68.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.29 -48.01 83.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -57.96 -43.97 86.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.02 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.218 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.36 -47.64 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.6 mtm -61.56 -51.76 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.33 -46.77 87.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.241 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.35 -31.48 70.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.7 p -69.56 -18.03 63.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 199' ' ' ILE . 93.9 mt -107.08 -0.12 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 57.09 45.16 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.239 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 197' ' ' LEU . 38.9 pt -128.65 158.19 72.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.7 161.77 33.4 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.725 1.617 . . . . 0.0 111.167 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.27 136.67 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 52.1 t -134.47 126.49 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.29 152.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.183 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.43 46.39 6.92 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.47 11.4 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.252 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.32 -89.72 1.42 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -137.58 45.42 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.196 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.36 -25.78 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.5 p -72.35 -6.63 44.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -112.3 5.42 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.215 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -118.06 -5.16 10.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.37 145.2 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.72 158.25 40.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.82 117.9 4.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 102.58 2.48 50.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.1 150.62 38.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.45 123.66 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.94 142.79 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.197 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.405 HG12 HG12 ' A' ' 13' ' ' ILE . 79.3 mt -116.16 125.81 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.225 171.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.1 99.34 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -90.89 91.65 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.216 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.25 -35.36 76.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.35 -47.13 85.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.241 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.57 -36.8 65.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.65 34.71 6.47 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.3 pt -131.4 154.45 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 111.172 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.7 t -133.3 136.4 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.61 118.41 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.31 130.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.192 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.92 57.79 3.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.205 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.41 154.97 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.695 1.596 . . . . 0.0 111.256 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 159.61 33.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.156 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -53.85 -49.15 69.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.14 -47.34 83.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.204 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.0 m -51.48 -46.86 63.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.57 -48.83 82.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.99 -32.56 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.01 -46.08 90.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.201 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.68 -26.51 63.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.11 -45.35 95.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 79.3 p -71.76 -29.24 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.2 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -66.88 -42.32 85.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.34 -42.14 81.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.47 -48.03 77.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.224 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 64.4 p -69.94 -23.23 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 173.548 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -98.74 107.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.186 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -103.82 135.68 44.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.46 -138.69 2.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.19 122.59 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 0.0 111.23 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.76 87.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.54 87.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -148.97 135.85 10.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 161.68 36.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.719 1.613 . . . . 0.0 111.209 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.6 -176.18 16.32 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.41 125.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.191 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 177' ' ' LEU . . . -116.48 126.24 53.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.218 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.5 mt -123.91 117.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.68 -157.59 13.04 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.53 167.69 13.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 218' ' ' VAL . . . -99.25 144.78 27.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 175.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -141.26 111.44 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 164.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.8 tp -87.47 115.08 24.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.209 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.74 97.01 6.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -86.59 164.17 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.224 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -115.56 106.88 14.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.41 128.33 36.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.171 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.78 127.03 29.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -87.22 111.96 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -87.72 124.88 34.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.204 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.98 118.93 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.53 102.93 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.209 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -87.4 -5.25 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.91 139.25 52.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.05 158.74 32.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 pt -119.02 172.5 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -76.19 157.75 32.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.78 -32.53 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -72.57 -14.84 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -96.48 -0.34 49.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.1 -51.08 77.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.07 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.33 -51.19 71.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -71.11 -34.12 70.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.85 -43.92 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.221 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.92 -45.18 90.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.216 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.16 -47.7 84.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.08 -36.21 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -40.51 94.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.81 76.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.95 -42.6 99.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.183 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.99 -43.43 98.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.71 -40.71 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.233 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.4 m -67.04 -43.63 82.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.186 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -63.98 -42.87 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -59.0 -49.17 78.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -52.09 -58.76 5.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.34 -42.05 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.196 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.98 -45.91 82.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.202 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.41 -34.59 77.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.27 -49.26 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -68.21 -27.06 66.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.39 -51.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.242 170.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.8 -37.02 83.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.24 93.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.204 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.4 tt -60.15 -46.76 88.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.213 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.94 -34.32 77.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.148 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -87.65 -45.13 10.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.218 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.73 -36.42 3.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.47 -172.08 14.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.86 -26.29 68.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 111.207 -175.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -43.53 -45.77 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.22 -31.25 12.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.71 91.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.42 -30.99 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.183 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.41 -45.78 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.01 -27.52 57.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.58 -44.27 89.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.92 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -61.68 -38.37 87.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.18 -44.14 89.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.21 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.4 mtm -62.61 -38.02 88.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.234 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.11 -39.87 95.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.218 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.56 -23.31 66.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.254 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.1 p -98.38 -3.75 36.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -66.11 113.71 13.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.29 -32.89 82.94 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.71 1.607 . . . . 0.0 111.239 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -67.4 -43.71 80.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.97 -36.58 69.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.35 -52.29 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.49 -34.48 77.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.48 -47.06 90.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.44 -44.87 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.218 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -62.85 -39.59 94.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.66 -33.83 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.0 tpp -65.32 -41.54 93.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.29 -47.75 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.29 -46.53 49.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.235 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.2 m -65.14 -48.43 73.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 -172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.32 -9.82 34.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.8 mt 57.48 64.08 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 179.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.9 p -80.3 163.37 24.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.96 86.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.85 -50.71 72.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.17 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -67.31 -40.24 86.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.211 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.65 85.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.34 -45.8 97.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.201 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -58.48 -43.81 89.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -67.48 -49.67 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.192 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.64 -46.31 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.195 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.4 mm -65.93 -42.54 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.178 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -67.0 -38.2 85.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.201 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -65.75 -44.85 84.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.186 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -66.7 -40.45 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.194 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.08 97.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.186 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.3 m -59.24 -42.98 92.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.77 -52.91 56.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 56.9 mtt -54.74 -42.09 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -69.66 -39.53 77.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.3 p -70.39 -19.86 62.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.184 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.11 -7.14 56.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 60.44 37.45 19.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -115.05 112.54 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.06 -30.35 70.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.12 -50.3 72.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.255 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.44 -28.78 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.6 -42.96 99.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -42.03 95.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.98 -34.04 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.97 94.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.46 -41.81 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -57.07 -43.33 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.195 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -62.48 -41.19 98.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.223 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.84 -50.32 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.189 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.87 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -44.64 95.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.21 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.07 -38.03 89.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.35 -48.43 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.205 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.23 -41.24 90.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.9 -38.42 88.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.07 -28.26 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.3 mt -68.67 -48.31 64.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.1 tp -74.7 -52.46 11.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.59 35.76 0.83 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.76 127.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.234 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.13 155.47 25.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.182 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 85.1 p -156.79 169.67 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.6 128.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -86.66 106.15 17.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.4 mt -90.77 10.82 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.3 p -90.91 -7.46 52.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -106.71 27.53 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.69 137.3 51.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.0 27.99 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -169.56 138.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.18 123.14 17.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.197 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.84 144.36 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -167.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.96 121.49 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.1 t -93.66 118.3 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 -174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.401 HG22 HG22 ' A' ' 209' ' ' THR . 48.5 mm -112.13 126.79 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.219 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 148.06 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.225 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.87 -41.56 82.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.22 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -112.91 151.65 30.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.4 tp -154.24 122.24 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.8 p -112.48 161.65 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.214 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.23 -35.86 84.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.691 1.594 . . . . 0.0 111.235 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.5 p -74.6 -10.08 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.204 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.99 -40.85 12.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 171.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 -22.93 64.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.52 -9.29 58.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.6 p -111.91 -28.47 8.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.6 mtp -57.29 94.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -41.73 105.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.185 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -64.43 -22.03 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -72.15 -27.92 62.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.1 -39.66 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.25 119.0 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.417 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 94.7 mt -96.18 -15.56 22.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.99 178.4 43.89 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -158.49 137.05 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -115.71 139.24 50.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.216 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.3 m -120.43 138.36 53.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.09 -42.95 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.227 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.58 137.61 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.225 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.85 177.75 29.4 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.32 54.02 0.66 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.9 26.84 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.8 p -74.21 -30.58 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.196 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.2 p -77.24 -30.83 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -61.2 -48.78 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 172.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.2 m -55.77 -42.43 75.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.225 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.19 97.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.45 -45.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 ttp -58.11 -53.07 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.26 99.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -70.84 -33.11 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.18 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.6 m -69.96 -37.47 75.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.7 -7.44 57.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 61.33 48.98 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 47.6 pt -126.82 149.32 68.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.22 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 49.3 Cg_exo -60.76 146.41 97.4 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.744 1.629 . . . . 0.0 111.201 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.44 138.87 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.196 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 76.9 t -129.81 127.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.6 164.93 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.65 26.1 59.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 90.9 mt -78.33 -31.65 48.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.9 4.57 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -100.27 2.81 43.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 111.247 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.07 -27.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.184 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 159' ' ' ILE . 29.7 p -81.84 -6.92 59.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 96.3 p -106.07 -29.35 9.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.216 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -91.59 -24.48 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.212 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.0 t -111.88 119.14 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.227 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.6 157.75 33.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.241 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.39 128.36 35.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 108.18 -20.91 30.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -71.15 165.11 24.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.21 138.32 34.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 16' ' ' ALA . 86.1 t -127.29 131.06 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.171 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.8 mt -114.92 112.54 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.46 96.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -93.39 88.11 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.246 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.86 79.63 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.83 -38.46 88.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 111.22 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -94.07 -31.09 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.186 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.32 34.85 7.27 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 pt -131.8 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.3 t -128.42 135.09 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.237 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.46 127.47 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.186 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.23 133.66 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.404 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 95.7 m-20 50.67 56.56 17.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.211 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 70.7 Cg_endo -70.49 156.81 60.66 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.697 1.598 . . . . 0.0 111.192 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.03 161.01 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -52.46 -48.97 65.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.89 -46.43 84.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.186 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -55.65 -43.6 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 64.1 t -60.12 -46.05 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.99 -34.38 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.244 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.92 -48.26 79.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.51 -26.21 60.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.229 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.11 -46.71 86.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.9 p -69.27 -31.83 70.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 -38.56 79.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.207 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -61.05 -43.27 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.55 -40.73 95.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.22 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 75.2 m -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.221 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.208 175.065 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 87.7 mt -80.18 80.3 6.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.54 130.91 41.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.96 -150.52 5.23 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.1 114.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.5 87.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.07 73.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -151.32 141.51 14.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.07 160.75 29.96 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.699 1.6 . . . . 0.0 111.204 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.06 -177.17 18.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -134.41 122.87 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 111.216 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.88 123.48 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.31 112.75 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.73 -160.86 20.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -83.41 150.55 25.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.37 128.37 38.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.21 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -126.8 139.05 53.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.3 tp -105.85 131.92 52.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -113.09 116.79 30.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.1 p -125.46 169.7 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.243 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -150.8 136.59 18.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -58.78 136.01 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.86 137.37 58.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -86.7 113.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.3 m -120.34 117.08 26.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.35 127.21 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.211 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -80.65 107.29 13.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.22 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.24 22.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.778 ' O ' ' CB ' ' A' ' 30' ' ' LYS . 88.8 tt0 -59.51 -61.57 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.778 ' CB ' ' O ' ' A' ' 29' ' ' GLU . 87.1 tttt 124.9 140.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.201 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.427 ' C ' HD12 ' A' ' 31' ' ' ILE . 2.9 pp -121.17 166.23 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -90.93 165.9 13.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.212 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -52.23 -41.21 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.198 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.8 p -69.88 -18.17 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.92 2.5 49.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.256 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.88 -52.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.04 -32.6 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.1 -50.84 72.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.25 -33.77 72.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.196 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.64 -44.83 99.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.51 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.38 -46.67 88.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.179 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -60.0 -51.14 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.31 -39.7 80.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.63 -58.8 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.199 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.8 69.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.201 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.3 tm? -65.32 -50.46 65.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.93 -38.91 90.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.21 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.02 -41.3 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.6 m -60.49 -41.95 95.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -57.23 -49.89 74.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.81 -46.18 88.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -52.65 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.06 -40.87 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.42 -43.14 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.178 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -34.46 72.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.8 mt -63.81 -47.97 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -72.08 -27.47 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.222 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.47 -46.31 90.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.35 -40.14 67.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.92 78.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.0 tt -52.33 -45.38 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.07 -33.17 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.22 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.71 -44.16 24.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.233 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -118.13 -35.64 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.17 170.33 12.74 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.5 -26.89 68.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.205 -174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.8 -44.88 39.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.98 -33.91 39.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.03 83.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.251 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.35 -38.13 86.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.219 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.3 mt -60.34 -44.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -78.27 -24.57 46.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.01 -41.26 96.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.77 87.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.39 -39.72 94.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.206 174.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.68 -43.61 96.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.2 ttp -52.49 -48.12 66.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.202 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.9 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.32 67.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.8 p -92.14 -14.58 28.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -64.87 118.94 53.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -52.95 -32.29 56.88 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.71 1.607 . . . . 0.0 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -50.54 -39.27 48.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.16 -47.69 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.39 -56.77 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.229 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -75.09 -31.31 61.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.18 -48.27 81.25 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.22 -42.34 84.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.203 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -53.71 -47.22 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.47 -35.44 79.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.7 tpp -63.78 -41.88 97.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.87 -47.97 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.58 -44.55 64.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -65.83 -48.22 72.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.198 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -94.65 -10.95 30.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.95 63.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.224 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.79 169.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -70.57 163.09 27.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.182 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.29 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.12 -42.73 99.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.86 96.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -55.91 -48.45 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.226 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -57.87 -44.19 86.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.5 -45.42 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.55 -44.08 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.404 HG21 ' HA ' ' A' ' 131' ' ' ARG . 38.6 mm -65.57 -45.54 92.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.03 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.168 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -59.85 -54.86 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -67.72 -39.01 84.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.212 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.29 99.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 m -61.17 -42.86 99.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.202 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.3 -49.78 83.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 59.4 mtt -56.4 -41.15 75.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.78 -38.83 73.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.203 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.8 p -69.37 -20.58 63.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.0 -9.6 59.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.24 32.82 20.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -104.36 106.99 17.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.42 -33.16 74.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.231 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.32 -50.01 75.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.53 -30.09 68.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.74 -42.04 98.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.64 -40.94 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.192 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -66.03 -33.63 76.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.177 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.53 92.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.07 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -57.37 -42.94 83.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.36 -42.55 96.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.197 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.404 ' HA ' HG21 ' A' ' 108' ' ' ILE . 91.3 mtt180 -63.8 -39.65 94.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.243 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.3 -47.59 83.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.17 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.53 -44.62 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.53 -42.97 97.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -61.38 -41.87 97.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -59.97 -42.47 94.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.68 -47.23 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.05 -43.61 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.17 -38.25 88.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -71.55 -30.71 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -69.94 -40.39 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.13 -28.99 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.201 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.19 35.8 9.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 82.6 t -71.19 123.66 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.232 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.23 165.83 14.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 88.1 p -143.69 171.29 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -84.56 78.55 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.245 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.11 -6.28 59.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.4 p -74.29 -9.25 58.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.13 0.65 55.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.56 145.35 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.54 32.54 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -143.92 140.88 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.59 99.28 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.19 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.74 -179.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.6 t -94.8 122.95 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.58 117.75 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.76 125.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.218 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.09 49.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -63.14 -56.47 16.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -146.34 176.76 9.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.69 145.12 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.6 p -129.6 155.69 79.89 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.34 -38.34 72.95 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.714 1.609 . . . . 0.0 111.215 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -43.85 75.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.28 -46.28 64.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 65.0 p -67.89 -29.71 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.85 -29.37 70.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.1 p -108.46 14.55 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 63.1 tpp -71.65 115.58 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.55 77.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.2 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.424 ' HB2' HD11 ' A' ' 197' ' ' LEU . 63.7 pttt -63.16 -20.7 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.241 -172.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.11 -31.02 68.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -112.47 32.27 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.43 106.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.1 tp -80.52 -40.04 26.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.43 176.81 27.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -154.89 139.59 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 111.185 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.02 25.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.6 t -143.65 154.42 43.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.63 -53.31 57.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.14 124.78 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.11 74.22 0.84 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.5 -31.69 81.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.51 60.11 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.19 174.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.6 m -59.21 -37.36 77.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.211 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t -58.31 -56.46 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -59.37 -40.14 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.3 -46.87 88.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.84 92.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.09 -48.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.236 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.85 -35.71 81.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.19 98.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.184 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.55 -38.62 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.174 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 t -61.53 -43.03 99.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 173' ' ' LYS . 90.3 mt -88.24 -16.09 34.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 61.69 51.26 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.174 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 44.4 pt -127.68 159.67 64.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 92.3 Cg_endo -76.68 163.35 31.76 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.666 1.577 . . . . 0.0 111.251 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.55 135.73 11.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.18 122.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.95 160.35 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.91 38.64 35.42 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.17 -6.41 57.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.327 . . . . 0.0 111.201 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.28 -64.73 4.14 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 171.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -141.38 44.33 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.69 -22.67 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.7 p -70.44 -22.29 62.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.0 p -90.29 -27.08 19.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -90.69 -27.94 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.242 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.6 116.6 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.243 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.15 166.4 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.52 125.6 24.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.11 -18.06 40.09 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.83 165.27 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.23 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 62.4 tp -100.26 125.98 46.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.172 171.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.58 138.71 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.203 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.38 126.01 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.2 171.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.08 100.77 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -99.68 93.61 5.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.34 -22.51 73.08 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.25 -39.22 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -103.23 -15.3 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.71 37.33 26.81 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.96 155.73 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 73.6 t -120.27 135.31 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -109.21 129.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.65 117.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.177 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.76 60.4 11.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.223 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.0 153.18 68.07 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.714 1.609 . . . . 0.0 111.209 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -88.78 -176.52 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.76 -53.95 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -59.27 -48.87 80.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.9 m -53.99 -47.37 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.63 -45.82 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.203 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.72 -34.22 77.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.32 -41.73 98.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.215 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -75.96 -29.62 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -63.23 -41.62 99.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 47.8 t -62.67 -46.56 87.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.199 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.61 -42.83 93.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.62 -47.16 85.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.01 -47.07 88.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.5 p -61.94 -28.32 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 176.791 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.8 mt -100.79 140.55 34.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.06 136.3 43.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.228 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.8 -138.45 2.52 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -102.19 119.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 111.233 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.54 87.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.95 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.218 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 t -150.28 138.64 12.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.238 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.81 160.67 34.04 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.696 1.597 . . . . 0.0 111.199 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.87 175.16 13.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -125.09 124.6 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 177' ' ' LEU . . . -125.92 132.8 52.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -129.57 127.39 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.31 -153.74 24.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.01 154.71 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.171 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.67 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 31.7 m-85 -121.46 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.59 117.96 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -66.28 124.37 22.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -117.83 131.5 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.96 130.09 50.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.04 135.07 56.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.73 128.2 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.68 93.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.1 m -97.73 112.88 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.48 126.83 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -99.68 103.43 15.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.27 20.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.214 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.16 138.9 47.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.22 139.51 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 pt -118.12 170.28 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.214 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.42 146.19 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -64.03 -20.65 66.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.0 p -73.56 -14.44 61.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -98.42 4.43 48.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.2 -51.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.01 -32.8 74.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.85 -49.26 78.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.196 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.7 -37.3 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.65 -44.6 98.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.27 84.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -64.01 -37.97 89.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -59.28 -49.15 78.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.2 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.49 -36.68 84.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.7 -40.41 92.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.19 -33.49 76.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.65 -40.97 98.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.253 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.64 -42.76 99.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.58 -39.98 85.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.206 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.0 m -63.17 -41.61 99.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -60.97 -44.81 96.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.225 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -59.39 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.58 -55.91 21.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.58 -42.99 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.166 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.95 -49.33 77.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.36 -36.76 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.7 mt -63.03 -45.61 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.17 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.7 -43.72 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -55.35 -52.95 61.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -60.03 -42.85 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -43.11 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.42 -45.02 95.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.21 -31.71 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -97.06 -39.78 9.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.3 -34.91 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.25 -171.91 15.72 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -63.26 -26.13 68.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 111.175 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -45.59 -42.28 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.98 -34.74 10.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.46 -39.21 93.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.9 -32.68 74.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.16 -41.61 91.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.214 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -77.46 -24.09 50.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.36 -41.07 96.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.192 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.79 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -59.64 -41.16 89.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.187 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.73 -43.37 93.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.9 mtm -64.82 -36.09 83.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.86 -45.68 88.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.65 -33.12 74.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.3 m -94.69 1.93 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -65.79 114.17 15.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.86 -33.9 83.48 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.689 1.593 . . . . 0.0 111.216 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -67.94 -43.74 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.198 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.12 -36.69 72.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.96 -51.85 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.19 -35.16 79.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.19 -46.25 91.81 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.29 -46.59 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.37 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.76 -36.39 80.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp -63.68 -40.34 96.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.177 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.88 -50.91 77.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.51 -42.19 71.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.8 m -63.69 -47.37 81.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -99.17 -6.07 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt 59.97 45.05 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.66 -179.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -76.31 163.2 27.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.207 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.66 77.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.19 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.49 -53.17 60.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -59.86 -47.55 85.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -51.24 70.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.247 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.73 -46.1 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -54.84 -47.27 74.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -73.07 -47.86 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.81 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.416 HG23 ' HG ' ' A' ' 130' ' ' LEU . 33.5 mm -65.42 -43.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.43 -44.69 95.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.86 -56.15 25.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.211 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.77 94.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.2 p -67.16 -30.59 70.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.164 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.72 -51.61 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 76.1 mtm -60.3 -35.42 75.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.79 -37.93 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.5 p -70.63 -20.0 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.86 -12.54 61.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.44 32.05 14.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.199 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -105.53 112.45 25.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.176 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.41 -30.67 68.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.38 -50.05 71.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.24 -25.18 62.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.99 -45.23 89.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.218 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.51 -42.13 91.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.93 -33.76 76.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.61 94.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.76 -43.47 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -56.39 -45.82 80.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.416 ' HG ' HG23 ' A' ' 108' ' ' ILE . 57.7 tp -63.06 -45.08 93.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.229 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -58.41 -43.01 88.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.178 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.53 -48.84 79.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.0 -47.16 90.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.06 -45.14 95.69 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -61.69 -41.67 97.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.346 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -69.71 -33.04 71.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.04 -46.08 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.92 -43.02 96.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.31 -35.65 79.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.76 -31.15 64.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.37 -38.93 88.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.193 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.5 -28.09 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.72 38.23 10.84 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.26 120.37 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.208 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.75 161.37 14.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 72.0 p -160.32 169.73 22.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.8 t -72.42 123.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.185 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.74 74.89 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.215 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.37 -25.67 66.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.196 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.1 p -70.45 -14.05 62.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.219 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -96.46 5.5 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.25 137.67 41.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -110.15 41.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -148.38 143.58 26.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.173 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -57.99 104.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.219 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.49 157.03 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.28 134.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.19 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.1 105.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.18 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.3 mm -104.22 124.21 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -157.95 156.86 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -78.51 -39.92 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -159.11 111.17 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.55 151.15 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -108.4 162.06 21.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.04 -32.98 60.85 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.714 1.609 . . . . 0.0 111.194 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.3 p -69.79 -19.02 63.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -94.54 -38.6 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -77.92 -16.93 57.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.212 -175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.45 -2.97 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.209 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.6 p -88.92 -18.28 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 96.0 mmm -77.95 130.49 36.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.1 129.72 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -48.66 -50.12 34.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -82.12 -3.36 54.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.191 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.5 mmt -110.19 10.35 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.182 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -119.86 122.39 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.402 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 79.2 mt -79.78 -36.04 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.22 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.85 -178.68 45.64 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.54 144.25 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 65.5 p -131.41 159.11 38.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.214 -170.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.57 -33.08 64.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.3 m -115.36 163.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -108.93 24.3 21.75 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.46 -21.86 70.9 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.35 31.43 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 111.197 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.6 m -51.99 -48.52 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.7 p -65.37 -30.31 71.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -76.51 -39.16 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.9 p -70.29 -28.12 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -67.61 -52.78 34.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.65 -46.5 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 43.7 ttp -61.65 -55.0 35.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.234 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.19 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.198 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.09 -41.51 97.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -70.93 -22.6 62.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.227 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.1 -2.17 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.23 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.64 35.37 9.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 45.9 pt -132.31 154.26 81.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.234 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.11 160.63 39.58 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.754 1.636 . . . . 0.0 111.166 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 139.33 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 57.3 t -132.64 109.43 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.02 165.41 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.193 -168.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 70.43 39.3 69.71 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.77 -35.37 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 119.53 -53.95 0.66 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -143.95 31.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.54 -25.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -70.57 -22.52 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.21 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.1 p -94.38 -25.82 16.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -94.61 -24.24 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.11 125.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -115.69 164.27 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . . . -61.01 125.37 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.74 -12.38 50.12 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -71.23 144.68 50.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.08 124.26 27.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -132.4 136.77 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.48 124.81 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 80.8 t -97.78 112.6 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -108.91 93.14 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.94 -10.56 83.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.37 -39.5 47.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 111.195 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -93.72 -25.59 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.2 39.36 8.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.7 pt -132.44 160.55 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 111.183 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.12 133.0 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 78.5 mt -113.15 121.39 65.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.89 134.7 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.512 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 87.2 m-20 54.63 61.79 8.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 -171.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 230' ' ' ASN . 50.8 Cg_exo -58.43 145.85 92.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.736 1.624 . . . . 0.0 111.173 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.94 157.74 36.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.186 169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.06 -48.46 61.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.14 -45.22 93.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.224 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.5 m -57.55 -42.6 83.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.225 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.5 -48.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.67 -35.09 74.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.85 -51.92 66.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.198 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -72.58 -26.83 61.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.19 -51.56 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 92.1 p -69.32 -34.48 74.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.2 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.26 -42.85 75.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -53.52 -49.81 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.216 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -35.83 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 72.4 m -58.52 -38.91 78.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.206 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -90.38 -31.77 16.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -76.26 -48.6 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.233 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.9 mttt . . . . . 0 C--O 1.2 -1.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 -177.096 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 91.5 mt -79.76 81.75 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.253 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.61 134.84 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.1 -141.19 3.14 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.06 115.06 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 111.174 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.62 133.12 35.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.1 -32.5 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 44.8 t -165.39 137.05 3.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 72.5 Cg_exo -55.82 144.65 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.675 1.583 . . . . 0.0 111.198 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.94 173.14 16.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.3 mt -133.73 120.51 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 111.202 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.08 124.62 49.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.72 115.71 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.97 -157.41 14.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.59 162.75 13.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 111.18 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.02 132.53 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.183 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -121.13 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -102.13 133.0 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.151 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -134.01 114.79 13.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.3 p -105.91 172.13 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -154.42 132.21 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -109.61 157.08 19.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.176 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.27 128.43 34.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.1 t -102.09 132.44 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.183 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -62.59 129.37 40.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.76 133.31 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -74.24 104.24 4.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.212 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.26 21.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.54 -98.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.21 149.15 44.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.03 165.53 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -59.33 137.51 57.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -54.33 -38.07 65.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -68.59 -15.72 63.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.8 0.03 57.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.15 -51.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -65.43 -33.06 75.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.11 -50.03 75.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -69.82 -34.49 73.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.208 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.28 -43.78 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.51 89.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.04 -45.73 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -60.12 -51.18 70.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.06 -42.61 99.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.25 -55.26 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.46 75.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.202 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.11 -47.05 75.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.61 -40.73 88.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.31 -44.89 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -57.62 -45.04 85.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.222 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -60.53 -47.82 84.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -58.31 -47.96 82.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.57 -48.81 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.68 -44.24 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.205 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.04 -49.62 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.85 -45.9 76.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.43 -26.66 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.16 -50.85 72.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.19 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.64 -46.23 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.219 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.22 -48.77 79.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.24 93.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 62' ' ' LEU . 9.8 tt -55.64 -47.35 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.204 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.81 -34.25 34.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -79.88 -42.34 24.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.12 -33.63 4.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.56 168.64 12.62 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.36 -22.05 66.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.164 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.16 -36.85 80.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -85.23 -30.52 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.94 77.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -54.01 -36.26 62.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.206 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.09 -46.9 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -75.61 -28.05 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.211 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -59.53 -49.06 79.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.198 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -69.16 -33.1 72.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.76 -43.25 80.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.99 -40.76 98.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.55 -40.66 97.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.81 70.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.175 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.8 p -91.87 -1.02 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.3 115.95 28.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.38 -17.56 23.89 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.735 1.623 . . . . 0.0 111.228 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -71.62 -41.28 69.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.215 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.71 -38.32 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.224 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.2 -48.87 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.215 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.86 -43.48 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.64 64.15 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.66 -45.97 96.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 111.188 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.91 -38.3 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.71 -33.22 72.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.6 tpp -64.18 -43.0 96.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.204 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.0 mt -58.85 -47.86 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.16 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -73.52 -46.57 46.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -66.51 -48.4 69.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -96.2 -7.55 35.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.233 -174.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.9 64.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.161 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.86 169.0 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.24 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.9 p -76.01 162.4 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.4 81.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.02 -48.52 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.12 -45.68 80.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -47.67 85.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.201 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.48 -48.17 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.225 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.63 -41.14 85.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.203 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -68.47 -50.9 49.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.28 -44.41 91.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -61.76 -44.5 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.227 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -65.29 -42.35 93.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -59.17 -54.91 41.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -66.75 -38.83 87.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.89 93.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.0 p -65.8 -32.24 73.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.14 -51.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 96.7 mtp -57.23 -37.46 72.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -73.07 -37.96 66.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.198 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.2 p -70.21 -19.21 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.05 -11.78 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.211 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.59 32.35 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -105.89 113.01 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.198 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -59.86 -30.33 68.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.73 -50.02 70.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.32 -27.34 65.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.73 -46.55 84.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.77 -43.58 90.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.217 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -69.39 -32.4 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.238 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.9 85.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.248 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.0 t -60.02 -45.83 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.228 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.62 -43.5 84.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -45.53 93.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.95 -41.2 95.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.21 -48.1 83.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.34 -44.34 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.84 -44.44 92.13 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.98 -39.69 95.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.221 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.78 -37.01 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.219 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.99 -45.49 98.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -60.73 -41.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -47.08 77.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.222 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -71.24 -29.44 65.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.68 -40.18 88.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 172.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.07 -26.23 39.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.33 30.62 15.92 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.29 126.32 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.76 163.14 13.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.2 p -148.88 163.1 38.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -118.92 131.04 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.211 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -82.75 114.58 21.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 149' ' ' LEU . 3.6 pp -67.72 -23.11 65.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.4 p -73.12 -13.27 61.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -99.02 8.55 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.23 148.27 35.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -95.87 -21.59 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.55 156.13 30.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -76.32 129.68 36.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.07 167.7 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 93.6 t -98.58 126.53 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.4 t -86.45 113.76 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.59 117.97 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.9 147.31 30.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.217 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.53 -32.94 60.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -126.36 94.93 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.76 109.12 17.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 71.7 p -110.16 164.01 15.83 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.173 -167.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -54.39 -31.2 66.91 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.682 1.588 . . . . 0.0 111.216 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.9 p -69.37 -16.37 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -91.02 -31.42 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 93.7 m -59.52 -38.03 79.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.36 -29.32 63.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.222 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -109.65 37.21 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 62.4 ttp -93.85 105.19 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -91.45 99.43 12.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.181 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.57 -20.15 64.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.08 -33.75 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 39.1 mmt -92.57 -34.14 14.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.48 122.52 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.209 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.8 -26.38 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.232 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.7 178.1 48.46 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.58 152.66 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -156.88 152.72 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.3 t -159.69 -176.21 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.235 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -120.48 -43.93 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 p -172.73 138.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 174.5 176.77 43.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.27 14.05 65.6 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.33 27.51 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.152 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.2 m -68.74 -46.19 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 96.4 p -64.56 -31.64 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.18 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -64.96 -46.01 83.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 99.1 m -52.54 -45.01 66.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.27 -42.84 99.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.206 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.49 -44.06 95.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.225 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.5 mtp -55.54 -48.3 74.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.39 81.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.69 -33.92 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.234 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.7 p -68.43 -19.99 64.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.2 mt -107.6 1.47 23.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 57.22 47.04 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.206 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.5 pt -127.37 156.89 74.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.46 154.37 31.46 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.673 1.582 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.33 144.79 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.205 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.9 117.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.227 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.8 163.4 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.68 55.95 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.65 -48.87 12.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.24 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.99 -11.9 58.94 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -132.57 -14.51 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -170.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.5 -28.67 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -160.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.0 p -80.31 -11.3 59.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.215 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.6 p -105.61 -30.23 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.222 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -81.11 -34.69 32.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.64 120.42 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.244 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.41 152.02 32.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.22 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 126.65 27.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.82 -16.85 46.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.1 175.25 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 111.191 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -99.23 139.39 34.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 170.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.32 134.7 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.178 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.87 127.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.246 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -105.33 94.5 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.182 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -84.6 82.03 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.187 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.35 73.96 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.39 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -78.18 -40.22 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.28 32.66 5.15 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -131.61 156.19 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.212 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 97.6 t -121.32 135.36 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.54 127.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.38 117.3 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.13 62.48 8.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.55 147.0 63.26 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.731 1.62 . . . . 0.0 111.216 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.91 162.7 28.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 173.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.68 -46.12 58.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -62.32 -43.87 97.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.2 m -59.66 -43.18 94.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.242 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.06 -46.29 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -64.61 -35.24 80.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.63 -46.29 90.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.196 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -73.62 -28.75 61.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -62.61 -45.6 92.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.77 -32.34 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.66 -42.42 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.14 -39.63 87.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.83 -43.31 99.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.2 p -71.06 -27.73 63.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.31 -49.94 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 172.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 248' ' ' LYS . 98.1 mt-10 -66.22 -39.19 89.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 247' ' ' GLU . 99.7 mttt . . . . . 0 C--O 1.2 -1.538 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.214 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HE3' ' HB ' ' A' ' 228' ' ' ILE . 99.6 mtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.48 109.34 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -103.85 138.27 40.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.86 -139.43 2.84 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.88 121.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.363 . . . . 0.0 111.191 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.53 87.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.33 -33.01 72.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.186 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -148.56 135.64 10.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 164.31 31.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.659 1.573 . . . . 0.0 111.177 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.89 -168.02 15.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 tt -158.73 144.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 111.239 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.76 154.95 33.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 219' ' ' ILE . 81.9 mt -122.91 128.16 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.26 -177.06 29.07 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.53 150.6 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 111.204 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.28 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -111.0 120.38 42.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.2 tp -93.44 109.22 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.197 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -64.11 108.24 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -91.44 117.12 29.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.211 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -120.85 108.71 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 139.37 54.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.65 160.07 29.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.55 119.3 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.5 m -119.33 118.02 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 101' ' ' ASP . 97.0 mt -71.4 125.65 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.204 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -78.93 114.64 18.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.65 22.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.57 136.35 52.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.226 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.5 128.98 39.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -102.9 127.25 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -57.98 136.81 57.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.2 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.58 -44.59 26.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.8 p -68.5 -20.82 64.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.18 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.04 2.33 43.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.96 -38.16 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.48 -21.94 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -68.44 -35.42 77.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 171.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.89 -35.45 80.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.56 -46.01 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.91 87.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.239 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.35 -47.34 81.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.98 -49.96 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -59.4 -42.03 90.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.25 -37.68 52.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.47 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.71 -42.3 82.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -50.87 -50.48 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.99 -44.74 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.7 m -52.86 -50.09 64.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.73 -42.9 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.5 -46.11 89.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.2 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -60.96 -42.38 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -61.03 -40.96 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.25 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.51 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -57.19 -47.39 81.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.5 -51.35 67.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.211 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.17 -31.55 70.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.46 93.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.4 tt -63.17 -46.96 84.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.67 -39.22 93.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.221 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -83.32 -34.13 25.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.185 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.12 -58.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.18 -168.26 23.45 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -60.81 -27.5 68.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -43.79 -44.34 6.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.22 -34.35 11.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.205 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.49 -39.11 93.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -176.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.03 -32.7 74.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.22 -43.93 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.168 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -76.81 -19.83 57.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -63.36 -49.1 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.98 81.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.195 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -56.19 -47.24 78.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.214 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -64.33 -44.74 90.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.8 ttp -49.72 -48.4 49.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.171 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.75 -38.61 91.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.0 66.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.5 p -94.56 4.54 53.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -62.55 116.54 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.0 -33.61 73.66 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.733 1.622 . . . . 0.0 111.16 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.39 -35.95 78.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.2 tp -67.55 -46.53 72.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.5 -58.25 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.52 -35.12 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.19 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.59 -48.5 84.19 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.5 t -68.84 -43.88 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.24 -42.7 91.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.265 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -68.89 -36.72 78.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.99 -43.55 98.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.76 -50.78 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.9 -40.86 87.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.5 m -67.07 -47.61 70.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -91.62 -15.89 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.8 mt 64.98 43.75 3.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.223 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.64 -177.59 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -72.1 156.62 38.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.217 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.1 76.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.424 ' HB3' HG23 ' A' ' 26' ' ' ILE . 94.3 m-20 -58.95 -50.49 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.233 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -65.01 -41.31 95.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.95 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -45.36 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.242 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -56.49 -46.81 80.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -68.19 -50.05 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.71 -45.07 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.2 mm -60.0 -43.65 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -64.42 -43.35 94.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.214 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.03 -45.9 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -57.89 -47.62 82.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -50.3 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 93.0 mtp -58.26 -38.56 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.186 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -72.09 -38.58 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.194 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 p -70.01 -20.08 63.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.197 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.38 -15.41 63.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.211 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 62.54 32.31 16.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.248 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -100.33 109.84 22.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -42.4 -44.79 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -62.24 -54.64 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.241 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.46 -31.71 71.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.184 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -46.79 86.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.8 -43.81 94.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.206 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -68.74 -31.38 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.48 87.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -61.48 -44.21 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.196 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.57 -41.99 91.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.247 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.63 -41.66 97.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -58.99 -38.64 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.27 -41.36 89.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -54.55 -46.03 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.04 93.49 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.05 -42.43 99.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.18 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -62.56 -40.59 97.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.206 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.53 -48.06 86.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -60.73 -39.89 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.211 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -56.07 -46.71 78.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -71.38 -29.37 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.4 mt -66.45 -37.23 84.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.246 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.24 -32.18 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.27 31.75 7.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 81.9 t -72.01 123.52 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.19 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -122.49 163.22 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -152.31 165.83 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.1 t -69.88 130.25 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -76.49 108.79 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.56 -3.39 58.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.208 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 84.6 p -90.78 0.18 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -94.82 5.49 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.16 78.25 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -68.76 -30.94 69.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -87.91 151.85 22.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.55 113.08 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.09 170.4 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.44 134.24 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.87 113.27 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.65 116.05 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.235 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -147.57 156.65 43.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -171.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -97.8 -20.97 17.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.212 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -161.7 110.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.19 96.91 8.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.231 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 46.5 p -80.99 165.38 45.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.222 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 93.9 Cg_exo -50.25 -37.44 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.736 1.624 . . . . 0.0 111.166 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.2 p -76.22 -30.41 57.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.65 -35.07 72.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.7 p -80.79 -29.62 36.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.93 86.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.183 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.8 p -95.95 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 58.5 ttp -136.39 133.02 36.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -77.35 89.37 3.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.231 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -54.99 -35.0 63.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.246 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -47.89 -38.56 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.215 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -109.53 31.4 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.201 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 92.0 t -106.72 124.21 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.197 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.9 mt -100.84 -10.78 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.59 170.73 38.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -121.79 141.61 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -143.38 108.84 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.185 169.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 67.9 p -118.82 154.73 32.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.86 -42.11 95.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.1 m -108.07 157.16 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.194 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.76 3.86 45.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.81 73.11 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -108.4 22.8 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.328 . . . . 0.0 111.182 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.6 m -49.14 -45.89 44.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.0 m -58.82 -44.09 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.18 -49.9 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 80.7 p -72.28 -30.7 65.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.74 72.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.22 -49.07 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.8 mtm -64.79 -46.16 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.45 83.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.185 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -59.63 -45.88 90.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 85.7 p -77.89 -23.62 48.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.227 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.81 -16.02 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 60.81 50.09 5.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.243 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.44 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 42.1 pt -128.64 159.84 65.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.186 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 71.8 Cg_endo -72.36 150.27 52.18 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.658 1.572 . . . . 0.0 111.198 177.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.12 126.16 12.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.229 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.17 123.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.67 159.34 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.78 39.98 32.49 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.09 -14.01 58.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.91 -59.82 1.45 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -152.06 45.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.84 -23.55 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.193 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.0 p -75.38 -15.51 60.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.5 p -97.47 -27.22 14.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.2 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.41 -23.46 20.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.15 122.96 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.236 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.86 159.85 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.11 26.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.79 -16.68 36.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.09 163.82 27.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.0 129.59 44.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.186 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.92 136.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.204 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 13' ' ' ILE . 74.7 mt -122.95 126.03 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 175.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.6 t -107.97 112.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -98.54 91.1 4.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.18 -33.73 69.35 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 67.2 tp -57.74 -49.79 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 111.213 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.59 -26.38 30.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.82 10.68 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.2 pt -133.71 149.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.94 135.95 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.417 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 7.9 tp -115.4 140.46 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.39 138.24 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.178 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 89.0 m-20 56.05 52.3 7.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -173.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.3 Cg_endo -71.76 155.28 58.63 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.665 1.576 . . . . 0.0 111.235 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -88.09 -177.88 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.04 -54.37 45.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.238 -172.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.79 -46.56 88.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.243 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.6 m -56.23 -45.55 79.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.62 -45.54 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.59 -35.6 77.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.04 -45.75 90.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -76.15 -26.06 55.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.189 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.181 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 75.3 m -59.16 -41.48 88.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.17 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.55 -49.97 75.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.221 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.64 -40.27 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 73.4 m -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.245 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -68.4 -51.32 45.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.4 -40.45 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 -170.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.199 -1.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 -176.897 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.845 0.355 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.9 mt -98.08 122.43 41.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.06 136.8 47.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -140.67 2.93 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.36 113.71 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 111.168 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.31 87.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.72 76.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.194 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.9 t -148.33 135.77 10.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.19 162.01 31.78 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.699 1.599 . . . . 0.0 111.239 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 177.59 14.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.94 130.41 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 111.176 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.02 140.11 36.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.65 124.91 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.72 -156.02 7.85 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.24 179.27 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.22 131.2 41.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -121.56 97.66 5.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.84 118.23 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 -170.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -98.72 111.26 23.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 p -104.33 167.82 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.165 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.94 132.19 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.197 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.41 132.68 54.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.191 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.19 131.43 50.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t -83.58 99.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.6 m -97.67 114.11 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -96.24 126.4 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -80.44 115.78 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.65 23.54 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.219 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -83.19 157.57 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -84.3 160.14 20.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.2 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.7 pt -122.64 165.03 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.54 146.26 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -51.27 -39.29 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -69.88 -16.31 63.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.25 -0.13 53.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -58.61 -46.79 90.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.209 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.93 -32.14 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.211 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.55 -42.47 87.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.192 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.81 -37.58 76.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 84.5 mt -63.63 -43.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.47 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.18 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -64.27 -37.92 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.83 -48.48 81.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.99 -35.62 81.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.93 -42.13 99.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.89 85.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.173 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.38 -41.6 97.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.75 -38.33 90.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.15 -46.54 95.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.2 p -68.93 -29.89 68.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.216 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -60.03 -51.26 70.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.218 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -49.93 75.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.18 -55.1 39.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.36 -41.77 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.12 -51.33 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.5 -38.18 83.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.191 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.8 mt -64.55 -41.85 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.02 -49.35 60.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -54.7 -52.94 60.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -60.74 -40.02 90.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.46 99.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.3 tt -57.41 -47.21 82.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.183 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.23 -28.88 57.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.225 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.23 -44.02 9.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.208 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.17 -32.76 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -168.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.89 164.34 11.48 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.9 -34.97 66.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -45.88 -44.51 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -76.56 -34.7 58.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.79 81.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.239 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.51 -35.87 82.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.93 -42.54 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -76.91 -24.25 52.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.209 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -64.59 -41.01 96.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.18 98.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.46 -40.74 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.211 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.97 -43.68 87.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -64.86 -36.81 85.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.9 -44.96 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.63 78.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.2 p -104.57 20.6 18.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.234 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -72.66 114.87 34.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.98 -34.55 77.4 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.69 1.593 . . . . 0.0 111.192 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -69.11 -43.36 74.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.226 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 99.5 mt -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.86 -51.78 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.42 -30.75 69.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.216 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.97 -47.09 91.29 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.11 -43.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.201 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.78 -44.93 90.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -67.68 -34.87 77.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.206 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 tpp -63.71 -43.25 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.79 -48.02 89.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -73.97 -45.91 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.3 m -63.62 -48.83 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.91 -12.07 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.217 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.5 mt 59.05 65.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.246 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 165.61 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.201 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.4 p -66.4 154.78 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.89 97.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.241 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.89 -37.12 85.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.22 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.49 -43.86 84.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.88 94.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.37 -46.5 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.5 -47.07 76.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -69.47 -51.62 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.61 -46.92 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -68.83 -47.13 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.71 -39.77 84.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.201 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -57.19 -54.56 45.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.188 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.84 -38.2 89.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.217 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.07 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.9 p -66.98 -31.19 71.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.47 -49.16 79.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 98.7 mtp -58.5 -37.38 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -74.32 -34.52 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 p -69.98 -17.56 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.251 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.62 -11.29 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.193 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 64.49 32.79 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.14 112.99 25.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.46 -31.37 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -63.34 -51.01 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.39 -25.28 63.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.223 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.48 -47.96 81.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.19 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.84 -39.59 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.48 -33.41 75.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.227 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.89 84.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.46 -43.53 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.173 173.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.01 -48.07 73.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.85 -49.14 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 131' ' ' ARG . 39.7 ttm105 -56.89 -45.18 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.35 -42.91 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.211 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.52 -48.87 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.56 -40.45 99.15 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -59.64 -43.94 93.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.81 -37.23 76.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.219 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.49 -44.87 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.236 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.3 -44.44 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.52 -47.53 85.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.14 -33.3 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.56 77.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.54 -34.38 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.17 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.76 35.09 5.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.84 122.53 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 111.177 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -107.0 163.62 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 71.7 p -158.59 177.71 10.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.4 125.65 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -81.31 105.9 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.199 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.58 -26.78 67.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.242 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -77.53 -9.01 58.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.194 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.68 -3.34 58.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.194 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.08 120.41 16.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.213 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -122.72 30.21 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -145.9 137.61 25.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.82 98.46 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 173.29 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.211 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -89.2 127.24 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.6 125.19 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.87 112.05 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.229 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.92 143.92 43.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -170.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -89.54 -7.73 54.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 172.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -169.27 152.01 4.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.5 tp -173.61 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.8 p -99.99 161.04 25.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.215 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.1 -34.89 59.96 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.744 1.629 . . . . 0.0 111.179 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 p -67.21 -19.98 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -91.92 -34.12 14.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.1 p -63.65 -32.87 74.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.182 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.31 71.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.7 p -113.2 14.14 19.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.4 ttt -77.59 131.79 37.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -67.35 74.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -66.34 -22.42 66.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.86 -25.03 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.03 23.48 14.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.194 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.4 t -110.26 116.13 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.185 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.68 -4.68 33.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.52 169.48 38.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -150.4 132.04 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -141.59 150.17 41.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.3 p -137.0 165.47 25.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -104.87 7.92 34.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.99 153.43 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 139.28 145.42 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.97 -76.41 1.07 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.08 140.78 47.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.226 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.9 p -123.14 25.19 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -60.17 -59.27 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -60.07 -38.89 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 79.8 m -58.25 -47.51 83.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.8 87.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.35 -47.89 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.21 -44.86 94.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.8 82.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.201 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -61.56 -46.48 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 78.5 p -70.58 -25.03 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -22.88 28.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.209 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 60.6 47.43 8.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.203 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.03 155.87 80.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.94 161.6 23.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.664 1.576 . . . . 0.0 111.219 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.88 132.22 8.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.15 112.62 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.224 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.77 169.83 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 -170.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.64 78.68 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.5 mt -80.35 -27.44 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.29 -62.77 4.44 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -93.21 -6.12 48.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.167 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.92 -29.13 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.9 p -79.56 -14.08 59.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.259 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.2 p -102.62 -28.8 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.215 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -92.37 -23.94 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.66 120.8 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.189 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -117.49 157.57 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.23 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.46 127.31 29.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.76 -20.05 32.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.63 163.48 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.767 0.318 . . . . 0.0 111.239 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.86 134.15 36.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.6 t -133.27 128.58 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.233 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.5 mt -113.7 127.51 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.186 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.1 t -106.52 118.89 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.172 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -116.4 96.98 5.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.63 -23.7 66.78 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.66 -38.23 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 111.176 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.36 -27.64 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.187 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.45 36.45 14.32 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.68 157.68 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 111.185 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.59 134.84 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.199 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 mm -103.23 128.85 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 72.4 t -105.2 120.9 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 54.97 58.4 11.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.93 156.17 63.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.748 1.632 . . . . 0.0 111.232 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -86.47 -178.23 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.99 -42.67 99.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -64.06 -44.18 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.6 m -61.6 -44.22 97.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.99 -44.97 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.234 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.89 -35.7 80.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.221 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.02 -50.57 72.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.185 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -72.37 -27.21 62.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -59.56 -45.48 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.198 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.7 p -69.36 -31.45 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.18 -42.96 83.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.86 -44.95 86.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.85 -50.61 73.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.0 p -67.7 -26.57 66.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.228 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.63 -48.28 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.233 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.8 -38.72 80.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.208 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.2 -1.514 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -177.704 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.759 0.314 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -97.14 99.36 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -87.37 131.31 34.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.31 -150.82 5.45 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.6 119.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.83 87.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.74 -31.84 65.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -148.28 133.98 9.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.6 163.44 31.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.735 1.623 . . . . 0.0 111.171 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.4 179.66 15.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -130.67 121.36 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 111.208 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.01 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.225 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.9 mt -124.11 119.53 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.23 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.81 -161.82 13.66 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.0 157.42 16.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 111.215 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.41 95.15 4.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -105.64 105.23 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.11 140.27 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -85.29 97.94 10.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -120.83 137.89 54.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -123.09 160.18 26.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -68.67 139.46 55.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.215 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.02 115.04 29.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.27 127.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.218 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.0 m -70.66 133.67 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.35 127.26 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -79.82 113.05 17.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.84 16.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -56.96 133.6 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.207 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.44 129.74 43.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.08 125.37 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.03 145.79 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.33 -34.87 61.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.7 p -75.85 -21.69 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.233 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.61 -9.35 41.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 93' ' ' ILE . 42.6 t -54.78 -45.0 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.52 -32.93 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -67.0 -41.83 86.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.65 -36.2 78.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.21 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 173.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.93 90.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.3 -45.82 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.94 -47.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.51 -36.33 83.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.48 -39.69 92.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.77 -35.08 79.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.2 -42.36 99.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.48 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.36 -44.06 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.199 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.3 m -60.21 -48.82 80.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.3 -42.19 99.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.15 -49.81 74.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.31 -45.77 92.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.66 -44.22 93.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.49 -45.76 78.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.36 -41.57 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.86 -40.77 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.195 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -50.58 -47.33 58.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.195 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.68 -49.14 68.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.01 -42.06 98.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.07 85.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.4 tt -62.45 -46.08 90.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.49 -29.96 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.197 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -82.38 -53.83 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -117.36 -34.49 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.38 -168.46 16.51 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.56 -19.0 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.776 0.322 . . . . 0.0 111.208 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -55.92 -52.91 62.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -77.9 -28.99 49.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.211 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.64 76.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.211 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.75 -34.84 79.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.49 -47.2 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -76.38 -26.61 55.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.189 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.0 -45.39 90.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.73 97.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -60.19 -41.36 92.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.172 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.2 tp -64.72 -43.96 91.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.4 mtp -57.2 -45.85 83.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.216 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.77 -40.75 98.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.232 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.75 66.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.234 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 -2.64 37.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.74 113.79 14.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.04 -33.37 83.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.658 1.572 . . . . 0.0 111.199 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -67.67 -44.44 77.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.04 -37.29 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.96 -52.52 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.208 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.27 -35.05 78.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.81 -47.6 87.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.5 -45.29 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 111.17 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -62.09 -38.76 90.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -67.01 -37.88 84.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.151 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.4 tpp -63.01 -42.46 99.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.404 HG22 HG13 ' A' ' 36' ' ' VAL . 96.1 mt -57.25 -48.01 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.49 -43.21 57.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.211 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 m -62.28 -50.33 72.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -172.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.27 -11.35 32.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.0 mt 59.0 63.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.49 158.95 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.22 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.3 t -66.18 150.0 49.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.04 -31.87 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.234 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -54.73 -43.7 72.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -84.82 -31.67 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.91 -45.41 93.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.17 -46.31 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.19 -48.21 71.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.28 -49.41 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 -174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.9 -45.1 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.443 HG23 ' HG ' ' A' ' 130' ' ' LEU . 31.1 mm -64.57 -46.34 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -69.1 -38.28 78.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.73 -54.34 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.82 -31.33 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.72 98.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.5 p -69.42 -29.33 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.19 -48.98 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 66.4 mtt -51.91 -42.65 62.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.234 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.22 -40.46 82.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.0 p -69.34 -19.98 63.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.98 -8.69 57.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 62.62 33.9 15.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -110.73 112.76 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.84 -31.0 69.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.198 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.2 -49.94 75.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.53 -25.69 62.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.195 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.17 -40.49 97.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -67.17 -35.69 80.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 17.2 mmp_? -69.57 -31.6 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.3 96.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.181 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.33 -46.55 96.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.221 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -57.29 -44.0 83.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.443 ' HG ' HG23 ' A' ' 108' ' ' ILE . 56.3 tp -62.44 -46.05 90.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 -58.36 -45.28 88.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.12 -42.44 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.205 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.38 -49.69 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.79 98.5 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -60.2 -44.09 95.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 111.183 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -70.0 -36.14 74.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.0 mt -57.56 -46.23 86.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.37 -42.61 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.71 -40.11 91.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.186 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.47 -30.33 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.76 -38.78 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.2 -26.0 36.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.198 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.05 27.31 23.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.51 125.97 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.77 161.74 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -144.96 175.87 9.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.18 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.75 124.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.44 72.51 7.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -21.01 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -67.42 -18.01 64.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.2 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -105.47 20.11 19.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 156' ' ' VAL . 60.3 tp -63.62 130.92 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.28 22.22 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -137.73 140.52 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.54 97.83 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.19 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.407 HG22 HD21 ' A' ' 152' ' ' LEU . 34.8 m -137.72 -168.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.69 132.34 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.8 t -96.41 125.13 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 98.7 mt -122.42 132.08 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.71 170.06 22.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.207 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.401 ' HD2' ' HB2' ' A' ' 182' ' ' ASP . 29.8 tpt180 -66.34 -46.24 77.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.202 175.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.71 173.38 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.202 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.68 84.51 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 51.5 p -78.22 165.25 51.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.174 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 95.3 Cg_exo -50.03 -36.68 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.7 1.6 . . . . 0.0 111.209 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 93.7 p -73.27 -31.06 63.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -45.85 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.6 p -68.74 -27.31 65.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.176 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.56 -1.39 37.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 74.2 p -113.96 5.05 16.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.0 mtp -78.16 126.89 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -67.06 106.48 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.238 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.5 -48.81 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.204 -166.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.21 8.5 44.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 -164.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -123.84 16.81 9.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.4 112.45 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.5 mt -91.03 -13.45 33.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.6 178.41 41.96 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -165.15 162.48 20.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 111.21 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -150.2 144.65 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.244 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.6 p -127.85 154.78 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.227 -170.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.401 ' HB2' ' HD2' ' A' ' 161' ' ' ARG . 99.5 m-20 -63.86 -55.35 23.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.186 172.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.46 129.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 59.1 4.51 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.88 73.89 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -118.0 62.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.3 m -63.18 -40.1 96.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.1 m -52.8 -53.41 48.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -72.73 -33.1 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.258 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -58.42 -48.94 79.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.0 mt -58.31 -46.05 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 tpp -64.3 -46.83 81.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.27 91.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.167 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.1 -36.64 69.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 82.8 p -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -98.59 -14.97 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 60.95 51.03 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.183 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 44.2 pt -125.45 153.21 72.4 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.219 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.55 148.74 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.663 1.576 . . . . 0.0 111.205 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -148.2 122.09 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.44 120.33 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.177 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.86 160.81 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.01 38.75 29.5 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.18 -5.57 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.79 -62.97 4.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -151.94 45.06 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.2 -174.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.9 -23.26 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.7 p -70.66 -17.92 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.8 p -101.01 -27.85 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.189 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -83.18 -17.89 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.79 134.36 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -109.05 149.75 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.89 126.21 26.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.06 -14.99 44.26 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.58 166.21 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 111.195 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.27 133.41 36.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.245 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.94 126.31 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.35 114.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.251 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.67 91.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -85.94 78.91 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.186 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.01 -24.44 73.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 64.1 tp -58.2 -48.31 80.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.186 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -91.79 -17.89 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.12 36.53 14.72 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -132.28 155.16 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 96.1 t -121.64 133.94 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 175.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.7 127.43 66.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.9 122.85 62.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 94.0 m-20 55.71 55.52 9.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.7 Cg_endo -69.64 155.33 66.64 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.7 1.6 . . . . 0.0 111.219 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.39 161.61 29.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.174 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.91 -50.46 63.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -57.72 -46.88 83.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.219 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 99.9 m -54.19 -45.39 72.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.92 -47.55 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.87 -32.37 73.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.209 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -64.47 -41.35 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.43 -28.23 64.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.85 -43.07 99.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 78.6 p -71.03 -30.96 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -68.56 -39.98 80.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.192 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -59.84 -41.57 91.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.51 -49.19 77.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.1 p -67.06 -28.91 68.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -63.32 -50.08 71.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.212 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -33.97 75.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.527 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.372 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.6 mt -91.61 120.18 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.3 129.62 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.17 -150.91 5.31 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.4 t -105.21 124.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 111.177 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.56 87.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.57 96.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.218 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.4 p -149.09 148.84 28.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.64 161.81 24.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.699 1.599 . . . . 0.0 111.236 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.64 177.13 14.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -133.92 117.03 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 219' ' ' ILE . . . -97.81 113.31 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.92 111.56 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.71 -156.75 13.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.5 150.83 22.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 111.224 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 120.72 31.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -119.82 100.42 7.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.3 tp -78.25 113.79 16.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.66 106.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.3 m -92.77 133.66 35.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.58 127.55 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.163 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -67.19 146.35 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.73 125.82 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.49 82.04 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.6 m -85.42 112.22 20.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.201 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -81.57 122.1 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -80.2 109.01 14.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.7 24.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.196 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.12 173.55 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.2 164.83 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 pt -123.24 165.26 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -72.92 142.96 47.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.19 -43.1 66.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.2 p -69.28 -17.88 63.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.31 4.72 46.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.2 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.43 -46.78 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.24 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.74 -36.31 82.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -67.85 -40.38 83.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.171 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.33 -37.89 74.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.217 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.24 -42.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.91 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.211 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.95 -42.86 94.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.214 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.27 -48.3 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.39 -36.91 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.91 -39.37 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.218 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.61 81.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.212 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.68 -40.53 97.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.54 -45.27 94.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.5 t -67.44 -42.67 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.0 m -58.0 -53.83 53.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.24 -39.38 94.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.42 -50.89 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.199 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -65.35 -39.13 91.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.229 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.44 -49.09 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.231 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -67.24 -45.94 75.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.55 -43.94 83.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.224 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.82 -39.88 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -49.24 -47.22 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.73 -51.75 59.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.227 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.42 -40.92 98.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.98 95.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.198 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.17 -44.87 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.16 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.31 -35.78 81.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.214 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -87.04 -67.77 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.09 -31.58 15.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.33 -163.24 13.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.06 -23.4 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.194 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -48.0 -41.0 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -102.04 -32.36 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.159 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -37.99 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -65.66 -33.44 75.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -58.57 -46.57 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.225 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.01 -35.56 78.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.182 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -57.12 -46.7 82.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.61 98.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -67.38 -34.42 77.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.0 -46.04 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.54 -41.97 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.209 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.26 -39.43 93.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.03 79.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.18 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -87.49 -14.85 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.63 113.77 10.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.232 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.32 -28.58 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.683 1.589 . . . . 0.0 111.209 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -63.56 -28.62 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.252 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.55 -35.87 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -53.43 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.31 -35.39 80.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.94 94.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.8 -45.61 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.64 -36.19 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.202 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -65.16 -42.08 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.06 -47.0 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.67 -43.98 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -67.28 -47.27 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -97.4 -8.07 30.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.41 63.71 1.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.48 165.92 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.2 p -65.91 159.53 25.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.41 78.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.215 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -55.39 -51.22 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.201 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.39 -43.68 89.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.68 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.65 -46.28 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.19 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.89 -55.1 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.21 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.75 -52.28 63.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.49 -50.03 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -172.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.9 mt -71.62 -42.95 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.247 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -57.69 -41.58 81.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.83 -52.95 63.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.35 -37.04 81.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.8 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.8 p -68.59 -29.64 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.178 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.68 -49.98 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 60.1 mtt -53.58 -40.77 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.81 -41.12 83.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 73.2 p -69.69 -21.25 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.4 mt -73.65 -13.06 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.94 32.19 17.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -103.83 108.98 20.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.54 -33.45 74.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -169.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.28 -49.28 77.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.236 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.45 -26.08 63.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -42.47 97.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.68 -41.75 91.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.219 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -67.25 -32.91 74.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.01 88.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.217 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.73 -43.05 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.84 -41.35 86.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.07 -43.17 95.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -59.99 -42.32 93.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.95 -46.51 81.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.41 -46.12 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.74 -46.32 93.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.11 -41.77 97.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 111.235 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -62.86 -41.62 99.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.44 -46.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.62 -41.78 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.67 -39.82 85.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -72.66 -31.05 64.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.192 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.06 -38.32 82.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.247 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.43 -33.17 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.56 8.84 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.61 119.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.186 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.81 161.94 13.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.3 p -153.92 165.13 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.73 123.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.213 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -93.54 94.67 8.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.03 -3.25 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.22 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.3 p -74.56 -13.17 60.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -110.93 23.66 13.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.17 132.61 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -101.18 -6.25 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.85 156.87 43.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.16 121.24 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -138.12 170.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.0 t -94.76 133.36 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.44 121.17 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 79.3 mt -122.21 135.34 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.45 24.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.55 -45.58 30.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -168.71 147.21 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.8 mt -135.9 148.89 48.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.6 p -84.26 163.39 47.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.66 -29.63 33.82 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.703 1.602 . . . . 0.0 111.165 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.9 p -84.73 -25.31 28.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -83.5 -34.14 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.6 p -67.01 -18.15 65.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 1.5 56.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.5 p -101.94 36.39 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 77.0 mtm -122.42 143.62 49.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.187 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -81.64 93.77 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.202 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -47.33 -46.69 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.212 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.12 -26.64 68.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.93 27.57 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.2 t -105.83 118.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.23 -29.6 24.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.18 174.82 43.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -122.8 154.49 38.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 0.0 111.226 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -151.51 144.82 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 168.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 -171.43 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -152.1 -0.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.31 152.69 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.72 171.89 26.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 166.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 -6.22 87.91 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -75.24 -1.36 23.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.9 p -66.57 -21.6 66.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 98.8 p -101.48 -35.06 9.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.254 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.06 -47.12 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 53.6 m -49.8 -44.16 48.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.232 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -58.17 -45.45 87.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.7 mt -62.59 -49.28 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.239 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mmm -63.75 -50.04 70.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.63 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.81 -30.84 68.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 81.0 p -79.54 -24.85 41.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.56 -5.36 58.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.207 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 60.32 41.76 15.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 35.7 pt -129.59 155.62 79.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 156.05 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.756 1.637 . . . . 0.0 111.187 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.54 142.55 12.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.78 129.32 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.201 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.56 153.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.229 -173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 73.49 40.75 46.72 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 227' ' ' VAL . 91.3 mt -69.66 -24.43 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.235 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 121.26 -54.7 0.67 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -161.31 27.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 -175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.9 p -51.37 -33.56 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -74.34 -21.12 59.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.0 p -90.33 -20.94 22.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -103.36 23.2 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.19 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.95 149.81 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -139.18 142.06 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.204 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 122.85 12.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 114.01 -19.3 18.17 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.29 -179.26 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.21 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.87 153.46 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.43 141.99 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 89.0 mt -119.72 120.41 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 170.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.92 97.29 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -83.37 80.81 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.79 -33.1 86.34 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 68.7 tp -56.41 -49.21 75.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -80.01 -40.73 27.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 102.06 28.47 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.88 158.57 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 111.218 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 205' ' ' LEU . 99.5 t -133.85 134.69 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.06 127.44 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 130.8 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.37 56.97 9.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.66 153.15 64.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.74 1.627 . . . . 0.0 111.177 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -88.42 -178.48 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.2 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.55 -54.41 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -59.23 -48.37 81.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.4 m -54.14 -46.8 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.216 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 67.6 t -61.13 -46.59 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -68.73 -33.46 73.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.168 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.59 -42.93 99.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.247 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -68.14 -31.83 71.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.47 -44.68 96.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.72 -31.97 69.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.204 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.96 -42.29 76.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -61.88 -37.76 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.183 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.32 -49.77 75.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.7 p -67.94 -28.58 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -63.41 -49.92 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.13 -34.17 75.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.515 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.1 mt -74.95 79.84 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.65 130.01 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.28 -153.17 5.8 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.6 136.44 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 111.218 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.7 76.22 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.184 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.82 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 t -149.94 128.67 6.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.232 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 155.38 33.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.636 1.557 . . . . 0.0 111.195 -175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 170.78 12.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.2 mm -113.18 130.36 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.184 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 220' ' ' VAL . . . -126.42 112.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.55 111.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.23 -162.06 18.02 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.27 163.64 15.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.346 . . . . 0.0 111.236 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.44 109.49 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.58 137.56 52.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 168.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.64 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.207 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -88.1 97.56 11.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.208 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -118.1 135.35 54.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -140.79 159.3 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.173 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -58.93 135.17 57.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.55 130.56 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.179 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.15 109.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.4 p -124.15 152.27 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.85 127.48 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.218 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -81.49 105.14 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.91 14.0 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 -171.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 150.08 25.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.73 158.48 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.55 167.27 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 144.81 55.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -52.38 -37.12 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.1 p -69.52 -15.46 63.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.192 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -94.7 0.01 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.47 -50.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.66 -32.0 73.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.219 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.88 -50.73 72.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.15 -34.28 72.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.188 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.14 -43.61 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.212 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.77 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.93 -44.93 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.52 -48.94 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.182 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.45 -36.2 82.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -66.94 -40.09 87.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.209 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.66 80.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.95 -42.5 99.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.56 -50.99 70.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.16 -43.09 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.209 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.5 m -58.0 -53.1 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -64.0 -39.06 93.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.53 -46.72 88.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.88 -39.8 91.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.73 -39.93 87.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.213 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -56.47 -46.95 80.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.27 -40.36 97.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.75 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -52.36 -49.91 63.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.238 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -57.83 -51.56 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.253 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.66 -42.43 92.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.183 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.05 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.4 tt -56.48 -47.32 79.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.85 -32.31 52.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.229 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -84.79 -47.88 9.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.6 -34.55 5.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.52 161.15 9.86 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.32 -37.97 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.189 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.64 -46.34 63.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -65.8 -37.83 87.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.71 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.69 -34.29 77.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.6 mt -59.27 -44.71 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.48 -30.4 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -58.11 -42.36 85.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.7 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -58.13 -41.91 84.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 77' ' ' LEU . 9.3 tt -59.65 -48.93 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -63.62 -34.95 78.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.4 -39.21 91.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.202 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.26 80.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.7 p -85.0 -9.05 58.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.208 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -63.47 115.45 18.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.207 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.52 -31.26 68.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 0.0 111.207 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.82 -33.2 75.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -81.21 -44.29 18.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.224 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -53.53 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -65.93 -34.76 78.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.99 -46.37 93.81 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.52 -45.47 88.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -64.57 -39.07 93.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.208 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -67.64 -34.34 76.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -64.64 -41.79 95.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.52 -47.37 91.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.59 -46.75 36.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.9 m -64.23 -47.53 79.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -172.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.68 -9.53 34.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.1 mt 57.82 63.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.04 -179.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.172 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.4 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 70.4 p -81.11 164.15 22.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.227 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.04 90.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.4 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 35.6 p-10 -68.6 -36.7 79.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.2 -174.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -64.28 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.84 95.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.19 -49.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.227 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -60.89 -43.49 98.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -66.91 -50.39 62.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.199 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.93 -46.28 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.229 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.22 -44.86 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -64.1 -39.38 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -60.39 -52.94 63.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.99 -37.5 87.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.55 96.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.198 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.6 p -65.85 -30.56 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.193 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.35 -51.56 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.212 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 67.1 mtt -54.71 -40.27 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -68.47 -41.56 79.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.4 p -69.96 -22.11 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.17 -13.42 60.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.16 32.97 19.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -103.74 106.67 17.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.193 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.65 -32.84 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -169.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -60.88 -50.16 74.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.14 -30.4 69.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.55 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.89 -41.96 97.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.96 -34.2 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.95 -41.4 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -56.41 -44.37 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.21 -37.58 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.225 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -61.39 -41.74 97.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.5 -41.89 96.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.13 -44.7 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.19 97.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -55.81 -47.91 76.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -61.0 -45.52 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.212 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.75 -48.73 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.67 -43.59 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.32 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.39 -32.84 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.23 -39.35 86.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.21 -36.94 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.22 27.3 10.18 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.41 125.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -109.88 156.22 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.246 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.0 p -143.32 174.59 10.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.35 106.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -83.8 115.75 22.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.72 -16.07 59.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.9 p -69.43 -13.37 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -88.85 -3.68 58.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.212 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.94 149.48 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.241 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.75 28.55 7.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -150.09 141.42 23.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.222 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.54 113.5 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.12 172.59 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.204 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.04 134.13 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.8 t -113.76 129.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.155 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.7 mt -123.42 136.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -162.02 149.66 14.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -50.05 -49.96 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.177 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.56 153.08 31.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -133.58 141.82 47.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.8 p -116.6 163.89 20.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.61 -35.31 67.07 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.729 1.62 . . . . 0.0 111.192 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.7 p -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -87.76 -30.3 20.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.185 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.425 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 69.7 p -78.9 -11.18 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.78 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.5 p -106.91 21.86 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 168' ' ' THR . 60.9 mtt -100.32 150.59 22.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -117.64 107.45 14.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -62.01 -26.42 68.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.98 -22.42 66.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -105.6 5.56 31.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.51 119.38 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.64 -17.38 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.71 173.55 29.43 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.25 165.99 33.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.246 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.31 152.08 36.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.215 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 38.6 p -126.25 161.86 26.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -172.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -76.47 -41.37 47.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.84 167.55 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 -171.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -113.09 15.02 23.44 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -67.67 -16.0 67.23 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -124.62 37.97 4.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -54.98 -40.55 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.232 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.6 p -63.88 -32.57 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.8 -35.22 62.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -70.43 -27.24 64.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.51 76.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.38 -46.28 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 28.4 ttt -60.89 -52.87 63.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.234 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -64.37 -56.56 13.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.2 m -63.42 -42.19 98.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.187 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.65 -17.63 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 63.4 51.79 2.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.169 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.26 157.15 76.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 158.25 56.59 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.73 1.62 . . . . 0.0 111.161 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -154.28 135.55 14.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.09 123.16 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 157.58 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.47 17.7 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.45 -3.02 58.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.233 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.35 -65.43 3.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.36 42.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 111.186 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -24.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.4 p -68.21 -21.59 64.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.2 p -97.08 -25.36 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -85.24 -23.05 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.209 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.92 128.43 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.89 150.97 26.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.45 129.11 40.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.46 -19.06 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.97 159.85 32.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.28 133.29 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.37 132.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.2 117.05 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 171.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 12' ' ' ALA . 67.3 t -104.78 115.27 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.99 98.69 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.7 -39.32 86.22 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.1 -46.76 87.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.771 0.32 . . . . 0.0 111.194 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -73.97 -35.86 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 173.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.36 7.28 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.5 pt -132.67 154.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.218 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.76 134.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.83 130.54 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.11 136.81 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.261 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 90.3 m-20 59.11 51.43 3.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 98.6 Cg_endo -72.25 155.77 55.82 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.683 1.589 . . . . 0.0 111.219 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -91.39 -177.83 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.65 -50.79 72.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.63 -48.78 78.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.6 m -54.41 -46.71 73.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 57.9 t -59.11 -45.02 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -69.26 -34.12 74.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -50.15 73.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.41 -26.88 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.12 -43.66 95.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 80.5 p -72.13 -29.55 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.93 -36.59 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -53.39 -52.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.33 -39.16 93.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.8 m -61.03 -38.77 87.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -70.93 -38.5 72.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.17 -32.99 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.9 mttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -175.003 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.63 148.7 24.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.82 134.32 38.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.74 -149.39 5.07 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -97.02 122.7 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.72 88.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.183 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.93 -38.78 76.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.191 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -148.49 141.41 15.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.212 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.07 165.11 24.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.728 1.619 . . . . 0.0 111.203 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.4 -178.51 16.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -131.11 132.04 63.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.64 127.03 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 HG12 HG12 ' A' ' 219' ' ' ILE . 69.5 mt -127.87 122.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.57 -147.19 10.01 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.43 149.63 25.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 111.207 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.26 127.49 53.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.66 140.74 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.199 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 tp -106.7 122.93 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.194 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -97.27 90.21 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.1 m -116.5 129.1 56.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -100.8 152.18 20.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.87 127.29 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.176 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -78.8 119.24 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.34 162.2 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.4 p -129.36 171.61 12.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.235 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -118.32 127.75 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.52 114.12 20.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.78 2.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.84 136.16 57.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.33 130.4 46.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.185 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.51 172.98 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.29 143.94 50.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.59 -37.5 63.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.236 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.4 p -69.03 -15.19 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.92 2.89 55.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.76 -49.97 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.15 -32.77 74.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -59.44 -48.85 80.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -68.42 -34.63 76.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.2 -45.12 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.207 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.58 95.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.22 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -58.35 -45.51 88.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.243 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.98 -50.27 74.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.5 -44.01 93.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.174 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.45 -46.64 79.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.9 79.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.9 -45.72 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.23 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.75 -44.97 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -56.95 -43.36 81.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.28 -44.26 88.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.21 -38.4 87.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.249 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -65.59 -40.45 92.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.25 -40.74 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.201 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -63.42 -39.69 95.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.63 -38.76 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.197 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.57 -41.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -55.7 -46.33 77.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.0 -53.08 62.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.21 -36.89 84.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.51 94.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.428 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.5 tt -55.55 -44.46 76.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.13 -43.66 77.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -88.87 -48.02 7.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -91.95 -48.04 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.197 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.83 162.19 10.15 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.21 -37.74 64.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.205 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -49.63 -42.53 45.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.83 -37.8 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.35 80.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.222 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.08 -33.65 76.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.68 -43.03 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.07 -20.56 55.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.41 -40.17 85.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.31 98.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.256 172.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -57.68 -41.72 82.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.48 -44.81 89.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.15 -37.06 85.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.248 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.44 -36.82 85.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.19 65.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -93.82 0.27 56.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.35 117.15 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.54 -32.05 61.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.689 1.593 . . . . 0.0 111.219 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.23 -35.75 78.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.44 -45.38 69.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.66 -56.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.64 -28.24 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.27 -50.02 71.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.4 t -69.06 -41.27 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.249 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -55.02 -49.12 72.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.191 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.03 -32.47 72.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.12 -42.3 94.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.61 -39.16 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.86 -40.35 95.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.1 m -72.13 -55.12 7.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -113.67 124.09 51.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 mp -77.04 75.03 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -126.08 167.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.4 m -58.83 138.48 57.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.81 -44.63 39.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.21 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -56.09 -41.46 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -63.12 -42.28 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.182 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.14 99.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.222 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.98 -47.66 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.54 -45.14 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.59 -48.66 76.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.22 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.11 -47.29 94.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.205 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.6 mt -65.33 -42.74 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -58.48 -43.99 89.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.31 -47.45 79.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.202 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.19 -37.8 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.85 97.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.6 p -65.95 -30.7 71.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.194 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.32 -50.21 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.212 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 68.1 mtt -56.84 -38.51 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.172 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.94 -41.52 82.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.225 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.9 p -69.24 -21.39 63.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.219 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.33 -10.98 59.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 59.67 35.22 22.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -103.69 104.95 15.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.186 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.01 -33.93 76.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -60.04 -50.33 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.65 -30.48 69.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.72 -42.63 93.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.19 -41.88 96.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -68.03 -32.14 72.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.281 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.02 97.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.95 -42.42 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.216 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.87 -38.73 82.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.28 -38.87 85.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.193 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.04 -42.36 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.79 -45.26 92.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.03 -46.58 91.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.64 -43.86 97.36 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.83 -39.76 90.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.156 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -70.04 -38.2 75.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.29 -44.68 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.214 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.34 -45.4 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -60.67 -43.0 98.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -69.48 -39.97 77.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -70.19 -44.4 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.13 -20.0 52.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.24 43.13 8.22 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.33 119.67 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 111.23 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.95 154.09 36.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 94.2 p -147.13 167.4 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.42 127.35 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -81.92 72.06 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.221 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.79 0.69 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.15 -9.88 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 170.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -107.61 23.73 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.93 132.37 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.199 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -109.43 -2.33 17.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.201 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -149.51 158.79 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.61 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.38 161.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.31 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.51 116.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.91 115.53 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.78 145.6 41.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 -170.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -67.22 -33.69 75.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.188 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -154.43 154.52 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -126.76 75.04 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -86.66 159.56 52.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.01 -40.6 67.35 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.733 1.622 . . . . 0.0 111.235 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.1 m -66.96 -39.84 87.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.5 -52.82 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.5 p -77.12 -20.41 55.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.72 67.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.159 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 66.7 p -90.83 -29.73 17.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 68.5 mtt -59.31 133.74 56.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.63 88.41 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.213 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -50.7 -43.39 57.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.64 -13.25 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.87 27.32 9.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.16 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.45 124.23 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.23 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.62 -25.94 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.41 158.9 22.52 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -108.68 148.59 30.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -155.97 150.37 25.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 t -162.27 -177.65 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.222 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.55 -27.48 8.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.231 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.27 126.09 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.201 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.0 166.33 48.42 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.78 -7.75 81.17 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -106.76 9.88 30.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.4 m -65.31 -44.77 86.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.9 p -71.63 -41.43 68.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.29 -48.01 83.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -57.96 -43.97 86.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.02 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.218 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.36 -47.64 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.6 mtm -61.56 -51.76 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.33 -46.77 87.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.241 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.35 -31.48 70.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.7 p -69.56 -18.03 63.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 199' ' ' ILE . 93.9 mt -107.08 -0.12 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 57.09 45.16 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.239 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 197' ' ' LEU . 38.9 pt -128.65 158.19 72.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.7 161.77 33.4 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.725 1.617 . . . . 0.0 111.167 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.27 136.67 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 52.1 t -134.47 126.49 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.29 152.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.183 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.43 46.39 6.92 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.47 11.4 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.252 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.32 -89.72 1.42 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -137.58 45.42 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.196 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.36 -25.78 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.5 p -72.35 -6.63 44.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -112.3 5.42 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.215 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -118.06 -5.16 10.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.37 145.2 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.72 158.25 40.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.82 117.9 4.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 102.58 2.48 50.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.1 150.62 38.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.45 123.66 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.94 142.79 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.197 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.405 HG12 HG12 ' A' ' 13' ' ' ILE . 79.3 mt -116.16 125.81 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.225 171.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.1 99.34 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -90.89 91.65 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.216 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.25 -35.36 76.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.35 -47.13 85.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.241 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.57 -36.8 65.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.65 34.71 6.47 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.3 pt -131.4 154.45 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 111.172 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.7 t -133.3 136.4 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.61 118.41 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.31 130.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.192 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.92 57.79 3.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.205 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.41 154.97 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.695 1.596 . . . . 0.0 111.256 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 159.61 33.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.156 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -53.85 -49.15 69.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.14 -47.34 83.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.204 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.0 m -51.48 -46.86 63.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.57 -48.83 82.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.99 -32.56 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.01 -46.08 90.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.201 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.68 -26.51 63.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.11 -45.35 95.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 79.3 p -71.76 -29.24 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.2 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -66.88 -42.32 85.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.34 -42.14 81.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.47 -48.03 77.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.224 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 64.4 p -69.94 -23.23 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -71.12 -38.44 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 173.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -79.37 -34.36 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.2 -1.507 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.199 -177.243 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -98.74 107.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.186 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -103.82 135.68 44.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.46 -138.69 2.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.19 122.59 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 0.0 111.23 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.76 87.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.54 87.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -148.97 135.85 10.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 161.68 36.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.719 1.613 . . . . 0.0 111.209 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.6 -176.18 16.32 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.41 125.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.191 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 177' ' ' LEU . . . -116.48 126.24 53.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.218 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.5 mt -123.91 117.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.68 -157.59 13.04 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.53 167.69 13.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 218' ' ' VAL . . . -99.25 144.78 27.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 175.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -141.26 111.44 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 164.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.8 tp -87.47 115.08 24.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.209 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.74 97.01 6.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -86.59 164.17 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.224 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -115.56 106.88 14.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.41 128.33 36.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.171 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.78 127.03 29.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -87.22 111.96 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -87.72 124.88 34.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.204 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.98 118.93 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.53 102.93 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.209 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -87.4 -5.25 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.91 139.25 52.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.05 158.74 32.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 pt -119.02 172.5 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -76.19 157.75 32.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.78 -32.53 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -72.57 -14.84 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -96.48 -0.34 49.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.1 -51.08 77.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.07 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.33 -51.19 71.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -71.11 -34.12 70.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.85 -43.92 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.221 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.92 -45.18 90.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.216 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.16 -47.7 84.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.08 -36.21 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -40.51 94.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.81 76.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.95 -42.6 99.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.183 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.99 -43.43 98.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.71 -40.71 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.233 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.4 m -67.04 -43.63 82.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.186 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -63.98 -42.87 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -59.0 -49.17 78.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -52.09 -58.76 5.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.34 -42.05 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.196 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.98 -45.91 82.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.202 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.41 -34.59 77.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.27 -49.26 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -68.21 -27.06 66.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.39 -51.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.242 170.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.8 -37.02 83.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.24 93.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.204 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.4 tt -60.15 -46.76 88.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.213 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.94 -34.32 77.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.148 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -87.65 -45.13 10.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.218 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.73 -36.42 3.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.47 -172.08 14.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.86 -26.29 68.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 111.207 -175.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -43.53 -45.77 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.22 -31.25 12.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.71 91.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.42 -30.99 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.183 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.41 -45.78 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.01 -27.52 57.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.58 -44.27 89.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.92 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -61.68 -38.37 87.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.18 -44.14 89.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.21 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.4 mtm -62.61 -38.02 88.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.234 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.11 -39.87 95.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.218 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.56 -23.31 66.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.254 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.1 p -98.38 -3.75 36.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -66.11 113.71 13.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.29 -32.89 82.94 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.71 1.607 . . . . 0.0 111.239 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -67.4 -43.71 80.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.97 -36.58 69.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.35 -52.29 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.49 -34.48 77.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.48 -47.06 90.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.44 -44.87 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.218 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -62.85 -39.59 94.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.66 -33.83 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.0 tpp -65.32 -41.54 93.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.29 -47.75 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.29 -46.53 49.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.235 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.2 m -65.14 -48.43 73.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 -172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.32 -9.82 34.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.8 mt 57.48 64.08 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 179.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.9 p -80.3 163.37 24.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.96 86.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.85 -50.71 72.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.17 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -67.31 -40.24 86.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.211 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.65 85.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.34 -45.8 97.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.201 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -58.48 -43.81 89.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -67.48 -49.67 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.192 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.64 -46.31 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.195 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.4 mm -65.93 -42.54 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.178 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -67.0 -38.2 85.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.201 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -65.75 -44.85 84.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.186 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -66.7 -40.45 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.194 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.08 97.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.186 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.3 m -59.24 -42.98 92.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.77 -52.91 56.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 56.9 mtt -54.74 -42.09 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -69.66 -39.53 77.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.3 p -70.39 -19.86 62.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.184 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.11 -7.14 56.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 60.44 37.45 19.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -115.05 112.54 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.06 -30.35 70.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.12 -50.3 72.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.255 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.44 -28.78 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.6 -42.96 99.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -42.03 95.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.98 -34.04 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.97 94.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.46 -41.81 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -57.07 -43.33 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.195 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -62.48 -41.19 98.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.223 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.84 -50.32 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.189 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.87 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -44.64 95.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.21 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.07 -38.03 89.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.35 -48.43 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.205 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.23 -41.24 90.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.9 -38.42 88.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.07 -28.26 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.3 mt -68.67 -48.31 64.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.1 tp -74.7 -52.46 11.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.59 35.76 0.83 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.76 127.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.234 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.13 155.47 25.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.182 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 85.1 p -156.79 169.67 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.6 128.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -86.66 106.15 17.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.4 mt -90.77 10.82 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.3 p -90.91 -7.46 52.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -106.71 27.53 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.69 137.3 51.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.0 27.99 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -169.56 138.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.18 123.14 17.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.197 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.84 144.36 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -167.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.96 121.49 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.1 t -93.66 118.3 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 -174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.401 HG22 HG22 ' A' ' 209' ' ' THR . 48.5 mm -112.13 126.79 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.219 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 148.06 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.225 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.87 -41.56 82.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.22 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -112.91 151.65 30.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.4 tp -154.24 122.24 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.8 p -112.48 161.65 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.214 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.23 -35.86 84.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.691 1.594 . . . . 0.0 111.235 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.5 p -74.6 -10.08 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.204 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.99 -40.85 12.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 171.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 -22.93 64.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.52 -9.29 58.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.6 p -111.91 -28.47 8.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.6 mtp -57.29 94.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -41.73 105.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.185 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -64.43 -22.03 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -72.15 -27.92 62.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.1 -39.66 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.25 119.0 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.417 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 94.7 mt -96.18 -15.56 22.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.99 178.4 43.89 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -158.49 137.05 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -115.71 139.24 50.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.216 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.3 m -120.43 138.36 53.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.09 -42.95 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.227 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.58 137.61 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.225 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.85 177.75 29.4 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.32 54.02 0.66 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.9 26.84 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.8 p -74.21 -30.58 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.196 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.2 p -77.24 -30.83 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -61.2 -48.78 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 172.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.2 m -55.77 -42.43 75.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.225 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.19 97.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.45 -45.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 ttp -58.11 -53.07 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.26 99.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -70.84 -33.11 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.18 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.6 m -69.96 -37.47 75.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.7 -7.44 57.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 61.33 48.98 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 47.6 pt -126.82 149.32 68.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.22 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 49.3 Cg_exo -60.76 146.41 97.4 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.744 1.629 . . . . 0.0 111.201 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.44 138.87 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.196 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 76.9 t -129.81 127.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.6 164.93 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.65 26.1 59.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 90.9 mt -78.33 -31.65 48.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.9 4.57 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -100.27 2.81 43.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 111.247 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.07 -27.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.184 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 159' ' ' ILE . 29.7 p -81.84 -6.92 59.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 96.3 p -106.07 -29.35 9.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.216 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -91.59 -24.48 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.212 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.0 t -111.88 119.14 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.227 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.6 157.75 33.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.241 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.39 128.36 35.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 108.18 -20.91 30.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -71.15 165.11 24.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.21 138.32 34.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 16' ' ' ALA . 86.1 t -127.29 131.06 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.171 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.8 mt -114.92 112.54 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.46 96.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -93.39 88.11 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.246 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.86 79.63 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.83 -38.46 88.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 111.22 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -94.07 -31.09 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.186 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.32 34.85 7.27 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 pt -131.8 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.3 t -128.42 135.09 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.237 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.46 127.47 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.186 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.23 133.66 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.404 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 95.7 m-20 50.67 56.56 17.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.211 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 70.7 Cg_endo -70.49 156.81 60.66 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.697 1.598 . . . . 0.0 111.192 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.03 161.01 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -52.46 -48.97 65.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.89 -46.43 84.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.186 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -55.65 -43.6 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 64.1 t -60.12 -46.05 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.99 -34.38 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.244 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.92 -48.26 79.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.51 -26.21 60.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.229 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.11 -46.71 86.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.9 p -69.27 -31.83 70.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 -38.56 79.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.207 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -61.05 -43.27 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.55 -40.73 95.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.22 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 75.2 m -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.221 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.83 -49.29 78.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.208 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.52 -36.09 82.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.219 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.52 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 87.7 mt -80.18 80.3 6.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.54 130.91 41.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.96 -150.52 5.23 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.1 114.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.5 87.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.07 73.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -151.32 141.51 14.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.07 160.75 29.96 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.699 1.6 . . . . 0.0 111.204 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.06 -177.17 18.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -134.41 122.87 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 111.216 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.88 123.48 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.31 112.75 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.73 -160.86 20.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -83.41 150.55 25.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.37 128.37 38.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.21 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -126.8 139.05 53.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.3 tp -105.85 131.92 52.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -113.09 116.79 30.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.1 p -125.46 169.7 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.243 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -150.8 136.59 18.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -58.78 136.01 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.86 137.37 58.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -86.7 113.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.3 m -120.34 117.08 26.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.35 127.21 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.211 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -80.65 107.29 13.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.22 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.24 22.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.778 ' O ' ' CB ' ' A' ' 30' ' ' LYS . 88.8 tt0 -59.51 -61.57 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.778 ' CB ' ' O ' ' A' ' 29' ' ' GLU . 87.1 tttt 124.9 140.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.201 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.427 ' C ' HD12 ' A' ' 31' ' ' ILE . 2.9 pp -121.17 166.23 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -90.93 165.9 13.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.212 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -52.23 -41.21 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.198 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.8 p -69.88 -18.17 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.92 2.5 49.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.256 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.88 -52.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.04 -32.6 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.1 -50.84 72.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.25 -33.77 72.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.196 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.64 -44.83 99.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.51 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.38 -46.67 88.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.179 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -60.0 -51.14 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.31 -39.7 80.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.63 -58.8 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.199 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.8 69.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.201 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.3 tm? -65.32 -50.46 65.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.93 -38.91 90.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.21 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.02 -41.3 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.6 m -60.49 -41.95 95.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -57.23 -49.89 74.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.81 -46.18 88.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -52.65 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.06 -40.87 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.42 -43.14 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.178 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -34.46 72.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.8 mt -63.81 -47.97 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -72.08 -27.47 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.222 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.47 -46.31 90.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.35 -40.14 67.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.92 78.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 62' ' ' LEU . 10.0 tt -52.33 -45.38 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.07 -33.17 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.22 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.71 -44.16 24.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.233 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -118.13 -35.64 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.17 170.33 12.74 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.5 -26.89 68.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.205 -174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.8 -44.88 39.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.98 -33.91 39.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.03 83.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.251 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.35 -38.13 86.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.219 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.3 mt -60.34 -44.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -78.27 -24.57 46.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.01 -41.26 96.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.77 87.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.39 -39.72 94.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.206 174.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.68 -43.61 96.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.2 ttp -52.49 -48.12 66.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.202 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.9 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.32 67.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.8 p -92.14 -14.58 28.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -64.87 118.94 53.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -52.95 -32.29 56.88 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.71 1.607 . . . . 0.0 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -50.54 -39.27 48.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.16 -47.69 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.39 -56.77 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.229 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -75.09 -31.31 61.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.18 -48.27 81.25 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.22 -42.34 84.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.203 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -53.71 -47.22 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.47 -35.44 79.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.7 tpp -63.78 -41.88 97.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.87 -47.97 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.58 -44.55 64.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -65.83 -48.22 72.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.198 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -94.65 -10.95 30.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.95 63.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.224 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.79 169.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -70.57 163.09 27.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.182 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.29 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.12 -42.73 99.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.86 96.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -55.91 -48.45 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.226 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -57.87 -44.19 86.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.5 -45.42 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.55 -44.08 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.404 HG21 ' HA ' ' A' ' 131' ' ' ARG . 38.6 mm -65.57 -45.54 92.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.03 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.168 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -59.85 -54.86 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -67.72 -39.01 84.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.212 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.29 99.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 m -61.17 -42.86 99.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.202 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.3 -49.78 83.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 59.4 mtt -56.4 -41.15 75.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.78 -38.83 73.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.203 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.8 p -69.37 -20.58 63.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.0 -9.6 59.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.24 32.82 20.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -104.36 106.99 17.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.42 -33.16 74.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.231 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.32 -50.01 75.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.53 -30.09 68.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.74 -42.04 98.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.64 -40.94 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.192 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -66.03 -33.63 76.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.177 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.53 92.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.07 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -57.37 -42.94 83.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.36 -42.55 96.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.197 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.404 ' HA ' HG21 ' A' ' 108' ' ' ILE . 91.3 mtt180 -63.8 -39.65 94.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.243 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.3 -47.59 83.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.17 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.53 -44.62 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.53 -42.97 97.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -61.38 -41.87 97.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -59.97 -42.47 94.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.68 -47.23 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.05 -43.61 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.17 -38.25 88.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -71.55 -30.71 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -69.94 -40.39 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.13 -28.99 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.201 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.19 35.8 9.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 82.6 t -71.19 123.66 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.232 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.23 165.83 14.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 88.1 p -143.69 171.29 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -84.56 78.55 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.245 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.11 -6.28 59.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.4 p -74.29 -9.25 58.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.13 0.65 55.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.56 145.35 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.54 32.54 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -143.92 140.88 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.59 99.28 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.19 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.74 -179.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.6 t -94.8 122.95 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.58 117.75 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.76 125.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.218 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.09 49.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -63.14 -56.47 16.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -146.34 176.76 9.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.69 145.12 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.6 p -129.6 155.69 79.89 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.34 -38.34 72.95 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.714 1.609 . . . . 0.0 111.215 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -43.85 75.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.28 -46.28 64.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 65.0 p -67.89 -29.71 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.85 -29.37 70.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.1 p -108.46 14.55 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 63.1 tpp -71.65 115.58 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.55 77.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.2 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.424 ' HB2' HD11 ' A' ' 197' ' ' LEU . 63.7 pttt -63.16 -20.7 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.241 -172.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.11 -31.02 68.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -112.47 32.27 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.43 106.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.1 tp -80.52 -40.04 26.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.43 176.81 27.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -154.89 139.59 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 111.185 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.02 25.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.6 t -143.65 154.42 43.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.63 -53.31 57.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.14 124.78 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.11 74.22 0.84 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.5 -31.69 81.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.51 60.11 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.19 174.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.6 m -59.21 -37.36 77.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.211 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t -58.31 -56.46 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -59.37 -40.14 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.3 -46.87 88.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.84 92.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.09 -48.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.236 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.85 -35.71 81.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.19 98.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.184 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.55 -38.62 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.174 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 t -61.53 -43.03 99.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 173' ' ' LYS . 90.3 mt -88.24 -16.09 34.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 61.69 51.26 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.174 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 44.4 pt -127.68 159.67 64.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 92.3 Cg_endo -76.68 163.35 31.76 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.666 1.577 . . . . 0.0 111.251 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.55 135.73 11.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.18 122.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.95 160.35 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.91 38.64 35.42 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.17 -6.41 57.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.327 . . . . 0.0 111.201 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.28 -64.73 4.14 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 171.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -141.38 44.33 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.69 -22.67 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.7 p -70.44 -22.29 62.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.0 p -90.29 -27.08 19.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -90.69 -27.94 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.242 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.6 116.6 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.243 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.15 166.4 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.52 125.6 24.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.11 -18.06 40.09 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.83 165.27 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.23 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 62.4 tp -100.26 125.98 46.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.172 171.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.58 138.71 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.203 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.38 126.01 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.2 171.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.08 100.77 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -99.68 93.61 5.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.34 -22.51 73.08 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.25 -39.22 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -103.23 -15.3 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.71 37.33 26.81 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.96 155.73 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 73.6 t -120.27 135.31 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -109.21 129.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.65 117.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.177 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.76 60.4 11.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.223 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.0 153.18 68.07 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.714 1.609 . . . . 0.0 111.209 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -88.78 -176.52 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.76 -53.95 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -59.27 -48.87 80.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.9 m -53.99 -47.37 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.63 -45.82 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.203 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.72 -34.22 77.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.32 -41.73 98.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.215 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -75.96 -29.62 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -63.23 -41.62 99.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 47.8 t -62.67 -46.56 87.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.199 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.61 -42.83 93.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.62 -47.16 85.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.01 -47.07 88.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.5 p -61.94 -28.32 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.57 -53.65 6.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -77.45 -42.41 36.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.529 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.179 -176.531 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.8 mt -100.79 140.55 34.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.06 136.3 43.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.228 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.8 -138.45 2.52 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -102.19 119.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 111.233 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.54 87.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.95 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.218 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 t -150.28 138.64 12.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.238 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.81 160.67 34.04 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.696 1.597 . . . . 0.0 111.199 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.87 175.16 13.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -125.09 124.6 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.92 132.8 52.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -129.57 127.39 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.31 -153.74 24.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.01 154.71 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.171 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.67 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 31.7 m-85 -121.46 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.59 117.96 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -66.28 124.37 22.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -117.83 131.5 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.96 130.09 50.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.04 135.07 56.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.73 128.2 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.68 93.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.1 m -97.73 112.88 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.48 126.83 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -99.68 103.43 15.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.27 20.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.214 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.16 138.9 47.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.22 139.51 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 pt -118.12 170.28 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.214 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.42 146.19 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -64.03 -20.65 66.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.0 p -73.56 -14.44 61.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -98.42 4.43 48.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.2 -51.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.01 -32.8 74.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.85 -49.26 78.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.196 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.7 -37.3 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.65 -44.6 98.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.27 84.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -64.01 -37.97 89.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -59.28 -49.15 78.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.2 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.49 -36.68 84.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.7 -40.41 92.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.19 -33.49 76.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.65 -40.97 98.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.253 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.64 -42.76 99.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.58 -39.98 85.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.206 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.0 m -63.17 -41.61 99.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -60.97 -44.81 96.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.225 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -59.39 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.58 -55.91 21.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.58 -42.99 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.166 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.95 -49.33 77.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.36 -36.76 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.7 mt -63.03 -45.61 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.17 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.7 -43.72 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -55.35 -52.95 61.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -60.03 -42.85 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -43.11 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.42 -45.02 95.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.21 -31.71 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -97.06 -39.78 9.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.3 -34.91 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.25 -171.91 15.72 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -63.26 -26.13 68.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 111.175 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -45.59 -42.28 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.98 -34.74 10.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.46 -39.21 93.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.9 -32.68 74.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.16 -41.61 91.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.214 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -77.46 -24.09 50.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.36 -41.07 96.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.192 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.79 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -59.64 -41.16 89.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.187 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.73 -43.37 93.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.9 mtm -64.82 -36.09 83.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.86 -45.68 88.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.65 -33.12 74.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.3 m -94.69 1.93 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -65.79 114.17 15.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.86 -33.9 83.48 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.689 1.593 . . . . 0.0 111.216 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -67.94 -43.74 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.198 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.12 -36.69 72.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.96 -51.85 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.19 -35.16 79.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.19 -46.25 91.81 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.29 -46.59 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.37 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.76 -36.39 80.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp -63.68 -40.34 96.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.177 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.88 -50.91 77.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.51 -42.19 71.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.8 m -63.69 -47.37 81.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -99.17 -6.07 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt 59.97 45.05 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.66 -179.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -76.31 163.2 27.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.207 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.66 77.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.19 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.49 -53.17 60.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -59.86 -47.55 85.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -51.24 70.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.247 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.73 -46.1 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -54.84 -47.27 74.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -73.07 -47.86 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.81 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.411 HG23 ' HG ' ' A' ' 130' ' ' LEU . 33.5 mm -65.42 -43.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.43 -44.69 95.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.86 -56.15 25.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.211 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.77 94.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.2 p -67.16 -30.59 70.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.164 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.72 -51.61 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 76.1 mtm -60.3 -35.42 75.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.79 -37.93 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.5 p -70.63 -20.0 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.86 -12.54 61.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.44 32.05 14.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.199 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -105.53 112.45 25.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.176 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.41 -30.67 68.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.38 -50.05 71.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.24 -25.18 62.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.99 -45.23 89.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.218 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.51 -42.13 91.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.93 -33.76 76.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.61 94.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.76 -43.47 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -56.39 -45.82 80.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HG ' HG23 ' A' ' 108' ' ' ILE . 57.7 tp -63.06 -45.08 93.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.229 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -58.41 -43.01 88.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.178 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.53 -48.84 79.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.0 -47.16 90.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.06 -45.14 95.69 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -61.69 -41.67 97.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.346 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -69.71 -33.04 71.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.04 -46.08 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.92 -43.02 96.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.31 -35.65 79.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.76 -31.15 64.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.37 -38.93 88.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.193 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.5 -28.09 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.72 38.23 10.84 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.26 120.37 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.208 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.75 161.37 14.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 72.0 p -160.32 169.73 22.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.8 t -72.42 123.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.185 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.74 74.89 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.215 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.37 -25.67 66.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.196 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.1 p -70.45 -14.05 62.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.219 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -96.46 5.5 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.25 137.67 41.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -110.15 41.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -148.38 143.58 26.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.173 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -57.99 104.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.219 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.49 157.03 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.28 134.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.19 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.1 105.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.18 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.3 mm -104.22 124.21 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -157.95 156.86 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -78.51 -39.92 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -159.11 111.17 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.55 151.15 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -108.4 162.06 21.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.04 -32.98 60.85 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.714 1.609 . . . . 0.0 111.194 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.3 p -69.79 -19.02 63.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -94.54 -38.6 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -77.92 -16.93 57.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.212 -175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.45 -2.97 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.209 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.6 p -88.92 -18.28 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 96.0 mmm -77.95 130.49 36.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.1 129.72 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -48.66 -50.12 34.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -82.12 -3.36 54.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.191 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.5 mmt -110.19 10.35 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.182 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -119.86 122.39 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.78 -36.04 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.22 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.85 -178.68 45.64 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.54 144.25 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 65.5 p -131.41 159.11 38.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.214 -170.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.57 -33.08 64.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.3 m -115.36 163.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -108.93 24.3 21.75 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.46 -21.86 70.9 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.35 31.43 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 111.197 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.6 m -51.99 -48.52 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.7 p -65.37 -30.31 71.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -76.51 -39.16 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.9 p -70.29 -28.12 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -67.61 -52.78 34.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.65 -46.5 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 43.7 ttp -61.65 -55.0 35.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.234 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.19 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.198 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.09 -41.51 97.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -70.93 -22.6 62.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.227 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.1 -2.17 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.23 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.64 35.37 9.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 45.9 pt -132.31 154.26 81.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.234 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.11 160.63 39.58 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.754 1.636 . . . . 0.0 111.166 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 139.33 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 57.3 t -132.64 109.43 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.02 165.41 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.193 -168.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 70.43 39.3 69.71 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.77 -35.37 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 119.53 -53.95 0.66 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -143.95 31.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.54 -25.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -70.57 -22.52 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.21 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.1 p -94.38 -25.82 16.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -94.61 -24.24 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.11 125.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -115.69 164.27 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . . . -61.01 125.37 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.74 -12.38 50.12 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -71.23 144.68 50.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.08 124.26 27.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -132.4 136.77 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.48 124.81 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 80.8 t -97.78 112.6 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -108.91 93.14 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.94 -10.56 83.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.37 -39.5 47.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 111.195 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -93.72 -25.59 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.2 39.36 8.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.7 pt -132.44 160.55 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 111.183 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.12 133.0 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 78.5 mt -113.15 121.39 65.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.89 134.7 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.539 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 87.2 m-20 54.63 61.79 8.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 -171.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 230' ' ' ASN . 50.8 Cg_exo -58.43 145.85 92.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.736 1.624 . . . . 0.0 111.173 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.94 157.74 36.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.186 169.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.06 -48.46 61.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.14 -45.22 93.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.224 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.5 m -57.55 -42.6 83.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.225 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.5 -48.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.67 -35.09 74.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.85 -51.92 66.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.198 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -72.58 -26.83 61.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.19 -51.56 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 92.1 p -69.32 -34.48 74.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.2 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.26 -42.85 75.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -53.52 -49.81 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.216 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -35.83 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 72.4 m -58.52 -38.91 78.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.206 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -178.63 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 91.5 mt -79.76 81.75 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.253 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.61 134.84 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.1 -141.19 3.14 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.06 115.06 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 111.174 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.62 133.12 35.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.1 -32.5 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.8 t -165.39 137.05 3.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.82 144.65 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.675 1.583 . . . . 0.0 111.198 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.94 173.14 16.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.3 mt -133.73 120.51 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 111.202 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.08 124.62 49.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.72 115.71 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.97 -157.41 14.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.59 162.75 13.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 111.18 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.02 132.53 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.183 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -121.13 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -102.13 133.0 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.151 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -134.01 114.79 13.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.3 p -105.91 172.13 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -154.42 132.21 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -109.61 157.08 19.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.176 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.27 128.43 34.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.1 t -102.09 132.44 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.183 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -62.59 129.37 40.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.76 133.31 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -74.24 104.24 4.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.212 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.26 21.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.54 -98.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.21 149.15 44.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.03 165.53 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -59.33 137.51 57.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -54.33 -38.07 65.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -68.59 -15.72 63.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.8 0.03 57.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.15 -51.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -65.43 -33.06 75.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.11 -50.03 75.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -69.82 -34.49 73.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.208 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.28 -43.78 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.51 89.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.04 -45.73 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -60.12 -51.18 70.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.06 -42.61 99.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.25 -55.26 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.46 75.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.202 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.11 -47.05 75.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.61 -40.73 88.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.31 -44.89 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -57.62 -45.04 85.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.222 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -60.53 -47.82 84.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -58.31 -47.96 82.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.57 -48.81 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.68 -44.24 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.205 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.04 -49.62 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.85 -45.9 76.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.43 -26.66 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.16 -50.85 72.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.19 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.64 -46.23 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.219 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.22 -48.77 79.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.24 93.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 62' ' ' LEU . 9.8 tt -55.64 -47.35 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.204 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.81 -34.25 34.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -79.88 -42.34 24.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.12 -33.63 4.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.56 168.64 12.62 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.36 -22.05 66.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.164 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.16 -36.85 80.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -85.23 -30.52 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.94 77.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -54.01 -36.26 62.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.206 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.09 -46.9 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -75.61 -28.05 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.211 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -59.53 -49.06 79.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.198 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -69.16 -33.1 72.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.76 -43.25 80.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.99 -40.76 98.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.55 -40.66 97.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.81 70.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.175 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.8 p -91.87 -1.02 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.3 115.95 28.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.38 -17.56 23.89 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.735 1.623 . . . . 0.0 111.228 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -71.62 -41.28 69.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.215 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.71 -38.32 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.224 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.2 -48.87 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.215 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.86 -43.48 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.64 64.15 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.66 -45.97 96.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 111.188 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.91 -38.3 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.71 -33.22 72.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.6 tpp -64.18 -43.0 96.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.204 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.0 mt -58.85 -47.86 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.16 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -73.52 -46.57 46.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -66.51 -48.4 69.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -96.2 -7.55 35.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.233 -174.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.9 64.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.161 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.86 169.0 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.24 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.9 p -76.01 162.4 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.4 81.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.02 -48.52 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.12 -45.68 80.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -47.67 85.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.201 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.48 -48.17 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.225 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.63 -41.14 85.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.203 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -68.47 -50.9 49.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.28 -44.41 91.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -61.76 -44.5 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.227 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -65.29 -42.35 93.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -59.17 -54.91 41.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -66.75 -38.83 87.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.89 93.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.0 p -65.8 -32.24 73.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.14 -51.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 96.7 mtp -57.23 -37.46 72.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -73.07 -37.96 66.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.198 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.2 p -70.21 -19.21 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.05 -11.78 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.211 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.59 32.35 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -105.89 113.01 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.198 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -59.86 -30.33 68.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.73 -50.02 70.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.32 -27.34 65.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.73 -46.55 84.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.77 -43.58 90.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.217 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -69.39 -32.4 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.238 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.9 85.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.248 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.0 t -60.02 -45.83 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.228 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.62 -43.5 84.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -45.53 93.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.95 -41.2 95.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.21 -48.1 83.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.34 -44.34 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.84 -44.44 92.13 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.98 -39.69 95.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.221 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.78 -37.01 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.219 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.99 -45.49 98.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -60.73 -41.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -47.08 77.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.222 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -71.24 -29.44 65.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.68 -40.18 88.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 172.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.07 -26.23 39.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.33 30.62 15.92 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.29 126.32 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.76 163.14 13.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.2 p -148.88 163.1 38.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -118.92 131.04 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.211 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -82.75 114.58 21.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.407 HD12 ' C ' ' A' ' 149' ' ' LEU . 3.6 pp -67.72 -23.11 65.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.4 p -73.12 -13.27 61.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -99.02 8.55 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.23 148.27 35.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -95.87 -21.59 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.55 156.13 30.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -76.32 129.68 36.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.07 167.7 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 93.6 t -98.58 126.53 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.4 t -86.45 113.76 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.59 117.97 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.9 147.31 30.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.217 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.53 -32.94 60.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -126.36 94.93 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.76 109.12 17.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 71.7 p -110.16 164.01 15.83 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.173 -167.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 76.5 Cg_exo -54.39 -31.2 66.91 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.682 1.588 . . . . 0.0 111.216 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.9 p -69.37 -16.37 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -91.02 -31.42 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 93.7 m -59.52 -38.03 79.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.36 -29.32 63.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.222 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -109.65 37.21 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 62.4 ttp -93.85 105.19 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -91.45 99.43 12.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.181 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.57 -20.15 64.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.08 -33.75 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 39.1 mmt -92.57 -34.14 14.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.48 122.52 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.209 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.8 -26.38 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.232 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.7 178.1 48.46 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.58 152.66 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -156.88 152.72 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.3 t -159.69 -176.21 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.235 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -120.48 -43.93 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 p -172.73 138.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 174.5 176.77 43.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.27 14.05 65.6 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.33 27.51 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.152 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.2 m -68.74 -46.19 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 96.4 p -64.56 -31.64 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.18 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -64.96 -46.01 83.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 99.1 m -52.54 -45.01 66.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.27 -42.84 99.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.206 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.49 -44.06 95.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.225 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.5 mtp -55.54 -48.3 74.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.39 81.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.69 -33.92 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.234 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.7 p -68.43 -19.99 64.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.2 mt -107.6 1.47 23.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 57.22 47.04 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.206 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.5 pt -127.37 156.89 74.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.46 154.37 31.46 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.673 1.582 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.33 144.79 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.205 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.9 117.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.227 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.8 163.4 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.68 55.95 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.65 -48.87 12.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.24 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.99 -11.9 58.94 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -132.57 -14.51 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -170.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.5 -28.67 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -160.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.0 p -80.31 -11.3 59.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.215 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.6 p -105.61 -30.23 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.222 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -81.11 -34.69 32.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.64 120.42 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.244 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.41 152.02 32.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.22 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 126.65 27.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.82 -16.85 46.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.1 175.25 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 111.191 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -99.23 139.39 34.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 170.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.32 134.7 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.178 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.87 127.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.246 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -105.33 94.5 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.182 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -84.6 82.03 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.187 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.35 73.96 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.39 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -78.18 -40.22 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.28 32.66 5.15 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -131.61 156.19 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.212 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 97.6 t -121.32 135.36 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.54 127.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.38 117.3 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.13 62.48 8.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.55 147.0 63.26 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.731 1.62 . . . . 0.0 111.216 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.91 162.7 28.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 173.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.68 -46.12 58.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -62.32 -43.87 97.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.2 m -59.66 -43.18 94.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.242 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.06 -46.29 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -64.61 -35.24 80.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.63 -46.29 90.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.196 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -73.62 -28.75 61.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -62.61 -45.6 92.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.77 -32.34 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.66 -42.42 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.14 -39.63 87.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.83 -43.31 99.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.2 p -71.06 -27.73 63.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 172.627 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.423 ' HE3' ' HB ' ' A' ' 228' ' ' ILE . 99.6 mtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.48 109.34 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -103.85 138.27 40.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.86 -139.43 2.84 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.88 121.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.363 . . . . 0.0 111.191 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.53 87.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.33 -33.01 72.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.186 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -148.56 135.64 10.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 164.31 31.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.659 1.573 . . . . 0.0 111.177 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.89 -168.02 15.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 tt -158.73 144.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 111.239 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.76 154.95 33.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 219' ' ' ILE . 81.9 mt -122.91 128.16 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.26 -177.06 29.07 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.53 150.6 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 111.204 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.28 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -111.0 120.38 42.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.2 tp -93.44 109.22 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.197 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -64.11 108.24 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -91.44 117.12 29.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.211 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -120.85 108.71 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 139.37 54.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.65 160.07 29.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.55 119.3 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.5 m -119.33 118.02 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 101' ' ' ASP . 97.0 mt -71.4 125.65 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.204 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -78.93 114.64 18.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.65 22.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.57 136.35 52.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.226 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.5 128.98 39.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -102.9 127.25 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -57.98 136.81 57.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.2 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.58 -44.59 26.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.8 p -68.5 -20.82 64.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.18 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.04 2.33 43.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.96 -38.16 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.48 -21.94 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -68.44 -35.42 77.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 171.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.89 -35.45 80.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.56 -46.01 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.91 87.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.239 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.35 -47.34 81.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.98 -49.96 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -59.4 -42.03 90.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.25 -37.68 52.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.47 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.71 -42.3 82.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -50.87 -50.48 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.99 -44.74 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.7 m -52.86 -50.09 64.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.73 -42.9 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.5 -46.11 89.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.2 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -60.96 -42.38 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -61.03 -40.96 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.25 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.51 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -57.19 -47.39 81.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.5 -51.35 67.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.211 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.17 -31.55 70.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.46 93.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -63.17 -46.96 84.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.67 -39.22 93.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.221 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -83.32 -34.13 25.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.185 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.12 -58.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.18 -168.26 23.45 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -60.81 -27.5 68.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -43.79 -44.34 6.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.22 -34.35 11.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.205 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.49 -39.11 93.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -176.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.03 -32.7 74.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.22 -43.93 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.168 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -76.81 -19.83 57.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -63.36 -49.1 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.98 81.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.195 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -56.19 -47.24 78.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.214 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -64.33 -44.74 90.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.8 ttp -49.72 -48.4 49.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.171 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.75 -38.61 91.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.0 66.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.5 p -94.56 4.54 53.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -62.55 116.54 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.0 -33.61 73.66 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.733 1.622 . . . . 0.0 111.16 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.39 -35.95 78.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.2 tp -67.55 -46.53 72.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.5 -58.25 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.52 -35.12 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.19 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.59 -48.5 84.19 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.5 t -68.84 -43.88 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.24 -42.7 91.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.265 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -68.89 -36.72 78.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.99 -43.55 98.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.76 -50.78 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.9 -40.86 87.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.5 m -67.07 -47.61 70.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -91.62 -15.89 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.8 mt 64.98 43.75 3.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.223 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.64 -177.59 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -72.1 156.62 38.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.217 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.1 76.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 26' ' ' ILE . 94.3 m-20 -58.95 -50.49 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.233 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -65.01 -41.31 95.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.95 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -45.36 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.242 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -56.49 -46.81 80.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -68.19 -50.05 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.71 -45.07 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.2 mm -60.0 -43.65 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -64.42 -43.35 94.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.214 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.03 -45.9 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -57.89 -47.62 82.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -50.3 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 93.0 mtp -58.26 -38.56 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.186 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -72.09 -38.58 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.194 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 p -70.01 -20.08 63.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.197 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.38 -15.41 63.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.211 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 62.54 32.31 16.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.248 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -100.33 109.84 22.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -42.4 -44.79 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -62.24 -54.64 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.241 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.46 -31.71 71.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.184 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -46.79 86.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.8 -43.81 94.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.206 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -68.74 -31.38 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.48 87.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -61.48 -44.21 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.196 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.57 -41.99 91.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.247 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.63 -41.66 97.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -58.99 -38.64 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.27 -41.36 89.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -54.55 -46.03 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.04 93.49 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.05 -42.43 99.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.18 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -62.56 -40.59 97.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.206 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.53 -48.06 86.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -60.73 -39.89 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.211 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -56.07 -46.71 78.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -71.38 -29.37 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.4 mt -66.45 -37.23 84.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.246 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB2' HG23 ' A' ' 144' ' ' VAL . 88.4 mt -84.24 -32.18 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.27 31.75 7.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 142' ' ' LEU . 81.9 t -72.01 123.52 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.19 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -122.49 163.22 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -152.31 165.83 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.1 t -69.88 130.25 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -76.49 108.79 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.56 -3.39 58.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.208 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 84.6 p -90.78 0.18 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -94.82 5.49 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.16 78.25 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -68.76 -30.94 69.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -87.91 151.85 22.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.55 113.08 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.09 170.4 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.44 134.24 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.87 113.27 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.65 116.05 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.235 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -147.57 156.65 43.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -171.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -97.8 -20.97 17.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.212 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -161.7 110.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.19 96.91 8.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.231 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 46.5 p -80.99 165.38 45.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.222 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 93.9 Cg_exo -50.25 -37.44 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.736 1.624 . . . . 0.0 111.166 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.2 p -76.22 -30.41 57.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.65 -35.07 72.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.7 p -80.79 -29.62 36.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.93 86.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.183 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.8 p -95.95 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 58.5 ttp -136.39 133.02 36.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -77.35 89.37 3.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.231 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -54.99 -35.0 63.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.246 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -47.89 -38.56 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.215 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -109.53 31.4 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.201 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 92.0 t -106.72 124.21 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.197 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.9 mt -100.84 -10.78 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.59 170.73 38.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -121.79 141.61 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -143.38 108.84 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.185 169.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 67.9 p -118.82 154.73 32.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.86 -42.11 95.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.1 m -108.07 157.16 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.194 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.76 3.86 45.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.81 73.11 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -108.4 22.8 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.328 . . . . 0.0 111.182 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.6 m -49.14 -45.89 44.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.0 m -58.82 -44.09 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.18 -49.9 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 80.7 p -72.28 -30.7 65.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.74 72.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.22 -49.07 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.8 mtm -64.79 -46.16 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.45 83.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.185 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -59.63 -45.88 90.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 85.7 p -77.89 -23.62 48.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.227 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.81 -16.02 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 60.81 50.09 5.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.243 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 42.1 pt -128.64 159.84 65.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.186 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 71.8 Cg_endo -72.36 150.27 52.18 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.658 1.572 . . . . 0.0 111.198 177.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.12 126.16 12.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.229 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.17 123.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.67 159.34 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.78 39.98 32.49 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.09 -14.01 58.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.91 -59.82 1.45 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -152.06 45.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.84 -23.55 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.193 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.0 p -75.38 -15.51 60.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.5 p -97.47 -27.22 14.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.2 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.41 -23.46 20.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.15 122.96 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.236 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.86 159.85 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.11 26.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.79 -16.68 36.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.09 163.82 27.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.0 129.59 44.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.186 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.92 136.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.204 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 13' ' ' ILE . 74.7 mt -122.95 126.03 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 175.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.6 t -107.97 112.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -98.54 91.1 4.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.18 -33.73 69.35 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 67.2 tp -57.74 -49.79 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 111.213 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.59 -26.38 30.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.82 10.68 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.2 pt -133.71 149.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.94 135.95 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.423 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 7.9 tp -115.4 140.46 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.39 138.24 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.178 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 89.0 m-20 56.05 52.3 7.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -173.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.3 Cg_endo -71.76 155.28 58.63 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.665 1.576 . . . . 0.0 111.235 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -88.09 -177.88 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.04 -54.37 45.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.238 -172.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.79 -46.56 88.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.243 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.6 m -56.23 -45.55 79.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.62 -45.54 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.59 -35.6 77.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.04 -45.75 90.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -76.15 -26.06 55.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.189 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.181 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 75.3 m -59.16 -41.48 88.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.17 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.55 -49.97 75.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.221 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.64 -40.27 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 73.4 m -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.245 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 177.464 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.845 0.355 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.9 mt -98.08 122.43 41.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.06 136.8 47.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -140.67 2.93 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.36 113.71 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 111.168 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.31 87.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.72 76.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.194 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.9 t -148.33 135.77 10.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.19 162.01 31.78 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.699 1.599 . . . . 0.0 111.239 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 177.59 14.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.94 130.41 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 111.176 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.02 140.11 36.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.65 124.91 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.72 -156.02 7.85 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.24 179.27 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.22 131.2 41.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -121.56 97.66 5.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.84 118.23 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 -170.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -98.72 111.26 23.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 p -104.33 167.82 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.165 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.94 132.19 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.197 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.41 132.68 54.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.191 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.19 131.43 50.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t -83.58 99.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.6 m -97.67 114.11 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -96.24 126.4 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -80.44 115.78 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.65 23.54 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.219 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -83.19 157.57 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -84.3 160.14 20.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.2 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.7 pt -122.64 165.03 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.54 146.26 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -51.27 -39.29 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -69.88 -16.31 63.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.25 -0.13 53.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -58.61 -46.79 90.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.209 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.93 -32.14 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.211 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.55 -42.47 87.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.192 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.81 -37.58 76.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 84.5 mt -63.63 -43.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.47 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.18 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -64.27 -37.92 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.83 -48.48 81.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.99 -35.62 81.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.93 -42.13 99.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.89 85.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.173 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.38 -41.6 97.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.75 -38.33 90.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.15 -46.54 95.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.2 p -68.93 -29.89 68.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.216 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -60.03 -51.26 70.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.218 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -49.93 75.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.18 -55.1 39.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.36 -41.77 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.12 -51.33 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.5 -38.18 83.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.191 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.8 mt -64.55 -41.85 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.02 -49.35 60.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -54.7 -52.94 60.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -60.74 -40.02 90.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.46 99.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.3 tt -57.41 -47.21 82.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.183 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.23 -28.88 57.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.225 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.23 -44.02 9.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.208 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.17 -32.76 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -168.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.89 164.34 11.48 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.9 -34.97 66.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -45.88 -44.51 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -76.56 -34.7 58.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.79 81.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.239 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.51 -35.87 82.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.93 -42.54 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -76.91 -24.25 52.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.209 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -64.59 -41.01 96.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.18 98.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.46 -40.74 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.211 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.97 -43.68 87.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -64.86 -36.81 85.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.9 -44.96 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.63 78.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.2 p -104.57 20.6 18.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.234 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -72.66 114.87 34.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.98 -34.55 77.4 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.69 1.593 . . . . 0.0 111.192 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -69.11 -43.36 74.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.226 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 99.5 mt -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.86 -51.78 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.42 -30.75 69.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.216 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.97 -47.09 91.29 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.11 -43.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.201 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.78 -44.93 90.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -67.68 -34.87 77.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.206 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 tpp -63.71 -43.25 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.79 -48.02 89.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -73.97 -45.91 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.3 m -63.62 -48.83 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.91 -12.07 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.217 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.5 mt 59.05 65.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.246 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 165.61 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.201 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.4 p -66.4 154.78 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.89 97.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.241 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.89 -37.12 85.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.22 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.49 -43.86 84.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.88 94.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.37 -46.5 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.5 -47.07 76.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -69.47 -51.62 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.61 -46.92 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -68.83 -47.13 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.71 -39.77 84.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.201 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -57.19 -54.56 45.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.188 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.84 -38.2 89.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.217 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.07 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.9 p -66.98 -31.19 71.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.47 -49.16 79.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 98.7 mtp -58.5 -37.38 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -74.32 -34.52 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 p -69.98 -17.56 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.251 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.62 -11.29 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.193 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 64.49 32.79 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.14 112.99 25.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.46 -31.37 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -63.34 -51.01 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.39 -25.28 63.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.223 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.48 -47.96 81.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.19 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.84 -39.59 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.48 -33.41 75.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.227 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.89 84.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.46 -43.53 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.173 173.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.01 -48.07 73.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.85 -49.14 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -56.89 -45.18 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.35 -42.91 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.211 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.52 -48.87 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.56 -40.45 99.15 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -59.64 -43.94 93.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.81 -37.23 76.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.219 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.49 -44.87 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.236 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.3 -44.44 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.52 -47.53 85.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.14 -33.3 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.56 77.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.54 -34.38 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.17 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.76 35.09 5.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.84 122.53 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 111.177 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -107.0 163.62 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 71.7 p -158.59 177.71 10.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.4 125.65 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -81.31 105.9 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.199 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.58 -26.78 67.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.242 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -77.53 -9.01 58.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.194 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.68 -3.34 58.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.194 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.08 120.41 16.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.213 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -122.72 30.21 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -145.9 137.61 25.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.82 98.46 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 173.29 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.211 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -89.2 127.24 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.6 125.19 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.87 112.05 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.229 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.92 143.92 43.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -170.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -89.54 -7.73 54.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 172.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -169.27 152.01 4.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.5 tp -173.61 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.8 p -99.99 161.04 25.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.215 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.1 -34.89 59.96 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.744 1.629 . . . . 0.0 111.179 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 p -67.21 -19.98 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -91.92 -34.12 14.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.1 p -63.65 -32.87 74.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.182 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.31 71.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.7 p -113.2 14.14 19.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.4 ttt -77.59 131.79 37.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -67.35 74.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -66.34 -22.42 66.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.86 -25.03 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.03 23.48 14.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.194 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.4 t -110.26 116.13 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.185 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.68 -4.68 33.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.52 169.48 38.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -150.4 132.04 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -141.59 150.17 41.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.3 p -137.0 165.47 25.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -104.87 7.92 34.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.99 153.43 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 139.28 145.42 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.97 -76.41 1.07 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.08 140.78 47.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.226 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.9 p -123.14 25.19 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -60.17 -59.27 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -60.07 -38.89 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 79.8 m -58.25 -47.51 83.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.8 87.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.35 -47.89 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.21 -44.86 94.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.8 82.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.201 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -61.56 -46.48 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 78.5 p -70.58 -25.03 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -22.88 28.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.209 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 60.6 47.43 8.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.203 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.03 155.87 80.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.94 161.6 23.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.664 1.576 . . . . 0.0 111.219 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.88 132.22 8.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.15 112.62 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.224 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.77 169.83 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 -170.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.64 78.68 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.5 mt -80.35 -27.44 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.29 -62.77 4.44 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -93.21 -6.12 48.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.167 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.92 -29.13 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.9 p -79.56 -14.08 59.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.259 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.2 p -102.62 -28.8 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.215 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -92.37 -23.94 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.66 120.8 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.189 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -117.49 157.57 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.23 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.46 127.31 29.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.76 -20.05 32.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.63 163.48 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.767 0.318 . . . . 0.0 111.239 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.86 134.15 36.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.6 t -133.27 128.58 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.233 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.5 mt -113.7 127.51 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.186 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.1 t -106.52 118.89 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.172 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -116.4 96.98 5.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.63 -23.7 66.78 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.66 -38.23 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 111.176 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.36 -27.64 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.187 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.45 36.45 14.32 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.68 157.68 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 111.185 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.59 134.84 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.199 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 mm -103.23 128.85 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 72.4 t -105.2 120.9 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 54.97 58.4 11.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.93 156.17 63.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.748 1.632 . . . . 0.0 111.232 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -86.47 -178.23 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.99 -42.67 99.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -64.06 -44.18 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.6 m -61.6 -44.22 97.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.99 -44.97 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.234 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.89 -35.7 80.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.221 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.02 -50.57 72.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.185 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -72.37 -27.21 62.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -59.56 -45.48 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.198 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.7 p -69.36 -31.45 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.18 -42.96 83.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.86 -44.95 86.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.85 -50.61 73.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.0 p -67.7 -26.57 66.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.228 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.233 174.432 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.759 0.314 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -97.14 99.36 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -87.37 131.31 34.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.31 -150.82 5.45 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.6 119.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.83 87.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.74 -31.84 65.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -148.28 133.98 9.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.6 163.44 31.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.735 1.623 . . . . 0.0 111.171 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.4 179.66 15.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -130.67 121.36 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 111.208 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.01 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.225 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.9 mt -124.11 119.53 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.23 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.81 -161.82 13.66 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.0 157.42 16.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 111.215 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.41 95.15 4.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -105.64 105.23 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.11 140.27 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -85.29 97.94 10.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -120.83 137.89 54.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -123.09 160.18 26.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -68.67 139.46 55.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.215 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.02 115.04 29.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.27 127.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.218 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.0 m -70.66 133.67 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.35 127.26 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -79.82 113.05 17.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.84 16.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -56.96 133.6 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.207 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.44 129.74 43.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.08 125.37 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.03 145.79 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.33 -34.87 61.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.7 p -75.85 -21.69 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.233 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.61 -9.35 41.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 93' ' ' ILE . 42.6 t -54.78 -45.0 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.52 -32.93 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -67.0 -41.83 86.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.65 -36.2 78.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.21 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 173.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.93 90.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.3 -45.82 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.94 -47.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.51 -36.33 83.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.48 -39.69 92.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.77 -35.08 79.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.2 -42.36 99.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.48 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.36 -44.06 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.199 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.3 m -60.21 -48.82 80.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.3 -42.19 99.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.15 -49.81 74.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.31 -45.77 92.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.66 -44.22 93.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.49 -45.76 78.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.36 -41.57 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.86 -40.77 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.195 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -50.58 -47.33 58.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.195 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.68 -49.14 68.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.01 -42.06 98.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.07 85.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -62.45 -46.08 90.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.49 -29.96 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.197 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -82.38 -53.83 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -117.36 -34.49 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.38 -168.46 16.51 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.56 -19.0 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.776 0.322 . . . . 0.0 111.208 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -55.92 -52.91 62.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -77.9 -28.99 49.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.211 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.64 76.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.211 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.75 -34.84 79.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.49 -47.2 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -76.38 -26.61 55.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.189 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.0 -45.39 90.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.73 97.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -60.19 -41.36 92.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.172 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.2 tp -64.72 -43.96 91.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.4 mtp -57.2 -45.85 83.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.216 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.77 -40.75 98.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.232 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.75 66.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.234 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 -2.64 37.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.74 113.79 14.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.04 -33.37 83.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.658 1.572 . . . . 0.0 111.199 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -67.67 -44.44 77.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.04 -37.29 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.96 -52.52 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.208 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.27 -35.05 78.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.81 -47.6 87.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.5 -45.29 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 111.17 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -62.09 -38.76 90.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -67.01 -37.88 84.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.151 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.4 tpp -63.01 -42.46 99.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.404 HG22 HG13 ' A' ' 36' ' ' VAL . 96.1 mt -57.25 -48.01 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.49 -43.21 57.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.211 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 m -62.28 -50.33 72.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -172.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.27 -11.35 32.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.0 mt 59.0 63.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.49 158.95 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.22 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.3 t -66.18 150.0 49.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.04 -31.87 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.234 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -54.73 -43.7 72.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -84.82 -31.67 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.91 -45.41 93.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.17 -46.31 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.19 -48.21 71.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.28 -49.41 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 -174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.9 -45.1 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.442 HG23 ' HG ' ' A' ' 130' ' ' LEU . 31.1 mm -64.57 -46.34 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -69.1 -38.28 78.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.73 -54.34 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.82 -31.33 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.72 98.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.5 p -69.42 -29.33 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.19 -48.98 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 66.4 mtt -51.91 -42.65 62.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.234 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.22 -40.46 82.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.0 p -69.34 -19.98 63.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.98 -8.69 57.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 62.62 33.9 15.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -110.73 112.76 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.84 -31.0 69.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.198 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.2 -49.94 75.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.53 -25.69 62.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.195 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.17 -40.49 97.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -67.17 -35.69 80.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -69.57 -31.6 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.3 96.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.181 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.33 -46.55 96.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.221 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -57.29 -44.0 83.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 108' ' ' ILE . 56.3 tp -62.44 -46.05 90.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 -58.36 -45.28 88.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.12 -42.44 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.205 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.38 -49.69 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.79 98.5 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -60.2 -44.09 95.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 111.183 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -70.0 -36.14 74.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.0 mt -57.56 -46.23 86.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.37 -42.61 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.71 -40.11 91.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.186 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.47 -30.33 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.76 -38.78 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.2 -26.0 36.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.198 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.05 27.31 23.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.51 125.97 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.77 161.74 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -144.96 175.87 9.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.18 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.75 124.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.44 72.51 7.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -21.01 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -67.42 -18.01 64.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.2 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -105.47 20.11 19.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 156' ' ' VAL . 60.3 tp -63.62 130.92 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.28 22.22 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -137.73 140.52 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.54 97.83 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.19 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 152' ' ' LEU . 34.8 m -137.72 -168.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.69 132.34 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.8 t -96.41 125.13 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 98.7 mt -122.42 132.08 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.71 170.06 22.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.207 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -66.34 -46.24 77.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.202 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.71 173.38 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.202 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.68 84.51 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 51.5 p -78.22 165.25 51.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.174 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 95.3 Cg_exo -50.03 -36.68 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.7 1.6 . . . . 0.0 111.209 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 93.7 p -73.27 -31.06 63.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -45.85 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.6 p -68.74 -27.31 65.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.176 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.56 -1.39 37.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 74.2 p -113.96 5.05 16.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.0 mtp -78.16 126.89 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -67.06 106.48 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.238 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.5 -48.81 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.204 -166.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.21 8.5 44.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 -164.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -123.84 16.81 9.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.4 112.45 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.5 mt -91.03 -13.45 33.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.6 178.41 41.96 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -165.15 162.48 20.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 111.21 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -150.2 144.65 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.244 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.6 p -127.85 154.78 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.227 -170.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.86 -55.35 23.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.186 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.46 129.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 59.1 4.51 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.88 73.89 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -118.0 62.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.3 m -63.18 -40.1 96.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.1 m -52.8 -53.41 48.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -72.73 -33.1 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.258 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -58.42 -48.94 79.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.0 mt -58.31 -46.05 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 tpp -64.3 -46.83 81.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.27 91.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.167 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.1 -36.64 69.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 82.8 p -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -98.59 -14.97 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 60.95 51.03 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.183 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 44.2 pt -125.45 153.21 72.4 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.219 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 50.7 Cg_exo -60.55 148.74 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.663 1.576 . . . . 0.0 111.205 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -148.2 122.09 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.44 120.33 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.177 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.86 160.81 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.01 38.75 29.5 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.18 -5.57 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.79 -62.97 4.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -151.94 45.06 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.2 -174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.9 -23.26 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.7 p -70.66 -17.92 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.8 p -101.01 -27.85 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.189 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -83.18 -17.89 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.79 134.36 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -109.05 149.75 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.89 126.21 26.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.06 -14.99 44.26 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.58 166.21 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 111.195 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.27 133.41 36.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.245 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.94 126.31 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.35 114.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.251 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.67 91.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -85.94 78.91 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.186 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.01 -24.44 73.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 64.1 tp -58.2 -48.31 80.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.186 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -91.79 -17.89 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.12 36.53 14.72 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -132.28 155.16 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 96.1 t -121.64 133.94 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 175.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.7 127.43 66.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.9 122.85 62.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 94.0 m-20 55.71 55.52 9.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.7 Cg_endo -69.64 155.33 66.64 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.7 1.6 . . . . 0.0 111.219 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.39 161.61 29.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.174 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.91 -50.46 63.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -57.72 -46.88 83.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.219 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 99.9 m -54.19 -45.39 72.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.92 -47.55 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.87 -32.37 73.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.209 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -64.47 -41.35 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.43 -28.23 64.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.85 -43.07 99.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 78.6 p -71.03 -30.96 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -68.56 -39.98 80.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.192 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -59.84 -41.57 91.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.51 -49.19 77.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.1 p -67.06 -28.91 68.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.212 172.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.6 mt -91.61 120.18 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.3 129.62 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.17 -150.91 5.31 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.4 t -105.21 124.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 111.177 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.56 87.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.57 96.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.218 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.4 p -149.09 148.84 28.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.64 161.81 24.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.699 1.599 . . . . 0.0 111.236 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.64 177.13 14.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -133.92 117.03 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.81 113.31 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.92 111.56 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.71 -156.75 13.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.5 150.83 22.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 111.224 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 120.72 31.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -119.82 100.42 7.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.3 tp -78.25 113.79 16.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.66 106.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.3 m -92.77 133.66 35.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.58 127.55 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.163 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HB2' HG13 ' A' ' 144' ' ' VAL . 61.9 mt-10 -67.19 146.35 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.73 125.82 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.49 82.04 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.6 m -85.42 112.22 20.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.201 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -81.57 122.1 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -80.2 109.01 14.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.7 24.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.196 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.12 173.55 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.2 164.83 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 pt -123.24 165.26 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -72.92 142.96 47.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.19 -43.1 66.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.2 p -69.28 -17.88 63.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.31 4.72 46.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.2 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.43 -46.78 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.24 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.74 -36.31 82.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -67.85 -40.38 83.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.171 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.33 -37.89 74.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.217 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.24 -42.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.91 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.211 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.95 -42.86 94.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.214 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.27 -48.3 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.39 -36.91 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.91 -39.37 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.218 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.61 81.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.212 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.68 -40.53 97.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.54 -45.27 94.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.5 t -67.44 -42.67 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.0 m -58.0 -53.83 53.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.24 -39.38 94.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.42 -50.89 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.199 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -65.35 -39.13 91.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.229 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.44 -49.09 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.231 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -67.24 -45.94 75.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.55 -43.94 83.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.224 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.82 -39.88 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -49.24 -47.22 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.73 -51.75 59.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.227 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.42 -40.92 98.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.98 95.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.198 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.17 -44.87 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.16 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.31 -35.78 81.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.214 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -87.04 -67.77 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.09 -31.58 15.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.33 -163.24 13.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.06 -23.4 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.194 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -48.0 -41.0 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -102.04 -32.36 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.159 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -37.99 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -65.66 -33.44 75.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -58.57 -46.57 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.225 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.01 -35.56 78.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.182 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -57.12 -46.7 82.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.61 98.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -67.38 -34.42 77.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.0 -46.04 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.54 -41.97 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.209 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.26 -39.43 93.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.03 79.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.18 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -87.49 -14.85 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.63 113.77 10.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.232 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.32 -28.58 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.683 1.589 . . . . 0.0 111.209 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -63.56 -28.62 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.252 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.55 -35.87 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -53.43 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.31 -35.39 80.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.94 94.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.8 -45.61 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.64 -36.19 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.202 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -65.16 -42.08 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.06 -47.0 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.67 -43.98 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -67.28 -47.27 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -97.4 -8.07 30.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.41 63.71 1.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.48 165.92 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.2 p -65.91 159.53 25.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.41 78.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.215 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -55.39 -51.22 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.201 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.39 -43.68 89.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.68 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.65 -46.28 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.19 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.89 -55.1 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.21 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.75 -52.28 63.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.49 -50.03 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -172.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.9 mt -71.62 -42.95 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.247 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -57.69 -41.58 81.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.83 -52.95 63.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.35 -37.04 81.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.8 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.8 p -68.59 -29.64 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.178 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.68 -49.98 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 60.1 mtt -53.58 -40.77 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.81 -41.12 83.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 73.2 p -69.69 -21.25 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.4 mt -73.65 -13.06 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.94 32.19 17.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -103.83 108.98 20.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.54 -33.45 74.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -169.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.28 -49.28 77.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.236 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.45 -26.08 63.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -42.47 97.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.68 -41.75 91.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.219 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -67.25 -32.91 74.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.01 88.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.217 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.73 -43.05 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.84 -41.35 86.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.07 -43.17 95.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -59.99 -42.32 93.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.95 -46.51 81.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.41 -46.12 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.74 -46.32 93.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.11 -41.77 97.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 111.235 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -62.86 -41.62 99.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.44 -46.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.62 -41.78 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.67 -39.82 85.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -72.66 -31.05 64.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.192 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.06 -38.32 82.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.247 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.43 -33.17 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.56 8.84 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 22' ' ' GLU . 75.7 t -69.61 119.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.186 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.81 161.94 13.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.3 p -153.92 165.13 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.73 123.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.213 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -93.54 94.67 8.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.03 -3.25 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.22 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.3 p -74.56 -13.17 60.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -110.93 23.66 13.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.17 132.61 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -101.18 -6.25 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.85 156.87 43.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.16 121.24 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -138.12 170.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.0 t -94.76 133.36 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.44 121.17 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 79.3 mt -122.21 135.34 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.45 24.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.55 -45.58 30.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -168.71 147.21 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.8 mt -135.9 148.89 48.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 43.6 p -84.26 163.39 47.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 85.9 Cg_exo -51.66 -29.63 33.82 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.703 1.602 . . . . 0.0 111.165 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.9 p -84.73 -25.31 28.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -83.5 -34.14 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.6 p -67.01 -18.15 65.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 1.5 56.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.5 p -101.94 36.39 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 77.0 mtm -122.42 143.62 49.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.187 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -81.64 93.77 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.202 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -47.33 -46.69 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.212 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.12 -26.64 68.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.93 27.57 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.2 t -105.83 118.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.23 -29.6 24.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.18 174.82 43.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -122.8 154.49 38.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 0.0 111.226 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -151.51 144.82 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 168.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 -171.43 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -152.1 -0.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.31 152.69 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.72 171.89 26.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 166.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 -6.22 87.91 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -75.24 -1.36 23.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.9 p -66.57 -21.6 66.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 98.8 p -101.48 -35.06 9.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.254 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.06 -47.12 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 53.6 m -49.8 -44.16 48.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.232 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -58.17 -45.45 87.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.7 mt -62.59 -49.28 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.239 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mmm -63.75 -50.04 70.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.63 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.81 -30.84 68.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 81.0 p -79.54 -24.85 41.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.56 -5.36 58.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.207 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 60.32 41.76 15.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 35.7 pt -129.59 155.62 79.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 156.05 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.756 1.637 . . . . 0.0 111.187 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.54 142.55 12.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.78 129.32 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.201 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.56 153.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.229 -173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 73.49 40.75 46.72 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 227' ' ' VAL . 91.3 mt -69.66 -24.43 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.235 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 121.26 -54.7 0.67 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -161.31 27.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 -175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.9 p -51.37 -33.56 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -74.34 -21.12 59.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.0 p -90.33 -20.94 22.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -103.36 23.2 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.19 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.95 149.81 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -139.18 142.06 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.204 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 122.85 12.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 114.01 -19.3 18.17 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.29 -179.26 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.21 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.87 153.46 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.43 141.99 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 89.0 mt -119.72 120.41 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 170.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.92 97.29 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -83.37 80.81 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.79 -33.1 86.34 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 68.7 tp -56.41 -49.21 75.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -80.01 -40.73 27.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 102.06 28.47 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.88 158.57 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 111.218 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 205' ' ' LEU . 99.5 t -133.85 134.69 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.06 127.44 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 130.8 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.37 56.97 9.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.66 153.15 64.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.74 1.627 . . . . 0.0 111.177 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -88.42 -178.48 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.2 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.55 -54.41 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -59.23 -48.37 81.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.4 m -54.14 -46.8 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.216 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 67.6 t -61.13 -46.59 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -68.73 -33.46 73.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.168 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.59 -42.93 99.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.247 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -68.14 -31.83 71.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.47 -44.68 96.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.72 -31.97 69.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.204 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.96 -42.29 76.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -61.88 -37.76 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.183 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.32 -49.77 75.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.7 p -67.94 -28.58 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 64.8 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 172.921 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.1 mt -74.95 79.84 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.65 130.01 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.28 -153.17 5.8 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.6 136.44 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 111.218 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.7 76.22 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.184 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.82 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 t -149.94 128.67 6.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.232 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 155.38 33.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.636 1.557 . . . . 0.0 111.195 -175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 170.78 12.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.2 mm -113.18 130.36 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.184 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 220' ' ' VAL . . . -126.42 112.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.55 111.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.23 -162.06 18.02 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.27 163.64 15.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.346 . . . . 0.0 111.236 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.44 109.49 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.58 137.56 52.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 168.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.64 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.207 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 63.7 t80 -88.1 97.56 11.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.208 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -118.1 135.35 54.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -140.79 159.3 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.173 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -58.93 135.17 57.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.55 130.56 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.179 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.15 109.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.4 p -124.15 152.27 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.85 127.48 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.218 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -81.49 105.14 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.91 14.0 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 -171.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 150.08 25.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.73 158.48 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.55 167.27 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 144.81 55.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -52.38 -37.12 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.1 p -69.52 -15.46 63.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.192 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -94.7 0.01 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.47 -50.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.66 -32.0 73.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.219 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.88 -50.73 72.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.15 -34.28 72.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.188 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.14 -43.61 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.212 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.77 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.93 -44.93 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.52 -48.94 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.182 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.45 -36.2 82.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -66.94 -40.09 87.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.209 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.66 80.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.95 -42.5 99.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.56 -50.99 70.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.16 -43.09 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.209 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.5 m -58.0 -53.1 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -64.0 -39.06 93.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.53 -46.72 88.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.88 -39.8 91.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.73 -39.93 87.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.213 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -56.47 -46.95 80.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.27 -40.36 97.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.75 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -52.36 -49.91 63.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.238 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -57.83 -51.56 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.253 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.66 -42.43 92.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.183 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.05 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -56.48 -47.32 79.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.85 -32.31 52.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.229 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -84.79 -47.88 9.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.6 -34.55 5.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.52 161.15 9.86 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.32 -37.97 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.189 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.64 -46.34 63.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -65.8 -37.83 87.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.71 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.69 -34.29 77.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.6 mt -59.27 -44.71 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.48 -30.4 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -58.11 -42.36 85.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.7 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -58.13 -41.91 84.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 77' ' ' LEU . 9.3 tt -59.65 -48.93 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -63.62 -34.95 78.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.4 -39.21 91.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.202 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.26 80.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.7 p -85.0 -9.05 58.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.208 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -63.47 115.45 18.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.207 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.52 -31.26 68.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 0.0 111.207 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.82 -33.2 75.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -81.21 -44.29 18.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.224 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -53.53 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -65.93 -34.76 78.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.99 -46.37 93.81 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.52 -45.47 88.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -64.57 -39.07 93.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.208 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -67.64 -34.34 76.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -64.64 -41.79 95.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.52 -47.37 91.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.59 -46.75 36.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.9 m -64.23 -47.53 79.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -172.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.68 -9.53 34.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.1 mt 57.82 63.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.04 -179.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.172 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.4 p -81.11 164.15 22.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.227 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.04 90.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -68.6 -36.7 79.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.2 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -64.28 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.84 95.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.19 -49.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.227 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -60.89 -43.49 98.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -66.91 -50.39 62.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.199 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.93 -46.28 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.229 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.22 -44.86 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -64.1 -39.38 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -60.39 -52.94 63.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.99 -37.5 87.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.55 96.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.198 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.6 p -65.85 -30.56 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.193 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.35 -51.56 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.212 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 67.1 mtt -54.71 -40.27 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -68.47 -41.56 79.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.4 p -69.96 -22.11 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.17 -13.42 60.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.16 32.97 19.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -103.74 106.67 17.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.193 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.65 -32.84 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -169.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -60.88 -50.16 74.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.14 -30.4 69.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.55 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.89 -41.96 97.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.96 -34.2 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.95 -41.4 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -56.41 -44.37 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.21 -37.58 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.225 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -61.39 -41.74 97.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.5 -41.89 96.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.13 -44.7 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.19 97.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -55.81 -47.91 76.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -61.0 -45.52 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.212 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.75 -48.73 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.67 -43.59 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.32 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.39 -32.84 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.23 -39.35 86.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.21 -36.94 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.22 27.3 10.18 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.41 125.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -109.88 156.22 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.246 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.0 p -143.32 174.59 10.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.35 106.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -83.8 115.75 22.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.72 -16.07 59.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.9 p -69.43 -13.37 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -88.85 -3.68 58.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.212 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.94 149.48 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.241 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.75 28.55 7.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -150.09 141.42 23.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.222 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.54 113.5 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.12 172.59 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.204 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.04 134.13 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.8 t -113.76 129.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.155 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.7 mt -123.42 136.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 19' ' ' TYR . . . -162.02 149.66 14.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -50.05 -49.96 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.177 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.56 153.08 31.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -133.58 141.82 47.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 44.8 p -116.6 163.89 20.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 176.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 86.8 Cg_exo -52.61 -35.31 67.07 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.729 1.62 . . . . 0.0 111.192 177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.7 p -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -87.76 -30.3 20.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.185 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.427 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 69.7 p -78.9 -11.18 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.78 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.5 p -106.91 21.86 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 168' ' ' THR . 60.9 mtt -100.32 150.59 22.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -117.64 107.45 14.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -62.01 -26.42 68.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.98 -22.42 66.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -105.6 5.56 31.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.51 119.38 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.64 -17.38 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.71 173.55 29.43 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.25 165.99 33.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.246 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.31 152.08 36.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.215 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 38.6 p -126.25 161.86 26.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -76.47 -41.37 47.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.84 167.55 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 -171.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -113.09 15.02 23.44 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -67.67 -16.0 67.23 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -124.62 37.97 4.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -54.98 -40.55 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.232 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.6 p -63.88 -32.57 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.8 -35.22 62.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -70.43 -27.24 64.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.51 76.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.38 -46.28 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 28.4 ttt -60.89 -52.87 63.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.234 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -64.37 -56.56 13.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.2 m -63.42 -42.19 98.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.187 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.65 -17.63 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 63.4 51.79 2.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.169 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.26 157.15 76.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 158.25 56.59 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.73 1.62 . . . . 0.0 111.161 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -154.28 135.55 14.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.09 123.16 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 157.58 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.47 17.7 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.45 -3.02 58.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.233 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.35 -65.43 3.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.36 42.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 111.186 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -24.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.4 p -68.21 -21.59 64.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.2 p -97.08 -25.36 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -85.24 -23.05 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.209 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.92 128.43 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.89 150.97 26.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.45 129.11 40.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.46 -19.06 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.97 159.85 32.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.28 133.29 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.37 132.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.2 117.05 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 171.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 12' ' ' ALA . 67.3 t -104.78 115.27 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.99 98.69 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.7 -39.32 86.22 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.1 -46.76 87.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.771 0.32 . . . . 0.0 111.194 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -73.97 -35.86 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 173.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.36 7.28 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.5 pt -132.67 154.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.218 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.76 134.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.83 130.54 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.11 136.81 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.261 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 90.3 m-20 59.11 51.43 3.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 98.6 Cg_endo -72.25 155.77 55.82 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.683 1.589 . . . . 0.0 111.219 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -91.39 -177.83 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.65 -50.79 72.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.63 -48.78 78.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.6 m -54.41 -46.71 73.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 57.9 t -59.11 -45.02 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -69.26 -34.12 74.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -50.15 73.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.41 -26.88 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.12 -43.66 95.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 80.5 p -72.13 -29.55 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.93 -36.59 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -53.39 -52.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.33 -39.16 93.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.8 m -61.03 -38.77 87.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 178.823 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.63 148.7 24.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.82 134.32 38.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.74 -149.39 5.07 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -97.02 122.7 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.72 88.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.183 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.93 -38.78 76.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.191 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -148.49 141.41 15.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.212 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.07 165.11 24.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.728 1.619 . . . . 0.0 111.203 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.4 -178.51 16.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -131.11 132.04 63.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.64 127.03 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.409 HG12 HG12 ' A' ' 219' ' ' ILE . 69.5 mt -127.87 122.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.57 -147.19 10.01 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.43 149.63 25.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 111.207 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.26 127.49 53.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.66 140.74 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.199 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 tp -106.7 122.93 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.194 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 76.2 t80 -97.27 90.21 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.1 m -116.5 129.1 56.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -100.8 152.18 20.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.87 127.29 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.176 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -78.8 119.24 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.34 162.2 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.4 p -129.36 171.61 12.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.235 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -118.32 127.75 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.52 114.12 20.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.78 2.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.84 136.16 57.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.33 130.4 46.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.185 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.51 172.98 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.29 143.94 50.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.59 -37.5 63.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.236 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.4 p -69.03 -15.19 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.92 2.89 55.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.76 -49.97 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.15 -32.77 74.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -59.44 -48.85 80.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -68.42 -34.63 76.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.2 -45.12 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.207 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.58 95.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.22 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -58.35 -45.51 88.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.243 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.98 -50.27 74.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.5 -44.01 93.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.174 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.45 -46.64 79.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.9 79.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.9 -45.72 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.23 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.75 -44.97 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -56.95 -43.36 81.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.28 -44.26 88.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.21 -38.4 87.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.249 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -65.59 -40.45 92.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.25 -40.74 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.201 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -63.42 -39.69 95.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.63 -38.76 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.197 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.57 -41.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -55.7 -46.33 77.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.0 -53.08 62.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.21 -36.89 84.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.51 94.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.5 tt -55.55 -44.46 76.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.13 -43.66 77.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -88.87 -48.02 7.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -91.95 -48.04 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.197 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.83 162.19 10.15 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.21 -37.74 64.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.205 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -49.63 -42.53 45.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.83 -37.8 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.35 80.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.222 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.08 -33.65 76.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.68 -43.03 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.07 -20.56 55.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.41 -40.17 85.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.31 98.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.256 172.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -57.68 -41.72 82.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.48 -44.81 89.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.15 -37.06 85.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.248 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.44 -36.82 85.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.19 65.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -93.82 0.27 56.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.35 117.15 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.54 -32.05 61.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.689 1.593 . . . . 0.0 111.219 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.23 -35.75 78.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.44 -45.38 69.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.66 -56.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.64 -28.24 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.27 -50.02 71.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' HA ' HG21 ' A' ' 107' ' ' VAL . 69.4 t -69.06 -41.27 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.249 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -55.02 -49.12 72.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.191 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.03 -32.47 72.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.12 -42.3 94.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.61 -39.16 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.86 -40.35 95.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.1 m -72.13 -55.12 7.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -113.67 124.09 51.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 mp -77.04 75.03 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -126.08 167.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.4 m -58.83 138.48 57.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.81 -44.63 39.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.21 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -56.09 -41.46 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -63.12 -42.28 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.182 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.14 99.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.222 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.98 -47.66 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.54 -45.14 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.59 -48.66 76.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.22 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 89' ' ' VAL . 56.0 t -61.11 -47.29 94.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.205 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.6 mt -65.33 -42.74 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -58.48 -43.99 89.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.31 -47.45 79.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.202 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.19 -37.8 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.85 97.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.6 p -65.95 -30.7 71.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.194 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.32 -50.21 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.212 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 68.1 mtt -56.84 -38.51 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.172 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.94 -41.52 82.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.225 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.9 p -69.24 -21.39 63.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.219 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.33 -10.98 59.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 59.67 35.22 22.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -103.69 104.95 15.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.186 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.01 -33.93 76.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -60.04 -50.33 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.65 -30.48 69.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.72 -42.63 93.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.19 -41.88 96.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -68.03 -32.14 72.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.281 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.02 97.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.95 -42.42 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.216 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.87 -38.73 82.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.28 -38.87 85.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.193 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.04 -42.36 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.79 -45.26 92.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.03 -46.58 91.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.64 -43.86 97.36 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.83 -39.76 90.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.156 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -70.04 -38.2 75.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.29 -44.68 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.214 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.34 -45.4 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -60.67 -43.0 98.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -69.48 -39.97 77.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -70.19 -44.4 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.13 -20.0 52.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.24 43.13 8.22 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.33 119.67 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 111.23 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.95 154.09 36.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 94.2 p -147.13 167.4 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.42 127.35 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -81.92 72.06 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.221 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.79 0.69 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.15 -9.88 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 170.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -107.61 23.73 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.93 132.37 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.199 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -109.43 -2.33 17.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.201 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -149.51 158.79 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.61 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.38 161.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.31 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.51 116.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.91 115.53 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 19' ' ' TYR . . . -113.78 145.6 41.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 -170.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -67.22 -33.69 75.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.188 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -154.43 154.52 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -126.76 75.04 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -86.66 159.56 52.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.01 -40.6 67.35 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.733 1.622 . . . . 0.0 111.235 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.1 m -66.96 -39.84 87.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.5 -52.82 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.5 p -77.12 -20.41 55.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.72 67.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.159 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 66.7 p -90.83 -29.73 17.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 68.5 mtt -59.31 133.74 56.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.63 88.41 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.213 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -50.7 -43.39 57.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.64 -13.25 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.87 27.32 9.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.16 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.45 124.23 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.23 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.62 -25.94 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.41 158.9 22.52 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -108.68 148.59 30.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -155.97 150.37 25.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 t -162.27 -177.65 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.222 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.55 -27.48 8.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.231 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.27 126.09 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.201 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.0 166.33 48.42 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.78 -7.75 81.17 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -106.76 9.88 30.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.4 m -65.31 -44.77 86.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.9 p -71.63 -41.43 68.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.29 -48.01 83.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -57.96 -43.97 86.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.02 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.218 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.36 -47.64 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.6 mtm -61.56 -51.76 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.33 -46.77 87.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.241 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.35 -31.48 70.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.7 p -69.56 -18.03 63.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 199' ' ' ILE . 93.9 mt -107.08 -0.12 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 57.09 45.16 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.239 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 197' ' ' LEU . 38.9 pt -128.65 158.19 72.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.7 161.77 33.4 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.725 1.617 . . . . 0.0 111.167 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.27 136.67 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 52.1 t -134.47 126.49 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.29 152.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.183 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.43 46.39 6.92 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.47 11.4 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.252 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.32 -89.72 1.42 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -137.58 45.42 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.196 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.36 -25.78 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.5 p -72.35 -6.63 44.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -112.3 5.42 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.215 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -118.06 -5.16 10.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.37 145.2 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.72 158.25 40.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.82 117.9 4.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 102.58 2.48 50.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.1 150.62 38.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.45 123.66 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.94 142.79 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.197 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.409 HG12 HG12 ' A' ' 13' ' ' ILE . 79.3 mt -116.16 125.81 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.225 171.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.1 99.34 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -90.89 91.65 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.216 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.25 -35.36 76.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.35 -47.13 85.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.241 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.57 -36.8 65.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.65 34.71 6.47 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.3 pt -131.4 154.45 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 111.172 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.7 t -133.3 136.4 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.61 118.41 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.31 130.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.192 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.92 57.79 3.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.205 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.41 154.97 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.695 1.596 . . . . 0.0 111.256 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 159.61 33.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.156 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -53.85 -49.15 69.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.14 -47.34 83.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.204 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.0 m -51.48 -46.86 63.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.57 -48.83 82.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.99 -32.56 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.01 -46.08 90.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.201 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.68 -26.51 63.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.11 -45.35 95.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 79.3 p -71.76 -29.24 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.2 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -66.88 -42.32 85.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.34 -42.14 81.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.47 -48.03 77.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.224 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 64.4 p -69.94 -23.23 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 173.548 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -98.74 107.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.186 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -103.82 135.68 44.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.46 -138.69 2.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.19 122.59 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 0.0 111.23 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.76 87.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.54 87.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -148.97 135.85 10.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 161.68 36.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.719 1.613 . . . . 0.0 111.209 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.6 -176.18 16.32 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.41 125.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.191 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 177' ' ' LEU . . . -116.48 126.24 53.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.218 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.5 mt -123.91 117.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.68 -157.59 13.04 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.53 167.69 13.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB2' HG23 ' A' ' 218' ' ' VAL . . . -99.25 144.78 27.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 175.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -141.26 111.44 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 164.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.8 tp -87.47 115.08 24.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.209 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.74 97.01 6.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -86.59 164.17 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.224 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -115.56 106.88 14.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.41 128.33 36.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.171 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.78 127.03 29.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -87.22 111.96 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -87.72 124.88 34.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.204 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.98 118.93 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.53 102.93 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.209 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -87.4 -5.25 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.91 139.25 52.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.05 158.74 32.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 pt -119.02 172.5 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -76.19 157.75 32.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.78 -32.53 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -72.57 -14.84 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -96.48 -0.34 49.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.1 -51.08 77.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.07 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.33 -51.19 71.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -71.11 -34.12 70.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.85 -43.92 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.221 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.92 -45.18 90.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.216 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.16 -47.7 84.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.08 -36.21 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -40.51 94.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.81 76.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.95 -42.6 99.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.183 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.99 -43.43 98.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.71 -40.71 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.233 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.4 m -67.04 -43.63 82.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.186 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -63.98 -42.87 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -59.0 -49.17 78.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -52.09 -58.76 5.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.34 -42.05 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.196 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.98 -45.91 82.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.202 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.41 -34.59 77.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.27 -49.26 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -68.21 -27.06 66.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.39 -51.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.242 170.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.8 -37.02 83.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.24 93.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.204 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -60.15 -46.76 88.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.213 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.94 -34.32 77.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.148 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -87.65 -45.13 10.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.218 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.73 -36.42 3.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.47 -172.08 14.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.86 -26.29 68.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 111.207 -175.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -43.53 -45.77 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.22 -31.25 12.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.71 91.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.42 -30.99 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.183 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.41 -45.78 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.01 -27.52 57.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.58 -44.27 89.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.92 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -61.68 -38.37 87.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.18 -44.14 89.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.21 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.4 mtm -62.61 -38.02 88.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.234 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.11 -39.87 95.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.218 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.56 -23.31 66.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.254 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.1 p -98.38 -3.75 36.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -66.11 113.71 13.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.29 -32.89 82.94 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.71 1.607 . . . . 0.0 111.239 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -67.4 -43.71 80.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.97 -36.58 69.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.35 -52.29 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.49 -34.48 77.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.48 -47.06 90.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.44 -44.87 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.218 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -62.85 -39.59 94.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.66 -33.83 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.0 tpp -65.32 -41.54 93.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.29 -47.75 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.29 -46.53 49.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.235 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.2 m -65.14 -48.43 73.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 -172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.32 -9.82 34.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.8 mt 57.48 64.08 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 179.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.9 p -80.3 163.37 24.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.96 86.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.85 -50.71 72.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.17 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -67.31 -40.24 86.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.211 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.65 85.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.34 -45.8 97.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.201 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -58.48 -43.81 89.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -67.48 -49.67 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.192 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.64 -46.31 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.195 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.4 mm -65.93 -42.54 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.178 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -67.0 -38.2 85.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.201 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -65.75 -44.85 84.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.186 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -66.7 -40.45 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.194 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.08 97.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.186 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.3 m -59.24 -42.98 92.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.77 -52.91 56.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 56.9 mtt -54.74 -42.09 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -69.66 -39.53 77.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.3 p -70.39 -19.86 62.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.184 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.11 -7.14 56.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 60.44 37.45 19.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -115.05 112.54 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.06 -30.35 70.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.12 -50.3 72.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.255 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.44 -28.78 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.6 -42.96 99.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -42.03 95.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.98 -34.04 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.97 94.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.46 -41.81 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -57.07 -43.33 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.195 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -62.48 -41.19 98.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.223 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.84 -50.32 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.189 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.87 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -44.64 95.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.21 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.07 -38.03 89.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.35 -48.43 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.205 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.23 -41.24 90.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.9 -38.42 88.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.07 -28.26 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.3 mt -68.67 -48.31 64.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.1 tp -74.7 -52.46 11.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.59 35.76 0.83 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.76 127.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.234 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.13 155.47 25.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.182 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 85.1 p -156.79 169.67 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.6 128.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -86.66 106.15 17.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.4 mt -90.77 10.82 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.3 p -90.91 -7.46 52.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -106.71 27.53 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.69 137.3 51.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.0 27.99 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -169.56 138.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.18 123.14 17.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.197 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.84 144.36 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -167.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.96 121.49 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.1 t -93.66 118.3 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 -174.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.401 HG22 HG22 ' A' ' 209' ' ' THR . 48.5 mm -112.13 126.79 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.219 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 148.06 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.225 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.87 -41.56 82.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.22 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -112.91 151.65 30.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.4 tp -154.24 122.24 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.8 p -112.48 161.65 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.214 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.23 -35.86 84.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.691 1.594 . . . . 0.0 111.235 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.5 p -74.6 -10.08 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.204 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.99 -40.85 12.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 171.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 -22.93 64.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.52 -9.29 58.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.6 p -111.91 -28.47 8.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.6 mtp -57.29 94.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -41.73 105.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.185 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -64.43 -22.03 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -72.15 -27.92 62.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.1 -39.66 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.25 119.0 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.423 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 94.7 mt -96.18 -15.56 22.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.99 178.4 43.89 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -158.49 137.05 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -115.71 139.24 50.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.216 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.3 m -120.43 138.36 53.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.09 -42.95 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.227 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.58 137.61 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.225 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.85 177.75 29.4 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.32 54.02 0.66 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.9 26.84 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.8 p -74.21 -30.58 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.196 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.2 p -77.24 -30.83 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -61.2 -48.78 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 172.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.2 m -55.77 -42.43 75.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.225 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.19 97.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.45 -45.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 ttp -58.11 -53.07 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.26 99.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -70.84 -33.11 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.18 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.6 m -69.96 -37.47 75.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.7 -7.44 57.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 61.33 48.98 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 47.6 pt -126.82 149.32 68.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.22 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 49.3 Cg_exo -60.76 146.41 97.4 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.744 1.629 . . . . 0.0 111.201 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.44 138.87 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.196 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 76.9 t -129.81 127.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.6 164.93 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.65 26.1 59.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 90.9 mt -78.33 -31.65 48.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.9 4.57 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -100.27 2.81 43.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 111.247 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.07 -27.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.184 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 159' ' ' ILE . 29.7 p -81.84 -6.92 59.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 96.3 p -106.07 -29.35 9.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.216 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -91.59 -24.48 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.212 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.0 t -111.88 119.14 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.227 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.6 157.75 33.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.241 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.39 128.36 35.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 108.18 -20.91 30.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -71.15 165.11 24.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.21 138.32 34.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 16' ' ' ALA . 86.1 t -127.29 131.06 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.171 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.8 mt -114.92 112.54 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.46 96.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -93.39 88.11 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.246 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.86 79.63 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.83 -38.46 88.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 111.22 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -94.07 -31.09 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.186 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.32 34.85 7.27 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 pt -131.8 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.3 t -128.42 135.09 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.237 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.46 127.47 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.186 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.23 133.66 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.404 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 95.7 m-20 50.67 56.56 17.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.211 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 70.7 Cg_endo -70.49 156.81 60.66 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.697 1.598 . . . . 0.0 111.192 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.03 161.01 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -52.46 -48.97 65.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.89 -46.43 84.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.186 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -55.65 -43.6 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 64.1 t -60.12 -46.05 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.99 -34.38 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.244 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.92 -48.26 79.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.51 -26.21 60.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.229 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.11 -46.71 86.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.9 p -69.27 -31.83 70.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 -38.56 79.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.207 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -61.05 -43.27 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.55 -40.73 95.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.22 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 75.2 m -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.221 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.208 175.065 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 87.7 mt -80.18 80.3 6.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.54 130.91 41.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.96 -150.52 5.23 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.1 114.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.5 87.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.07 73.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -151.32 141.51 14.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.07 160.75 29.96 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.699 1.6 . . . . 0.0 111.204 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.06 -177.17 18.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -134.41 122.87 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 111.216 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.88 123.48 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.31 112.75 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.73 -160.86 20.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -83.41 150.55 25.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.37 128.37 38.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.21 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -126.8 139.05 53.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.3 tp -105.85 131.92 52.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -113.09 116.79 30.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.1 p -125.46 169.7 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.243 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -150.8 136.59 18.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.402 ' HB3' HG13 ' A' ' 144' ' ' VAL . 88.5 tt0 -58.78 136.01 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.86 137.37 58.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -86.7 113.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.3 m -120.34 117.08 26.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.35 127.21 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.211 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -80.65 107.29 13.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.22 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.24 22.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.778 ' O ' ' CB ' ' A' ' 30' ' ' LYS . 88.8 tt0 -59.51 -61.57 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.778 ' CB ' ' O ' ' A' ' 29' ' ' GLU . 87.1 tttt 124.9 140.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.201 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 31' ' ' ILE . 2.9 pp -121.17 166.23 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -90.93 165.9 13.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.212 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -52.23 -41.21 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.198 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.8 p -69.88 -18.17 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.92 2.5 49.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.256 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.88 -52.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.04 -32.6 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.1 -50.84 72.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.25 -33.77 72.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.196 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.64 -44.83 99.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.51 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.38 -46.67 88.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.179 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -60.0 -51.14 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.31 -39.7 80.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.63 -58.8 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.199 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.8 69.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.201 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.3 tm? -65.32 -50.46 65.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.93 -38.91 90.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.21 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.02 -41.3 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.6 m -60.49 -41.95 95.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -57.23 -49.89 74.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.81 -46.18 88.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -52.65 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.06 -40.87 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.42 -43.14 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.178 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -34.46 72.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.8 mt -63.81 -47.97 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -72.08 -27.47 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.222 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.47 -46.31 90.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.35 -40.14 67.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.92 78.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.0 tt -52.33 -45.38 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.07 -33.17 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.22 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.71 -44.16 24.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.233 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -118.13 -35.64 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.17 170.33 12.74 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.5 -26.89 68.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.205 -174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.8 -44.88 39.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.98 -33.91 39.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.03 83.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.251 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.35 -38.13 86.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.219 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.3 mt -60.34 -44.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -78.27 -24.57 46.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.01 -41.26 96.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.77 87.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.39 -39.72 94.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.206 174.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.68 -43.61 96.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.2 ttp -52.49 -48.12 66.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.202 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.9 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.32 67.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.8 p -92.14 -14.58 28.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -64.87 118.94 53.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -52.95 -32.29 56.88 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.71 1.607 . . . . 0.0 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -50.54 -39.27 48.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.16 -47.69 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.39 -56.77 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.229 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -75.09 -31.31 61.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.18 -48.27 81.25 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.22 -42.34 84.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.203 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -53.71 -47.22 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.47 -35.44 79.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.7 tpp -63.78 -41.88 97.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.87 -47.97 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.58 -44.55 64.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -65.83 -48.22 72.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.198 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -94.65 -10.95 30.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.95 63.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.224 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.79 169.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -70.57 163.09 27.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.182 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.29 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.12 -42.73 99.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.86 96.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -55.91 -48.45 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.226 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -57.87 -44.19 86.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.5 -45.42 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.55 -44.08 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 131' ' ' ARG . 38.6 mm -65.57 -45.54 92.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.03 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.168 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -59.85 -54.86 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -67.72 -39.01 84.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.212 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.29 99.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 m -61.17 -42.86 99.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.202 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.3 -49.78 83.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 59.4 mtt -56.4 -41.15 75.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.78 -38.83 73.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.203 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.8 p -69.37 -20.58 63.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.0 -9.6 59.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.24 32.82 20.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -104.36 106.99 17.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.42 -33.16 74.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.231 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.32 -50.01 75.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.53 -30.09 68.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.74 -42.04 98.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.64 -40.94 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.192 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -66.03 -33.63 76.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.177 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.53 92.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.07 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -57.37 -42.94 83.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.36 -42.55 96.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.197 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.406 ' HA ' HG21 ' A' ' 108' ' ' ILE . 91.3 mtt180 -63.8 -39.65 94.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.243 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.3 -47.59 83.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.17 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.53 -44.62 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.53 -42.97 97.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -61.38 -41.87 97.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -59.97 -42.47 94.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.68 -47.23 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.05 -43.61 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.17 -38.25 88.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -71.55 -30.71 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -69.94 -40.39 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.13 -28.99 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.201 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.19 35.8 9.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 22' ' ' GLU . 82.6 t -71.19 123.66 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.23 165.83 14.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 88.1 p -143.69 171.29 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -84.56 78.55 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.245 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.11 -6.28 59.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.4 p -74.29 -9.25 58.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.13 0.65 55.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.56 145.35 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.54 32.54 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -143.92 140.88 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.59 99.28 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.19 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.74 -179.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.6 t -94.8 122.95 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.58 117.75 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.76 125.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.218 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.09 49.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -63.14 -56.47 16.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -146.34 176.76 9.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.69 145.12 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.6 p -129.6 155.69 79.89 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.34 -38.34 72.95 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.714 1.609 . . . . 0.0 111.215 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -43.85 75.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.28 -46.28 64.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 65.0 p -67.89 -29.71 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.85 -29.37 70.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.1 p -108.46 14.55 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 63.1 tpp -71.65 115.58 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.55 77.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.2 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HB2' HD11 ' A' ' 197' ' ' LEU . 63.7 pttt -63.16 -20.7 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.241 -172.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.11 -31.02 68.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -112.47 32.27 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.43 106.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.1 tp -80.52 -40.04 26.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.43 176.81 27.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -154.89 139.59 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 111.185 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.02 25.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.6 t -143.65 154.42 43.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.63 -53.31 57.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.14 124.78 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.11 74.22 0.84 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.5 -31.69 81.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.51 60.11 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.19 174.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.6 m -59.21 -37.36 77.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.211 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t -58.31 -56.46 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -59.37 -40.14 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.3 -46.87 88.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.84 92.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.09 -48.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.236 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.85 -35.71 81.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.19 98.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.184 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.55 -38.62 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.174 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 t -61.53 -43.03 99.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 173' ' ' LYS . 90.3 mt -88.24 -16.09 34.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 61.69 51.26 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.174 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 44.4 pt -127.68 159.67 64.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 92.3 Cg_endo -76.68 163.35 31.76 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.666 1.577 . . . . 0.0 111.251 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.55 135.73 11.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.18 122.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.95 160.35 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.91 38.64 35.42 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.17 -6.41 57.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.327 . . . . 0.0 111.201 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.28 -64.73 4.14 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 171.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -141.38 44.33 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.69 -22.67 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.7 p -70.44 -22.29 62.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.0 p -90.29 -27.08 19.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -90.69 -27.94 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.242 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.6 116.6 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.243 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.15 166.4 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.52 125.6 24.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.11 -18.06 40.09 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.83 165.27 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.23 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 62.4 tp -100.26 125.98 46.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.172 171.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.58 138.71 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.203 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.38 126.01 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.2 171.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.08 100.77 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -99.68 93.61 5.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.34 -22.51 73.08 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.25 -39.22 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -103.23 -15.3 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.71 37.33 26.81 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.96 155.73 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 73.6 t -120.27 135.31 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -109.21 129.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.65 117.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.177 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.76 60.4 11.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.223 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.0 153.18 68.07 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.714 1.609 . . . . 0.0 111.209 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -88.78 -176.52 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.76 -53.95 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -59.27 -48.87 80.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.9 m -53.99 -47.37 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.63 -45.82 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.203 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.72 -34.22 77.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.32 -41.73 98.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.215 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -75.96 -29.62 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -63.23 -41.62 99.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 47.8 t -62.67 -46.56 87.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.199 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.61 -42.83 93.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.62 -47.16 85.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.01 -47.07 88.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.5 p -61.94 -28.32 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 176.791 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.8 mt -100.79 140.55 34.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.06 136.3 43.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.228 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.8 -138.45 2.52 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -102.19 119.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 111.233 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.54 87.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.95 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.218 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 t -150.28 138.64 12.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.238 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.81 160.67 34.04 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.696 1.597 . . . . 0.0 111.199 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.87 175.16 13.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -125.09 124.6 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.92 132.8 52.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -129.57 127.39 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.31 -153.74 24.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.01 154.71 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.171 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.67 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 31.7 m-85 -121.46 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.59 117.96 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -66.28 124.37 22.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -117.83 131.5 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.96 130.09 50.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.04 135.07 56.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.73 128.2 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.68 93.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.1 m -97.73 112.88 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.48 126.83 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -99.68 103.43 15.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.27 20.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.214 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.16 138.9 47.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.22 139.51 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 pt -118.12 170.28 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.214 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.42 146.19 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -64.03 -20.65 66.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.0 p -73.56 -14.44 61.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -98.42 4.43 48.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.2 -51.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.01 -32.8 74.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.85 -49.26 78.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.196 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.7 -37.3 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.65 -44.6 98.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.27 84.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -64.01 -37.97 89.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -59.28 -49.15 78.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.2 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.49 -36.68 84.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.7 -40.41 92.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.19 -33.49 76.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.65 -40.97 98.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.253 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.64 -42.76 99.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.58 -39.98 85.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.206 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.0 m -63.17 -41.61 99.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -60.97 -44.81 96.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.225 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -59.39 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.58 -55.91 21.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.58 -42.99 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.166 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.95 -49.33 77.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.36 -36.76 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.7 mt -63.03 -45.61 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.17 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.7 -43.72 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -55.35 -52.95 61.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -60.03 -42.85 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -43.11 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.42 -45.02 95.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.21 -31.71 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -97.06 -39.78 9.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.3 -34.91 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.25 -171.91 15.72 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -63.26 -26.13 68.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 111.175 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -45.59 -42.28 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.98 -34.74 10.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.46 -39.21 93.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.9 -32.68 74.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.16 -41.61 91.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.214 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -77.46 -24.09 50.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.36 -41.07 96.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.192 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.79 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -59.64 -41.16 89.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.187 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.73 -43.37 93.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.9 mtm -64.82 -36.09 83.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.86 -45.68 88.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.65 -33.12 74.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.3 m -94.69 1.93 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -65.79 114.17 15.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.86 -33.9 83.48 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.689 1.593 . . . . 0.0 111.216 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -67.94 -43.74 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.198 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.12 -36.69 72.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.96 -51.85 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.19 -35.16 79.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.19 -46.25 91.81 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.29 -46.59 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.37 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.76 -36.39 80.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp -63.68 -40.34 96.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.177 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.88 -50.91 77.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.51 -42.19 71.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.8 m -63.69 -47.37 81.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -99.17 -6.07 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt 59.97 45.05 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.66 -179.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -76.31 163.2 27.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.207 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.66 77.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.19 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.49 -53.17 60.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -59.86 -47.55 85.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -51.24 70.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.247 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.73 -46.1 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -54.84 -47.27 74.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -73.07 -47.86 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.81 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.411 HG23 ' HG ' ' A' ' 130' ' ' LEU . 33.5 mm -65.42 -43.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.43 -44.69 95.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.86 -56.15 25.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.211 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.77 94.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.2 p -67.16 -30.59 70.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.164 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.72 -51.61 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 76.1 mtm -60.3 -35.42 75.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.79 -37.93 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.5 p -70.63 -20.0 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.86 -12.54 61.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.44 32.05 14.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.199 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -105.53 112.45 25.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.176 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.41 -30.67 68.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.38 -50.05 71.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.24 -25.18 62.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.99 -45.23 89.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.218 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.51 -42.13 91.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.93 -33.76 76.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.61 94.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.76 -43.47 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -56.39 -45.82 80.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HG ' HG23 ' A' ' 108' ' ' ILE . 57.7 tp -63.06 -45.08 93.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.229 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -58.41 -43.01 88.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.178 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.53 -48.84 79.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.0 -47.16 90.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.06 -45.14 95.69 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -61.69 -41.67 97.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.346 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -69.71 -33.04 71.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.04 -46.08 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.92 -43.02 96.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.31 -35.65 79.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.76 -31.15 64.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.37 -38.93 88.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.193 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.5 -28.09 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.72 38.23 10.84 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.26 120.37 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.208 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.75 161.37 14.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 72.0 p -160.32 169.73 22.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.8 t -72.42 123.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.185 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.74 74.89 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.215 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.37 -25.67 66.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.196 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.1 p -70.45 -14.05 62.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.219 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -96.46 5.5 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.25 137.67 41.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -110.15 41.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -148.38 143.58 26.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.173 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -57.99 104.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.219 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.49 157.03 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.28 134.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.19 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.1 105.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.18 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.3 mm -104.22 124.21 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -157.95 156.86 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -78.51 -39.92 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -159.11 111.17 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.55 151.15 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -108.4 162.06 21.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.04 -32.98 60.85 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.714 1.609 . . . . 0.0 111.194 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.3 p -69.79 -19.02 63.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -94.54 -38.6 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -77.92 -16.93 57.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.212 -175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.45 -2.97 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.209 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.6 p -88.92 -18.28 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 96.0 mmm -77.95 130.49 36.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.1 129.72 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -48.66 -50.12 34.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -82.12 -3.36 54.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.191 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.5 mmt -110.19 10.35 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.182 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -119.86 122.39 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.78 -36.04 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.22 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.85 -178.68 45.64 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.54 144.25 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 65.5 p -131.41 159.11 38.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.214 -170.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.57 -33.08 64.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.3 m -115.36 163.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -108.93 24.3 21.75 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.46 -21.86 70.9 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.35 31.43 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 111.197 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.6 m -51.99 -48.52 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.7 p -65.37 -30.31 71.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -76.51 -39.16 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.9 p -70.29 -28.12 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -67.61 -52.78 34.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.65 -46.5 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 43.7 ttp -61.65 -55.0 35.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.234 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.19 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.198 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.09 -41.51 97.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -70.93 -22.6 62.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.227 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.1 -2.17 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.23 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.64 35.37 9.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 45.9 pt -132.31 154.26 81.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.234 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.11 160.63 39.58 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.754 1.636 . . . . 0.0 111.166 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 139.33 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 57.3 t -132.64 109.43 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.02 165.41 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.193 -168.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 70.43 39.3 69.71 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.77 -35.37 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 119.53 -53.95 0.66 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -143.95 31.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.54 -25.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -70.57 -22.52 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.21 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.1 p -94.38 -25.82 16.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -94.61 -24.24 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.11 125.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -115.69 164.27 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . . . -61.01 125.37 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.74 -12.38 50.12 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -71.23 144.68 50.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.08 124.26 27.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -132.4 136.77 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.48 124.81 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 80.8 t -97.78 112.6 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -108.91 93.14 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.94 -10.56 83.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.37 -39.5 47.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 111.195 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -93.72 -25.59 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.2 39.36 8.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.7 pt -132.44 160.55 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 111.183 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.12 133.0 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 78.5 mt -113.15 121.39 65.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.89 134.7 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.539 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 87.2 m-20 54.63 61.79 8.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 -171.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 230' ' ' ASN . 50.8 Cg_exo -58.43 145.85 92.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.736 1.624 . . . . 0.0 111.173 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.94 157.74 36.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.186 169.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.06 -48.46 61.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.14 -45.22 93.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.224 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.5 m -57.55 -42.6 83.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.225 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.5 -48.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.67 -35.09 74.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.85 -51.92 66.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.198 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -72.58 -26.83 61.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.19 -51.56 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 92.1 p -69.32 -34.48 74.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.2 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.26 -42.85 75.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -53.52 -49.81 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.216 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -35.83 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 72.4 m -58.52 -38.91 78.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.206 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -90.38 -31.77 16.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -76.26 -48.6 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.233 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.9 mttt . . . . . 0 C--O 1.2 -1.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 -177.096 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 91.5 mt -79.76 81.75 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.253 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.61 134.84 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.1 -141.19 3.14 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.06 115.06 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 111.174 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.62 133.12 35.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.1 -32.5 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.8 t -165.39 137.05 3.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.82 144.65 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.675 1.583 . . . . 0.0 111.198 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.94 173.14 16.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.3 mt -133.73 120.51 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 111.202 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.08 124.62 49.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.72 115.71 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.97 -157.41 14.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.59 162.75 13.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 111.18 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.02 132.53 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.183 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -121.13 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -102.13 133.0 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.151 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -134.01 114.79 13.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.3 p -105.91 172.13 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -154.42 132.21 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -109.61 157.08 19.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.176 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.27 128.43 34.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.1 t -102.09 132.44 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.183 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -62.59 129.37 40.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.76 133.31 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -74.24 104.24 4.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.212 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.26 21.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.54 -98.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.21 149.15 44.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.03 165.53 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -59.33 137.51 57.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -54.33 -38.07 65.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -68.59 -15.72 63.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.8 0.03 57.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.15 -51.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -65.43 -33.06 75.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.11 -50.03 75.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -69.82 -34.49 73.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.208 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.28 -43.78 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.51 89.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.04 -45.73 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -60.12 -51.18 70.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.06 -42.61 99.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.25 -55.26 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.46 75.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.202 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.11 -47.05 75.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.61 -40.73 88.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.31 -44.89 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -57.62 -45.04 85.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.222 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -60.53 -47.82 84.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -58.31 -47.96 82.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.57 -48.81 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.68 -44.24 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.205 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.04 -49.62 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.85 -45.9 76.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.43 -26.66 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.16 -50.85 72.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.19 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.64 -46.23 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.219 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.22 -48.77 79.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.24 93.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 62' ' ' LEU . 9.8 tt -55.64 -47.35 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.204 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.81 -34.25 34.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -79.88 -42.34 24.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.12 -33.63 4.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.56 168.64 12.62 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.36 -22.05 66.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.164 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.16 -36.85 80.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -85.23 -30.52 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.94 77.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -54.01 -36.26 62.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.206 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.09 -46.9 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -75.61 -28.05 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.211 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -59.53 -49.06 79.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.198 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -69.16 -33.1 72.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.76 -43.25 80.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.99 -40.76 98.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.55 -40.66 97.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.81 70.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.175 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.8 p -91.87 -1.02 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.3 115.95 28.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.38 -17.56 23.89 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.735 1.623 . . . . 0.0 111.228 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -71.62 -41.28 69.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.215 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.71 -38.32 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.224 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.2 -48.87 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.215 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.86 -43.48 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.64 64.15 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.66 -45.97 96.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 111.188 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.91 -38.3 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.71 -33.22 72.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.6 tpp -64.18 -43.0 96.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.204 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.0 mt -58.85 -47.86 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.16 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -73.52 -46.57 46.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -66.51 -48.4 69.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -96.2 -7.55 35.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.233 -174.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.9 64.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.161 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.86 169.0 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.24 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.9 p -76.01 162.4 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.4 81.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.02 -48.52 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.12 -45.68 80.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -47.67 85.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.201 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.48 -48.17 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.225 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.63 -41.14 85.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.203 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -68.47 -50.9 49.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.28 -44.41 91.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -61.76 -44.5 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.227 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -65.29 -42.35 93.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -59.17 -54.91 41.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -66.75 -38.83 87.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.89 93.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.0 p -65.8 -32.24 73.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.14 -51.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 96.7 mtp -57.23 -37.46 72.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -73.07 -37.96 66.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.198 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.2 p -70.21 -19.21 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.05 -11.78 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.211 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.59 32.35 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -105.89 113.01 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.198 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -59.86 -30.33 68.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.73 -50.02 70.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.32 -27.34 65.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.73 -46.55 84.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.77 -43.58 90.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.217 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -69.39 -32.4 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.238 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.9 85.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.248 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.0 t -60.02 -45.83 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.228 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.62 -43.5 84.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -45.53 93.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.95 -41.2 95.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.21 -48.1 83.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.34 -44.34 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.84 -44.44 92.13 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.98 -39.69 95.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.221 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.78 -37.01 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.219 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.99 -45.49 98.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -60.73 -41.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -47.08 77.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.222 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -71.24 -29.44 65.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.68 -40.18 88.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 172.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.07 -26.23 39.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.33 30.62 15.92 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.29 126.32 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.76 163.14 13.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.2 p -148.88 163.1 38.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -118.92 131.04 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.211 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -82.75 114.58 21.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.407 HD12 ' C ' ' A' ' 149' ' ' LEU . 3.6 pp -67.72 -23.11 65.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.4 p -73.12 -13.27 61.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -99.02 8.55 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.23 148.27 35.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -95.87 -21.59 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.55 156.13 30.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -76.32 129.68 36.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.07 167.7 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 93.6 t -98.58 126.53 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.4 t -86.45 113.76 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.59 117.97 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.9 147.31 30.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.217 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.53 -32.94 60.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -126.36 94.93 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.76 109.12 17.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 71.7 p -110.16 164.01 15.83 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.173 -167.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 76.5 Cg_exo -54.39 -31.2 66.91 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.682 1.588 . . . . 0.0 111.216 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.9 p -69.37 -16.37 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -91.02 -31.42 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 93.7 m -59.52 -38.03 79.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.36 -29.32 63.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.222 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -109.65 37.21 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 62.4 ttp -93.85 105.19 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -91.45 99.43 12.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.181 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.57 -20.15 64.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.08 -33.75 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 39.1 mmt -92.57 -34.14 14.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.48 122.52 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.209 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.8 -26.38 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.232 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.7 178.1 48.46 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.58 152.66 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -156.88 152.72 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.3 t -159.69 -176.21 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.235 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -120.48 -43.93 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 p -172.73 138.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 174.5 176.77 43.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.27 14.05 65.6 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.33 27.51 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.152 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.2 m -68.74 -46.19 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 96.4 p -64.56 -31.64 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.18 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -64.96 -46.01 83.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 99.1 m -52.54 -45.01 66.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.27 -42.84 99.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.206 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.49 -44.06 95.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.225 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.5 mtp -55.54 -48.3 74.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.39 81.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.69 -33.92 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.234 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.7 p -68.43 -19.99 64.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.2 mt -107.6 1.47 23.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 57.22 47.04 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.206 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.5 pt -127.37 156.89 74.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.46 154.37 31.46 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.673 1.582 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.33 144.79 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.205 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.9 117.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.227 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.8 163.4 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.68 55.95 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.65 -48.87 12.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.24 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.99 -11.9 58.94 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -132.57 -14.51 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -170.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.5 -28.67 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -160.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.0 p -80.31 -11.3 59.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.215 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.6 p -105.61 -30.23 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.222 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -81.11 -34.69 32.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.64 120.42 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.244 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.41 152.02 32.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.22 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 126.65 27.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.82 -16.85 46.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.1 175.25 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 111.191 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -99.23 139.39 34.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 170.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.32 134.7 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.178 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.87 127.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.246 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -105.33 94.5 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.182 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -84.6 82.03 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.187 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.35 73.96 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.39 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -78.18 -40.22 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.28 32.66 5.15 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -131.61 156.19 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.212 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 97.6 t -121.32 135.36 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.54 127.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.38 117.3 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.13 62.48 8.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.55 147.0 63.26 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.731 1.62 . . . . 0.0 111.216 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.91 162.7 28.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 173.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.68 -46.12 58.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -62.32 -43.87 97.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.2 m -59.66 -43.18 94.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.242 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.06 -46.29 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -64.61 -35.24 80.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.63 -46.29 90.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.196 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -73.62 -28.75 61.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -62.61 -45.6 92.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.77 -32.34 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.66 -42.42 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.14 -39.63 87.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.83 -43.31 99.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.2 p -71.06 -27.73 63.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.31 -49.94 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 172.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 248' ' ' LYS . 98.1 mt-10 -66.22 -39.19 89.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 247' ' ' GLU . 99.7 mttt . . . . . 0 C--O 1.2 -1.538 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.214 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HE3' ' HB ' ' A' ' 228' ' ' ILE . 99.6 mtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.48 109.34 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -103.85 138.27 40.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.86 -139.43 2.84 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.88 121.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.363 . . . . 0.0 111.191 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.53 87.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.33 -33.01 72.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.186 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -148.56 135.64 10.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 164.31 31.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.659 1.573 . . . . 0.0 111.177 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.89 -168.02 15.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 tt -158.73 144.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 111.239 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.76 154.95 33.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 219' ' ' ILE . 81.9 mt -122.91 128.16 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.26 -177.06 29.07 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.53 150.6 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 111.204 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.28 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -111.0 120.38 42.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.2 tp -93.44 109.22 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.197 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -64.11 108.24 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -91.44 117.12 29.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.211 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -120.85 108.71 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 139.37 54.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.65 160.07 29.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.55 119.3 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.5 m -119.33 118.02 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 101' ' ' ASP . 97.0 mt -71.4 125.65 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.204 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -78.93 114.64 18.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.65 22.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.57 136.35 52.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.226 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.5 128.98 39.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -102.9 127.25 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -57.98 136.81 57.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.2 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.58 -44.59 26.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.8 p -68.5 -20.82 64.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.18 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.04 2.33 43.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.96 -38.16 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.48 -21.94 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -68.44 -35.42 77.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 171.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.89 -35.45 80.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.56 -46.01 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.91 87.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.239 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.35 -47.34 81.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.98 -49.96 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -59.4 -42.03 90.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.25 -37.68 52.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.47 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.71 -42.3 82.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -50.87 -50.48 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.99 -44.74 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.7 m -52.86 -50.09 64.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.73 -42.9 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.5 -46.11 89.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.2 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -60.96 -42.38 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -61.03 -40.96 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.25 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.51 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -57.19 -47.39 81.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.5 -51.35 67.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.211 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.17 -31.55 70.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.46 93.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -63.17 -46.96 84.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.67 -39.22 93.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.221 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -83.32 -34.13 25.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.185 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.12 -58.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.18 -168.26 23.45 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -60.81 -27.5 68.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -43.79 -44.34 6.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.22 -34.35 11.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.205 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.49 -39.11 93.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -176.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.03 -32.7 74.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.22 -43.93 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.168 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -76.81 -19.83 57.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -63.36 -49.1 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.98 81.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.195 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -56.19 -47.24 78.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.214 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -64.33 -44.74 90.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.8 ttp -49.72 -48.4 49.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.171 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.75 -38.61 91.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.0 66.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.5 p -94.56 4.54 53.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -62.55 116.54 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.0 -33.61 73.66 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.733 1.622 . . . . 0.0 111.16 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.39 -35.95 78.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.2 tp -67.55 -46.53 72.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.5 -58.25 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.52 -35.12 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.19 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.59 -48.5 84.19 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.5 t -68.84 -43.88 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.24 -42.7 91.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.265 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -68.89 -36.72 78.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.99 -43.55 98.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.76 -50.78 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.9 -40.86 87.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.5 m -67.07 -47.61 70.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -91.62 -15.89 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.8 mt 64.98 43.75 3.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.223 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.64 -177.59 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -72.1 156.62 38.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.217 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.1 76.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 26' ' ' ILE . 94.3 m-20 -58.95 -50.49 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.233 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -65.01 -41.31 95.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.95 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -45.36 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.242 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -56.49 -46.81 80.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -68.19 -50.05 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.71 -45.07 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.2 mm -60.0 -43.65 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -64.42 -43.35 94.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.214 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.03 -45.9 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -57.89 -47.62 82.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -50.3 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 93.0 mtp -58.26 -38.56 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.186 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -72.09 -38.58 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.194 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 p -70.01 -20.08 63.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.197 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.38 -15.41 63.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.211 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 62.54 32.31 16.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.248 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -100.33 109.84 22.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -42.4 -44.79 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -62.24 -54.64 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.241 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.46 -31.71 71.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.184 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -46.79 86.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.8 -43.81 94.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.206 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -68.74 -31.38 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.48 87.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -61.48 -44.21 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.196 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.57 -41.99 91.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.247 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.63 -41.66 97.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -58.99 -38.64 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.27 -41.36 89.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -54.55 -46.03 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.04 93.49 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.05 -42.43 99.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.18 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -62.56 -40.59 97.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.206 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.53 -48.06 86.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -60.73 -39.89 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.211 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -56.07 -46.71 78.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -71.38 -29.37 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.4 mt -66.45 -37.23 84.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.246 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB2' HG23 ' A' ' 144' ' ' VAL . 88.4 mt -84.24 -32.18 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.27 31.75 7.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 142' ' ' LEU . 81.9 t -72.01 123.52 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.19 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -122.49 163.22 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -152.31 165.83 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.1 t -69.88 130.25 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -76.49 108.79 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.56 -3.39 58.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.208 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 84.6 p -90.78 0.18 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -94.82 5.49 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.16 78.25 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -68.76 -30.94 69.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -87.91 151.85 22.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.55 113.08 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.09 170.4 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.44 134.24 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.87 113.27 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.65 116.05 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.235 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -147.57 156.65 43.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -171.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -97.8 -20.97 17.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.212 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -161.7 110.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.19 96.91 8.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.231 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 46.5 p -80.99 165.38 45.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.222 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 93.9 Cg_exo -50.25 -37.44 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.736 1.624 . . . . 0.0 111.166 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.2 p -76.22 -30.41 57.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.65 -35.07 72.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.7 p -80.79 -29.62 36.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.93 86.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.183 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.8 p -95.95 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 58.5 ttp -136.39 133.02 36.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -77.35 89.37 3.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.231 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -54.99 -35.0 63.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.246 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -47.89 -38.56 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.215 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -109.53 31.4 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.201 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 92.0 t -106.72 124.21 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.197 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.9 mt -100.84 -10.78 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.59 170.73 38.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -121.79 141.61 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -143.38 108.84 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.185 169.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 67.9 p -118.82 154.73 32.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.86 -42.11 95.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.1 m -108.07 157.16 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.194 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.76 3.86 45.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.81 73.11 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -108.4 22.8 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.328 . . . . 0.0 111.182 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.6 m -49.14 -45.89 44.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.0 m -58.82 -44.09 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.18 -49.9 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 80.7 p -72.28 -30.7 65.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.74 72.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.22 -49.07 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.8 mtm -64.79 -46.16 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.45 83.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.185 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -59.63 -45.88 90.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 85.7 p -77.89 -23.62 48.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.227 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.81 -16.02 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 60.81 50.09 5.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.243 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 42.1 pt -128.64 159.84 65.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.186 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 71.8 Cg_endo -72.36 150.27 52.18 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.658 1.572 . . . . 0.0 111.198 177.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.12 126.16 12.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.229 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.17 123.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.67 159.34 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.78 39.98 32.49 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.09 -14.01 58.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.91 -59.82 1.45 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -152.06 45.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.84 -23.55 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.193 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.0 p -75.38 -15.51 60.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.5 p -97.47 -27.22 14.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.2 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.41 -23.46 20.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.15 122.96 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.236 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.86 159.85 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.11 26.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.79 -16.68 36.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.09 163.82 27.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.0 129.59 44.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.186 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.92 136.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.204 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 13' ' ' ILE . 74.7 mt -122.95 126.03 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 175.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.6 t -107.97 112.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -98.54 91.1 4.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.18 -33.73 69.35 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 67.2 tp -57.74 -49.79 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 111.213 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.59 -26.38 30.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.82 10.68 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.2 pt -133.71 149.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.94 135.95 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.423 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 7.9 tp -115.4 140.46 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.39 138.24 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.178 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 89.0 m-20 56.05 52.3 7.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -173.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.3 Cg_endo -71.76 155.28 58.63 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.665 1.576 . . . . 0.0 111.235 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -88.09 -177.88 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.04 -54.37 45.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.238 -172.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.79 -46.56 88.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.243 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.6 m -56.23 -45.55 79.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.62 -45.54 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.59 -35.6 77.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.04 -45.75 90.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -76.15 -26.06 55.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.189 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.181 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 75.3 m -59.16 -41.48 88.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.17 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.55 -49.97 75.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.221 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.64 -40.27 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 73.4 m -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.245 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -68.4 -51.32 45.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.4 -40.45 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 -170.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.199 -1.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 -176.897 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.845 0.355 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.9 mt -98.08 122.43 41.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.06 136.8 47.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -140.67 2.93 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.36 113.71 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 111.168 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.31 87.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.72 76.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.194 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.9 t -148.33 135.77 10.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.19 162.01 31.78 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.699 1.599 . . . . 0.0 111.239 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 177.59 14.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.94 130.41 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 111.176 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.02 140.11 36.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.65 124.91 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.72 -156.02 7.85 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.24 179.27 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.22 131.2 41.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -121.56 97.66 5.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.84 118.23 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 -170.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -98.72 111.26 23.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 p -104.33 167.82 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.165 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.94 132.19 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.197 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.41 132.68 54.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.191 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.19 131.43 50.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t -83.58 99.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.6 m -97.67 114.11 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -96.24 126.4 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -80.44 115.78 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.65 23.54 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.219 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -83.19 157.57 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -84.3 160.14 20.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.2 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.7 pt -122.64 165.03 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.54 146.26 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -51.27 -39.29 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -69.88 -16.31 63.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.25 -0.13 53.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -58.61 -46.79 90.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.209 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.93 -32.14 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.211 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.55 -42.47 87.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.192 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.81 -37.58 76.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 84.5 mt -63.63 -43.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.47 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.18 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -64.27 -37.92 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.83 -48.48 81.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.99 -35.62 81.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.93 -42.13 99.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.89 85.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.173 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.38 -41.6 97.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.75 -38.33 90.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.15 -46.54 95.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.2 p -68.93 -29.89 68.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.216 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -60.03 -51.26 70.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.218 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -49.93 75.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.18 -55.1 39.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.36 -41.77 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.12 -51.33 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.5 -38.18 83.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.191 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.8 mt -64.55 -41.85 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.02 -49.35 60.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -54.7 -52.94 60.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -60.74 -40.02 90.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.46 99.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.3 tt -57.41 -47.21 82.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.183 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.23 -28.88 57.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.225 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.23 -44.02 9.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.208 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.17 -32.76 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -168.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.89 164.34 11.48 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.9 -34.97 66.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -45.88 -44.51 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -76.56 -34.7 58.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.79 81.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.239 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.51 -35.87 82.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.93 -42.54 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -76.91 -24.25 52.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.209 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -64.59 -41.01 96.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.18 98.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.46 -40.74 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.211 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.97 -43.68 87.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -64.86 -36.81 85.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.9 -44.96 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.63 78.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.2 p -104.57 20.6 18.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.234 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -72.66 114.87 34.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.98 -34.55 77.4 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.69 1.593 . . . . 0.0 111.192 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -69.11 -43.36 74.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.226 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 99.5 mt -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.86 -51.78 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.42 -30.75 69.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.216 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.97 -47.09 91.29 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.11 -43.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.201 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.78 -44.93 90.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -67.68 -34.87 77.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.206 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 tpp -63.71 -43.25 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.79 -48.02 89.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -73.97 -45.91 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.3 m -63.62 -48.83 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.91 -12.07 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.217 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.5 mt 59.05 65.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.246 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 165.61 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.201 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.4 p -66.4 154.78 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.89 97.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.241 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.89 -37.12 85.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.22 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.49 -43.86 84.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.88 94.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.37 -46.5 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.5 -47.07 76.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -69.47 -51.62 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.61 -46.92 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -68.83 -47.13 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.71 -39.77 84.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.201 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -57.19 -54.56 45.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.188 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.84 -38.2 89.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.217 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.07 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.9 p -66.98 -31.19 71.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.47 -49.16 79.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 98.7 mtp -58.5 -37.38 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -74.32 -34.52 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 p -69.98 -17.56 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.251 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.62 -11.29 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.193 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 64.49 32.79 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.14 112.99 25.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.46 -31.37 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -63.34 -51.01 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.39 -25.28 63.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.223 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.48 -47.96 81.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.19 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.84 -39.59 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.48 -33.41 75.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.227 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.89 84.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.46 -43.53 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.173 173.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.01 -48.07 73.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.85 -49.14 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -56.89 -45.18 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.35 -42.91 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.211 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.52 -48.87 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.56 -40.45 99.15 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -59.64 -43.94 93.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.81 -37.23 76.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.219 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.49 -44.87 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.236 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.3 -44.44 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.52 -47.53 85.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.14 -33.3 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.56 77.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.54 -34.38 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.17 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.76 35.09 5.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.84 122.53 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 111.177 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -107.0 163.62 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 71.7 p -158.59 177.71 10.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.4 125.65 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -81.31 105.9 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.199 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.58 -26.78 67.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.242 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -77.53 -9.01 58.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.194 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.68 -3.34 58.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.194 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.08 120.41 16.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.213 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -122.72 30.21 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -145.9 137.61 25.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.82 98.46 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 173.29 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.211 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -89.2 127.24 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.6 125.19 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.87 112.05 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.229 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.92 143.92 43.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -170.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -89.54 -7.73 54.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 172.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -169.27 152.01 4.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.5 tp -173.61 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.8 p -99.99 161.04 25.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.215 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.1 -34.89 59.96 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.744 1.629 . . . . 0.0 111.179 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 p -67.21 -19.98 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -91.92 -34.12 14.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.1 p -63.65 -32.87 74.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.182 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.31 71.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.7 p -113.2 14.14 19.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.4 ttt -77.59 131.79 37.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -67.35 74.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -66.34 -22.42 66.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.86 -25.03 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.03 23.48 14.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.194 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.4 t -110.26 116.13 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.185 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.68 -4.68 33.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.52 169.48 38.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -150.4 132.04 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -141.59 150.17 41.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.3 p -137.0 165.47 25.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -104.87 7.92 34.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.99 153.43 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 139.28 145.42 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.97 -76.41 1.07 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.08 140.78 47.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.226 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.9 p -123.14 25.19 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -60.17 -59.27 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -60.07 -38.89 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 79.8 m -58.25 -47.51 83.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.8 87.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.35 -47.89 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.21 -44.86 94.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.8 82.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.201 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -61.56 -46.48 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 78.5 p -70.58 -25.03 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -22.88 28.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.209 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 60.6 47.43 8.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.203 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.03 155.87 80.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.94 161.6 23.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.664 1.576 . . . . 0.0 111.219 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.88 132.22 8.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.15 112.62 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.224 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.77 169.83 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 -170.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.64 78.68 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.5 mt -80.35 -27.44 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.29 -62.77 4.44 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -93.21 -6.12 48.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.167 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.92 -29.13 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.9 p -79.56 -14.08 59.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.259 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.2 p -102.62 -28.8 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.215 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -92.37 -23.94 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.66 120.8 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.189 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -117.49 157.57 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.23 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.46 127.31 29.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.76 -20.05 32.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.63 163.48 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.767 0.318 . . . . 0.0 111.239 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.86 134.15 36.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.6 t -133.27 128.58 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.233 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.5 mt -113.7 127.51 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.186 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.1 t -106.52 118.89 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.172 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -116.4 96.98 5.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.63 -23.7 66.78 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.66 -38.23 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 111.176 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.36 -27.64 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.187 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.45 36.45 14.32 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.68 157.68 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 111.185 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.59 134.84 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.199 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 mm -103.23 128.85 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 72.4 t -105.2 120.9 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 54.97 58.4 11.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.93 156.17 63.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.748 1.632 . . . . 0.0 111.232 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -86.47 -178.23 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.99 -42.67 99.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -64.06 -44.18 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.6 m -61.6 -44.22 97.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.99 -44.97 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.234 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.89 -35.7 80.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.221 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.02 -50.57 72.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.185 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -72.37 -27.21 62.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -59.56 -45.48 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.198 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.7 p -69.36 -31.45 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.18 -42.96 83.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.86 -44.95 86.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.85 -50.61 73.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.0 p -67.7 -26.57 66.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.228 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.63 -48.28 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.233 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.8 -38.72 80.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.208 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.2 -1.514 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -177.704 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.759 0.314 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -97.14 99.36 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -87.37 131.31 34.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.31 -150.82 5.45 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.6 119.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.83 87.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.74 -31.84 65.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -148.28 133.98 9.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.6 163.44 31.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.735 1.623 . . . . 0.0 111.171 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.4 179.66 15.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -130.67 121.36 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 111.208 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.01 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.225 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.9 mt -124.11 119.53 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.23 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.81 -161.82 13.66 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.0 157.42 16.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 111.215 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.41 95.15 4.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -105.64 105.23 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.11 140.27 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -85.29 97.94 10.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -120.83 137.89 54.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -123.09 160.18 26.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -68.67 139.46 55.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.215 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.02 115.04 29.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.27 127.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.218 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.0 m -70.66 133.67 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.35 127.26 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -79.82 113.05 17.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.84 16.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -56.96 133.6 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.207 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.44 129.74 43.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.08 125.37 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.03 145.79 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.33 -34.87 61.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.7 p -75.85 -21.69 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.233 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.61 -9.35 41.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 93' ' ' ILE . 42.6 t -54.78 -45.0 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.52 -32.93 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -67.0 -41.83 86.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.65 -36.2 78.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.21 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 173.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.93 90.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.3 -45.82 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.94 -47.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.51 -36.33 83.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.48 -39.69 92.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.77 -35.08 79.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.2 -42.36 99.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.48 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.36 -44.06 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.199 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.3 m -60.21 -48.82 80.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.3 -42.19 99.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.15 -49.81 74.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.31 -45.77 92.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.66 -44.22 93.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.49 -45.76 78.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.36 -41.57 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.86 -40.77 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.195 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -50.58 -47.33 58.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.195 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.68 -49.14 68.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.01 -42.06 98.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.07 85.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -62.45 -46.08 90.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.49 -29.96 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.197 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -82.38 -53.83 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -117.36 -34.49 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.38 -168.46 16.51 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.56 -19.0 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.776 0.322 . . . . 0.0 111.208 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -55.92 -52.91 62.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -77.9 -28.99 49.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.211 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.64 76.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.211 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.75 -34.84 79.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.49 -47.2 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -76.38 -26.61 55.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.189 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.0 -45.39 90.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.73 97.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -60.19 -41.36 92.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.172 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.2 tp -64.72 -43.96 91.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.4 mtp -57.2 -45.85 83.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.216 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.77 -40.75 98.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.232 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.75 66.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.234 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 -2.64 37.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.74 113.79 14.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.04 -33.37 83.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.658 1.572 . . . . 0.0 111.199 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -67.67 -44.44 77.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.04 -37.29 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.96 -52.52 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.208 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.27 -35.05 78.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.81 -47.6 87.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.5 -45.29 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 111.17 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -62.09 -38.76 90.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -67.01 -37.88 84.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.151 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.4 tpp -63.01 -42.46 99.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.404 HG22 HG13 ' A' ' 36' ' ' VAL . 96.1 mt -57.25 -48.01 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.49 -43.21 57.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.211 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 m -62.28 -50.33 72.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -172.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.27 -11.35 32.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.0 mt 59.0 63.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.49 158.95 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.22 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.3 t -66.18 150.0 49.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.04 -31.87 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.234 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -54.73 -43.7 72.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -84.82 -31.67 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.91 -45.41 93.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.17 -46.31 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.19 -48.21 71.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.28 -49.41 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 -174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.9 -45.1 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.442 HG23 ' HG ' ' A' ' 130' ' ' LEU . 31.1 mm -64.57 -46.34 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -69.1 -38.28 78.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.73 -54.34 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.82 -31.33 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.72 98.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.5 p -69.42 -29.33 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.19 -48.98 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 66.4 mtt -51.91 -42.65 62.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.234 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.22 -40.46 82.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.0 p -69.34 -19.98 63.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.98 -8.69 57.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 62.62 33.9 15.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -110.73 112.76 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.84 -31.0 69.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.198 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.2 -49.94 75.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.53 -25.69 62.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.195 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.17 -40.49 97.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -67.17 -35.69 80.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -69.57 -31.6 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.3 96.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.181 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.33 -46.55 96.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.221 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -57.29 -44.0 83.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 108' ' ' ILE . 56.3 tp -62.44 -46.05 90.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 -58.36 -45.28 88.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.12 -42.44 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.205 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.38 -49.69 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.79 98.5 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -60.2 -44.09 95.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 111.183 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -70.0 -36.14 74.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.0 mt -57.56 -46.23 86.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.37 -42.61 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.71 -40.11 91.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.186 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.47 -30.33 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.76 -38.78 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.2 -26.0 36.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.198 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.05 27.31 23.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.51 125.97 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.77 161.74 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -144.96 175.87 9.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.18 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.75 124.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.44 72.51 7.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -21.01 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -67.42 -18.01 64.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.2 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -105.47 20.11 19.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 156' ' ' VAL . 60.3 tp -63.62 130.92 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.28 22.22 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -137.73 140.52 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.54 97.83 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.19 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 152' ' ' LEU . 34.8 m -137.72 -168.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.69 132.34 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.8 t -96.41 125.13 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 98.7 mt -122.42 132.08 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.71 170.06 22.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.207 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -66.34 -46.24 77.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.202 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.71 173.38 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.202 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.68 84.51 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 51.5 p -78.22 165.25 51.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.174 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 95.3 Cg_exo -50.03 -36.68 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.7 1.6 . . . . 0.0 111.209 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 93.7 p -73.27 -31.06 63.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -45.85 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.6 p -68.74 -27.31 65.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.176 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.56 -1.39 37.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 74.2 p -113.96 5.05 16.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.0 mtp -78.16 126.89 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -67.06 106.48 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.238 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.5 -48.81 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.204 -166.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.21 8.5 44.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 -164.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -123.84 16.81 9.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.4 112.45 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.5 mt -91.03 -13.45 33.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.6 178.41 41.96 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -165.15 162.48 20.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 111.21 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -150.2 144.65 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.244 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.6 p -127.85 154.78 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.227 -170.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.86 -55.35 23.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.186 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.46 129.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 59.1 4.51 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.88 73.89 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -118.0 62.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.3 m -63.18 -40.1 96.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.1 m -52.8 -53.41 48.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -72.73 -33.1 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.258 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -58.42 -48.94 79.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.0 mt -58.31 -46.05 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 tpp -64.3 -46.83 81.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.27 91.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.167 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.1 -36.64 69.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 82.8 p -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -98.59 -14.97 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 60.95 51.03 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.183 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 44.2 pt -125.45 153.21 72.4 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.219 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 50.7 Cg_exo -60.55 148.74 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.663 1.576 . . . . 0.0 111.205 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -148.2 122.09 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.44 120.33 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.177 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.86 160.81 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.01 38.75 29.5 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.18 -5.57 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.79 -62.97 4.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -151.94 45.06 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.2 -174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.9 -23.26 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.7 p -70.66 -17.92 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.8 p -101.01 -27.85 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.189 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -83.18 -17.89 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.79 134.36 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -109.05 149.75 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.89 126.21 26.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.06 -14.99 44.26 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.58 166.21 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 111.195 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.27 133.41 36.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.245 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.94 126.31 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.35 114.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.251 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.67 91.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -85.94 78.91 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.186 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.01 -24.44 73.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 64.1 tp -58.2 -48.31 80.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.186 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -91.79 -17.89 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.12 36.53 14.72 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -132.28 155.16 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 96.1 t -121.64 133.94 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 175.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.7 127.43 66.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.9 122.85 62.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 94.0 m-20 55.71 55.52 9.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.7 Cg_endo -69.64 155.33 66.64 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.7 1.6 . . . . 0.0 111.219 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.39 161.61 29.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.174 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.91 -50.46 63.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -57.72 -46.88 83.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.219 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 99.9 m -54.19 -45.39 72.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.92 -47.55 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.87 -32.37 73.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.209 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -64.47 -41.35 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.43 -28.23 64.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.85 -43.07 99.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 78.6 p -71.03 -30.96 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -68.56 -39.98 80.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.192 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -59.84 -41.57 91.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.51 -49.19 77.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.1 p -67.06 -28.91 68.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -63.32 -50.08 71.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.212 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -33.97 75.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.527 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.372 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.6 mt -91.61 120.18 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.3 129.62 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.17 -150.91 5.31 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.4 t -105.21 124.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 111.177 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.56 87.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.57 96.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.218 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.4 p -149.09 148.84 28.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.64 161.81 24.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.699 1.599 . . . . 0.0 111.236 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.64 177.13 14.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -133.92 117.03 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.81 113.31 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.92 111.56 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.71 -156.75 13.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.5 150.83 22.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 111.224 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 120.72 31.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -119.82 100.42 7.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.3 tp -78.25 113.79 16.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.66 106.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.3 m -92.77 133.66 35.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.58 127.55 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.163 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HB2' HG13 ' A' ' 144' ' ' VAL . 61.9 mt-10 -67.19 146.35 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.73 125.82 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.49 82.04 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.6 m -85.42 112.22 20.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.201 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -81.57 122.1 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -80.2 109.01 14.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.7 24.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.196 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.12 173.55 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.2 164.83 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 pt -123.24 165.26 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -72.92 142.96 47.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.19 -43.1 66.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.2 p -69.28 -17.88 63.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.31 4.72 46.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.2 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.43 -46.78 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.24 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.74 -36.31 82.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -67.85 -40.38 83.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.171 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.33 -37.89 74.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.217 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.24 -42.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.91 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.211 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.95 -42.86 94.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.214 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.27 -48.3 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.39 -36.91 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.91 -39.37 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.218 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.61 81.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.212 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.68 -40.53 97.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.54 -45.27 94.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.5 t -67.44 -42.67 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.0 m -58.0 -53.83 53.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.24 -39.38 94.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.42 -50.89 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.199 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -65.35 -39.13 91.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.229 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.44 -49.09 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.231 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -67.24 -45.94 75.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.55 -43.94 83.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.224 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.82 -39.88 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -49.24 -47.22 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.73 -51.75 59.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.227 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.42 -40.92 98.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.98 95.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.198 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.17 -44.87 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.16 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.31 -35.78 81.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.214 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -87.04 -67.77 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.09 -31.58 15.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.33 -163.24 13.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.06 -23.4 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.194 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -48.0 -41.0 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -102.04 -32.36 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.159 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -37.99 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -65.66 -33.44 75.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -58.57 -46.57 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.225 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.01 -35.56 78.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.182 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -57.12 -46.7 82.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.61 98.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -67.38 -34.42 77.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.0 -46.04 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.54 -41.97 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.209 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.26 -39.43 93.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.03 79.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.18 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -87.49 -14.85 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.63 113.77 10.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.232 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.32 -28.58 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.683 1.589 . . . . 0.0 111.209 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -63.56 -28.62 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.252 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.55 -35.87 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -53.43 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.31 -35.39 80.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.94 94.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.8 -45.61 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.64 -36.19 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.202 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -65.16 -42.08 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.06 -47.0 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.67 -43.98 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -67.28 -47.27 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -97.4 -8.07 30.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.41 63.71 1.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.48 165.92 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.2 p -65.91 159.53 25.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.41 78.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.215 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -55.39 -51.22 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.201 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.39 -43.68 89.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.68 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.65 -46.28 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.19 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.89 -55.1 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.21 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.75 -52.28 63.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.49 -50.03 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -172.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.9 mt -71.62 -42.95 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.247 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -57.69 -41.58 81.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.83 -52.95 63.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.35 -37.04 81.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.8 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.8 p -68.59 -29.64 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.178 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.68 -49.98 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 60.1 mtt -53.58 -40.77 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.81 -41.12 83.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 73.2 p -69.69 -21.25 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.4 mt -73.65 -13.06 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.94 32.19 17.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -103.83 108.98 20.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.54 -33.45 74.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -169.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.28 -49.28 77.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.236 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.45 -26.08 63.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -42.47 97.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.68 -41.75 91.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.219 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -67.25 -32.91 74.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.01 88.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.217 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.73 -43.05 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.84 -41.35 86.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.07 -43.17 95.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -59.99 -42.32 93.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.95 -46.51 81.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.41 -46.12 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.74 -46.32 93.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.11 -41.77 97.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 111.235 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -62.86 -41.62 99.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.44 -46.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.62 -41.78 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.67 -39.82 85.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -72.66 -31.05 64.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.192 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.06 -38.32 82.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.247 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.43 -33.17 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.56 8.84 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 22' ' ' GLU . 75.7 t -69.61 119.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.186 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.81 161.94 13.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.3 p -153.92 165.13 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.73 123.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.213 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -93.54 94.67 8.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.03 -3.25 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.22 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.3 p -74.56 -13.17 60.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -110.93 23.66 13.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.17 132.61 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -101.18 -6.25 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.85 156.87 43.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.16 121.24 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -138.12 170.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.0 t -94.76 133.36 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.44 121.17 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 79.3 mt -122.21 135.34 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.45 24.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.55 -45.58 30.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -168.71 147.21 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.8 mt -135.9 148.89 48.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 43.6 p -84.26 163.39 47.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 85.9 Cg_exo -51.66 -29.63 33.82 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.703 1.602 . . . . 0.0 111.165 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.9 p -84.73 -25.31 28.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -83.5 -34.14 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.6 p -67.01 -18.15 65.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 1.5 56.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.5 p -101.94 36.39 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 77.0 mtm -122.42 143.62 49.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.187 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -81.64 93.77 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.202 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -47.33 -46.69 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.212 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.12 -26.64 68.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.93 27.57 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.2 t -105.83 118.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.23 -29.6 24.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.18 174.82 43.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -122.8 154.49 38.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 0.0 111.226 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -151.51 144.82 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 168.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 -171.43 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -152.1 -0.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.31 152.69 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.72 171.89 26.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 166.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 -6.22 87.91 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -75.24 -1.36 23.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.9 p -66.57 -21.6 66.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 98.8 p -101.48 -35.06 9.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.254 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.06 -47.12 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 53.6 m -49.8 -44.16 48.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.232 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -58.17 -45.45 87.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.7 mt -62.59 -49.28 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.239 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mmm -63.75 -50.04 70.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.63 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.81 -30.84 68.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 81.0 p -79.54 -24.85 41.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.56 -5.36 58.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.207 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 60.32 41.76 15.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 35.7 pt -129.59 155.62 79.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 156.05 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.756 1.637 . . . . 0.0 111.187 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.54 142.55 12.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.78 129.32 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.201 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.56 153.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.229 -173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 73.49 40.75 46.72 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 227' ' ' VAL . 91.3 mt -69.66 -24.43 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.235 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 121.26 -54.7 0.67 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -161.31 27.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 -175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.9 p -51.37 -33.56 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -74.34 -21.12 59.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.0 p -90.33 -20.94 22.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -103.36 23.2 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.19 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.95 149.81 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -139.18 142.06 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.204 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 122.85 12.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 114.01 -19.3 18.17 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.29 -179.26 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.21 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.87 153.46 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.43 141.99 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 89.0 mt -119.72 120.41 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 170.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.92 97.29 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -83.37 80.81 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.79 -33.1 86.34 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 68.7 tp -56.41 -49.21 75.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -80.01 -40.73 27.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 102.06 28.47 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.88 158.57 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 111.218 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 205' ' ' LEU . 99.5 t -133.85 134.69 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.06 127.44 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 130.8 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.37 56.97 9.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.66 153.15 64.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.74 1.627 . . . . 0.0 111.177 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -88.42 -178.48 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.2 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.55 -54.41 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -59.23 -48.37 81.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.4 m -54.14 -46.8 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.216 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 67.6 t -61.13 -46.59 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -68.73 -33.46 73.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.168 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.59 -42.93 99.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.247 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -68.14 -31.83 71.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.47 -44.68 96.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.72 -31.97 69.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.204 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.96 -42.29 76.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -61.88 -37.76 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.183 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.32 -49.77 75.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.7 p -67.94 -28.58 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -63.41 -49.92 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.13 -34.17 75.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.515 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.1 mt -74.95 79.84 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.65 130.01 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.28 -153.17 5.8 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.6 136.44 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 111.218 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.7 76.22 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.184 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.82 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 t -149.94 128.67 6.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.232 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 155.38 33.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.636 1.557 . . . . 0.0 111.195 -175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 170.78 12.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.2 mm -113.18 130.36 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.184 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 220' ' ' VAL . . . -126.42 112.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.55 111.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.23 -162.06 18.02 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.27 163.64 15.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.346 . . . . 0.0 111.236 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.44 109.49 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.58 137.56 52.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 168.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.64 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.207 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 63.7 t80 -88.1 97.56 11.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.208 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -118.1 135.35 54.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -140.79 159.3 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.173 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -58.93 135.17 57.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.55 130.56 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.179 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.15 109.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.4 p -124.15 152.27 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.85 127.48 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.218 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -81.49 105.14 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.91 14.0 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 -171.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 150.08 25.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.73 158.48 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.55 167.27 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 144.81 55.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -52.38 -37.12 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.1 p -69.52 -15.46 63.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.192 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -94.7 0.01 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.47 -50.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.66 -32.0 73.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.219 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.88 -50.73 72.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.15 -34.28 72.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.188 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.14 -43.61 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.212 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.77 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.93 -44.93 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.52 -48.94 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.182 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.45 -36.2 82.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -66.94 -40.09 87.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.209 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.66 80.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.95 -42.5 99.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.56 -50.99 70.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.16 -43.09 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.209 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.5 m -58.0 -53.1 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -64.0 -39.06 93.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.53 -46.72 88.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.88 -39.8 91.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.73 -39.93 87.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.213 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -56.47 -46.95 80.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.27 -40.36 97.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.75 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -52.36 -49.91 63.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.238 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -57.83 -51.56 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.253 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.66 -42.43 92.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.183 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.05 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -56.48 -47.32 79.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.85 -32.31 52.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.229 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -84.79 -47.88 9.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.6 -34.55 5.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.52 161.15 9.86 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.32 -37.97 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.189 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.64 -46.34 63.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -65.8 -37.83 87.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.71 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.69 -34.29 77.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.6 mt -59.27 -44.71 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.48 -30.4 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -58.11 -42.36 85.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.7 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -58.13 -41.91 84.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 77' ' ' LEU . 9.3 tt -59.65 -48.93 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -63.62 -34.95 78.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.4 -39.21 91.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.202 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.26 80.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.7 p -85.0 -9.05 58.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.208 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -63.47 115.45 18.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.207 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.52 -31.26 68.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 0.0 111.207 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.82 -33.2 75.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -81.21 -44.29 18.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.224 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -53.53 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -65.93 -34.76 78.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.99 -46.37 93.81 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.52 -45.47 88.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -64.57 -39.07 93.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.208 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -67.64 -34.34 76.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -64.64 -41.79 95.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.52 -47.37 91.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.59 -46.75 36.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.9 m -64.23 -47.53 79.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -172.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.68 -9.53 34.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.1 mt 57.82 63.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.04 -179.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.172 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.4 p -81.11 164.15 22.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.227 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.04 90.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -68.6 -36.7 79.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.2 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -64.28 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.84 95.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.19 -49.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.227 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -60.89 -43.49 98.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -66.91 -50.39 62.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.199 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.93 -46.28 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.229 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.22 -44.86 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -64.1 -39.38 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -60.39 -52.94 63.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.99 -37.5 87.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.55 96.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.198 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.6 p -65.85 -30.56 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.193 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.35 -51.56 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.212 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 67.1 mtt -54.71 -40.27 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -68.47 -41.56 79.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.4 p -69.96 -22.11 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.17 -13.42 60.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.16 32.97 19.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -103.74 106.67 17.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.193 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.65 -32.84 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -169.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -60.88 -50.16 74.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.14 -30.4 69.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.55 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.89 -41.96 97.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.96 -34.2 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.95 -41.4 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -56.41 -44.37 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.21 -37.58 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.225 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -61.39 -41.74 97.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.5 -41.89 96.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.13 -44.7 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.19 97.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -55.81 -47.91 76.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -61.0 -45.52 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.212 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.75 -48.73 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.67 -43.59 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.32 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.39 -32.84 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.23 -39.35 86.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.21 -36.94 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.22 27.3 10.18 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.41 125.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -109.88 156.22 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.246 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.0 p -143.32 174.59 10.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.35 106.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -83.8 115.75 22.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.72 -16.07 59.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.9 p -69.43 -13.37 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -88.85 -3.68 58.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.212 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.94 149.48 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.241 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.75 28.55 7.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -150.09 141.42 23.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.222 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.54 113.5 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.12 172.59 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.204 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.04 134.13 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.8 t -113.76 129.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.155 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.7 mt -123.42 136.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 19' ' ' TYR . . . -162.02 149.66 14.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -50.05 -49.96 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.177 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.56 153.08 31.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -133.58 141.82 47.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 44.8 p -116.6 163.89 20.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 176.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 86.8 Cg_exo -52.61 -35.31 67.07 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.729 1.62 . . . . 0.0 111.192 177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.7 p -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -87.76 -30.3 20.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.185 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.427 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 69.7 p -78.9 -11.18 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.78 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.5 p -106.91 21.86 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 168' ' ' THR . 60.9 mtt -100.32 150.59 22.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -117.64 107.45 14.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -62.01 -26.42 68.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.98 -22.42 66.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -105.6 5.56 31.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.51 119.38 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.64 -17.38 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.71 173.55 29.43 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.25 165.99 33.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.246 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.31 152.08 36.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.215 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 38.6 p -126.25 161.86 26.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -76.47 -41.37 47.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.84 167.55 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 -171.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -113.09 15.02 23.44 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -67.67 -16.0 67.23 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -124.62 37.97 4.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -54.98 -40.55 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.232 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.6 p -63.88 -32.57 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.8 -35.22 62.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -70.43 -27.24 64.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.51 76.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.38 -46.28 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 28.4 ttt -60.89 -52.87 63.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.234 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -64.37 -56.56 13.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.2 m -63.42 -42.19 98.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.187 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.65 -17.63 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 63.4 51.79 2.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.169 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.26 157.15 76.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 158.25 56.59 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.73 1.62 . . . . 0.0 111.161 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -154.28 135.55 14.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.09 123.16 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 157.58 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.47 17.7 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.45 -3.02 58.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.233 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.35 -65.43 3.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.36 42.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 111.186 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -24.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.4 p -68.21 -21.59 64.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.2 p -97.08 -25.36 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -85.24 -23.05 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.209 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.92 128.43 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.89 150.97 26.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.45 129.11 40.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.46 -19.06 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.97 159.85 32.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.28 133.29 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.37 132.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.2 117.05 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 171.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 12' ' ' ALA . 67.3 t -104.78 115.27 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.99 98.69 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.7 -39.32 86.22 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.1 -46.76 87.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.771 0.32 . . . . 0.0 111.194 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -73.97 -35.86 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 173.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.36 7.28 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.5 pt -132.67 154.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.218 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.76 134.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.83 130.54 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.11 136.81 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.261 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 90.3 m-20 59.11 51.43 3.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 98.6 Cg_endo -72.25 155.77 55.82 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.683 1.589 . . . . 0.0 111.219 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -91.39 -177.83 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.65 -50.79 72.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.63 -48.78 78.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.6 m -54.41 -46.71 73.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 57.9 t -59.11 -45.02 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -69.26 -34.12 74.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -50.15 73.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.41 -26.88 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.12 -43.66 95.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 80.5 p -72.13 -29.55 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.93 -36.59 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -53.39 -52.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.33 -39.16 93.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.8 m -61.03 -38.77 87.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -70.93 -38.5 72.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.17 -32.99 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.9 mttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -175.003 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.63 148.7 24.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.82 134.32 38.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.74 -149.39 5.07 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -97.02 122.7 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.72 88.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.183 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.93 -38.78 76.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.191 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -148.49 141.41 15.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.212 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.07 165.11 24.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.728 1.619 . . . . 0.0 111.203 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.4 -178.51 16.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -131.11 132.04 63.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.64 127.03 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.409 HG12 HG12 ' A' ' 219' ' ' ILE . 69.5 mt -127.87 122.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.57 -147.19 10.01 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.43 149.63 25.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 111.207 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.26 127.49 53.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.66 140.74 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.199 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 tp -106.7 122.93 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.194 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 76.2 t80 -97.27 90.21 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.1 m -116.5 129.1 56.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -100.8 152.18 20.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.87 127.29 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.176 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -78.8 119.24 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.34 162.2 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.4 p -129.36 171.61 12.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.235 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -118.32 127.75 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.52 114.12 20.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.78 2.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.84 136.16 57.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.33 130.4 46.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.185 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.51 172.98 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.29 143.94 50.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.59 -37.5 63.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.236 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.4 p -69.03 -15.19 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.92 2.89 55.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.76 -49.97 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.15 -32.77 74.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -59.44 -48.85 80.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -68.42 -34.63 76.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.2 -45.12 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.207 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.58 95.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.22 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -58.35 -45.51 88.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.243 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.98 -50.27 74.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.5 -44.01 93.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.174 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.45 -46.64 79.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.9 79.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.9 -45.72 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.23 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.75 -44.97 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -56.95 -43.36 81.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.28 -44.26 88.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.21 -38.4 87.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.249 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -65.59 -40.45 92.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.25 -40.74 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.201 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -63.42 -39.69 95.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.63 -38.76 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.197 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.57 -41.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -55.7 -46.33 77.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.0 -53.08 62.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.21 -36.89 84.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.51 94.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.5 tt -55.55 -44.46 76.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.13 -43.66 77.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -88.87 -48.02 7.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -91.95 -48.04 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.197 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.83 162.19 10.15 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.21 -37.74 64.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.205 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -49.63 -42.53 45.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.83 -37.8 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.35 80.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.222 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.08 -33.65 76.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.68 -43.03 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.07 -20.56 55.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.41 -40.17 85.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.31 98.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.256 172.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -57.68 -41.72 82.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.48 -44.81 89.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.15 -37.06 85.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.248 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.44 -36.82 85.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.19 65.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -93.82 0.27 56.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.35 117.15 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.54 -32.05 61.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.689 1.593 . . . . 0.0 111.219 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.23 -35.75 78.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.44 -45.38 69.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.66 -56.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.64 -28.24 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.27 -50.02 71.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' HA ' HG21 ' A' ' 107' ' ' VAL . 69.4 t -69.06 -41.27 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.249 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -55.02 -49.12 72.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.191 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.03 -32.47 72.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.12 -42.3 94.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.61 -39.16 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.86 -40.35 95.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.1 m -72.13 -55.12 7.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -113.67 124.09 51.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 mp -77.04 75.03 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -126.08 167.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.4 m -58.83 138.48 57.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.81 -44.63 39.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.21 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -56.09 -41.46 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -63.12 -42.28 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.182 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.14 99.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.222 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.98 -47.66 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.54 -45.14 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.59 -48.66 76.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.22 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 89' ' ' VAL . 56.0 t -61.11 -47.29 94.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.205 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.6 mt -65.33 -42.74 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -58.48 -43.99 89.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.31 -47.45 79.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.202 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.19 -37.8 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.85 97.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.6 p -65.95 -30.7 71.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.194 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.32 -50.21 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.212 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 68.1 mtt -56.84 -38.51 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.172 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.94 -41.52 82.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.225 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.9 p -69.24 -21.39 63.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.219 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.33 -10.98 59.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 59.67 35.22 22.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -103.69 104.95 15.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.186 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.01 -33.93 76.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -60.04 -50.33 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.65 -30.48 69.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.72 -42.63 93.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.19 -41.88 96.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -68.03 -32.14 72.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.281 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.02 97.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.95 -42.42 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.216 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.87 -38.73 82.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.28 -38.87 85.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.193 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.04 -42.36 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.79 -45.26 92.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.03 -46.58 91.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.64 -43.86 97.36 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.83 -39.76 90.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.156 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -70.04 -38.2 75.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.29 -44.68 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.214 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.34 -45.4 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -60.67 -43.0 98.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -69.48 -39.97 77.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -70.19 -44.4 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.13 -20.0 52.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.24 43.13 8.22 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.33 119.67 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 111.23 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.95 154.09 36.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 94.2 p -147.13 167.4 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.42 127.35 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -81.92 72.06 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.221 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.79 0.69 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.15 -9.88 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 170.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -107.61 23.73 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.93 132.37 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.199 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -109.43 -2.33 17.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.201 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -149.51 158.79 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.61 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.38 161.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.31 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.51 116.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.91 115.53 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 19' ' ' TYR . . . -113.78 145.6 41.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 -170.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -67.22 -33.69 75.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.188 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -154.43 154.52 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -126.76 75.04 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -86.66 159.56 52.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.01 -40.6 67.35 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.733 1.622 . . . . 0.0 111.235 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.1 m -66.96 -39.84 87.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.5 -52.82 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.5 p -77.12 -20.41 55.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.72 67.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.159 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 66.7 p -90.83 -29.73 17.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 68.5 mtt -59.31 133.74 56.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.63 88.41 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.213 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -50.7 -43.39 57.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.64 -13.25 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.87 27.32 9.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.16 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.45 124.23 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.23 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.62 -25.94 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.41 158.9 22.52 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -108.68 148.59 30.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -155.97 150.37 25.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 t -162.27 -177.65 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.222 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.55 -27.48 8.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.231 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.27 126.09 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.201 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.0 166.33 48.42 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.78 -7.75 81.17 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -106.76 9.88 30.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.4 m -65.31 -44.77 86.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.9 p -71.63 -41.43 68.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.29 -48.01 83.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -57.96 -43.97 86.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.02 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.218 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.36 -47.64 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.6 mtm -61.56 -51.76 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.33 -46.77 87.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.241 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.35 -31.48 70.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.7 p -69.56 -18.03 63.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 199' ' ' ILE . 93.9 mt -107.08 -0.12 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 57.09 45.16 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.239 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 197' ' ' LEU . 38.9 pt -128.65 158.19 72.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.7 161.77 33.4 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.725 1.617 . . . . 0.0 111.167 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.27 136.67 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 52.1 t -134.47 126.49 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.29 152.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.183 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.43 46.39 6.92 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.47 11.4 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.252 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.32 -89.72 1.42 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -137.58 45.42 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.196 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.36 -25.78 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.5 p -72.35 -6.63 44.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -112.3 5.42 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.215 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -118.06 -5.16 10.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.37 145.2 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.72 158.25 40.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.82 117.9 4.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 102.58 2.48 50.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.1 150.62 38.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.45 123.66 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.94 142.79 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.197 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.409 HG12 HG12 ' A' ' 13' ' ' ILE . 79.3 mt -116.16 125.81 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.225 171.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.1 99.34 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -90.89 91.65 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.216 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.25 -35.36 76.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.35 -47.13 85.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.241 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.57 -36.8 65.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.65 34.71 6.47 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.3 pt -131.4 154.45 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 111.172 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.7 t -133.3 136.4 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.61 118.41 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.31 130.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.192 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.92 57.79 3.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.205 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.41 154.97 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.695 1.596 . . . . 0.0 111.256 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 159.61 33.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.156 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -53.85 -49.15 69.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.14 -47.34 83.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.204 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.0 m -51.48 -46.86 63.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.57 -48.83 82.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.99 -32.56 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.01 -46.08 90.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.201 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.68 -26.51 63.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.11 -45.35 95.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 79.3 p -71.76 -29.24 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.2 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -66.88 -42.32 85.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.34 -42.14 81.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.47 -48.03 77.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.224 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 64.4 p -69.94 -23.23 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -71.12 -38.44 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 173.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -79.37 -34.36 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.2 -1.507 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.199 -177.243 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -98.74 107.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.186 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -103.82 135.68 44.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.46 -138.69 2.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.19 122.59 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 0.0 111.23 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.76 87.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.54 87.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -148.97 135.85 10.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 161.68 36.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.719 1.613 . . . . 0.0 111.209 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.6 -176.18 16.32 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.41 125.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.191 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 177' ' ' LEU . . . -116.48 126.24 53.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.218 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.5 mt -123.91 117.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.68 -157.59 13.04 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.53 167.69 13.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB2' HG23 ' A' ' 218' ' ' VAL . . . -99.25 144.78 27.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 175.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -141.26 111.44 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 164.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.8 tp -87.47 115.08 24.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.209 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.74 97.01 6.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -86.59 164.17 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.224 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -115.56 106.88 14.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.41 128.33 36.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.171 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.78 127.03 29.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -87.22 111.96 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -87.72 124.88 34.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.204 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.98 118.93 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.53 102.93 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.209 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -87.4 -5.25 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.91 139.25 52.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.05 158.74 32.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 pt -119.02 172.5 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -76.19 157.75 32.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.78 -32.53 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -72.57 -14.84 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -96.48 -0.34 49.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.1 -51.08 77.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.07 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.33 -51.19 71.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -71.11 -34.12 70.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.85 -43.92 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.221 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.92 -45.18 90.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.216 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.16 -47.7 84.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.08 -36.21 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -40.51 94.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.81 76.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.95 -42.6 99.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.183 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.99 -43.43 98.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.71 -40.71 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.233 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.4 m -67.04 -43.63 82.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.186 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -63.98 -42.87 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -59.0 -49.17 78.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -52.09 -58.76 5.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.34 -42.05 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.196 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.98 -45.91 82.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.202 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.41 -34.59 77.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.27 -49.26 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -68.21 -27.06 66.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.39 -51.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.242 170.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.8 -37.02 83.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.24 93.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.204 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -60.15 -46.76 88.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.213 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.94 -34.32 77.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.148 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -87.65 -45.13 10.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.218 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.73 -36.42 3.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.47 -172.08 14.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.86 -26.29 68.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 111.207 -175.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -43.53 -45.77 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.22 -31.25 12.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.71 91.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.42 -30.99 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.183 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.41 -45.78 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.01 -27.52 57.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.58 -44.27 89.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.92 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -61.68 -38.37 87.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.18 -44.14 89.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.21 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.4 mtm -62.61 -38.02 88.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.234 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.11 -39.87 95.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.218 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.56 -23.31 66.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.254 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.1 p -98.38 -3.75 36.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -66.11 113.71 13.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.29 -32.89 82.94 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.71 1.607 . . . . 0.0 111.239 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -67.4 -43.71 80.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.97 -36.58 69.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.35 -52.29 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.49 -34.48 77.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.48 -47.06 90.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.44 -44.87 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.218 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -62.85 -39.59 94.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.66 -33.83 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.0 tpp -65.32 -41.54 93.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.29 -47.75 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.29 -46.53 49.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.235 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.2 m -65.14 -48.43 73.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 -172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.32 -9.82 34.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.8 mt 57.48 64.08 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 179.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.9 p -80.3 163.37 24.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.96 86.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.85 -50.71 72.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.17 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -67.31 -40.24 86.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.211 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.65 85.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.34 -45.8 97.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.201 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -58.48 -43.81 89.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -67.48 -49.67 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.192 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.64 -46.31 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.195 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.4 mm -65.93 -42.54 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.178 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -67.0 -38.2 85.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.201 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -65.75 -44.85 84.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.186 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -66.7 -40.45 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.194 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.08 97.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.186 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.3 m -59.24 -42.98 92.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.77 -52.91 56.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 56.9 mtt -54.74 -42.09 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -69.66 -39.53 77.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.3 p -70.39 -19.86 62.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.184 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.11 -7.14 56.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 60.44 37.45 19.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -115.05 112.54 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.06 -30.35 70.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.12 -50.3 72.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.255 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.44 -28.78 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.6 -42.96 99.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -42.03 95.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.98 -34.04 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.97 94.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.46 -41.81 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -57.07 -43.33 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.195 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -62.48 -41.19 98.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.223 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.84 -50.32 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.189 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.87 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -44.64 95.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.21 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.07 -38.03 89.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.35 -48.43 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.205 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.23 -41.24 90.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.9 -38.42 88.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.07 -28.26 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.3 mt -68.67 -48.31 64.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.1 tp -74.7 -52.46 11.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.59 35.76 0.83 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.76 127.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.234 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.13 155.47 25.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.182 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 85.1 p -156.79 169.67 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.6 128.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -86.66 106.15 17.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.4 mt -90.77 10.82 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.3 p -90.91 -7.46 52.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -106.71 27.53 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.69 137.3 51.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.0 27.99 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -169.56 138.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.18 123.14 17.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.197 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.84 144.36 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -167.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.96 121.49 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.1 t -93.66 118.3 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 -174.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.401 HG22 HG22 ' A' ' 209' ' ' THR . 48.5 mm -112.13 126.79 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.219 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 148.06 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.225 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.87 -41.56 82.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.22 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -112.91 151.65 30.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.4 tp -154.24 122.24 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.8 p -112.48 161.65 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.214 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.23 -35.86 84.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.691 1.594 . . . . 0.0 111.235 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.5 p -74.6 -10.08 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.204 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.99 -40.85 12.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 171.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 -22.93 64.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.52 -9.29 58.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.6 p -111.91 -28.47 8.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.6 mtp -57.29 94.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -41.73 105.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.185 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -64.43 -22.03 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -72.15 -27.92 62.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.1 -39.66 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.25 119.0 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.423 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 94.7 mt -96.18 -15.56 22.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.99 178.4 43.89 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -158.49 137.05 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -115.71 139.24 50.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.216 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.3 m -120.43 138.36 53.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.09 -42.95 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.227 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.58 137.61 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.225 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.85 177.75 29.4 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.32 54.02 0.66 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.9 26.84 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.8 p -74.21 -30.58 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.196 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.2 p -77.24 -30.83 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -61.2 -48.78 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 172.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.2 m -55.77 -42.43 75.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.225 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.19 97.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.45 -45.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 ttp -58.11 -53.07 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.26 99.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -70.84 -33.11 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.18 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.6 m -69.96 -37.47 75.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.7 -7.44 57.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 61.33 48.98 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 47.6 pt -126.82 149.32 68.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.22 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 49.3 Cg_exo -60.76 146.41 97.4 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.744 1.629 . . . . 0.0 111.201 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.44 138.87 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.196 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 76.9 t -129.81 127.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.6 164.93 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.65 26.1 59.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 90.9 mt -78.33 -31.65 48.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.9 4.57 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -100.27 2.81 43.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 111.247 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.07 -27.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.184 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 159' ' ' ILE . 29.7 p -81.84 -6.92 59.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 96.3 p -106.07 -29.35 9.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.216 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -91.59 -24.48 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.212 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.0 t -111.88 119.14 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.227 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.6 157.75 33.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.241 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.39 128.36 35.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 108.18 -20.91 30.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -71.15 165.11 24.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.21 138.32 34.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 16' ' ' ALA . 86.1 t -127.29 131.06 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.171 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.8 mt -114.92 112.54 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.46 96.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -93.39 88.11 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.246 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.86 79.63 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.83 -38.46 88.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 111.22 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -94.07 -31.09 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.186 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.32 34.85 7.27 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 pt -131.8 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.3 t -128.42 135.09 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.237 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.46 127.47 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.186 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.23 133.66 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.404 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 95.7 m-20 50.67 56.56 17.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.211 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 70.7 Cg_endo -70.49 156.81 60.66 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.697 1.598 . . . . 0.0 111.192 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.03 161.01 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -52.46 -48.97 65.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.89 -46.43 84.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.186 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -55.65 -43.6 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 64.1 t -60.12 -46.05 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.99 -34.38 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.244 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.92 -48.26 79.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.51 -26.21 60.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.229 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.11 -46.71 86.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.9 p -69.27 -31.83 70.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 -38.56 79.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.207 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -61.05 -43.27 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.55 -40.73 95.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.22 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 75.2 m -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.221 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.83 -49.29 78.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.208 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.52 -36.09 82.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.219 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.52 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 87.7 mt -80.18 80.3 6.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.54 130.91 41.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.96 -150.52 5.23 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.1 114.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.5 87.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.07 73.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -151.32 141.51 14.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.07 160.75 29.96 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.699 1.6 . . . . 0.0 111.204 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.06 -177.17 18.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -134.41 122.87 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 111.216 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.88 123.48 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.31 112.75 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.73 -160.86 20.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -83.41 150.55 25.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.37 128.37 38.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.21 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -126.8 139.05 53.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.3 tp -105.85 131.92 52.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -113.09 116.79 30.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.1 p -125.46 169.7 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.243 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -150.8 136.59 18.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.402 ' HB3' HG13 ' A' ' 144' ' ' VAL . 88.5 tt0 -58.78 136.01 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.86 137.37 58.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -86.7 113.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.3 m -120.34 117.08 26.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.35 127.21 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.211 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -80.65 107.29 13.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.22 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.24 22.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.778 ' O ' ' CB ' ' A' ' 30' ' ' LYS . 88.8 tt0 -59.51 -61.57 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.778 ' CB ' ' O ' ' A' ' 29' ' ' GLU . 87.1 tttt 124.9 140.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.201 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 31' ' ' ILE . 2.9 pp -121.17 166.23 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -90.93 165.9 13.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.212 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -52.23 -41.21 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.198 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.8 p -69.88 -18.17 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.92 2.5 49.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.256 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.88 -52.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.04 -32.6 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.1 -50.84 72.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.25 -33.77 72.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.196 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.64 -44.83 99.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.51 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.38 -46.67 88.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.179 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -60.0 -51.14 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.31 -39.7 80.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.63 -58.8 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.199 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.8 69.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.201 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.3 tm? -65.32 -50.46 65.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.93 -38.91 90.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.21 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.02 -41.3 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.6 m -60.49 -41.95 95.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -57.23 -49.89 74.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.81 -46.18 88.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -52.65 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.06 -40.87 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.42 -43.14 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.178 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -34.46 72.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.8 mt -63.81 -47.97 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -72.08 -27.47 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.222 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.47 -46.31 90.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.35 -40.14 67.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.92 78.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.0 tt -52.33 -45.38 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.07 -33.17 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.22 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.71 -44.16 24.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.233 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -118.13 -35.64 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.17 170.33 12.74 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.5 -26.89 68.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.205 -174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.8 -44.88 39.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.98 -33.91 39.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.03 83.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.251 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.35 -38.13 86.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.219 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.3 mt -60.34 -44.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -78.27 -24.57 46.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.01 -41.26 96.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.77 87.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.39 -39.72 94.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.206 174.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.68 -43.61 96.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.2 ttp -52.49 -48.12 66.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.202 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.9 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.32 67.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.8 p -92.14 -14.58 28.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -64.87 118.94 53.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -52.95 -32.29 56.88 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.71 1.607 . . . . 0.0 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -50.54 -39.27 48.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.16 -47.69 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.39 -56.77 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.229 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -75.09 -31.31 61.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.18 -48.27 81.25 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.22 -42.34 84.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.203 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -53.71 -47.22 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.47 -35.44 79.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.7 tpp -63.78 -41.88 97.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.87 -47.97 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.58 -44.55 64.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -65.83 -48.22 72.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.198 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -94.65 -10.95 30.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.95 63.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.224 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.79 169.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -70.57 163.09 27.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.182 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.29 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.12 -42.73 99.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.86 96.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -55.91 -48.45 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.226 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -57.87 -44.19 86.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.5 -45.42 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.55 -44.08 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 131' ' ' ARG . 38.6 mm -65.57 -45.54 92.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.03 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.168 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -59.85 -54.86 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -67.72 -39.01 84.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.212 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.29 99.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 m -61.17 -42.86 99.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.202 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.3 -49.78 83.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 59.4 mtt -56.4 -41.15 75.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.78 -38.83 73.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.203 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.8 p -69.37 -20.58 63.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.0 -9.6 59.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.24 32.82 20.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -104.36 106.99 17.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.42 -33.16 74.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.231 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.32 -50.01 75.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.53 -30.09 68.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.74 -42.04 98.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.64 -40.94 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.192 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -66.03 -33.63 76.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.177 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.53 92.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.07 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -57.37 -42.94 83.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.36 -42.55 96.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.197 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.406 ' HA ' HG21 ' A' ' 108' ' ' ILE . 91.3 mtt180 -63.8 -39.65 94.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.243 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.3 -47.59 83.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.17 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.53 -44.62 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.53 -42.97 97.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -61.38 -41.87 97.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -59.97 -42.47 94.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.68 -47.23 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.05 -43.61 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.17 -38.25 88.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -71.55 -30.71 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -69.94 -40.39 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.13 -28.99 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.201 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.19 35.8 9.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 22' ' ' GLU . 82.6 t -71.19 123.66 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.23 165.83 14.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 88.1 p -143.69 171.29 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -84.56 78.55 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.245 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.11 -6.28 59.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.4 p -74.29 -9.25 58.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.13 0.65 55.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.56 145.35 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.54 32.54 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -143.92 140.88 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.59 99.28 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.19 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.74 -179.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.6 t -94.8 122.95 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.58 117.75 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.76 125.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.218 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.09 49.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -63.14 -56.47 16.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -146.34 176.76 9.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.69 145.12 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.6 p -129.6 155.69 79.89 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.34 -38.34 72.95 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.714 1.609 . . . . 0.0 111.215 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -43.85 75.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.28 -46.28 64.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 65.0 p -67.89 -29.71 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.85 -29.37 70.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.1 p -108.46 14.55 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 63.1 tpp -71.65 115.58 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.55 77.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.2 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HB2' HD11 ' A' ' 197' ' ' LEU . 63.7 pttt -63.16 -20.7 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.241 -172.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.11 -31.02 68.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -112.47 32.27 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.43 106.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.1 tp -80.52 -40.04 26.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.43 176.81 27.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -154.89 139.59 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 111.185 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.02 25.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.6 t -143.65 154.42 43.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.63 -53.31 57.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.14 124.78 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.11 74.22 0.84 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.5 -31.69 81.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.51 60.11 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.19 174.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.6 m -59.21 -37.36 77.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.211 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t -58.31 -56.46 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -59.37 -40.14 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.3 -46.87 88.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.84 92.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.09 -48.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.236 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.85 -35.71 81.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.19 98.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.184 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.55 -38.62 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.174 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 t -61.53 -43.03 99.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 173' ' ' LYS . 90.3 mt -88.24 -16.09 34.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 61.69 51.26 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.174 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 44.4 pt -127.68 159.67 64.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 92.3 Cg_endo -76.68 163.35 31.76 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.666 1.577 . . . . 0.0 111.251 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.55 135.73 11.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.18 122.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.95 160.35 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.91 38.64 35.42 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.17 -6.41 57.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.327 . . . . 0.0 111.201 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.28 -64.73 4.14 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 171.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -141.38 44.33 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.69 -22.67 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.7 p -70.44 -22.29 62.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.0 p -90.29 -27.08 19.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -90.69 -27.94 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.242 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.6 116.6 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.243 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.15 166.4 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.52 125.6 24.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.11 -18.06 40.09 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.83 165.27 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.23 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 62.4 tp -100.26 125.98 46.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.172 171.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.58 138.71 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.203 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.38 126.01 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.2 171.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.08 100.77 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -99.68 93.61 5.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.34 -22.51 73.08 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.25 -39.22 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -103.23 -15.3 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.71 37.33 26.81 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.96 155.73 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 73.6 t -120.27 135.31 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -109.21 129.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.65 117.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.177 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.76 60.4 11.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.223 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.0 153.18 68.07 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.714 1.609 . . . . 0.0 111.209 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -88.78 -176.52 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.76 -53.95 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -59.27 -48.87 80.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.9 m -53.99 -47.37 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.63 -45.82 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.203 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.72 -34.22 77.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.32 -41.73 98.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.215 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -75.96 -29.62 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -63.23 -41.62 99.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 47.8 t -62.67 -46.56 87.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.199 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.61 -42.83 93.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.62 -47.16 85.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.01 -47.07 88.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.5 p -61.94 -28.32 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.57 -53.65 6.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -77.45 -42.41 36.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.529 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.179 -176.531 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.8 mt -100.79 140.55 34.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.06 136.3 43.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.228 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.8 -138.45 2.52 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -102.19 119.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 111.233 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.54 87.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.95 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.218 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 t -150.28 138.64 12.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.238 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.81 160.67 34.04 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.696 1.597 . . . . 0.0 111.199 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.87 175.16 13.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -125.09 124.6 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.92 132.8 52.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -129.57 127.39 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.31 -153.74 24.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.01 154.71 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.171 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.67 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 31.7 m-85 -121.46 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.59 117.96 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -66.28 124.37 22.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -117.83 131.5 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.96 130.09 50.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.04 135.07 56.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.73 128.2 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.68 93.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.1 m -97.73 112.88 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.48 126.83 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -99.68 103.43 15.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.27 20.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.214 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.16 138.9 47.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.22 139.51 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 pt -118.12 170.28 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.214 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.42 146.19 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -64.03 -20.65 66.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.0 p -73.56 -14.44 61.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -98.42 4.43 48.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.2 -51.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.01 -32.8 74.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.85 -49.26 78.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.196 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.7 -37.3 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.65 -44.6 98.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.27 84.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -64.01 -37.97 89.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -59.28 -49.15 78.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.2 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.49 -36.68 84.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.7 -40.41 92.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.19 -33.49 76.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.65 -40.97 98.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.253 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.64 -42.76 99.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.58 -39.98 85.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.206 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.0 m -63.17 -41.61 99.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -60.97 -44.81 96.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.225 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -59.39 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.58 -55.91 21.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.58 -42.99 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.166 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.95 -49.33 77.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.36 -36.76 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.7 mt -63.03 -45.61 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.17 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.7 -43.72 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -55.35 -52.95 61.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -60.03 -42.85 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -43.11 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.42 -45.02 95.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.21 -31.71 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -97.06 -39.78 9.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.3 -34.91 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.25 -171.91 15.72 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -63.26 -26.13 68.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 111.175 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -45.59 -42.28 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.98 -34.74 10.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.46 -39.21 93.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.9 -32.68 74.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.16 -41.61 91.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.214 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -77.46 -24.09 50.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.36 -41.07 96.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.192 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.79 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -59.64 -41.16 89.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.187 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.73 -43.37 93.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.9 mtm -64.82 -36.09 83.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.86 -45.68 88.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.65 -33.12 74.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.3 m -94.69 1.93 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -65.79 114.17 15.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.86 -33.9 83.48 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.689 1.593 . . . . 0.0 111.216 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -67.94 -43.74 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.198 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.12 -36.69 72.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.96 -51.85 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.19 -35.16 79.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.19 -46.25 91.81 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.29 -46.59 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.37 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.76 -36.39 80.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp -63.68 -40.34 96.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.177 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.88 -50.91 77.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.51 -42.19 71.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.8 m -63.69 -47.37 81.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -99.17 -6.07 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt 59.97 45.05 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.66 -179.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -76.31 163.2 27.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.207 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.66 77.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.19 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.49 -53.17 60.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -59.86 -47.55 85.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -51.24 70.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.247 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.73 -46.1 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -54.84 -47.27 74.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -73.07 -47.86 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.81 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.411 HG23 ' HG ' ' A' ' 130' ' ' LEU . 33.5 mm -65.42 -43.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.43 -44.69 95.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.86 -56.15 25.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.211 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.77 94.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.2 p -67.16 -30.59 70.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.164 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.72 -51.61 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 76.1 mtm -60.3 -35.42 75.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.79 -37.93 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.5 p -70.63 -20.0 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.86 -12.54 61.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.44 32.05 14.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.199 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -105.53 112.45 25.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.176 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.41 -30.67 68.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.38 -50.05 71.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.24 -25.18 62.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.99 -45.23 89.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.218 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.51 -42.13 91.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.93 -33.76 76.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.61 94.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.76 -43.47 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -56.39 -45.82 80.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HG ' HG23 ' A' ' 108' ' ' ILE . 57.7 tp -63.06 -45.08 93.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.229 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -58.41 -43.01 88.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.178 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.53 -48.84 79.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.0 -47.16 90.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.06 -45.14 95.69 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -61.69 -41.67 97.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.346 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -69.71 -33.04 71.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.04 -46.08 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.92 -43.02 96.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.31 -35.65 79.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.76 -31.15 64.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.37 -38.93 88.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.193 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.5 -28.09 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.72 38.23 10.84 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.26 120.37 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.208 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.75 161.37 14.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 72.0 p -160.32 169.73 22.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.8 t -72.42 123.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.185 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.74 74.89 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.215 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.37 -25.67 66.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.196 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.1 p -70.45 -14.05 62.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.219 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -96.46 5.5 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.25 137.67 41.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -110.15 41.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -148.38 143.58 26.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.173 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -57.99 104.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.219 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.49 157.03 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.28 134.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.19 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.1 105.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.18 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.3 mm -104.22 124.21 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -157.95 156.86 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -78.51 -39.92 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -159.11 111.17 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.55 151.15 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -108.4 162.06 21.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.04 -32.98 60.85 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.714 1.609 . . . . 0.0 111.194 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.3 p -69.79 -19.02 63.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -94.54 -38.6 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -77.92 -16.93 57.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.212 -175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.45 -2.97 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.209 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.6 p -88.92 -18.28 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 96.0 mmm -77.95 130.49 36.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.1 129.72 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -48.66 -50.12 34.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -82.12 -3.36 54.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.191 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.5 mmt -110.19 10.35 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.182 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -119.86 122.39 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.78 -36.04 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.22 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.85 -178.68 45.64 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.54 144.25 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 65.5 p -131.41 159.11 38.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.214 -170.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.57 -33.08 64.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.3 m -115.36 163.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -108.93 24.3 21.75 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.46 -21.86 70.9 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.35 31.43 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 111.197 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.6 m -51.99 -48.52 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.7 p -65.37 -30.31 71.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -76.51 -39.16 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.9 p -70.29 -28.12 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -67.61 -52.78 34.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.65 -46.5 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 43.7 ttp -61.65 -55.0 35.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.234 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.19 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.198 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.09 -41.51 97.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -70.93 -22.6 62.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.227 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.1 -2.17 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.23 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.64 35.37 9.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 45.9 pt -132.31 154.26 81.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.234 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.11 160.63 39.58 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.754 1.636 . . . . 0.0 111.166 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 139.33 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 57.3 t -132.64 109.43 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.02 165.41 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.193 -168.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 70.43 39.3 69.71 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.77 -35.37 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 119.53 -53.95 0.66 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -143.95 31.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.54 -25.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -70.57 -22.52 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.21 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.1 p -94.38 -25.82 16.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -94.61 -24.24 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.11 125.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -115.69 164.27 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . . . -61.01 125.37 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.74 -12.38 50.12 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -71.23 144.68 50.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.08 124.26 27.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -132.4 136.77 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.48 124.81 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 80.8 t -97.78 112.6 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -108.91 93.14 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.94 -10.56 83.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.37 -39.5 47.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 111.195 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -93.72 -25.59 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.2 39.36 8.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.7 pt -132.44 160.55 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 111.183 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.12 133.0 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 78.5 mt -113.15 121.39 65.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.89 134.7 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.539 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 87.2 m-20 54.63 61.79 8.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 -171.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 230' ' ' ASN . 50.8 Cg_exo -58.43 145.85 92.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.736 1.624 . . . . 0.0 111.173 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.94 157.74 36.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.186 169.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.06 -48.46 61.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.14 -45.22 93.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.224 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.5 m -57.55 -42.6 83.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.225 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.5 -48.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.67 -35.09 74.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.85 -51.92 66.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.198 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -72.58 -26.83 61.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.19 -51.56 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 92.1 p -69.32 -34.48 74.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.2 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.26 -42.85 75.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -53.52 -49.81 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.216 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -35.83 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 72.4 m -58.52 -38.91 78.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.206 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -178.63 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 91.5 mt -79.76 81.75 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.253 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.61 134.84 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.1 -141.19 3.14 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.06 115.06 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 111.174 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.62 133.12 35.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.1 -32.5 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.8 t -165.39 137.05 3.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.82 144.65 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.675 1.583 . . . . 0.0 111.198 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.94 173.14 16.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.3 mt -133.73 120.51 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 111.202 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.08 124.62 49.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.72 115.71 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.97 -157.41 14.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.59 162.75 13.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 111.18 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.02 132.53 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.183 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -121.13 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -102.13 133.0 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.151 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -134.01 114.79 13.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.3 p -105.91 172.13 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -154.42 132.21 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -109.61 157.08 19.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.176 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.27 128.43 34.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.1 t -102.09 132.44 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.183 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -62.59 129.37 40.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.76 133.31 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -74.24 104.24 4.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.212 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.26 21.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.54 -98.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.21 149.15 44.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.03 165.53 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -59.33 137.51 57.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -54.33 -38.07 65.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -68.59 -15.72 63.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.8 0.03 57.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.15 -51.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -65.43 -33.06 75.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.11 -50.03 75.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -69.82 -34.49 73.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.208 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.28 -43.78 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.51 89.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.04 -45.73 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -60.12 -51.18 70.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.06 -42.61 99.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.25 -55.26 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.46 75.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.202 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.11 -47.05 75.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.61 -40.73 88.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.31 -44.89 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -57.62 -45.04 85.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.222 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -60.53 -47.82 84.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -58.31 -47.96 82.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.57 -48.81 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.68 -44.24 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.205 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.04 -49.62 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.85 -45.9 76.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.43 -26.66 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.16 -50.85 72.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.19 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.64 -46.23 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.219 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.22 -48.77 79.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.24 93.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 62' ' ' LEU . 9.8 tt -55.64 -47.35 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.204 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.81 -34.25 34.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -79.88 -42.34 24.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.12 -33.63 4.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.56 168.64 12.62 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.36 -22.05 66.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.164 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.16 -36.85 80.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -85.23 -30.52 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.94 77.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -54.01 -36.26 62.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.206 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.09 -46.9 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -75.61 -28.05 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.211 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -59.53 -49.06 79.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.198 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -69.16 -33.1 72.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.76 -43.25 80.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.99 -40.76 98.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.55 -40.66 97.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.81 70.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.175 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.8 p -91.87 -1.02 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.3 115.95 28.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.38 -17.56 23.89 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.735 1.623 . . . . 0.0 111.228 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -71.62 -41.28 69.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.215 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.71 -38.32 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.224 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.2 -48.87 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.215 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.86 -43.48 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.64 64.15 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.66 -45.97 96.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 111.188 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.91 -38.3 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.71 -33.22 72.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.6 tpp -64.18 -43.0 96.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.204 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.0 mt -58.85 -47.86 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.16 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -73.52 -46.57 46.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -66.51 -48.4 69.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -96.2 -7.55 35.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.233 -174.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.9 64.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.161 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.86 169.0 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.24 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.9 p -76.01 162.4 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.4 81.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.02 -48.52 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.12 -45.68 80.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -47.67 85.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.201 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.48 -48.17 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.225 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.63 -41.14 85.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.203 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -68.47 -50.9 49.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.28 -44.41 91.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -61.76 -44.5 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.227 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -65.29 -42.35 93.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -59.17 -54.91 41.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -66.75 -38.83 87.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.89 93.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.0 p -65.8 -32.24 73.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.14 -51.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 96.7 mtp -57.23 -37.46 72.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -73.07 -37.96 66.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.198 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.2 p -70.21 -19.21 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.05 -11.78 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.211 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.59 32.35 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -105.89 113.01 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.198 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -59.86 -30.33 68.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.73 -50.02 70.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.32 -27.34 65.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.73 -46.55 84.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.77 -43.58 90.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.217 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -69.39 -32.4 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.238 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.9 85.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.248 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.0 t -60.02 -45.83 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.228 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.62 -43.5 84.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -45.53 93.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.95 -41.2 95.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.21 -48.1 83.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.34 -44.34 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.84 -44.44 92.13 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.98 -39.69 95.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.221 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.78 -37.01 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.219 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.99 -45.49 98.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -60.73 -41.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -47.08 77.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.222 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -71.24 -29.44 65.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.68 -40.18 88.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 172.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.07 -26.23 39.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.33 30.62 15.92 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.29 126.32 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.76 163.14 13.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.2 p -148.88 163.1 38.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -118.92 131.04 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.211 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -82.75 114.58 21.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.407 HD12 ' C ' ' A' ' 149' ' ' LEU . 3.6 pp -67.72 -23.11 65.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.4 p -73.12 -13.27 61.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -99.02 8.55 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.23 148.27 35.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -95.87 -21.59 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.55 156.13 30.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -76.32 129.68 36.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.07 167.7 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 93.6 t -98.58 126.53 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.4 t -86.45 113.76 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.59 117.97 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.9 147.31 30.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.217 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.53 -32.94 60.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -126.36 94.93 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.76 109.12 17.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 71.7 p -110.16 164.01 15.83 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.173 -167.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 76.5 Cg_exo -54.39 -31.2 66.91 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.682 1.588 . . . . 0.0 111.216 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.9 p -69.37 -16.37 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -91.02 -31.42 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 93.7 m -59.52 -38.03 79.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.36 -29.32 63.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.222 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -109.65 37.21 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 62.4 ttp -93.85 105.19 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -91.45 99.43 12.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.181 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.57 -20.15 64.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.08 -33.75 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 39.1 mmt -92.57 -34.14 14.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.48 122.52 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.209 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.8 -26.38 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.232 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.7 178.1 48.46 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.58 152.66 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -156.88 152.72 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.3 t -159.69 -176.21 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.235 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -120.48 -43.93 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 p -172.73 138.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 174.5 176.77 43.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.27 14.05 65.6 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.33 27.51 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.152 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.2 m -68.74 -46.19 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 96.4 p -64.56 -31.64 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.18 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -64.96 -46.01 83.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 99.1 m -52.54 -45.01 66.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.27 -42.84 99.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.206 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.49 -44.06 95.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.225 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.5 mtp -55.54 -48.3 74.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.39 81.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.69 -33.92 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.234 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.7 p -68.43 -19.99 64.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.2 mt -107.6 1.47 23.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 57.22 47.04 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.206 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.5 pt -127.37 156.89 74.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.46 154.37 31.46 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.673 1.582 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.33 144.79 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.205 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.9 117.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.227 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.8 163.4 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.68 55.95 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.65 -48.87 12.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.24 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.99 -11.9 58.94 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -132.57 -14.51 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -170.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.5 -28.67 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -160.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.0 p -80.31 -11.3 59.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.215 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.6 p -105.61 -30.23 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.222 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -81.11 -34.69 32.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.64 120.42 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.244 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.41 152.02 32.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.22 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 126.65 27.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.82 -16.85 46.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.1 175.25 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 111.191 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -99.23 139.39 34.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 170.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.32 134.7 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.178 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.87 127.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.246 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -105.33 94.5 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.182 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -84.6 82.03 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.187 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.35 73.96 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.39 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -78.18 -40.22 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.28 32.66 5.15 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -131.61 156.19 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.212 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 97.6 t -121.32 135.36 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.54 127.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.38 117.3 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.13 62.48 8.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.55 147.0 63.26 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.731 1.62 . . . . 0.0 111.216 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.91 162.7 28.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 173.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.68 -46.12 58.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -62.32 -43.87 97.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.2 m -59.66 -43.18 94.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.242 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.06 -46.29 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -64.61 -35.24 80.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.63 -46.29 90.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.196 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -73.62 -28.75 61.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -62.61 -45.6 92.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.77 -32.34 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.66 -42.42 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.14 -39.63 87.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.83 -43.31 99.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.2 p -71.06 -27.73 63.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 172.627 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.423 ' HE3' ' HB ' ' A' ' 228' ' ' ILE . 99.6 mtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.48 109.34 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -103.85 138.27 40.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.86 -139.43 2.84 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.88 121.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.363 . . . . 0.0 111.191 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.53 87.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.33 -33.01 72.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.186 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -148.56 135.64 10.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 164.31 31.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.659 1.573 . . . . 0.0 111.177 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.89 -168.02 15.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 tt -158.73 144.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 111.239 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.76 154.95 33.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 219' ' ' ILE . 81.9 mt -122.91 128.16 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.26 -177.06 29.07 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.53 150.6 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 111.204 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.28 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -111.0 120.38 42.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.2 tp -93.44 109.22 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.197 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -64.11 108.24 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -91.44 117.12 29.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.211 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -120.85 108.71 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 139.37 54.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.65 160.07 29.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.55 119.3 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.5 m -119.33 118.02 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 101' ' ' ASP . 97.0 mt -71.4 125.65 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.204 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -78.93 114.64 18.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.65 22.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.57 136.35 52.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.226 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.5 128.98 39.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -102.9 127.25 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -57.98 136.81 57.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.2 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.58 -44.59 26.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.8 p -68.5 -20.82 64.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.18 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.04 2.33 43.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.96 -38.16 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.48 -21.94 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -68.44 -35.42 77.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 171.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.89 -35.45 80.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.56 -46.01 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.91 87.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.239 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.35 -47.34 81.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.98 -49.96 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -59.4 -42.03 90.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.25 -37.68 52.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.47 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.71 -42.3 82.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -50.87 -50.48 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.99 -44.74 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.7 m -52.86 -50.09 64.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.73 -42.9 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.5 -46.11 89.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.2 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -60.96 -42.38 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -61.03 -40.96 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.25 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.51 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -57.19 -47.39 81.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.5 -51.35 67.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.211 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.17 -31.55 70.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.46 93.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -63.17 -46.96 84.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.67 -39.22 93.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.221 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -83.32 -34.13 25.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.185 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.12 -58.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.18 -168.26 23.45 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -60.81 -27.5 68.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -43.79 -44.34 6.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.22 -34.35 11.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.205 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.49 -39.11 93.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -176.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.03 -32.7 74.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.22 -43.93 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.168 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -76.81 -19.83 57.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -63.36 -49.1 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.98 81.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.195 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -56.19 -47.24 78.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.214 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -64.33 -44.74 90.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.8 ttp -49.72 -48.4 49.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.171 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.75 -38.61 91.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.0 66.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.5 p -94.56 4.54 53.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -62.55 116.54 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.0 -33.61 73.66 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.733 1.622 . . . . 0.0 111.16 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.39 -35.95 78.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.2 tp -67.55 -46.53 72.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.5 -58.25 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.52 -35.12 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.19 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.59 -48.5 84.19 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.5 t -68.84 -43.88 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.24 -42.7 91.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.265 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -68.89 -36.72 78.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.99 -43.55 98.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.76 -50.78 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.9 -40.86 87.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.5 m -67.07 -47.61 70.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -91.62 -15.89 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.8 mt 64.98 43.75 3.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.223 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.64 -177.59 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -72.1 156.62 38.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.217 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.1 76.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 26' ' ' ILE . 94.3 m-20 -58.95 -50.49 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.233 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -65.01 -41.31 95.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.95 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -45.36 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.242 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -56.49 -46.81 80.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -68.19 -50.05 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.71 -45.07 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.2 mm -60.0 -43.65 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -64.42 -43.35 94.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.214 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.03 -45.9 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -57.89 -47.62 82.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -50.3 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 93.0 mtp -58.26 -38.56 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.186 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -72.09 -38.58 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.194 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 p -70.01 -20.08 63.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.197 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.38 -15.41 63.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.211 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 62.54 32.31 16.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.248 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -100.33 109.84 22.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -42.4 -44.79 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -62.24 -54.64 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.241 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.46 -31.71 71.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.184 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -46.79 86.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.8 -43.81 94.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.206 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -68.74 -31.38 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.48 87.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -61.48 -44.21 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.196 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.57 -41.99 91.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.247 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.63 -41.66 97.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -58.99 -38.64 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.27 -41.36 89.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -54.55 -46.03 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.04 93.49 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.05 -42.43 99.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.18 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -62.56 -40.59 97.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.206 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.53 -48.06 86.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -60.73 -39.89 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.211 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -56.07 -46.71 78.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -71.38 -29.37 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.4 mt -66.45 -37.23 84.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.246 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB2' HG23 ' A' ' 144' ' ' VAL . 88.4 mt -84.24 -32.18 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.27 31.75 7.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 142' ' ' LEU . 81.9 t -72.01 123.52 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.19 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -122.49 163.22 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -152.31 165.83 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.1 t -69.88 130.25 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -76.49 108.79 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.56 -3.39 58.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.208 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 84.6 p -90.78 0.18 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -94.82 5.49 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.16 78.25 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -68.76 -30.94 69.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -87.91 151.85 22.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.55 113.08 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.09 170.4 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.44 134.24 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.87 113.27 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.65 116.05 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.235 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -147.57 156.65 43.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -171.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -97.8 -20.97 17.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.212 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -161.7 110.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.19 96.91 8.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.231 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 46.5 p -80.99 165.38 45.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.222 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 93.9 Cg_exo -50.25 -37.44 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.736 1.624 . . . . 0.0 111.166 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.2 p -76.22 -30.41 57.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.65 -35.07 72.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.7 p -80.79 -29.62 36.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.93 86.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.183 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.8 p -95.95 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 58.5 ttp -136.39 133.02 36.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -77.35 89.37 3.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.231 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -54.99 -35.0 63.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.246 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -47.89 -38.56 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.215 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -109.53 31.4 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.201 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 92.0 t -106.72 124.21 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.197 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.9 mt -100.84 -10.78 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.59 170.73 38.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -121.79 141.61 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -143.38 108.84 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.185 169.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 67.9 p -118.82 154.73 32.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.86 -42.11 95.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.1 m -108.07 157.16 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.194 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.76 3.86 45.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.81 73.11 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -108.4 22.8 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.328 . . . . 0.0 111.182 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.6 m -49.14 -45.89 44.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.0 m -58.82 -44.09 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.18 -49.9 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 80.7 p -72.28 -30.7 65.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.74 72.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.22 -49.07 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.8 mtm -64.79 -46.16 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.45 83.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.185 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -59.63 -45.88 90.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 85.7 p -77.89 -23.62 48.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.227 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.81 -16.02 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 60.81 50.09 5.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.243 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 42.1 pt -128.64 159.84 65.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.186 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 71.8 Cg_endo -72.36 150.27 52.18 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.658 1.572 . . . . 0.0 111.198 177.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.12 126.16 12.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.229 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.17 123.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.67 159.34 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.78 39.98 32.49 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.09 -14.01 58.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.91 -59.82 1.45 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -152.06 45.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.84 -23.55 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.193 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.0 p -75.38 -15.51 60.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.5 p -97.47 -27.22 14.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.2 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.41 -23.46 20.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.15 122.96 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.236 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.86 159.85 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.11 26.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.79 -16.68 36.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.09 163.82 27.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.0 129.59 44.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.186 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.92 136.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.204 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 13' ' ' ILE . 74.7 mt -122.95 126.03 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 175.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.6 t -107.97 112.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -98.54 91.1 4.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.18 -33.73 69.35 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 67.2 tp -57.74 -49.79 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 111.213 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.59 -26.38 30.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.82 10.68 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.2 pt -133.71 149.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.94 135.95 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.423 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 7.9 tp -115.4 140.46 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.39 138.24 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.178 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 89.0 m-20 56.05 52.3 7.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -173.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.3 Cg_endo -71.76 155.28 58.63 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.665 1.576 . . . . 0.0 111.235 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -88.09 -177.88 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.04 -54.37 45.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.238 -172.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.79 -46.56 88.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.243 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.6 m -56.23 -45.55 79.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.62 -45.54 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.59 -35.6 77.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.04 -45.75 90.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -76.15 -26.06 55.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.189 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.181 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 75.3 m -59.16 -41.48 88.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.17 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.55 -49.97 75.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.221 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.64 -40.27 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 73.4 m -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.245 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 177.464 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.845 0.355 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.9 mt -98.08 122.43 41.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.06 136.8 47.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -140.67 2.93 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.36 113.71 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 111.168 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.31 87.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.72 76.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.194 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.9 t -148.33 135.77 10.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.19 162.01 31.78 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.699 1.599 . . . . 0.0 111.239 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 177.59 14.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.94 130.41 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 111.176 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.02 140.11 36.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.65 124.91 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.72 -156.02 7.85 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.24 179.27 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.22 131.2 41.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -121.56 97.66 5.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.84 118.23 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 -170.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -98.72 111.26 23.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 p -104.33 167.82 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.165 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.94 132.19 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.197 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.41 132.68 54.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.191 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.19 131.43 50.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t -83.58 99.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.6 m -97.67 114.11 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -96.24 126.4 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -80.44 115.78 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.65 23.54 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.219 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -83.19 157.57 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -84.3 160.14 20.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.2 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.7 pt -122.64 165.03 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.54 146.26 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -51.27 -39.29 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -69.88 -16.31 63.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.25 -0.13 53.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -58.61 -46.79 90.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.209 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.93 -32.14 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.211 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.55 -42.47 87.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.192 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.81 -37.58 76.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 84.5 mt -63.63 -43.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.47 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.18 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -64.27 -37.92 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.83 -48.48 81.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.99 -35.62 81.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.93 -42.13 99.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.89 85.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.173 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.38 -41.6 97.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.75 -38.33 90.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.15 -46.54 95.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.2 p -68.93 -29.89 68.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.216 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -60.03 -51.26 70.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.218 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -49.93 75.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.18 -55.1 39.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.36 -41.77 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.12 -51.33 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.5 -38.18 83.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.191 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.8 mt -64.55 -41.85 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.02 -49.35 60.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -54.7 -52.94 60.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -60.74 -40.02 90.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.46 99.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.3 tt -57.41 -47.21 82.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.183 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.23 -28.88 57.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.225 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.23 -44.02 9.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.208 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.17 -32.76 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -168.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.89 164.34 11.48 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.9 -34.97 66.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -45.88 -44.51 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -76.56 -34.7 58.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.79 81.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.239 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.51 -35.87 82.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.93 -42.54 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -76.91 -24.25 52.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.209 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -64.59 -41.01 96.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.18 98.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.46 -40.74 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.211 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.97 -43.68 87.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -64.86 -36.81 85.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.9 -44.96 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.63 78.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.2 p -104.57 20.6 18.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.234 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -72.66 114.87 34.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.98 -34.55 77.4 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.69 1.593 . . . . 0.0 111.192 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -69.11 -43.36 74.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.226 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 99.5 mt -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.86 -51.78 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.42 -30.75 69.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.216 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.97 -47.09 91.29 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.11 -43.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.201 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.78 -44.93 90.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -67.68 -34.87 77.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.206 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 tpp -63.71 -43.25 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.79 -48.02 89.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -73.97 -45.91 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.3 m -63.62 -48.83 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.91 -12.07 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.217 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.5 mt 59.05 65.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.246 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 165.61 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.201 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.4 p -66.4 154.78 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.89 97.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.241 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.89 -37.12 85.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.22 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.49 -43.86 84.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.88 94.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.37 -46.5 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.5 -47.07 76.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -69.47 -51.62 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.61 -46.92 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -68.83 -47.13 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.71 -39.77 84.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.201 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -57.19 -54.56 45.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.188 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.84 -38.2 89.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.217 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.07 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.9 p -66.98 -31.19 71.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.47 -49.16 79.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 98.7 mtp -58.5 -37.38 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -74.32 -34.52 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 p -69.98 -17.56 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.251 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.62 -11.29 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.193 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 64.49 32.79 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.14 112.99 25.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.46 -31.37 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -63.34 -51.01 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.39 -25.28 63.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.223 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.48 -47.96 81.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.19 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.84 -39.59 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.48 -33.41 75.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.227 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.89 84.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.46 -43.53 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.173 173.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.01 -48.07 73.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.85 -49.14 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -56.89 -45.18 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.35 -42.91 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.211 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.52 -48.87 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.56 -40.45 99.15 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -59.64 -43.94 93.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.81 -37.23 76.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.219 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.49 -44.87 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.236 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.3 -44.44 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.52 -47.53 85.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.14 -33.3 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.56 77.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.54 -34.38 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.17 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.76 35.09 5.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.84 122.53 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 111.177 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -107.0 163.62 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 71.7 p -158.59 177.71 10.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.4 125.65 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -81.31 105.9 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.199 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.58 -26.78 67.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.242 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -77.53 -9.01 58.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.194 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.68 -3.34 58.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.194 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.08 120.41 16.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.213 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -122.72 30.21 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -145.9 137.61 25.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.82 98.46 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 173.29 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.211 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -89.2 127.24 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.6 125.19 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.87 112.05 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.229 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.92 143.92 43.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -170.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -89.54 -7.73 54.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 172.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -169.27 152.01 4.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.5 tp -173.61 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.8 p -99.99 161.04 25.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.215 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.1 -34.89 59.96 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.744 1.629 . . . . 0.0 111.179 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 p -67.21 -19.98 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -91.92 -34.12 14.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.1 p -63.65 -32.87 74.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.182 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.31 71.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.7 p -113.2 14.14 19.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.4 ttt -77.59 131.79 37.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -67.35 74.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -66.34 -22.42 66.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.86 -25.03 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.03 23.48 14.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.194 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.4 t -110.26 116.13 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.185 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.68 -4.68 33.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.52 169.48 38.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -150.4 132.04 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -141.59 150.17 41.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.3 p -137.0 165.47 25.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -104.87 7.92 34.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.99 153.43 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 139.28 145.42 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.97 -76.41 1.07 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.08 140.78 47.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.226 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.9 p -123.14 25.19 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -60.17 -59.27 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -60.07 -38.89 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 79.8 m -58.25 -47.51 83.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.8 87.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.35 -47.89 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.21 -44.86 94.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.8 82.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.201 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -61.56 -46.48 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 78.5 p -70.58 -25.03 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -22.88 28.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.209 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 60.6 47.43 8.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.203 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.03 155.87 80.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.94 161.6 23.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.664 1.576 . . . . 0.0 111.219 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.88 132.22 8.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.15 112.62 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.224 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.77 169.83 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 -170.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.64 78.68 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.5 mt -80.35 -27.44 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.29 -62.77 4.44 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -93.21 -6.12 48.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.167 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.92 -29.13 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.9 p -79.56 -14.08 59.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.259 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.2 p -102.62 -28.8 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.215 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -92.37 -23.94 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.66 120.8 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.189 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -117.49 157.57 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.23 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.46 127.31 29.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.76 -20.05 32.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.63 163.48 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.767 0.318 . . . . 0.0 111.239 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.86 134.15 36.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.6 t -133.27 128.58 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.233 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.5 mt -113.7 127.51 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.186 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.1 t -106.52 118.89 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.172 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -116.4 96.98 5.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.63 -23.7 66.78 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.66 -38.23 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 111.176 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.36 -27.64 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.187 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.45 36.45 14.32 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.68 157.68 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 111.185 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.59 134.84 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.199 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 mm -103.23 128.85 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 72.4 t -105.2 120.9 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 54.97 58.4 11.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.93 156.17 63.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.748 1.632 . . . . 0.0 111.232 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -86.47 -178.23 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.99 -42.67 99.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -64.06 -44.18 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.6 m -61.6 -44.22 97.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.99 -44.97 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.234 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.89 -35.7 80.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.221 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.02 -50.57 72.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.185 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -72.37 -27.21 62.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -59.56 -45.48 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.198 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.7 p -69.36 -31.45 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.18 -42.96 83.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.86 -44.95 86.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.85 -50.61 73.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.0 p -67.7 -26.57 66.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.228 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.233 174.432 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.759 0.314 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -97.14 99.36 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -87.37 131.31 34.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.31 -150.82 5.45 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.6 119.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.83 87.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.74 -31.84 65.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -148.28 133.98 9.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.6 163.44 31.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.735 1.623 . . . . 0.0 111.171 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.4 179.66 15.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -130.67 121.36 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 111.208 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.01 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.225 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.9 mt -124.11 119.53 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.23 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.81 -161.82 13.66 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.0 157.42 16.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 111.215 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.41 95.15 4.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -105.64 105.23 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.11 140.27 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -85.29 97.94 10.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -120.83 137.89 54.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -123.09 160.18 26.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -68.67 139.46 55.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.215 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.02 115.04 29.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.27 127.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.218 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.0 m -70.66 133.67 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.35 127.26 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -79.82 113.05 17.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.84 16.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -56.96 133.6 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.207 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.44 129.74 43.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.08 125.37 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.03 145.79 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.33 -34.87 61.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.7 p -75.85 -21.69 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.233 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.61 -9.35 41.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 93' ' ' ILE . 42.6 t -54.78 -45.0 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.52 -32.93 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -67.0 -41.83 86.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.65 -36.2 78.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.21 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 173.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.93 90.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.3 -45.82 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.94 -47.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.51 -36.33 83.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.48 -39.69 92.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.77 -35.08 79.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.2 -42.36 99.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.48 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.36 -44.06 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.199 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.3 m -60.21 -48.82 80.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.3 -42.19 99.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.15 -49.81 74.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.31 -45.77 92.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.66 -44.22 93.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.49 -45.76 78.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.36 -41.57 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.86 -40.77 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.195 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -50.58 -47.33 58.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.195 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.68 -49.14 68.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.01 -42.06 98.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.07 85.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -62.45 -46.08 90.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.49 -29.96 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.197 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -82.38 -53.83 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -117.36 -34.49 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.38 -168.46 16.51 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.56 -19.0 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.776 0.322 . . . . 0.0 111.208 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -55.92 -52.91 62.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -77.9 -28.99 49.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.211 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.64 76.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.211 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.75 -34.84 79.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.49 -47.2 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -76.38 -26.61 55.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.189 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.0 -45.39 90.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.73 97.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -60.19 -41.36 92.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.172 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.2 tp -64.72 -43.96 91.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.4 mtp -57.2 -45.85 83.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.216 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.77 -40.75 98.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.232 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.75 66.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.234 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 -2.64 37.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.74 113.79 14.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.04 -33.37 83.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.658 1.572 . . . . 0.0 111.199 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -67.67 -44.44 77.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.04 -37.29 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.96 -52.52 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.208 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.27 -35.05 78.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.81 -47.6 87.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.5 -45.29 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 111.17 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -62.09 -38.76 90.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -67.01 -37.88 84.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.151 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.4 tpp -63.01 -42.46 99.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.404 HG22 HG13 ' A' ' 36' ' ' VAL . 96.1 mt -57.25 -48.01 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.49 -43.21 57.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.211 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 m -62.28 -50.33 72.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -172.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.27 -11.35 32.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.0 mt 59.0 63.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.49 158.95 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.22 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.3 t -66.18 150.0 49.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.04 -31.87 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.234 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -54.73 -43.7 72.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -84.82 -31.67 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.91 -45.41 93.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.17 -46.31 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.19 -48.21 71.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.28 -49.41 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 -174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.9 -45.1 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.442 HG23 ' HG ' ' A' ' 130' ' ' LEU . 31.1 mm -64.57 -46.34 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -69.1 -38.28 78.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.73 -54.34 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.82 -31.33 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.72 98.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.5 p -69.42 -29.33 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.19 -48.98 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 66.4 mtt -51.91 -42.65 62.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.234 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.22 -40.46 82.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.0 p -69.34 -19.98 63.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.98 -8.69 57.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 62.62 33.9 15.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -110.73 112.76 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.84 -31.0 69.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.198 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.2 -49.94 75.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.53 -25.69 62.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.195 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.17 -40.49 97.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -67.17 -35.69 80.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -69.57 -31.6 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.3 96.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.181 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.33 -46.55 96.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.221 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -57.29 -44.0 83.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 108' ' ' ILE . 56.3 tp -62.44 -46.05 90.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 -58.36 -45.28 88.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.12 -42.44 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.205 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.38 -49.69 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.79 98.5 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -60.2 -44.09 95.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 111.183 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -70.0 -36.14 74.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.0 mt -57.56 -46.23 86.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.37 -42.61 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.71 -40.11 91.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.186 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.47 -30.33 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.76 -38.78 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.2 -26.0 36.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.198 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.05 27.31 23.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.51 125.97 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.77 161.74 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -144.96 175.87 9.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.18 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.75 124.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.44 72.51 7.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -21.01 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -67.42 -18.01 64.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.2 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -105.47 20.11 19.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 156' ' ' VAL . 60.3 tp -63.62 130.92 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.28 22.22 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -137.73 140.52 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.54 97.83 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.19 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 152' ' ' LEU . 34.8 m -137.72 -168.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.69 132.34 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.8 t -96.41 125.13 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 98.7 mt -122.42 132.08 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.71 170.06 22.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.207 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -66.34 -46.24 77.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.202 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.71 173.38 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.202 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.68 84.51 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 51.5 p -78.22 165.25 51.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.174 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 95.3 Cg_exo -50.03 -36.68 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.7 1.6 . . . . 0.0 111.209 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 93.7 p -73.27 -31.06 63.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -45.85 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.6 p -68.74 -27.31 65.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.176 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.56 -1.39 37.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 74.2 p -113.96 5.05 16.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.0 mtp -78.16 126.89 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -67.06 106.48 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.238 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.5 -48.81 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.204 -166.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.21 8.5 44.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 -164.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -123.84 16.81 9.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.4 112.45 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.5 mt -91.03 -13.45 33.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.6 178.41 41.96 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -165.15 162.48 20.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 111.21 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -150.2 144.65 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.244 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.6 p -127.85 154.78 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.227 -170.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.86 -55.35 23.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.186 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.46 129.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 59.1 4.51 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.88 73.89 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -118.0 62.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.3 m -63.18 -40.1 96.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.1 m -52.8 -53.41 48.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -72.73 -33.1 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.258 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -58.42 -48.94 79.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.0 mt -58.31 -46.05 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 tpp -64.3 -46.83 81.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.27 91.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.167 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.1 -36.64 69.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 82.8 p -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -98.59 -14.97 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 60.95 51.03 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.183 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 44.2 pt -125.45 153.21 72.4 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.219 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 50.7 Cg_exo -60.55 148.74 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.663 1.576 . . . . 0.0 111.205 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -148.2 122.09 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.44 120.33 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.177 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.86 160.81 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.01 38.75 29.5 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.18 -5.57 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.79 -62.97 4.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -151.94 45.06 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.2 -174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.9 -23.26 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.7 p -70.66 -17.92 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.8 p -101.01 -27.85 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.189 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -83.18 -17.89 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.79 134.36 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -109.05 149.75 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.89 126.21 26.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.06 -14.99 44.26 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.58 166.21 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 111.195 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.27 133.41 36.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.245 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.94 126.31 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.35 114.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.251 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.67 91.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -85.94 78.91 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.186 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.01 -24.44 73.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 64.1 tp -58.2 -48.31 80.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.186 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -91.79 -17.89 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.12 36.53 14.72 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -132.28 155.16 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 96.1 t -121.64 133.94 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 175.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.7 127.43 66.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.9 122.85 62.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 94.0 m-20 55.71 55.52 9.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.7 Cg_endo -69.64 155.33 66.64 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.7 1.6 . . . . 0.0 111.219 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.39 161.61 29.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.174 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.91 -50.46 63.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -57.72 -46.88 83.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.219 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 99.9 m -54.19 -45.39 72.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.92 -47.55 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.87 -32.37 73.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.209 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -64.47 -41.35 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.43 -28.23 64.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.85 -43.07 99.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 78.6 p -71.03 -30.96 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -68.56 -39.98 80.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.192 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -59.84 -41.57 91.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.51 -49.19 77.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.1 p -67.06 -28.91 68.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.212 172.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.6 mt -91.61 120.18 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.3 129.62 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.17 -150.91 5.31 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.4 t -105.21 124.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 111.177 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.56 87.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.57 96.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.218 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.4 p -149.09 148.84 28.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.64 161.81 24.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.699 1.599 . . . . 0.0 111.236 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.64 177.13 14.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -133.92 117.03 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.81 113.31 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.92 111.56 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.71 -156.75 13.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.5 150.83 22.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 111.224 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 120.72 31.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -119.82 100.42 7.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.3 tp -78.25 113.79 16.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.66 106.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.3 m -92.77 133.66 35.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.58 127.55 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.163 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HB2' HG13 ' A' ' 144' ' ' VAL . 61.9 mt-10 -67.19 146.35 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.73 125.82 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.49 82.04 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.6 m -85.42 112.22 20.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.201 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -81.57 122.1 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -80.2 109.01 14.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.7 24.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.196 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.12 173.55 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.2 164.83 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 pt -123.24 165.26 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -72.92 142.96 47.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.19 -43.1 66.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.2 p -69.28 -17.88 63.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.31 4.72 46.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.2 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.43 -46.78 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.24 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.74 -36.31 82.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -67.85 -40.38 83.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.171 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.33 -37.89 74.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.217 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.24 -42.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.91 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.211 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.95 -42.86 94.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.214 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.27 -48.3 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.39 -36.91 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.91 -39.37 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.218 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.61 81.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.212 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.68 -40.53 97.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.54 -45.27 94.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.5 t -67.44 -42.67 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.0 m -58.0 -53.83 53.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.24 -39.38 94.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.42 -50.89 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.199 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -65.35 -39.13 91.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.229 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.44 -49.09 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.231 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -67.24 -45.94 75.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.55 -43.94 83.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.224 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.82 -39.88 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -49.24 -47.22 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.73 -51.75 59.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.227 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.42 -40.92 98.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.98 95.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.198 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.17 -44.87 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.16 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.31 -35.78 81.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.214 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -87.04 -67.77 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.09 -31.58 15.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.33 -163.24 13.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.06 -23.4 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.194 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -48.0 -41.0 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -102.04 -32.36 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.159 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -37.99 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -65.66 -33.44 75.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -58.57 -46.57 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.225 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.01 -35.56 78.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.182 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -57.12 -46.7 82.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.61 98.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -67.38 -34.42 77.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.0 -46.04 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.54 -41.97 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.209 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.26 -39.43 93.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.03 79.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.18 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -87.49 -14.85 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.63 113.77 10.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.232 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.32 -28.58 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.683 1.589 . . . . 0.0 111.209 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -63.56 -28.62 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.252 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.55 -35.87 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -53.43 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.31 -35.39 80.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.94 94.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.8 -45.61 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.64 -36.19 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.202 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -65.16 -42.08 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.06 -47.0 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.67 -43.98 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -67.28 -47.27 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -97.4 -8.07 30.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.41 63.71 1.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.48 165.92 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.2 p -65.91 159.53 25.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.41 78.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.215 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -55.39 -51.22 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.201 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.39 -43.68 89.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.68 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.65 -46.28 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.19 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.89 -55.1 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.21 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.75 -52.28 63.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.49 -50.03 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -172.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.9 mt -71.62 -42.95 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.247 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -57.69 -41.58 81.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.83 -52.95 63.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.35 -37.04 81.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.8 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.8 p -68.59 -29.64 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.178 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.68 -49.98 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 60.1 mtt -53.58 -40.77 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.81 -41.12 83.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 73.2 p -69.69 -21.25 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.4 mt -73.65 -13.06 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.94 32.19 17.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -103.83 108.98 20.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.54 -33.45 74.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -169.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.28 -49.28 77.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.236 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.45 -26.08 63.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -42.47 97.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.68 -41.75 91.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.219 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -67.25 -32.91 74.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.01 88.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.217 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.73 -43.05 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.84 -41.35 86.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.07 -43.17 95.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -59.99 -42.32 93.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.95 -46.51 81.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.41 -46.12 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.74 -46.32 93.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.11 -41.77 97.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 111.235 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -62.86 -41.62 99.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.44 -46.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.62 -41.78 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.67 -39.82 85.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -72.66 -31.05 64.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.192 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.06 -38.32 82.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.247 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.43 -33.17 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.56 8.84 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 22' ' ' GLU . 75.7 t -69.61 119.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.186 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.81 161.94 13.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.3 p -153.92 165.13 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.73 123.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.213 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -93.54 94.67 8.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.03 -3.25 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.22 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.3 p -74.56 -13.17 60.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -110.93 23.66 13.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.17 132.61 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -101.18 -6.25 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.85 156.87 43.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.16 121.24 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -138.12 170.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.0 t -94.76 133.36 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.44 121.17 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 79.3 mt -122.21 135.34 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.45 24.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.55 -45.58 30.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -168.71 147.21 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.8 mt -135.9 148.89 48.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 43.6 p -84.26 163.39 47.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 85.9 Cg_exo -51.66 -29.63 33.82 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.703 1.602 . . . . 0.0 111.165 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.9 p -84.73 -25.31 28.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -83.5 -34.14 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.6 p -67.01 -18.15 65.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 1.5 56.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.5 p -101.94 36.39 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 77.0 mtm -122.42 143.62 49.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.187 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -81.64 93.77 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.202 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -47.33 -46.69 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.212 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.12 -26.64 68.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.93 27.57 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.2 t -105.83 118.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.23 -29.6 24.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.18 174.82 43.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -122.8 154.49 38.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 0.0 111.226 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -151.51 144.82 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 168.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 -171.43 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -152.1 -0.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.31 152.69 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.72 171.89 26.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 166.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 -6.22 87.91 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -75.24 -1.36 23.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.9 p -66.57 -21.6 66.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 98.8 p -101.48 -35.06 9.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.254 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.06 -47.12 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 53.6 m -49.8 -44.16 48.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.232 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -58.17 -45.45 87.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.7 mt -62.59 -49.28 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.239 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mmm -63.75 -50.04 70.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.63 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.81 -30.84 68.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 81.0 p -79.54 -24.85 41.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.56 -5.36 58.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.207 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 60.32 41.76 15.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 35.7 pt -129.59 155.62 79.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 156.05 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.756 1.637 . . . . 0.0 111.187 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.54 142.55 12.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.78 129.32 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.201 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.56 153.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.229 -173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 73.49 40.75 46.72 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 227' ' ' VAL . 91.3 mt -69.66 -24.43 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.235 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 121.26 -54.7 0.67 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -161.31 27.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 -175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.9 p -51.37 -33.56 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -74.34 -21.12 59.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.0 p -90.33 -20.94 22.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -103.36 23.2 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.19 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.95 149.81 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -139.18 142.06 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.204 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 122.85 12.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 114.01 -19.3 18.17 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.29 -179.26 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.21 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.87 153.46 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.43 141.99 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 89.0 mt -119.72 120.41 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 170.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.92 97.29 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -83.37 80.81 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.79 -33.1 86.34 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 68.7 tp -56.41 -49.21 75.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -80.01 -40.73 27.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 102.06 28.47 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.88 158.57 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 111.218 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 205' ' ' LEU . 99.5 t -133.85 134.69 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.06 127.44 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 130.8 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.37 56.97 9.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.66 153.15 64.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.74 1.627 . . . . 0.0 111.177 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -88.42 -178.48 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.2 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.55 -54.41 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -59.23 -48.37 81.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.4 m -54.14 -46.8 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.216 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 67.6 t -61.13 -46.59 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -68.73 -33.46 73.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.168 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.59 -42.93 99.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.247 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -68.14 -31.83 71.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.47 -44.68 96.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.72 -31.97 69.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.204 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.96 -42.29 76.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -61.88 -37.76 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.183 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.32 -49.77 75.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.7 p -67.94 -28.58 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 64.8 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 172.921 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.1 mt -74.95 79.84 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.65 130.01 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.28 -153.17 5.8 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.6 136.44 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 111.218 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.7 76.22 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.184 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.82 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 t -149.94 128.67 6.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.232 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 155.38 33.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.636 1.557 . . . . 0.0 111.195 -175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 170.78 12.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.2 mm -113.18 130.36 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.184 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 220' ' ' VAL . . . -126.42 112.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.55 111.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.23 -162.06 18.02 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.27 163.64 15.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.346 . . . . 0.0 111.236 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.44 109.49 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.58 137.56 52.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 168.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.64 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.207 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 63.7 t80 -88.1 97.56 11.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.208 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -118.1 135.35 54.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -140.79 159.3 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.173 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -58.93 135.17 57.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.55 130.56 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.179 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.15 109.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.4 p -124.15 152.27 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.85 127.48 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.218 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -81.49 105.14 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.91 14.0 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 -171.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 150.08 25.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.73 158.48 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.55 167.27 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 144.81 55.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -52.38 -37.12 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.1 p -69.52 -15.46 63.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.192 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -94.7 0.01 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.47 -50.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.66 -32.0 73.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.219 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.88 -50.73 72.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.15 -34.28 72.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.188 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.14 -43.61 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.212 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.77 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.93 -44.93 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.52 -48.94 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.182 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.45 -36.2 82.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -66.94 -40.09 87.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.209 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.66 80.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.95 -42.5 99.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.56 -50.99 70.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.16 -43.09 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.209 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.5 m -58.0 -53.1 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -64.0 -39.06 93.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.53 -46.72 88.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.88 -39.8 91.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.73 -39.93 87.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.213 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -56.47 -46.95 80.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.27 -40.36 97.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.75 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -52.36 -49.91 63.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.238 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -57.83 -51.56 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.253 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.66 -42.43 92.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.183 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.05 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -56.48 -47.32 79.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.85 -32.31 52.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.229 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -84.79 -47.88 9.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.6 -34.55 5.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.52 161.15 9.86 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.32 -37.97 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.189 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.64 -46.34 63.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -65.8 -37.83 87.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.71 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.69 -34.29 77.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.6 mt -59.27 -44.71 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.48 -30.4 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -58.11 -42.36 85.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.7 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -58.13 -41.91 84.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 77' ' ' LEU . 9.3 tt -59.65 -48.93 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -63.62 -34.95 78.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.4 -39.21 91.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.202 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.26 80.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.7 p -85.0 -9.05 58.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.208 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -63.47 115.45 18.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.207 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.52 -31.26 68.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 0.0 111.207 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.82 -33.2 75.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -81.21 -44.29 18.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.224 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -53.53 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -65.93 -34.76 78.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.99 -46.37 93.81 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.52 -45.47 88.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -64.57 -39.07 93.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.208 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -67.64 -34.34 76.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -64.64 -41.79 95.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.52 -47.37 91.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.59 -46.75 36.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.9 m -64.23 -47.53 79.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -172.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.68 -9.53 34.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.1 mt 57.82 63.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.04 -179.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.172 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.4 p -81.11 164.15 22.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.227 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.04 90.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -68.6 -36.7 79.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.2 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -64.28 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.84 95.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.19 -49.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.227 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -60.89 -43.49 98.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -66.91 -50.39 62.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.199 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.93 -46.28 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.229 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.22 -44.86 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -64.1 -39.38 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -60.39 -52.94 63.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.99 -37.5 87.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.55 96.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.198 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.6 p -65.85 -30.56 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.193 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.35 -51.56 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.212 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 67.1 mtt -54.71 -40.27 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -68.47 -41.56 79.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.4 p -69.96 -22.11 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.17 -13.42 60.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.16 32.97 19.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -103.74 106.67 17.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.193 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.65 -32.84 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -169.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -60.88 -50.16 74.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.14 -30.4 69.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.55 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.89 -41.96 97.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.96 -34.2 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.95 -41.4 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -56.41 -44.37 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.21 -37.58 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.225 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -61.39 -41.74 97.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.5 -41.89 96.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.13 -44.7 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.19 97.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -55.81 -47.91 76.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -61.0 -45.52 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.212 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.75 -48.73 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.67 -43.59 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.32 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.39 -32.84 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.23 -39.35 86.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.21 -36.94 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.22 27.3 10.18 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.41 125.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -109.88 156.22 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.246 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.0 p -143.32 174.59 10.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.35 106.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -83.8 115.75 22.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.72 -16.07 59.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.9 p -69.43 -13.37 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -88.85 -3.68 58.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.212 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.94 149.48 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.241 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.75 28.55 7.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -150.09 141.42 23.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.222 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.54 113.5 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.12 172.59 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.204 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.04 134.13 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.8 t -113.76 129.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.155 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.7 mt -123.42 136.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 19' ' ' TYR . . . -162.02 149.66 14.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -50.05 -49.96 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.177 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.56 153.08 31.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -133.58 141.82 47.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 44.8 p -116.6 163.89 20.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 176.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 86.8 Cg_exo -52.61 -35.31 67.07 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.729 1.62 . . . . 0.0 111.192 177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.7 p -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -87.76 -30.3 20.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.185 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.427 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 69.7 p -78.9 -11.18 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.78 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.5 p -106.91 21.86 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 168' ' ' THR . 60.9 mtt -100.32 150.59 22.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -117.64 107.45 14.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -62.01 -26.42 68.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.98 -22.42 66.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -105.6 5.56 31.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.51 119.38 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.64 -17.38 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.71 173.55 29.43 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.25 165.99 33.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.246 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.31 152.08 36.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.215 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 38.6 p -126.25 161.86 26.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -76.47 -41.37 47.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.84 167.55 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 -171.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -113.09 15.02 23.44 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -67.67 -16.0 67.23 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -124.62 37.97 4.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -54.98 -40.55 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.232 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.6 p -63.88 -32.57 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.8 -35.22 62.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -70.43 -27.24 64.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.51 76.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.38 -46.28 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 28.4 ttt -60.89 -52.87 63.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.234 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -64.37 -56.56 13.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.2 m -63.42 -42.19 98.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.187 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.65 -17.63 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 63.4 51.79 2.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.169 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.26 157.15 76.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 158.25 56.59 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.73 1.62 . . . . 0.0 111.161 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -154.28 135.55 14.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.09 123.16 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 157.58 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.47 17.7 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.45 -3.02 58.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.233 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.35 -65.43 3.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.36 42.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 111.186 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -24.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.4 p -68.21 -21.59 64.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.2 p -97.08 -25.36 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -85.24 -23.05 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.209 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.92 128.43 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.89 150.97 26.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.45 129.11 40.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.46 -19.06 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.97 159.85 32.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.28 133.29 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.37 132.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.2 117.05 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 171.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 12' ' ' ALA . 67.3 t -104.78 115.27 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.99 98.69 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.7 -39.32 86.22 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.1 -46.76 87.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.771 0.32 . . . . 0.0 111.194 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -73.97 -35.86 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 173.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.36 7.28 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.5 pt -132.67 154.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.218 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.76 134.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.83 130.54 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.11 136.81 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.261 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 90.3 m-20 59.11 51.43 3.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 98.6 Cg_endo -72.25 155.77 55.82 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.683 1.589 . . . . 0.0 111.219 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -91.39 -177.83 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.65 -50.79 72.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.63 -48.78 78.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.6 m -54.41 -46.71 73.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 57.9 t -59.11 -45.02 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -69.26 -34.12 74.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -50.15 73.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.41 -26.88 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.12 -43.66 95.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 80.5 p -72.13 -29.55 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.93 -36.59 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -53.39 -52.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.33 -39.16 93.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.8 m -61.03 -38.77 87.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 178.823 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.63 148.7 24.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.82 134.32 38.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.74 -149.39 5.07 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -97.02 122.7 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.72 88.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.183 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.93 -38.78 76.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.191 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -148.49 141.41 15.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.212 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.07 165.11 24.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.728 1.619 . . . . 0.0 111.203 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.4 -178.51 16.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -131.11 132.04 63.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.64 127.03 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.409 HG12 HG12 ' A' ' 219' ' ' ILE . 69.5 mt -127.87 122.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.57 -147.19 10.01 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.43 149.63 25.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 111.207 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.26 127.49 53.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.66 140.74 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.199 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 tp -106.7 122.93 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.194 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 76.2 t80 -97.27 90.21 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.1 m -116.5 129.1 56.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -100.8 152.18 20.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.87 127.29 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.176 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -78.8 119.24 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.34 162.2 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.4 p -129.36 171.61 12.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.235 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -118.32 127.75 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.52 114.12 20.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.78 2.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.84 136.16 57.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.33 130.4 46.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.185 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.51 172.98 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.29 143.94 50.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.59 -37.5 63.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.236 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.4 p -69.03 -15.19 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.92 2.89 55.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.76 -49.97 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.15 -32.77 74.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -59.44 -48.85 80.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -68.42 -34.63 76.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.2 -45.12 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.207 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.58 95.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.22 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -58.35 -45.51 88.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.243 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.98 -50.27 74.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.5 -44.01 93.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.174 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.45 -46.64 79.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.9 79.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.9 -45.72 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.23 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.75 -44.97 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -56.95 -43.36 81.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.28 -44.26 88.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.21 -38.4 87.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.249 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -65.59 -40.45 92.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.25 -40.74 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.201 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -63.42 -39.69 95.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.63 -38.76 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.197 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.57 -41.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -55.7 -46.33 77.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.0 -53.08 62.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.21 -36.89 84.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.51 94.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.5 tt -55.55 -44.46 76.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.13 -43.66 77.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -88.87 -48.02 7.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -91.95 -48.04 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.197 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.83 162.19 10.15 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.21 -37.74 64.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.205 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -49.63 -42.53 45.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.83 -37.8 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.35 80.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.222 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.08 -33.65 76.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.68 -43.03 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.07 -20.56 55.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.41 -40.17 85.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.31 98.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.256 172.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -57.68 -41.72 82.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.48 -44.81 89.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.15 -37.06 85.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.248 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.44 -36.82 85.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.19 65.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -93.82 0.27 56.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.35 117.15 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.54 -32.05 61.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.689 1.593 . . . . 0.0 111.219 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.23 -35.75 78.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.44 -45.38 69.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.66 -56.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.64 -28.24 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.27 -50.02 71.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' HA ' HG21 ' A' ' 107' ' ' VAL . 69.4 t -69.06 -41.27 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.249 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -55.02 -49.12 72.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.191 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.03 -32.47 72.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.12 -42.3 94.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.61 -39.16 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.86 -40.35 95.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.1 m -72.13 -55.12 7.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -113.67 124.09 51.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 mp -77.04 75.03 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -126.08 167.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.4 m -58.83 138.48 57.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.81 -44.63 39.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.21 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -56.09 -41.46 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -63.12 -42.28 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.182 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.14 99.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.222 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.98 -47.66 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.54 -45.14 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.59 -48.66 76.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.22 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 89' ' ' VAL . 56.0 t -61.11 -47.29 94.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.205 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.6 mt -65.33 -42.74 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -58.48 -43.99 89.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.31 -47.45 79.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.202 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.19 -37.8 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.85 97.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.6 p -65.95 -30.7 71.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.194 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.32 -50.21 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.212 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 68.1 mtt -56.84 -38.51 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.172 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.94 -41.52 82.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.225 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.9 p -69.24 -21.39 63.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.219 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.33 -10.98 59.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 59.67 35.22 22.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -103.69 104.95 15.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.186 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.01 -33.93 76.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -60.04 -50.33 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.65 -30.48 69.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.72 -42.63 93.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.19 -41.88 96.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -68.03 -32.14 72.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.281 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.02 97.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.95 -42.42 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.216 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.87 -38.73 82.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.28 -38.87 85.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.193 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.04 -42.36 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.79 -45.26 92.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.03 -46.58 91.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.64 -43.86 97.36 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.83 -39.76 90.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.156 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -70.04 -38.2 75.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.29 -44.68 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.214 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.34 -45.4 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -60.67 -43.0 98.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -69.48 -39.97 77.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -70.19 -44.4 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.13 -20.0 52.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.24 43.13 8.22 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.33 119.67 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 111.23 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.95 154.09 36.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 94.2 p -147.13 167.4 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.42 127.35 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -81.92 72.06 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.221 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.79 0.69 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.15 -9.88 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 170.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -107.61 23.73 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.93 132.37 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.199 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -109.43 -2.33 17.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.201 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -149.51 158.79 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.61 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.38 161.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.31 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.51 116.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.91 115.53 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 19' ' ' TYR . . . -113.78 145.6 41.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 -170.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -67.22 -33.69 75.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.188 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -154.43 154.52 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -126.76 75.04 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -86.66 159.56 52.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.01 -40.6 67.35 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.733 1.622 . . . . 0.0 111.235 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.1 m -66.96 -39.84 87.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.5 -52.82 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.5 p -77.12 -20.41 55.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.72 67.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.159 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 66.7 p -90.83 -29.73 17.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 68.5 mtt -59.31 133.74 56.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.63 88.41 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.213 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -50.7 -43.39 57.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.64 -13.25 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.87 27.32 9.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.16 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.45 124.23 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.23 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.62 -25.94 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.41 158.9 22.52 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -108.68 148.59 30.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -155.97 150.37 25.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 t -162.27 -177.65 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.222 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.55 -27.48 8.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.231 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.27 126.09 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.201 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.0 166.33 48.42 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.78 -7.75 81.17 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -106.76 9.88 30.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.4 m -65.31 -44.77 86.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.9 p -71.63 -41.43 68.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.29 -48.01 83.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -57.96 -43.97 86.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.02 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.218 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.36 -47.64 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.6 mtm -61.56 -51.76 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.33 -46.77 87.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.241 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.35 -31.48 70.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.7 p -69.56 -18.03 63.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 199' ' ' ILE . 93.9 mt -107.08 -0.12 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 57.09 45.16 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.239 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 197' ' ' LEU . 38.9 pt -128.65 158.19 72.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.7 161.77 33.4 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.725 1.617 . . . . 0.0 111.167 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.27 136.67 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 52.1 t -134.47 126.49 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.29 152.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.183 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.43 46.39 6.92 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.47 11.4 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.252 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.32 -89.72 1.42 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -137.58 45.42 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.196 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.36 -25.78 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.5 p -72.35 -6.63 44.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -112.3 5.42 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.215 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -118.06 -5.16 10.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.37 145.2 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.72 158.25 40.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.82 117.9 4.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 102.58 2.48 50.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.1 150.62 38.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.45 123.66 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.94 142.79 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.197 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.409 HG12 HG12 ' A' ' 13' ' ' ILE . 79.3 mt -116.16 125.81 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.225 171.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.1 99.34 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -90.89 91.65 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.216 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.25 -35.36 76.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.35 -47.13 85.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.241 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.57 -36.8 65.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.65 34.71 6.47 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.3 pt -131.4 154.45 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 111.172 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.7 t -133.3 136.4 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.61 118.41 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.31 130.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.192 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.92 57.79 3.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.205 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.41 154.97 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.695 1.596 . . . . 0.0 111.256 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 159.61 33.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.156 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -53.85 -49.15 69.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.14 -47.34 83.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.204 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.0 m -51.48 -46.86 63.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.57 -48.83 82.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.99 -32.56 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.01 -46.08 90.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.201 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.68 -26.51 63.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.11 -45.35 95.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 79.3 p -71.76 -29.24 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.2 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -66.88 -42.32 85.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.34 -42.14 81.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.47 -48.03 77.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.224 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 64.4 p -69.94 -23.23 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 173.548 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -98.74 107.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.186 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -103.82 135.68 44.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.46 -138.69 2.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.19 122.59 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 0.0 111.23 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.76 87.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.54 87.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -148.97 135.85 10.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 161.68 36.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.719 1.613 . . . . 0.0 111.209 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.6 -176.18 16.32 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.41 125.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.191 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 177' ' ' LEU . . . -116.48 126.24 53.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.218 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.5 mt -123.91 117.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.68 -157.59 13.04 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.53 167.69 13.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB2' HG23 ' A' ' 218' ' ' VAL . . . -99.25 144.78 27.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 175.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -141.26 111.44 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 164.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.8 tp -87.47 115.08 24.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.209 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.74 97.01 6.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -86.59 164.17 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.224 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -115.56 106.88 14.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.41 128.33 36.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.171 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.78 127.03 29.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -87.22 111.96 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -87.72 124.88 34.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.204 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.98 118.93 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.53 102.93 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.209 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -87.4 -5.25 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.91 139.25 52.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.05 158.74 32.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 pt -119.02 172.5 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -76.19 157.75 32.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.78 -32.53 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -72.57 -14.84 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -96.48 -0.34 49.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.1 -51.08 77.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.07 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.33 -51.19 71.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -71.11 -34.12 70.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.85 -43.92 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.221 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.92 -45.18 90.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.216 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.16 -47.7 84.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.08 -36.21 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -40.51 94.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.81 76.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.95 -42.6 99.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.183 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.99 -43.43 98.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.71 -40.71 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.233 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.4 m -67.04 -43.63 82.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.186 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -63.98 -42.87 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -59.0 -49.17 78.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -52.09 -58.76 5.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.34 -42.05 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.196 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.98 -45.91 82.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.202 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.41 -34.59 77.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.27 -49.26 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -68.21 -27.06 66.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.39 -51.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.242 170.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.8 -37.02 83.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.24 93.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.204 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -60.15 -46.76 88.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.213 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.94 -34.32 77.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.148 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -87.65 -45.13 10.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.218 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.73 -36.42 3.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.47 -172.08 14.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.86 -26.29 68.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 111.207 -175.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -43.53 -45.77 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.22 -31.25 12.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.71 91.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.42 -30.99 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.183 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.41 -45.78 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.01 -27.52 57.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.58 -44.27 89.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.92 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -61.68 -38.37 87.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.18 -44.14 89.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.21 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.4 mtm -62.61 -38.02 88.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.234 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.11 -39.87 95.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.218 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.56 -23.31 66.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.254 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.1 p -98.38 -3.75 36.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -66.11 113.71 13.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.29 -32.89 82.94 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.71 1.607 . . . . 0.0 111.239 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -67.4 -43.71 80.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.97 -36.58 69.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.35 -52.29 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.49 -34.48 77.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.48 -47.06 90.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.44 -44.87 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.218 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -62.85 -39.59 94.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.66 -33.83 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.0 tpp -65.32 -41.54 93.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.29 -47.75 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.29 -46.53 49.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.235 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.2 m -65.14 -48.43 73.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 -172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.32 -9.82 34.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.8 mt 57.48 64.08 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 179.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.9 p -80.3 163.37 24.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.96 86.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.85 -50.71 72.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.17 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -67.31 -40.24 86.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.211 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.65 85.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.34 -45.8 97.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.201 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -58.48 -43.81 89.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -67.48 -49.67 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.192 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.64 -46.31 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.195 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.4 mm -65.93 -42.54 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.178 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -67.0 -38.2 85.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.201 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -65.75 -44.85 84.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.186 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -66.7 -40.45 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.194 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.08 97.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.186 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.3 m -59.24 -42.98 92.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.77 -52.91 56.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 56.9 mtt -54.74 -42.09 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -69.66 -39.53 77.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.3 p -70.39 -19.86 62.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.184 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.11 -7.14 56.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 60.44 37.45 19.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -115.05 112.54 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.06 -30.35 70.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.12 -50.3 72.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.255 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.44 -28.78 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.6 -42.96 99.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -42.03 95.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.98 -34.04 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.97 94.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.46 -41.81 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -57.07 -43.33 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.195 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -62.48 -41.19 98.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.223 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.84 -50.32 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.189 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.87 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -44.64 95.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.21 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.07 -38.03 89.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.35 -48.43 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.205 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.23 -41.24 90.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.9 -38.42 88.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.07 -28.26 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.3 mt -68.67 -48.31 64.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.1 tp -74.7 -52.46 11.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.59 35.76 0.83 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.76 127.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.234 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.13 155.47 25.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.182 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 85.1 p -156.79 169.67 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.6 128.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -86.66 106.15 17.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.4 mt -90.77 10.82 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.3 p -90.91 -7.46 52.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -106.71 27.53 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.69 137.3 51.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.0 27.99 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -169.56 138.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.18 123.14 17.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.197 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.84 144.36 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -167.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.96 121.49 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.1 t -93.66 118.3 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 -174.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.401 HG22 HG22 ' A' ' 209' ' ' THR . 48.5 mm -112.13 126.79 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.219 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 148.06 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.225 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.87 -41.56 82.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.22 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -112.91 151.65 30.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.4 tp -154.24 122.24 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.8 p -112.48 161.65 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.214 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.23 -35.86 84.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.691 1.594 . . . . 0.0 111.235 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.5 p -74.6 -10.08 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.204 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.99 -40.85 12.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 171.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 -22.93 64.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.52 -9.29 58.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.6 p -111.91 -28.47 8.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.6 mtp -57.29 94.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -41.73 105.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.185 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -64.43 -22.03 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -72.15 -27.92 62.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.1 -39.66 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.25 119.0 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.423 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 94.7 mt -96.18 -15.56 22.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.99 178.4 43.89 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -158.49 137.05 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -115.71 139.24 50.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.216 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.3 m -120.43 138.36 53.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.09 -42.95 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.227 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.58 137.61 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.225 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.85 177.75 29.4 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.32 54.02 0.66 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.9 26.84 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.8 p -74.21 -30.58 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.196 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.2 p -77.24 -30.83 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -61.2 -48.78 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 172.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.2 m -55.77 -42.43 75.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.225 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.19 97.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.45 -45.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 ttp -58.11 -53.07 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.26 99.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -70.84 -33.11 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.18 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.6 m -69.96 -37.47 75.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.7 -7.44 57.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 61.33 48.98 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 47.6 pt -126.82 149.32 68.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.22 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 49.3 Cg_exo -60.76 146.41 97.4 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.744 1.629 . . . . 0.0 111.201 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.44 138.87 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.196 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 76.9 t -129.81 127.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.6 164.93 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.65 26.1 59.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 90.9 mt -78.33 -31.65 48.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.9 4.57 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -100.27 2.81 43.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 111.247 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.07 -27.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.184 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 159' ' ' ILE . 29.7 p -81.84 -6.92 59.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 96.3 p -106.07 -29.35 9.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.216 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -91.59 -24.48 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.212 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.0 t -111.88 119.14 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.227 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.6 157.75 33.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.241 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.39 128.36 35.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 108.18 -20.91 30.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -71.15 165.11 24.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.21 138.32 34.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 16' ' ' ALA . 86.1 t -127.29 131.06 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.171 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.8 mt -114.92 112.54 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.46 96.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -93.39 88.11 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.246 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.86 79.63 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.83 -38.46 88.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 111.22 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -94.07 -31.09 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.186 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.32 34.85 7.27 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 pt -131.8 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.3 t -128.42 135.09 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.237 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.46 127.47 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.186 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.23 133.66 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.404 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 95.7 m-20 50.67 56.56 17.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.211 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 70.7 Cg_endo -70.49 156.81 60.66 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.697 1.598 . . . . 0.0 111.192 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.03 161.01 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -52.46 -48.97 65.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.89 -46.43 84.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.186 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -55.65 -43.6 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 64.1 t -60.12 -46.05 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.99 -34.38 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.244 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.92 -48.26 79.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.51 -26.21 60.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.229 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.11 -46.71 86.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.9 p -69.27 -31.83 70.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 -38.56 79.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.207 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -61.05 -43.27 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.55 -40.73 95.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.22 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 75.2 m -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.221 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.208 175.065 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 87.7 mt -80.18 80.3 6.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.54 130.91 41.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.96 -150.52 5.23 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.1 114.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.5 87.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.07 73.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -151.32 141.51 14.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.07 160.75 29.96 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.699 1.6 . . . . 0.0 111.204 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.06 -177.17 18.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -134.41 122.87 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 111.216 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.88 123.48 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.31 112.75 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.73 -160.86 20.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -83.41 150.55 25.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.37 128.37 38.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.21 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -126.8 139.05 53.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.3 tp -105.85 131.92 52.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -113.09 116.79 30.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.1 p -125.46 169.7 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.243 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -150.8 136.59 18.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.402 ' HB3' HG13 ' A' ' 144' ' ' VAL . 88.5 tt0 -58.78 136.01 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.86 137.37 58.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -86.7 113.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.3 m -120.34 117.08 26.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.35 127.21 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.211 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -80.65 107.29 13.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.22 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.24 22.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.778 ' O ' ' CB ' ' A' ' 30' ' ' LYS . 88.8 tt0 -59.51 -61.57 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.778 ' CB ' ' O ' ' A' ' 29' ' ' GLU . 87.1 tttt 124.9 140.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.201 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 31' ' ' ILE . 2.9 pp -121.17 166.23 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -90.93 165.9 13.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.212 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -52.23 -41.21 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.198 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.8 p -69.88 -18.17 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.92 2.5 49.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.256 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.88 -52.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.04 -32.6 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.1 -50.84 72.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.25 -33.77 72.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.196 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.64 -44.83 99.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.51 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.38 -46.67 88.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.179 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -60.0 -51.14 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.31 -39.7 80.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.63 -58.8 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.199 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.8 69.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.201 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.3 tm? -65.32 -50.46 65.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.93 -38.91 90.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.21 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.02 -41.3 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.6 m -60.49 -41.95 95.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -57.23 -49.89 74.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.81 -46.18 88.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -52.65 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.06 -40.87 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.42 -43.14 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.178 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -34.46 72.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.8 mt -63.81 -47.97 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -72.08 -27.47 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.222 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.47 -46.31 90.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.35 -40.14 67.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.92 78.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.0 tt -52.33 -45.38 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.07 -33.17 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.22 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.71 -44.16 24.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.233 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -118.13 -35.64 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.17 170.33 12.74 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.5 -26.89 68.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.205 -174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.8 -44.88 39.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.98 -33.91 39.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.03 83.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.251 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.35 -38.13 86.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.219 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.3 mt -60.34 -44.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -78.27 -24.57 46.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.01 -41.26 96.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.77 87.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.39 -39.72 94.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.206 174.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.68 -43.61 96.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.2 ttp -52.49 -48.12 66.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.202 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.9 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.32 67.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.8 p -92.14 -14.58 28.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -64.87 118.94 53.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -52.95 -32.29 56.88 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.71 1.607 . . . . 0.0 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -50.54 -39.27 48.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.16 -47.69 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.39 -56.77 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.229 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -75.09 -31.31 61.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.18 -48.27 81.25 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.22 -42.34 84.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.203 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -53.71 -47.22 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.47 -35.44 79.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.7 tpp -63.78 -41.88 97.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.87 -47.97 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.58 -44.55 64.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -65.83 -48.22 72.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.198 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -94.65 -10.95 30.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.95 63.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.224 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.79 169.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -70.57 163.09 27.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.182 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.29 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.12 -42.73 99.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.86 96.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -55.91 -48.45 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.226 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -57.87 -44.19 86.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.5 -45.42 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.55 -44.08 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 131' ' ' ARG . 38.6 mm -65.57 -45.54 92.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.03 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.168 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -59.85 -54.86 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -67.72 -39.01 84.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.212 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.29 99.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 m -61.17 -42.86 99.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.202 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.3 -49.78 83.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 59.4 mtt -56.4 -41.15 75.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.78 -38.83 73.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.203 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.8 p -69.37 -20.58 63.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.0 -9.6 59.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.24 32.82 20.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -104.36 106.99 17.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.42 -33.16 74.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.231 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.32 -50.01 75.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.53 -30.09 68.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.74 -42.04 98.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.64 -40.94 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.192 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -66.03 -33.63 76.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.177 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.53 92.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.07 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -57.37 -42.94 83.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.36 -42.55 96.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.197 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.406 ' HA ' HG21 ' A' ' 108' ' ' ILE . 91.3 mtt180 -63.8 -39.65 94.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.243 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.3 -47.59 83.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.17 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.53 -44.62 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.53 -42.97 97.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -61.38 -41.87 97.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -59.97 -42.47 94.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.68 -47.23 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.05 -43.61 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.17 -38.25 88.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -71.55 -30.71 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -69.94 -40.39 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.13 -28.99 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.201 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.19 35.8 9.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 22' ' ' GLU . 82.6 t -71.19 123.66 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.23 165.83 14.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 88.1 p -143.69 171.29 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -84.56 78.55 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.245 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.11 -6.28 59.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.4 p -74.29 -9.25 58.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.13 0.65 55.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.56 145.35 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.54 32.54 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -143.92 140.88 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.59 99.28 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.19 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.74 -179.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.6 t -94.8 122.95 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.58 117.75 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.76 125.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.218 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.09 49.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -63.14 -56.47 16.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -146.34 176.76 9.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.69 145.12 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.6 p -129.6 155.69 79.89 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.34 -38.34 72.95 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.714 1.609 . . . . 0.0 111.215 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -43.85 75.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.28 -46.28 64.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 65.0 p -67.89 -29.71 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.85 -29.37 70.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.1 p -108.46 14.55 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 63.1 tpp -71.65 115.58 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.55 77.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.2 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HB2' HD11 ' A' ' 197' ' ' LEU . 63.7 pttt -63.16 -20.7 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.241 -172.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.11 -31.02 68.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -112.47 32.27 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.43 106.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.1 tp -80.52 -40.04 26.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.43 176.81 27.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -154.89 139.59 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 111.185 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.02 25.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.6 t -143.65 154.42 43.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.63 -53.31 57.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.14 124.78 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.11 74.22 0.84 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.5 -31.69 81.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.51 60.11 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.19 174.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.6 m -59.21 -37.36 77.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.211 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t -58.31 -56.46 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -59.37 -40.14 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.3 -46.87 88.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.84 92.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.09 -48.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.236 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.85 -35.71 81.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.19 98.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.184 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.55 -38.62 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.174 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 t -61.53 -43.03 99.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 173' ' ' LYS . 90.3 mt -88.24 -16.09 34.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 61.69 51.26 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.174 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 44.4 pt -127.68 159.67 64.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 92.3 Cg_endo -76.68 163.35 31.76 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.666 1.577 . . . . 0.0 111.251 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.55 135.73 11.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.18 122.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.95 160.35 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.91 38.64 35.42 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.17 -6.41 57.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.327 . . . . 0.0 111.201 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.28 -64.73 4.14 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 171.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -141.38 44.33 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.69 -22.67 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.7 p -70.44 -22.29 62.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.0 p -90.29 -27.08 19.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -90.69 -27.94 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.242 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.6 116.6 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.243 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.15 166.4 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.52 125.6 24.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.11 -18.06 40.09 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.83 165.27 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.23 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 62.4 tp -100.26 125.98 46.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.172 171.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.58 138.71 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.203 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.38 126.01 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.2 171.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.08 100.77 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -99.68 93.61 5.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.34 -22.51 73.08 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.25 -39.22 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -103.23 -15.3 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.71 37.33 26.81 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.96 155.73 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 73.6 t -120.27 135.31 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -109.21 129.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.65 117.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.177 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.76 60.4 11.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.223 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.0 153.18 68.07 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.714 1.609 . . . . 0.0 111.209 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -88.78 -176.52 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.76 -53.95 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -59.27 -48.87 80.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.9 m -53.99 -47.37 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.63 -45.82 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.203 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.72 -34.22 77.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.32 -41.73 98.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.215 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -75.96 -29.62 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -63.23 -41.62 99.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 47.8 t -62.67 -46.56 87.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.199 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.61 -42.83 93.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.62 -47.16 85.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.01 -47.07 88.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.5 p -61.94 -28.32 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 176.791 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.7 mtm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.773 0.321 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.8 mt -100.79 140.55 34.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.06 136.3 43.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.228 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.8 -138.45 2.52 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.4 t -102.19 119.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 111.233 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.54 87.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.95 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.218 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 t -150.28 138.64 12.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.238 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.81 160.67 34.04 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.696 1.597 . . . . 0.0 111.199 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.87 175.16 13.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -125.09 124.6 67.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.92 132.8 52.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.231 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -129.57 127.39 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.31 -153.74 24.37 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -76.01 154.71 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.171 -174.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.6 141.67 51.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.237 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 214' ' ' ALA . 31.7 m-85 -121.46 140.16 52.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.3 tp -99.59 117.96 35.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -66.28 124.37 22.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -117.83 131.5 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.215 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.96 130.09 50.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.198 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.04 135.07 56.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.73 128.2 33.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.204 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -91.68 93.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.1 m -97.73 112.88 24.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.2 mt -96.48 126.83 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -99.68 103.43 15.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.8 m -110.27 20.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.214 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -72.16 138.9 47.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.22 139.51 58.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.224 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 pt -118.12 170.28 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.214 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.42 146.19 53.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -64.03 -20.65 66.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.0 p -73.56 -14.44 61.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.18 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -98.42 4.43 48.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.2 -51.07 76.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.01 -32.8 74.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.85 -49.26 78.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.196 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -67.7 -37.3 82.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.65 -44.6 98.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.27 84.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -64.01 -37.97 89.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -59.28 -49.15 78.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.2 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.49 -36.68 84.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.7 -40.41 92.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.19 -33.49 76.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.65 -40.97 98.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.253 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.64 -42.76 99.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.203 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.58 -39.98 85.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.206 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.0 m -63.17 -41.61 99.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -60.97 -44.81 96.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.225 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -59.39 -49.29 78.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.58 -55.91 21.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.58 -42.99 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.166 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.95 -49.33 77.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.228 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.36 -36.76 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.7 mt -63.03 -45.61 98.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.17 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.7 -43.72 76.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -55.35 -52.95 61.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -60.03 -42.85 95.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -43.11 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.42 -45.02 95.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.21 -31.71 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -97.06 -39.78 9.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.3 -34.91 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.25 -171.91 15.72 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -63.26 -26.13 68.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 111.175 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -45.59 -42.28 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.98 -34.74 10.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.46 -39.21 93.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.216 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.9 -32.68 74.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.16 -41.61 91.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.214 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -77.46 -24.09 50.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.36 -41.07 96.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.192 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.79 99.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -59.64 -41.16 89.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.187 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.73 -43.37 93.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.233 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.9 mtm -64.82 -36.09 83.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.9 mt -63.86 -45.68 88.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.65 -33.12 74.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.183 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.3 m -94.69 1.93 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.177 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -65.79 114.17 15.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.86 -33.9 83.48 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.689 1.593 . . . . 0.0 111.216 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -67.94 -43.74 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.198 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.12 -36.69 72.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.96 -51.85 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.19 -35.16 79.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.19 -46.25 91.81 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.29 -46.59 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.37 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.76 -36.39 80.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp -63.68 -40.34 96.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.177 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.88 -50.91 77.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.199 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.51 -42.19 71.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.8 m -63.69 -47.37 81.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -99.17 -6.07 28.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt 59.97 45.05 12.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.5 m -117.66 -179.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.3 p -76.31 163.2 27.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.207 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.66 77.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.19 171.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -56.49 -53.17 60.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.181 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -59.86 -47.55 85.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -51.24 70.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.247 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.73 -46.1 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -54.84 -47.27 74.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.173 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -73.07 -47.86 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 -174.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.81 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.411 HG23 ' HG ' ' A' ' 130' ' ' LEU . 33.5 mm -65.42 -43.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.43 -44.69 95.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.86 -56.15 25.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.211 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -64.16 -37.43 87.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.9 -42.77 94.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.2 p -67.16 -30.59 70.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.164 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.72 -51.61 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 76.1 mtm -60.3 -35.42 75.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.184 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.79 -37.93 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.5 p -70.63 -20.0 62.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.86 -12.54 61.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.44 32.05 14.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.199 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -105.53 112.45 25.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.176 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.41 -30.67 68.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.24 -172.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -63.38 -50.05 71.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.218 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.24 -25.18 62.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.99 -45.23 89.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.218 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.51 -42.13 91.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.93 -33.76 76.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.195 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.61 94.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.76 -43.47 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -56.39 -45.82 80.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HG ' HG23 ' A' ' 108' ' ' ILE . 57.7 tp -63.06 -45.08 93.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.229 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -58.41 -43.01 88.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.178 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.53 -48.84 79.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.0 -47.16 90.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.06 -45.14 95.69 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -61.69 -41.67 97.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.346 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -69.71 -33.04 71.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.04 -46.08 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.179 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.92 -43.02 96.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.31 -35.65 79.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -72.76 -31.15 64.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 61.2 mt -66.37 -38.93 88.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.193 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.5 -28.09 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.72 38.23 10.84 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.0 t -71.26 120.37 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.77 0.319 . . . . 0.0 111.208 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.75 161.37 14.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 72.0 p -160.32 169.73 22.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.215 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.8 t -72.42 123.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.185 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.74 74.89 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.215 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 89.8 mt -66.37 -25.67 66.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.196 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.1 p -70.45 -14.05 62.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.219 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -96.46 5.5 50.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.25 137.67 41.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -110.15 41.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -148.38 143.58 26.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.173 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -57.99 104.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.219 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.49 157.03 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.28 134.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.19 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.1 105.44 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.18 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.3 mm -104.22 124.21 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -157.95 156.86 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -78.51 -39.92 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.199 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -159.11 111.17 2.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.225 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.55 151.15 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.192 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -108.4 162.06 21.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -53.04 -32.98 60.85 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.714 1.609 . . . . 0.0 111.194 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.3 p -69.79 -19.02 63.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -94.54 -38.6 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -77.92 -16.93 57.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.212 -175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.45 -2.97 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.209 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.6 p -88.92 -18.28 27.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.213 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 96.0 mmm -77.95 130.49 36.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.1 129.72 39.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -48.66 -50.12 34.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.19 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -82.12 -3.36 54.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.191 -167.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 24.5 mmt -110.19 10.35 23.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.182 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.0 t -119.86 122.39 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.78 -36.04 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.22 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.85 -178.68 45.64 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -123.54 144.25 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 65.5 p -131.41 159.11 38.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.214 -170.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.57 -33.08 64.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.3 m -115.36 163.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.184 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -108.93 24.3 21.75 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.46 -21.86 70.9 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.35 31.43 4.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.813 0.34 . . . . 0.0 111.197 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.6 m -51.99 -48.52 64.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.7 p -65.37 -30.31 71.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -76.51 -39.16 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.9 p -70.29 -28.12 64.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -67.61 -52.78 34.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.65 -46.5 96.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 43.7 ttp -61.65 -55.0 35.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.234 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.19 77.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.198 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.09 -41.51 97.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -70.93 -22.6 62.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.227 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.1 -2.17 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.23 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.64 35.37 9.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 45.9 pt -132.31 154.26 81.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.234 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.11 160.63 39.58 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.754 1.636 . . . . 0.0 111.166 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 139.33 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 57.3 t -132.64 109.43 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.02 165.41 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.193 -168.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 70.43 39.3 69.71 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.77 -35.37 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 119.53 -53.95 0.66 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -143.95 31.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.54 -25.62 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.1 p -70.57 -22.52 62.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.21 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.1 p -94.38 -25.82 16.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -94.61 -24.24 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 72.9 t -120.11 125.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -115.69 164.27 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . . . -61.01 125.37 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.74 -12.38 50.12 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -71.23 144.68 50.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.194 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.08 124.26 27.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.191 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -132.4 136.77 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.18 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.48 124.81 66.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 80.8 t -97.78 112.6 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -108.91 93.14 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -81.94 -10.56 83.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.37 -39.5 47.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.787 0.327 . . . . 0.0 111.195 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -93.72 -25.59 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.2 39.36 8.51 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.7 pt -132.44 160.55 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 111.183 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.12 133.0 64.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 78.5 mt -113.15 121.39 65.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.7 p -106.89 134.7 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.539 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 87.2 m-20 54.63 61.79 8.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 -171.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 230' ' ' ASN . 50.8 Cg_exo -58.43 145.85 92.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.736 1.624 . . . . 0.0 111.173 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.94 157.74 36.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.186 169.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.06 -48.46 61.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.14 -45.22 93.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.224 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.5 m -57.55 -42.6 83.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.225 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.5 -48.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.67 -35.09 74.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.85 -51.92 66.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.198 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -72.58 -26.83 61.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.155 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.19 -51.56 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.184 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 92.1 p -69.32 -34.48 74.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.2 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.26 -42.85 75.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.178 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -53.52 -49.81 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.216 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -67.61 -35.83 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 72.4 m -58.52 -38.91 78.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.206 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -90.38 -31.77 16.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -76.26 -48.6 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.233 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.9 mttt . . . . . 0 C--O 1.2 -1.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 -177.096 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.797 0.332 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 91.5 mt -79.76 81.75 5.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.253 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -79.61 134.84 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.1 -141.19 3.14 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.06 115.06 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 111.174 -176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.62 133.12 35.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.1 -32.5 18.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.8 t -165.39 137.05 3.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.82 144.65 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.675 1.583 . . . . 0.0 111.198 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.94 173.14 16.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.3 mt -133.73 120.51 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 111.202 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.08 124.62 49.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.72 115.71 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.182 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.97 -157.41 14.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.59 162.75 13.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.805 0.336 . . . . 0.0 111.18 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.02 132.53 34.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.183 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -121.13 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.214 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.5 tp -102.13 133.0 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.151 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -134.01 114.79 13.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 167.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.3 p -105.91 172.13 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -154.42 132.21 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -109.61 157.08 19.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.176 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.27 128.43 34.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.1 t -102.09 132.44 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.183 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.6 m -62.59 129.37 40.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.232 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.76 133.31 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -74.24 104.24 4.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.212 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.26 21.11 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.54 -98.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.167 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.21 149.15 44.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.03 165.53 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -59.33 137.51 57.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -54.33 -38.07 65.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -68.59 -15.72 63.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.222 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.8 0.03 57.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.235 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.15 -51.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -65.43 -33.06 75.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -59.11 -50.03 75.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -69.82 -34.49 73.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.208 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.28 -43.78 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.51 89.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.04 -45.73 91.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -60.12 -51.18 70.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.06 -42.61 99.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.25 -55.26 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.164 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.46 75.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.202 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.11 -47.05 75.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.61 -40.73 88.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.205 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.31 -44.89 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -57.62 -45.04 85.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.222 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -60.53 -47.82 84.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -58.31 -47.96 82.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.57 -48.81 79.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.68 -44.24 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.205 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.04 -49.62 76.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.85 -45.9 76.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.6 tp -69.43 -26.66 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.16 -50.85 72.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.19 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -58.64 -46.23 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.219 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.22 -48.77 79.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.24 93.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 62' ' ' LEU . 9.8 tt -55.64 -47.35 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.204 177.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.81 -34.25 34.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -79.88 -42.34 24.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -118.12 -33.63 4.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.206 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.56 168.64 12.62 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.36 -22.05 66.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 111.164 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.16 -36.85 80.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.194 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -85.23 -30.52 23.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.199 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.94 77.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -54.01 -36.26 62.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.206 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.09 -46.9 88.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -75.61 -28.05 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.211 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -59.53 -49.06 79.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.199 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.198 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -69.16 -33.1 72.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.224 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.4 tp -67.76 -43.25 80.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.99 -40.76 98.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.55 -40.66 97.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.81 70.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.175 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.8 p -91.87 -1.02 57.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -66.3 115.95 28.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.38 -17.56 23.89 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.735 1.623 . . . . 0.0 111.228 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -71.62 -41.28 69.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.215 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.71 -38.32 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.224 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.2 -48.87 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.215 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.86 -43.48 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.191 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.64 64.15 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.66 -45.97 96.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 111.188 -175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.91 -38.3 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 -176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.71 -33.22 72.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.218 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.6 tpp -64.18 -43.0 96.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.204 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.0 mt -58.85 -47.86 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.16 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -73.52 -46.57 46.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -66.51 -48.4 69.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -96.2 -7.55 35.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.233 -174.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.9 64.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.161 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.86 169.0 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.24 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.9 p -76.01 162.4 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.4 81.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.02 -48.52 81.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.12 -45.68 80.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -47.67 85.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.201 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.48 -48.17 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.225 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.63 -41.14 85.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.203 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -68.47 -50.9 49.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.28 -44.41 91.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -61.76 -44.5 98.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.227 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -65.29 -42.35 93.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -59.17 -54.91 41.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.211 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -66.75 -38.83 87.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.89 93.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 85.0 p -65.8 -32.24 73.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.14 -51.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 96.7 mtp -57.23 -37.46 72.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -73.07 -37.96 66.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.198 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.2 p -70.21 -19.21 63.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.05 -11.78 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.211 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 63.59 32.35 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -105.89 113.01 26.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.198 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -59.86 -30.33 68.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.73 -50.02 70.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.187 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.32 -27.34 65.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.73 -46.55 84.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.77 -43.58 90.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.217 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -69.39 -32.4 71.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.238 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.9 85.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.248 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.0 t -60.02 -45.83 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.228 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.62 -43.5 84.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.58 -45.53 93.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -60.95 -41.2 95.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.21 -48.1 83.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.34 -44.34 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.19 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -56.84 -44.44 92.13 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.98 -39.69 95.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.221 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.78 -37.01 83.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.219 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.99 -45.49 98.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.184 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -60.73 -41.43 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -47.08 77.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.222 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -71.24 -29.44 65.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.68 -40.18 88.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 172.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.07 -26.23 39.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.189 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.33 30.62 15.92 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.29 126.32 35.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 0.0 111.141 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.76 163.14 13.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.2 p -148.88 163.1 38.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.216 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -118.92 131.04 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.211 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -82.75 114.58 21.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.208 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.407 HD12 ' C ' ' A' ' 149' ' ' LEU . 3.6 pp -67.72 -23.11 65.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.4 p -73.12 -13.27 61.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -99.02 8.55 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.209 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.23 148.27 35.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.198 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -95.87 -21.59 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.55 156.13 30.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -76.32 129.68 36.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -137.07 167.7 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 93.6 t -98.58 126.53 51.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.4 t -86.45 113.76 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.59 117.97 54.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.9 147.31 30.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.217 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.53 -32.94 60.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -126.36 94.93 4.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.205 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 61.8 tp -114.76 109.12 17.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.192 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 71.7 p -110.16 164.01 15.83 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.173 -167.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 76.5 Cg_exo -54.39 -31.2 66.91 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.682 1.588 . . . . 0.0 111.216 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.9 p -69.37 -16.37 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -91.02 -31.42 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 93.7 m -59.52 -38.03 79.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.36 -29.32 63.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.222 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -109.65 37.21 2.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.223 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 62.4 ttp -93.85 105.19 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -91.45 99.43 12.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.181 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -62.57 -20.15 64.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.215 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.08 -33.75 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 39.1 mmt -92.57 -34.14 14.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.48 122.52 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.209 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.8 -26.38 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.232 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.7 178.1 48.46 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.58 152.66 49.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 111.249 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -156.88 152.72 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.171 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.3 t -159.69 -176.21 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.235 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -120.48 -43.93 2.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.189 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.4 p -172.73 138.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 174.5 176.77 43.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.27 14.05 65.6 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.33 27.51 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.77 0.319 . . . . 0.0 111.152 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.2 m -68.74 -46.19 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 96.4 p -64.56 -31.64 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.18 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -64.96 -46.01 83.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 99.1 m -52.54 -45.01 66.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.27 -42.84 99.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.206 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.7 mt -60.49 -44.06 95.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.225 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.5 mtp -55.54 -48.3 74.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.39 81.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.69 -33.92 76.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.234 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.7 p -68.43 -19.99 64.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.164 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.2 mt -107.6 1.47 23.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.219 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 57.22 47.04 17.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.206 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 41.5 pt -127.37 156.89 74.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.46 154.37 31.46 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.673 1.582 . . . . 0.0 111.166 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.33 144.79 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.205 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.9 117.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.227 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.8 163.4 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.168 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.68 55.95 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.65 -48.87 12.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.24 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 100.99 -11.9 58.94 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -132.57 -14.51 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -170.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.5 -28.67 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -160.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.0 p -80.31 -11.3 59.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.215 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 95.6 p -105.61 -30.23 9.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.222 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -81.11 -34.69 32.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.64 120.42 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.244 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -114.41 152.02 32.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.22 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 126.65 27.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 104.82 -16.85 46.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.1 175.25 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 0.0 111.191 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -99.23 139.39 34.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 170.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.32 134.7 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.178 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.87 127.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.246 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -105.33 94.5 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.182 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -84.6 82.03 8.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.187 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.92 -26.35 73.96 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.39 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 111.187 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -78.18 -40.22 38.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.28 32.66 5.15 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -131.61 156.19 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.331 . . . . 0.0 111.212 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 97.6 t -121.32 135.36 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.194 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.54 127.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.38 117.3 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.13 62.48 8.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.191 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.55 147.0 63.26 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.731 1.62 . . . . 0.0 111.216 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.91 162.7 28.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 173.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.68 -46.12 58.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.231 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -62.32 -43.87 97.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.2 m -59.66 -43.18 94.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.242 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 56.8 t -60.06 -46.29 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -64.61 -35.24 80.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.63 -46.29 90.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.196 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -73.62 -28.75 61.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -62.61 -45.6 92.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.77 -32.34 69.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.66 -42.42 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.14 -39.63 87.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.166 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.83 -43.31 99.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.201 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.2 p -71.06 -27.73 63.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.31 -49.94 67.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 172.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 248' ' ' LYS . 98.1 mt-10 -66.22 -39.19 89.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 247' ' ' GLU . 99.7 mttt . . . . . 0 C--O 1.2 -1.538 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.214 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HE3' ' HB ' ' A' ' 228' ' ' ILE . 99.6 mtp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.48 109.34 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -103.85 138.27 40.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.86 -139.43 2.84 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.7 t -103.88 121.07 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.363 . . . . 0.0 111.191 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.53 87.52 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.33 -33.01 72.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.186 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -148.56 135.64 10.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 164.31 31.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.659 1.573 . . . . 0.0 111.177 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.89 -168.02 15.17 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.2 tt -158.73 144.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.763 0.316 . . . . 0.0 111.239 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.76 154.95 33.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 219' ' ' ILE . 81.9 mt -122.91 128.16 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.26 -177.06 29.07 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 -176.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.53 150.6 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 111.204 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.28 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.156 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -111.0 120.38 42.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.2 tp -93.44 109.22 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.197 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -64.11 108.24 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.169 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -91.44 117.12 29.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.211 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -120.85 108.71 14.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -58.15 139.37 54.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 -176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.65 160.07 29.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.196 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.55 119.3 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.5 m -119.33 118.02 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.21 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 101' ' ' ASP . 97.0 mt -71.4 125.65 30.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.204 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -78.93 114.64 18.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.218 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.65 22.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.57 136.35 52.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.226 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.5 128.98 39.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.184 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -102.9 127.25 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -57.98 136.81 57.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.2 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -47.58 -44.59 26.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.8 p -68.5 -20.82 64.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.18 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -100.04 2.33 43.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.96 -38.16 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.48 -21.94 61.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -68.44 -35.42 77.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.23 171.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.89 -35.45 80.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.7 mt -61.56 -46.01 97.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.91 87.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.239 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.35 -47.34 81.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.98 -49.96 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -59.4 -42.03 90.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.25 -37.68 52.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.47 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.16 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.71 -42.3 82.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -50.87 -50.48 56.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.99 -44.74 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.7 m -52.86 -50.09 64.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -60.73 -42.9 98.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.5 -46.11 89.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.75 -34.09 75.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.2 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -60.96 -42.38 92.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.222 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -61.03 -40.96 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.25 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.51 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.224 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -57.19 -47.39 81.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.5 -51.35 67.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.211 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.17 -31.55 70.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -41.46 93.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.177 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -63.17 -46.96 84.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.67 -39.22 93.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.221 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -83.32 -34.13 25.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.185 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.12 -58.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 134.18 -168.26 23.45 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 98.1 mttt -60.81 -27.5 68.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -43.79 -44.34 6.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.214 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.22 -34.35 11.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.205 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -64.49 -39.11 93.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.189 -176.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.03 -32.7 74.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.236 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.22 -43.93 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.168 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -76.81 -19.83 57.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -63.36 -49.1 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.207 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.98 81.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.195 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -56.19 -47.24 78.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.214 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -64.33 -44.74 90.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.8 ttp -49.72 -48.4 49.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.171 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.75 -38.61 91.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.83 -26.0 66.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.5 p -94.56 4.54 53.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.218 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -62.55 116.54 23.95 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.0 -33.61 73.66 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.733 1.622 . . . . 0.0 111.16 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.39 -35.95 78.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.2 tp -67.55 -46.53 72.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.4 mt -56.5 -58.25 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.52 -35.12 73.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.19 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.59 -48.5 84.19 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.5 t -68.84 -43.88 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 111.207 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.24 -42.7 91.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.265 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -68.89 -36.72 78.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 59.7 tpp -61.99 -43.55 98.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.76 -50.78 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.177 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -66.9 -40.86 87.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 -176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.5 m -67.07 -47.61 70.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -91.62 -15.89 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.8 mt 64.98 43.75 3.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.223 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.64 -177.59 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -72.1 156.62 38.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.217 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.1 76.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 173.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 26' ' ' ILE . 94.3 m-20 -58.95 -50.49 73.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.233 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -65.01 -41.31 95.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.95 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -45.36 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.242 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -56.49 -46.81 80.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -68.19 -50.05 56.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.187 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t -62.71 -45.07 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.2 mm -60.0 -43.65 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.197 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -64.42 -43.35 94.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.214 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.03 -45.9 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.241 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.52 -44.02 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.219 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -57.89 -47.62 82.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.175 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -50.3 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 93.0 mtp -58.26 -38.56 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.186 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -72.09 -38.58 69.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.194 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 p -70.01 -20.08 63.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.197 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.38 -15.41 63.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.211 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 62.54 32.31 16.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.248 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -100.33 109.84 22.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -42.4 -44.79 4.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.198 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -62.24 -54.64 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.241 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.46 -31.71 71.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.184 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -46.79 86.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.8 -43.81 94.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.206 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.7 mmp_? -68.74 -31.38 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.36 -37.48 87.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.177 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 62.5 t -61.48 -44.21 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.196 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.57 -41.99 91.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.247 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.1 tp -61.63 -41.66 97.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -58.99 -38.64 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.213 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.27 -41.36 89.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.174 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -54.55 -46.03 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.04 93.49 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -62.05 -42.43 99.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.18 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.6 mmp_? -62.56 -40.59 97.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.206 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.53 -48.06 86.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.5 mt -60.73 -39.89 83.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.211 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -56.07 -46.71 78.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.21 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -71.38 -29.37 64.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.4 mt -66.45 -37.23 84.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.246 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB2' HG23 ' A' ' 144' ' ' VAL . 88.4 mt -84.24 -32.18 24.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.179 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.27 31.75 7.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 142' ' ' LEU . 81.9 t -72.01 123.52 26.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.19 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -122.49 163.22 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -152.31 165.83 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.1 t -69.88 130.25 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.188 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -76.49 108.79 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.187 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.56 -3.39 58.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.208 -170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 84.6 p -90.78 0.18 57.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -94.82 5.49 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.16 78.25 1.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -68.76 -30.94 69.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.206 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -87.91 151.85 22.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.236 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.55 113.08 10.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -138.09 170.4 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.44 134.24 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.3 t -83.87 113.27 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.191 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 32.0 mm -103.65 116.05 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.235 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 181' ' ' THR . . . -147.57 156.65 43.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -171.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -97.8 -20.97 17.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.212 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -161.7 110.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.19 96.91 8.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.231 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.474 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 46.5 p -80.99 165.38 45.54 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.222 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 93.9 Cg_exo -50.25 -37.44 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.736 1.624 . . . . 0.0 111.166 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.2 p -76.22 -30.41 57.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -70.65 -35.07 72.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 71.7 p -80.79 -29.62 36.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.93 86.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.183 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 72.8 p -95.95 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 58.5 ttp -136.39 133.02 36.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -77.35 89.37 3.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.231 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -54.99 -35.0 63.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.246 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -47.89 -38.56 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.215 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -109.53 31.4 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.201 -170.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 92.0 t -106.72 124.21 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.197 173.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.9 mt -100.84 -10.78 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.59 170.73 38.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -121.79 141.61 51.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -143.38 108.84 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.185 169.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 160' ' ' ALA . 67.9 p -118.82 154.73 32.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.86 -42.11 95.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.1 m -108.07 157.16 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.194 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.76 3.86 45.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.54 -17.81 73.11 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -108.4 22.8 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.328 . . . . 0.0 111.182 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.6 m -49.14 -45.89 44.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.0 m -58.82 -44.09 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -55.18 -49.9 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 80.7 p -72.28 -30.7 65.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.37 -43.74 72.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.156 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.22 -49.07 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 77.8 mtm -64.79 -46.16 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.23 -36.45 83.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.185 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -59.63 -45.88 90.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 85.7 p -77.89 -23.62 48.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.227 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.81 -16.02 22.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 60.81 50.09 5.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.243 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 42.1 pt -128.64 159.84 65.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.186 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 71.8 Cg_endo -72.36 150.27 52.18 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.658 1.572 . . . . 0.0 111.198 177.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.12 126.16 12.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.229 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.17 123.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.67 159.34 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.78 39.98 32.49 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.09 -14.01 58.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.91 -59.82 1.45 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -152.06 45.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.84 -23.55 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.193 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.0 p -75.38 -15.51 60.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.5 p -97.47 -27.22 14.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.2 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.41 -23.46 20.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.15 122.96 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.236 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.86 159.85 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.181 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.11 26.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.79 -16.68 36.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.09 163.82 27.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.0 129.59 44.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.186 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.92 136.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.204 -174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.404 HG12 HG12 ' A' ' 13' ' ' ILE . 74.7 mt -122.95 126.03 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 175.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.6 t -107.97 112.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.163 -174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -98.54 91.1 4.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.18 -33.73 69.35 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 67.2 tp -57.74 -49.79 75.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 111.213 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.59 -26.38 30.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 84.26 37.82 10.68 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.2 pt -133.71 149.17 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.191 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.94 135.95 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.199 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.423 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 7.9 tp -115.4 140.46 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.39 138.24 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.178 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.471 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 89.0 m-20 56.05 52.3 7.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -173.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.3 Cg_endo -71.76 155.28 58.63 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.665 1.576 . . . . 0.0 111.235 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -88.09 -177.88 5.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.04 -54.37 45.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.238 -172.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.79 -46.56 88.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.243 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 95.6 m -56.23 -45.55 79.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.62 -45.54 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -68.59 -35.6 77.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.04 -45.75 90.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -76.15 -26.06 55.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.189 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.89 -42.89 97.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.181 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 75.3 m -59.16 -41.48 88.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.17 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.55 -49.97 75.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.221 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.64 -40.27 95.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 73.4 m -59.48 -40.37 86.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.245 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -68.4 -51.32 45.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -73.4 -40.45 64.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 -170.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.199 -1.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 -176.897 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.845 0.355 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.9 mt -98.08 122.43 41.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.06 136.8 47.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -140.67 2.93 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -104.36 113.71 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 111.168 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.31 87.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.72 76.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.194 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.9 t -148.33 135.77 10.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.19 162.01 31.78 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.699 1.599 . . . . 0.0 111.239 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.38 177.59 14.94 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.94 130.41 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 111.176 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.02 140.11 36.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.65 124.91 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.72 -156.02 7.85 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.24 179.27 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.22 131.2 41.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -121.56 97.66 5.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.183 171.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.84 118.23 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.201 -170.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -98.72 111.26 23.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 p -104.33 167.82 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.165 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.94 132.19 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.197 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -61.41 132.68 54.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.191 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.19 131.43 50.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.9 t -83.58 99.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.6 m -97.67 114.11 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -96.24 126.4 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.179 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -80.44 115.78 20.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -106.65 23.54 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.219 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -83.19 157.57 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -84.3 160.14 20.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.2 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.7 pt -122.64 165.03 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.54 146.26 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.25 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -51.27 -39.29 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -69.88 -16.31 63.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -95.25 -0.13 53.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -58.61 -46.79 90.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.209 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.93 -32.14 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.211 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.55 -42.47 87.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.192 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.81 -37.58 76.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 84.5 mt -63.63 -43.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.201 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.47 78.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.18 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -64.27 -37.92 89.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.83 -48.48 81.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.99 -35.62 81.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.93 -42.13 99.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.89 85.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.173 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.38 -41.6 97.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.75 -38.33 90.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.225 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.15 -46.54 95.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.195 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.2 p -68.93 -29.89 68.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.216 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -60.03 -51.26 70.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.218 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -49.93 75.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.217 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -58.18 -55.1 39.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.36 -41.77 88.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.12 -51.33 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.5 -38.18 83.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.191 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.8 mt -64.55 -41.85 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.02 -49.35 60.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -54.7 -52.94 60.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -60.74 -40.02 90.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.46 99.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.3 tt -57.41 -47.21 82.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.183 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.23 -28.88 57.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.225 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.23 -44.02 9.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.208 -174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.17 -32.76 4.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.217 -168.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.89 164.34 11.48 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.9 -34.97 66.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -45.88 -44.51 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.19 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -76.56 -34.7 58.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.79 81.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.239 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.51 -35.87 82.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.9 mt -60.93 -42.54 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -76.91 -24.25 52.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.209 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -64.59 -41.01 96.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.149 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.18 98.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.211 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.46 -40.74 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.211 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.97 -43.68 87.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -64.86 -36.81 85.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.9 -44.96 83.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.63 78.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.2 p -104.57 20.6 18.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.234 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -72.66 114.87 34.14 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -53.98 -34.55 77.4 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.69 1.593 . . . . 0.0 111.192 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -69.11 -43.36 74.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.226 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 99.5 mt -72.61 -36.07 68.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.86 -51.78 62.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.42 -30.75 69.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.216 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.97 -47.09 91.29 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.11 -43.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.201 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.78 -44.93 90.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -67.68 -34.87 77.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.206 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 tpp -63.71 -43.25 97.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.79 -48.02 89.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -73.97 -45.91 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.3 m -63.62 -48.83 75.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.91 -12.07 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.217 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.5 mt 59.05 65.28 1.23 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.246 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.19 165.61 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.201 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.4 p -66.4 154.78 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.89 97.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.241 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.89 -37.12 85.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.22 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.49 -43.86 84.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.212 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.88 94.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.37 -46.5 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.2 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.5 -47.07 76.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -69.47 -51.62 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.61 -46.92 94.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.237 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mm -68.83 -47.13 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.201 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.71 -39.77 84.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.201 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -57.19 -54.56 45.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.188 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.84 -38.2 89.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.217 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.07 97.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.9 p -66.98 -31.19 71.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.47 -49.16 79.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 98.7 mtp -58.5 -37.38 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -74.32 -34.52 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.176 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.5 p -69.98 -17.56 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.251 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.62 -11.29 60.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.193 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 64.49 32.79 11.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.193 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.14 112.99 25.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.46 -31.37 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 -172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -63.34 -51.01 67.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.39 -25.28 63.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.223 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.48 -47.96 81.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.19 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.84 -39.59 94.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -66.48 -33.41 75.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.227 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.89 84.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.46 -43.53 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.173 173.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.01 -48.07 73.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 173.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.85 -49.14 78.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -56.89 -45.18 82.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -61.35 -42.91 99.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.211 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.52 -48.87 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.199 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.56 -40.45 99.15 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -59.64 -43.94 93.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -69.81 -37.23 76.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.219 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 92.0 mt -57.49 -44.87 85.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.236 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.3 -44.44 97.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.52 -47.53 85.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.14 -33.3 71.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.225 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.06 -46.56 77.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.163 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.54 -34.38 69.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.17 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.76 35.09 5.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.84 122.53 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 111.177 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -107.0 163.62 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.221 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 71.7 p -158.59 177.71 10.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.224 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.4 125.65 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -81.31 105.9 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.199 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.58 -26.78 67.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.242 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -77.53 -9.01 58.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.194 -173.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.68 -3.34 58.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.194 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.08 120.41 16.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.213 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -122.72 30.21 6.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -145.9 137.61 25.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.82 98.46 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.47 173.29 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.211 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -89.2 127.24 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -96.6 125.19 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.87 112.05 38.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.229 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.92 143.92 43.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 -170.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -89.54 -7.73 54.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 172.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -169.27 152.01 4.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 34.5 tp -173.61 118.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.189 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.8 p -99.99 161.04 25.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.215 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -52.1 -34.89 59.96 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.744 1.629 . . . . 0.0 111.179 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 p -67.21 -19.98 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -91.92 -34.12 14.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 75.1 p -63.65 -32.87 74.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.182 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.31 71.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.7 p -113.2 14.14 19.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 27.4 ttt -77.59 131.79 37.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.177 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -67.35 74.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -66.34 -22.42 66.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.86 -25.03 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.03 23.48 14.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.194 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.4 t -110.26 116.13 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.185 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.68 -4.68 33.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 177.52 169.48 38.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -150.4 132.04 14.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -141.59 150.17 41.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.3 p -137.0 165.47 25.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -104.87 7.92 34.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 165.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.99 153.43 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 139.28 145.42 4.73 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.97 -76.41 1.07 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.08 140.78 47.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.226 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.9 p -123.14 25.19 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t -60.17 -59.27 5.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -60.07 -38.89 84.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 79.8 m -58.25 -47.51 83.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.8 87.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.35 -47.89 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.213 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.21 -44.86 94.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.62 -37.8 82.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.201 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -61.56 -46.48 89.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.191 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 78.5 p -70.58 -25.03 62.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.35 -22.88 28.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.209 175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 60.6 47.43 8.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.203 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.03 155.87 80.02 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.94 161.6 23.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.664 1.576 . . . . 0.0 111.219 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.88 132.22 8.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.15 112.62 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.224 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.77 169.83 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 -170.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.59 38.64 78.68 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.5 mt -80.35 -27.44 38.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.178 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.29 -62.77 4.44 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -93.21 -6.12 48.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.167 -172.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.92 -29.13 42.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.175 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.9 p -79.56 -14.08 59.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.259 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.2 p -102.62 -28.8 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.215 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -92.37 -23.94 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.227 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -115.66 120.8 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.189 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -117.49 157.57 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.23 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.46 127.31 29.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 107.76 -20.05 32.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.63 163.48 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.767 0.318 . . . . 0.0 111.239 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.86 134.15 36.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.6 t -133.27 128.58 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.233 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.5 mt -113.7 127.51 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.186 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.1 t -106.52 118.89 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.172 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -116.4 96.98 5.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.171 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.63 -23.7 66.78 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.66 -38.23 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 111.176 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.36 -27.64 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.187 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.45 36.45 14.32 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 pt -129.68 157.68 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 111.185 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 74.8 t -127.59 134.84 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.199 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 mm -103.23 128.85 55.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.218 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 72.4 t -105.2 120.9 56.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 54.97 58.4 11.1 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.93 156.17 63.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.748 1.632 . . . . 0.0 111.232 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -86.47 -178.23 6.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.99 -42.67 99.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.182 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -64.06 -44.18 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.6 m -61.6 -44.22 97.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.99 -44.97 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.234 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.89 -35.7 80.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.221 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.02 -50.57 72.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.185 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -72.37 -27.21 62.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -59.56 -45.48 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.198 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.7 p -69.36 -31.45 69.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.218 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.18 -42.96 83.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.86 -44.95 86.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.85 -50.61 73.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.0 p -67.7 -26.57 66.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.228 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.63 -48.28 64.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.233 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.8 -38.72 80.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.208 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.2 -1.514 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -177.704 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.759 0.314 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.1 mt -97.14 99.36 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -87.37 131.31 34.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.31 -150.82 5.45 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.6 119.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.83 87.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.198 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.74 -31.84 65.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -148.28 133.98 9.55 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.168 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.6 163.44 31.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.735 1.623 . . . . 0.0 111.171 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.4 179.66 15.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.9 mt -130.67 121.36 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 111.208 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.01 132.85 55.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.225 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.9 mt -124.11 119.53 56.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.23 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.81 -161.82 13.66 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.0 157.42 16.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 0.0 111.215 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.41 95.15 4.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.192 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -105.64 105.23 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 168.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.11 140.27 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -85.29 97.94 10.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.2 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -120.83 137.89 54.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.256 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -123.09 160.18 26.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.164 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -68.67 139.46 55.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.215 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.02 115.04 29.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.197 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.27 127.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.218 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.0 m -70.66 133.67 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.35 127.26 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -79.82 113.05 17.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.2 m -96.84 16.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -56.96 133.6 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.207 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.44 129.74 43.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -87.08 125.37 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.03 145.79 54.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.17 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -54.33 -34.87 61.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.208 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.7 p -75.85 -21.69 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.233 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.61 -9.35 41.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 93' ' ' ILE . 42.6 t -54.78 -45.0 73.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.52 -32.93 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -67.0 -41.83 86.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.191 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.65 -36.2 78.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.21 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 173.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.93 90.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.226 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -57.3 -45.82 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.207 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.94 -47.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.51 -36.33 83.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.48 -39.69 92.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.77 -35.08 79.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.21 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.2 -42.36 99.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.195 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.48 -45.02 95.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.36 -44.06 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.199 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.3 m -60.21 -48.82 80.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.246 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.3 -42.19 99.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.15 -49.81 74.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.18 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.31 -45.77 92.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.66 -44.22 93.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.49 -45.76 78.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.36 -41.57 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.86 -40.77 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.195 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -50.58 -47.33 58.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.195 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.68 -49.14 68.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.01 -42.06 98.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.07 85.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.214 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -62.45 -46.08 90.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.218 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.49 -29.96 70.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.197 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -82.38 -53.83 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -117.36 -34.49 4.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 -170.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.38 -168.46 16.51 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.56 -19.0 65.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.776 0.322 . . . . 0.0 111.208 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -55.92 -52.91 62.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -77.9 -28.99 49.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.211 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.64 76.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.211 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.75 -34.84 79.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.49 -47.2 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -76.38 -26.61 55.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.189 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.0 -45.39 90.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.73 97.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -60.19 -41.36 92.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.172 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.2 tp -64.72 -43.96 91.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 98.4 mtp -57.2 -45.85 83.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.216 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.77 -40.75 98.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.232 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.75 66.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.234 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 -2.64 37.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.74 113.79 14.69 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.04 -33.37 83.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.658 1.572 . . . . 0.0 111.199 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -67.67 -44.44 77.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.04 -37.29 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.96 -52.52 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.208 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.27 -35.05 78.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.213 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.81 -47.6 87.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.5 -45.29 93.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.732 0.301 . . . . 0.0 111.17 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -62.09 -38.76 90.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -67.01 -37.88 84.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.151 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.4 tpp -63.01 -42.46 99.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.218 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.404 HG22 HG13 ' A' ' 36' ' ' VAL . 96.1 mt -57.25 -48.01 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.49 -43.21 57.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.211 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 m -62.28 -50.33 72.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -172.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.27 -11.35 32.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.244 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.0 mt 59.0 63.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.204 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.49 158.95 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.22 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.3 t -66.18 150.0 49.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.04 -31.87 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.234 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -54.73 -43.7 72.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -84.82 -31.67 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.217 -176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.91 -45.41 93.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.17 -46.31 96.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.19 -48.21 71.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.28 -49.41 60.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.178 -174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.9 -45.1 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.442 HG23 ' HG ' ' A' ' 130' ' ' LEU . 31.1 mm -64.57 -46.34 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -69.1 -38.28 78.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -55.73 -54.34 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.82 -31.33 71.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.209 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.72 98.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.5 p -69.42 -29.33 67.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.246 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.19 -48.98 83.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.202 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 66.4 mtt -51.91 -42.65 62.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.234 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.22 -40.46 82.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.0 p -69.34 -19.98 63.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.98 -8.69 57.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 62.62 33.9 15.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -110.73 112.76 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.84 -31.0 69.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.198 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -61.2 -49.94 75.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.53 -25.69 62.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.195 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.17 -40.49 97.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -67.17 -35.69 80.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -69.57 -31.6 69.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.3 96.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.181 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.33 -46.55 96.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.221 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -57.29 -44.0 83.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 108' ' ' ILE . 56.3 tp -62.44 -46.05 90.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 -58.36 -45.28 88.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.12 -42.44 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.205 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.38 -49.69 83.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.79 98.5 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -60.2 -44.09 95.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 111.183 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -70.0 -36.14 74.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.0 mt -57.56 -46.23 86.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.37 -42.61 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.71 -40.11 91.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.186 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.47 -30.33 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.219 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.76 -38.78 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 172.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.2 -26.0 36.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.198 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.05 27.31 23.88 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.51 125.97 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.77 161.74 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 173.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.3 p -144.96 175.87 9.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.18 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 93.0 t -74.75 124.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -80.44 72.51 7.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.41 -21.01 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.1 p -67.42 -18.01 64.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.2 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -105.47 20.11 19.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.242 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 156' ' ' VAL . 60.3 tp -63.62 130.92 46.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.28 22.22 8.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -137.73 140.52 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.152 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.54 97.83 5.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.19 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 152' ' ' LEU . 34.8 m -137.72 -168.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -169.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.69 132.34 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.8 t -96.41 125.13 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.199 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 98.7 mt -122.42 132.08 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.71 170.06 22.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.207 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -66.34 -46.24 77.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.202 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.71 173.38 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.202 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.68 84.51 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 51.5 p -78.22 165.25 51.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.174 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 95.3 Cg_exo -50.03 -36.68 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.7 1.6 . . . . 0.0 111.209 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 93.7 p -73.27 -31.06 63.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -45.85 50.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.6 p -68.74 -27.31 65.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.176 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.56 -1.39 37.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.2 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 74.2 p -113.96 5.05 16.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 99.0 mtp -78.16 126.89 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -67.06 106.48 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.238 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.5 -48.81 56.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.204 -166.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.21 8.5 44.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.215 -164.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -123.84 16.81 9.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.4 112.45 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.172 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.5 mt -91.03 -13.45 33.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.167 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.6 178.41 41.96 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -165.15 162.48 20.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.329 . . . . 0.0 111.21 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -150.2 144.65 25.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.244 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.6 p -127.85 154.78 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.227 -170.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.86 -55.35 23.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.186 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.46 129.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 59.1 4.51 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.79 -26.88 73.89 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -118.0 62.22 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.178 169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.3 m -63.18 -40.1 96.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.1 m -52.8 -53.41 48.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -72.73 -33.1 66.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.258 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -58.42 -48.94 79.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.224 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.66 93.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.242 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.0 mt -58.31 -46.05 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 61.8 tpp -64.3 -46.83 81.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.15 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.27 91.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.167 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.1 -36.64 69.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 82.8 p -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -98.59 -14.97 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.203 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 60.95 51.03 4.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.183 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 44.2 pt -125.45 153.21 72.4 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.219 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 50.7 Cg_exo -60.55 148.74 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.663 1.576 . . . . 0.0 111.205 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -148.2 122.09 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 97.5 t -122.44 120.33 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.177 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.86 160.81 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.01 38.75 29.5 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.18 -5.57 59.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.79 -62.97 4.16 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -151.94 45.06 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.2 -174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.9 -23.26 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.236 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 70.7 p -70.66 -17.92 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.237 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.8 p -101.01 -27.85 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.189 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -83.18 -17.89 41.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.79 134.36 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.206 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -109.05 149.75 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.89 126.21 26.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.06 -14.99 44.26 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -69.58 166.21 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 111.195 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.27 133.41 36.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.245 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.94 126.31 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.35 114.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.251 168.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.67 91.35 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.208 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -85.94 78.91 9.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.186 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.01 -24.44 73.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 64.1 tp -58.2 -48.31 80.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.186 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -91.79 -17.89 24.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.12 36.53 14.72 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 pt -132.28 155.16 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.342 . . . . 0.0 111.184 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 96.1 t -121.64 133.94 66.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 175.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.7 127.43 66.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.9 122.85 62.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.194 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.436 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 94.0 m-20 55.71 55.52 9.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 73.7 Cg_endo -69.64 155.33 66.64 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.7 1.6 . . . . 0.0 111.219 175.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.39 161.61 29.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.174 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.91 -50.46 63.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -57.72 -46.88 83.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.219 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 99.9 m -54.19 -45.39 72.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.171 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.92 -47.55 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.87 -32.37 73.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.209 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -64.47 -41.35 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.2 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.43 -28.23 64.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.215 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.85 -43.07 99.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.194 172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 78.6 p -71.03 -30.96 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -68.56 -39.98 80.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.192 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -59.84 -41.57 91.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.51 -49.19 77.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.1 p -67.06 -28.91 68.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.232 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -63.32 -50.08 71.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.212 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -33.97 75.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.527 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.372 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.799 0.333 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.6 mt -91.61 120.18 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.3 129.62 55.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.17 -150.91 5.31 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.4 t -105.21 124.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 111.177 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.56 87.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.57 96.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.218 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.4 p -149.09 148.84 28.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.64 161.81 24.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.699 1.599 . . . . 0.0 111.236 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.64 177.13 14.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.6 mt -133.92 117.03 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.156 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.81 113.31 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.92 111.56 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.193 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.71 -156.75 13.84 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.5 150.83 22.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 111.224 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 120.72 31.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.213 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -119.82 100.42 7.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.3 tp -78.25 113.79 16.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.219 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -59.66 106.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.227 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.3 m -92.77 133.66 35.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.58 127.55 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.163 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HB2' HG13 ' A' ' 144' ' ' VAL . 61.9 mt-10 -67.19 146.35 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.73 125.82 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.49 82.04 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.6 m -85.42 112.22 20.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.201 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.4 mt -81.57 122.1 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -80.2 109.01 14.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.7 24.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.196 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.12 173.55 9.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -99.2 164.83 11.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.191 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.6 pt -123.24 165.26 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -72.92 142.96 47.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.169 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.19 -43.1 66.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.2 p -69.28 -17.88 63.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.31 4.72 46.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.2 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.43 -46.78 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.24 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.74 -36.31 82.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -67.85 -40.38 83.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.171 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -70.33 -37.89 74.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.217 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.24 -42.25 94.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.91 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.211 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.95 -42.86 94.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.214 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.27 -48.3 82.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.39 -36.91 85.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.91 -39.37 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.218 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.61 81.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.212 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.68 -40.53 97.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.172 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.54 -45.27 94.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.5 t -67.44 -42.67 87.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.0 m -58.0 -53.83 53.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.24 -39.38 94.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.42 -50.89 72.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.199 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -65.35 -39.13 91.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.229 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.44 -49.09 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.231 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -67.24 -45.94 75.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.55 -43.94 83.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.224 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.82 -39.88 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.215 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -49.24 -47.22 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.73 -51.75 59.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.227 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.42 -40.92 98.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.98 95.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.198 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.1 tp -60.17 -44.87 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.16 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.31 -35.78 81.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.214 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -87.04 -67.77 0.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.216 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.09 -31.58 15.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.33 -163.24 13.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.06 -23.4 67.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 111.194 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -48.0 -41.0 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -102.04 -32.36 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.159 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.86 -37.99 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -65.66 -33.44 75.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.198 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -58.57 -46.57 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.225 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -68.01 -35.56 78.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.182 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -57.12 -46.7 82.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.61 98.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -67.38 -34.42 77.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.185 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.0 -46.04 89.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 78.2 mtm -62.54 -41.97 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.209 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.26 -39.43 93.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.03 79.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.18 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 84.8 p -87.49 -14.85 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.191 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.63 113.77 10.03 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.232 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.32 -28.58 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.683 1.589 . . . . 0.0 111.209 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -63.56 -28.62 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.252 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.55 -35.87 12.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -53.43 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.31 -35.39 80.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.7 -45.94 94.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.8 -45.61 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.64 -36.19 81.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.202 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -65.16 -42.08 94.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.06 -47.0 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.67 -43.98 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 98.7 m -67.28 -47.27 71.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.215 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -97.4 -8.07 30.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.41 63.71 1.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.48 165.92 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.2 p -65.91 159.53 25.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.52 -34.41 78.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.215 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -55.39 -51.22 67.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.201 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -65.39 -43.68 89.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.195 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -49.68 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.65 -46.28 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.19 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.89 -55.1 38.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.21 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.75 -52.28 63.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 -172.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.49 -50.03 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -172.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.9 mt -71.62 -42.95 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.247 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -57.69 -41.58 81.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.83 -52.95 63.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.186 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.35 -37.04 81.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.8 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.8 p -68.59 -29.64 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.178 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -64.68 -49.98 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 60.1 mtt -53.58 -40.77 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -67.81 -41.12 83.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 73.2 p -69.69 -21.25 63.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.4 mt -73.65 -13.06 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.94 32.19 17.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -103.83 108.98 20.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.54 -33.45 74.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 -169.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.28 -49.28 77.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.236 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.45 -26.08 63.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.88 -42.47 97.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.68 -41.75 91.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.219 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -67.25 -32.91 74.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.224 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.01 88.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.217 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.73 -43.05 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.171 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -58.84 -41.35 86.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 69.0 mt -60.07 -43.17 95.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.193 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -59.99 -42.32 93.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.229 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.95 -46.51 81.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.219 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.41 -46.12 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.225 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.74 -46.32 93.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.11 -41.77 97.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 111.235 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -62.86 -41.62 99.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.184 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.44 -46.34 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -60.62 -41.78 89.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.208 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.67 -39.82 85.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -72.66 -31.05 64.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.192 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.06 -38.32 82.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.247 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.43 -33.17 42.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.56 8.84 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 22' ' ' GLU . 75.7 t -69.61 119.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.186 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -104.81 161.94 13.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.222 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.3 p -153.92 165.13 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.149 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.73 123.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.213 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -93.54 94.67 8.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.03 -3.25 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.22 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.3 p -74.56 -13.17 60.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -110.93 23.66 13.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.4 mt -60.17 132.61 54.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.207 174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -101.18 -6.25 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.211 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.85 156.87 43.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.16 121.24 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.9 m -138.12 170.02 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.0 t -94.76 133.36 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.44 121.17 49.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 79.3 mt -122.21 135.34 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.45 24.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.154 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.55 -45.58 30.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -168.71 147.21 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.18 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.8 mt -135.9 148.89 48.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 43.6 p -84.26 163.39 47.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 85.9 Cg_exo -51.66 -29.63 33.82 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.703 1.602 . . . . 0.0 111.165 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 85.9 p -84.73 -25.31 28.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.194 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -83.5 -34.14 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.198 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.6 p -67.01 -18.15 65.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 1.5 56.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.206 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 75.5 p -101.94 36.39 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 77.0 mtm -122.42 143.62 49.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.187 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -81.64 93.77 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.202 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -47.33 -46.69 25.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.212 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.12 -26.64 68.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.19 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.93 27.57 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -172.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.2 t -105.83 118.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.23 -29.6 24.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.18 174.82 43.03 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -122.8 154.49 38.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 0.0 111.226 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -151.51 144.82 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.185 168.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 -171.43 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -152.1 -0.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.31 152.69 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.72 171.89 26.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 166.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 -6.22 87.91 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -75.24 -1.36 23.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.9 p -66.57 -21.6 66.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 98.8 p -101.48 -35.06 9.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.254 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.06 -47.12 78.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 53.6 m -49.8 -44.16 48.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.232 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -58.17 -45.45 87.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.7 mt -62.59 -49.28 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.239 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mmm -63.75 -50.04 70.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.63 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.81 -30.84 68.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 81.0 p -79.54 -24.85 41.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 9.0 mp -88.56 -5.36 58.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.207 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 60.32 41.76 15.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 35.7 pt -129.59 155.62 79.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.263 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 156.05 47.57 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.756 1.637 . . . . 0.0 111.187 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.54 142.55 12.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.206 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.78 129.32 63.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.201 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.56 153.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.229 -173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 73.49 40.75 46.72 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 227' ' ' VAL . 91.3 mt -69.66 -24.43 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 111.235 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 121.26 -54.7 0.67 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -161.31 27.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 111.17 -175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.9 p -51.37 -33.56 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 68.9 p -74.34 -21.12 59.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.233 -172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.0 p -90.33 -20.94 22.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -103.36 23.2 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.19 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.95 149.81 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.195 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -139.18 142.06 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.204 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.58 122.85 12.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 114.01 -19.3 18.17 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.29 -179.26 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.21 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.87 153.46 22.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.43 141.99 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 89.0 mt -119.72 120.41 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 170.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.92 97.29 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.179 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -83.37 80.81 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.79 -33.1 86.34 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 68.7 tp -56.41 -49.21 75.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -80.01 -40.73 27.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 102.06 28.47 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.7 pt -132.88 158.57 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 111.218 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 205' ' ' LEU . 99.5 t -133.85 134.69 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.217 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 48.1 mm -115.06 127.44 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 130.8 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.158 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 56.37 56.97 9.26 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.66 153.15 64.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.74 1.627 . . . . 0.0 111.177 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -88.42 -178.48 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.2 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.55 -54.41 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -59.23 -48.37 81.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 96.4 m -54.14 -46.8 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.216 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 67.6 t -61.13 -46.59 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -68.73 -33.46 73.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.168 -176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.59 -42.93 99.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.247 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -68.14 -31.83 71.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.227 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.47 -44.68 96.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 82.9 p -70.72 -31.97 69.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.204 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -68.96 -42.29 76.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -61.88 -37.76 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.183 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -57.32 -49.77 75.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.7 p -67.94 -28.58 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -63.41 -49.92 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 172.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.13 -34.17 75.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.515 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.1 mt -74.95 79.84 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.65 130.01 34.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.28 -153.17 5.8 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.6 136.44 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 111.218 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.7 76.22 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.184 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.82 96.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 t -149.94 128.67 6.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.232 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 155.38 33.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.636 1.557 . . . . 0.0 111.195 -175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 170.78 12.0 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.2 mm -113.18 130.36 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.184 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 220' ' ' VAL . . . -126.42 112.12 15.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.2 mt -119.55 111.4 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.23 -162.06 18.02 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.27 163.64 15.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.346 . . . . 0.0 111.236 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.44 109.49 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -116.58 137.56 52.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 168.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.64 132.11 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.207 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 63.7 t80 -88.1 97.56 11.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.208 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.9 m -118.1 135.35 54.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -140.79 159.3 42.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.173 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -58.93 135.17 57.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.214 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -54.55 130.56 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.179 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.15 109.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.4 p -124.15 152.27 43.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 mp -112.85 127.48 70.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.218 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -81.49 105.14 12.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -96.91 14.0 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 -171.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 150.08 25.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.73 158.48 26.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.55 167.27 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -67.1 144.81 55.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -52.38 -37.12 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.226 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.1 p -69.52 -15.46 63.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.192 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -94.7 0.01 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.47 -50.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.66 -32.0 73.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.219 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.88 -50.73 72.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -70.15 -34.28 72.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.188 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.14 -43.61 98.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.212 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.77 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.93 -44.93 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 175.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.52 -48.94 79.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.182 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.45 -36.2 82.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.169 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -66.94 -40.09 87.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.209 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -35.66 80.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.95 -42.5 99.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.185 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.56 -50.99 70.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.7 t -66.16 -43.09 92.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.209 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 84.5 m -58.0 -53.1 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.191 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -64.0 -39.06 93.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.184 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.53 -46.72 88.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.88 -39.8 91.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.73 -39.93 87.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.213 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -56.47 -46.95 80.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.27 -40.36 97.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.75 -42.74 95.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -52.36 -49.91 63.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.238 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -57.83 -51.56 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.253 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.66 -42.43 92.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.183 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.05 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -56.48 -47.32 79.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.85 -32.31 52.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.229 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -84.79 -47.88 9.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.231 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.6 -34.55 5.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 -171.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.52 161.15 9.86 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.32 -37.97 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.189 -176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.64 -46.34 63.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.229 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -65.8 -37.83 87.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.71 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.197 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.69 -34.29 77.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.216 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.6 mt -59.27 -44.71 92.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.192 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -75.48 -30.4 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -58.11 -42.36 85.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.22 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.7 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -58.13 -41.91 84.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 77' ' ' LEU . 9.3 tt -59.65 -48.93 79.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.201 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.2 mtm -63.62 -34.95 78.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.4 -39.21 91.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.202 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.67 -35.26 80.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.217 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.7 p -85.0 -9.05 58.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.208 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -63.47 115.45 18.35 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.207 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.52 -31.26 68.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 0.0 111.207 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.82 -33.2 75.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.5 tp -81.21 -44.29 18.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.224 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -53.53 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.197 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -65.93 -34.76 78.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.99 -46.37 93.81 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.52 -45.47 88.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -64.57 -39.07 93.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.208 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -67.64 -34.34 76.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.0 tpp -64.64 -41.79 95.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.52 -47.37 91.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.59 -46.75 36.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.9 m -64.23 -47.53 79.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.175 -172.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.68 -9.53 34.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.1 mt 57.82 63.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.209 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.04 -179.86 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.172 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.4 p -81.11 164.15 22.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.227 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.04 90.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.194 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -68.6 -36.7 79.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.2 -174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -64.28 -43.85 93.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.01 -44.84 95.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.19 -49.15 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.227 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -60.89 -43.49 98.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -66.91 -50.39 62.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.199 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.93 -46.28 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.229 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.22 -44.86 87.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -64.1 -39.38 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -60.39 -52.94 63.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.99 -37.5 87.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.55 96.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.198 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.6 p -65.85 -30.56 71.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.193 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.35 -51.56 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.212 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 67.1 mtt -54.71 -40.27 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -68.47 -41.56 79.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.4 p -69.96 -22.11 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.17 -13.42 60.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 61.16 32.97 19.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.21 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -103.74 106.67 17.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.193 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.65 -32.84 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -169.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -60.88 -50.16 74.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.14 -30.4 69.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.213 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.55 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.89 -41.96 97.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.96 -34.2 77.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.95 -41.4 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -56.41 -44.37 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.174 174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.21 -37.58 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.225 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -61.39 -41.74 97.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.5 -41.89 96.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.13 -44.7 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.19 97.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -55.81 -47.91 76.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -61.0 -45.52 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.212 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.75 -48.73 83.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.67 -43.59 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.245 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.32 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.39 -32.84 68.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.23 -39.35 86.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.216 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.21 -36.94 54.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.22 27.3 10.18 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.41 125.26 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -109.88 156.22 20.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.246 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 62.0 p -143.32 174.59 10.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.234 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.35 106.96 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.206 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -83.8 115.75 22.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.5 mt -76.72 -16.07 59.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -172.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.9 p -69.43 -13.37 62.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -88.85 -3.68 58.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.212 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.94 149.48 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.241 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.75 28.55 7.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -150.09 141.42 23.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.222 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.54 113.5 10.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.12 172.59 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.204 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.04 134.13 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.8 t -113.76 129.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.155 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.7 mt -123.42 136.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.187 -176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 19' ' ' TYR . . . -162.02 149.66 14.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.221 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -50.05 -49.96 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.177 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -153.56 153.08 31.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -133.58 141.82 47.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 165' ' ' PRO . 44.8 p -116.6 163.89 20.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 176.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 164' ' ' THR . 86.8 Cg_exo -52.61 -35.31 67.07 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.729 1.62 . . . . 0.0 111.192 177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.7 p -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -87.76 -30.3 20.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.185 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.427 ' HA ' ' SD ' ' A' ' 171' ' ' MET . 69.7 p -78.9 -11.18 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.63 -35.78 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.5 p -106.91 21.86 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 168' ' ' THR . 60.9 mtt -100.32 150.59 22.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -117.64 107.45 14.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -62.01 -26.42 68.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.98 -22.42 66.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -105.6 5.56 31.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.51 119.38 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.64 -17.38 28.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.71 173.55 29.43 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.25 165.99 33.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.246 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -148.31 152.08 36.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.215 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 38.6 p -126.25 161.86 26.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.207 -172.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -76.47 -41.37 47.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.218 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.84 167.55 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.221 -171.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -113.09 15.02 23.44 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -67.67 -16.0 67.23 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -124.62 37.97 4.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 0.0 111.195 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -54.98 -40.55 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.232 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.6 p -63.88 -32.57 74.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -74.8 -35.22 62.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.206 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.1 p -70.43 -27.24 64.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.51 76.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.184 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.38 -46.28 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 28.4 ttt -60.89 -52.87 63.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.234 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -64.37 -56.56 13.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.2 m -63.42 -42.19 98.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.187 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.65 -17.63 43.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 63.4 51.79 2.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.169 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.9 pt -136.26 157.15 76.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 158.25 56.59 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.73 1.62 . . . . 0.0 111.161 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -154.28 135.55 14.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -127.09 123.16 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.219 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.34 157.58 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.47 17.7 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.0 mt -88.45 -3.02 58.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.233 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.35 -65.43 3.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.36 42.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 111.186 -176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -24.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 71.4 p -68.21 -21.59 64.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 87.2 p -97.08 -25.36 15.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -85.24 -23.05 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.209 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.92 128.43 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.89 150.97 26.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.45 129.11 40.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.46 -19.06 37.42 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.97 159.85 32.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.28 133.29 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.37 132.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.206 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.2 117.05 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.235 171.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 12' ' ' ALA . 67.3 t -104.78 115.27 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.213 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.99 98.69 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.7 -39.32 86.22 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.1 -46.76 87.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.771 0.32 . . . . 0.0 111.194 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -73.97 -35.86 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.186 173.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 88.24 38.36 7.28 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.5 pt -132.67 154.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.218 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.76 134.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.224 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.83 130.54 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.11 136.81 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.261 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 90.3 m-20 59.11 51.43 3.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.229 -178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 98.6 Cg_endo -72.25 155.77 55.82 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.683 1.589 . . . . 0.0 111.219 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -91.39 -177.83 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -57.65 -50.79 72.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.63 -48.78 78.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.6 m -54.41 -46.71 73.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 57.9 t -59.11 -45.02 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -69.26 -34.12 74.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -50.15 73.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -72.41 -26.88 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.12 -43.66 95.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 80.5 p -72.13 -29.55 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.15 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.93 -36.59 80.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.189 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -53.39 -52.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.33 -39.16 93.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.8 m -61.03 -38.77 87.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -70.93 -38.5 72.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.17 -32.99 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.9 mttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -175.003 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.63 148.7 24.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.21 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.82 134.32 38.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.74 -149.39 5.07 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.6 t -97.02 122.7 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.173 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.72 88.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.183 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.93 -38.78 76.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.191 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -148.49 141.41 15.33 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.212 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.07 165.11 24.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.728 1.619 . . . . 0.0 111.203 -175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.4 -178.51 16.56 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.1 mt -131.11 132.04 63.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.64 127.03 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.409 HG12 HG12 ' A' ' 219' ' ' ILE . 69.5 mt -127.87 122.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.57 -147.19 10.01 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -85.43 149.63 25.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 111.207 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.26 127.49 53.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.66 140.74 51.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.199 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 tp -106.7 122.93 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.194 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HB3' ' HA ' ' A' ' 160' ' ' ALA . 76.2 t80 -97.27 90.21 5.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.1 m -116.5 129.1 56.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.205 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -100.8 152.18 20.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.146 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.87 127.29 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.176 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -78.8 119.24 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.34 162.2 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.4 p -129.36 171.61 12.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.235 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -118.32 127.75 75.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.52 114.12 20.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.78 2.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.84 136.16 57.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.33 130.4 46.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.185 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.51 172.98 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -71.29 143.94 50.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -53.59 -37.5 63.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.236 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.4 p -69.03 -15.19 63.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -94.92 2.89 55.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.76 -49.97 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.15 -32.77 74.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -59.44 -48.85 80.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.198 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -68.42 -34.63 76.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.2 -45.12 99.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.207 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.58 95.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.22 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -58.35 -45.51 88.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.243 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -59.98 -50.27 74.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -59.5 -44.01 93.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.174 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -65.45 -46.64 79.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.209 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.9 79.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.9 -45.72 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.9 -43.05 90.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.23 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.75 -44.97 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -56.95 -43.36 81.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.28 -44.26 88.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.21 -38.4 87.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.249 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -65.59 -40.45 92.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.25 -40.74 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.201 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -63.42 -39.69 95.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -66.63 -38.76 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.197 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.57 -41.53 92.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -55.7 -46.33 77.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.0 -53.08 62.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.21 -36.89 84.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.51 94.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.5 tt -55.55 -44.46 76.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.13 -43.66 77.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.192 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -88.87 -48.02 7.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -171.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -91.95 -48.04 6.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.197 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.83 162.19 10.15 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.21 -37.74 64.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.205 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -49.63 -42.53 45.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.83 -37.8 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.35 80.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.222 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.08 -33.65 76.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.7 mt -61.68 -43.03 96.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.155 171.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.07 -20.56 55.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.41 -40.17 85.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.31 98.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.256 172.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -57.68 -41.72 82.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.48 -44.81 89.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.15 -37.06 85.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.248 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.44 -36.82 85.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.19 65.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.6 p -93.82 0.27 56.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -65.35 117.15 37.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.54 -32.05 61.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.689 1.593 . . . . 0.0 111.219 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -68.23 -35.75 78.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.185 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.44 -45.38 69.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 171.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.66 -56.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.64 -28.24 45.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -61.27 -50.02 71.53 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' HA ' HG21 ' A' ' 107' ' ' VAL . 69.4 t -69.06 -41.27 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.249 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -55.02 -49.12 72.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.191 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -68.03 -32.47 72.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.12 -42.3 94.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.61 -39.16 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.86 -40.35 95.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.1 m -72.13 -55.12 7.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -113.67 124.09 51.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 mp -77.04 75.03 3.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 32.9 m -126.08 167.81 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.4 m -58.83 138.48 57.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.139 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.81 -44.63 39.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.21 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -56.09 -41.46 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -63.12 -42.28 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.182 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.14 99.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.222 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.98 -47.66 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.209 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.54 -45.14 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.59 -48.66 76.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.22 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 89' ' ' VAL . 56.0 t -61.11 -47.29 94.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.205 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.6 mt -65.33 -42.74 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -58.48 -43.99 89.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.31 -47.45 79.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.202 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.19 -37.8 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.85 97.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.227 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.6 p -65.95 -30.7 71.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.194 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.32 -50.21 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.212 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 68.1 mtt -56.84 -38.51 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.172 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.94 -41.52 82.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.225 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.9 p -69.24 -21.39 63.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.219 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.33 -10.98 59.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 59.67 35.22 22.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.226 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -103.69 104.95 15.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.186 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.01 -33.93 76.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -60.04 -50.33 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.65 -30.48 69.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -59.72 -42.63 93.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.218 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.19 -41.88 96.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.203 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -68.03 -32.14 72.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.281 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.02 97.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.95 -42.42 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.216 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.87 -38.73 82.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.2 tp -67.28 -38.87 85.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.193 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.04 -42.36 76.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.194 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.79 -45.26 92.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.03 -46.58 91.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.64 -43.86 97.36 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.83 -39.76 90.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.156 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -70.04 -38.2 75.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.225 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.29 -44.68 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.214 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.34 -45.4 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -60.67 -43.0 98.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -69.48 -39.97 77.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -70.19 -44.4 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.151 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.13 -20.0 52.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.24 43.13 8.22 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.5 t -65.33 119.67 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 111.23 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -75.95 154.09 36.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 94.2 p -147.13 167.4 24.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.8 t -94.42 127.35 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -81.92 72.06 8.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.221 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.79 0.69 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.9 p -81.15 -9.88 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 170.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -107.61 23.73 14.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.166 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.93 132.37 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.199 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -109.43 -2.33 17.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.201 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -149.51 158.79 44.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.17 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.61 119.6 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.2 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.38 161.53 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.183 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.31 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -103.51 116.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -173.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.91 115.53 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' A' ' 19' ' ' TYR . . . -113.78 145.6 41.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.221 -170.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -67.22 -33.69 75.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.188 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -154.43 154.52 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -126.76 75.04 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.217 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.8 p -86.66 159.56 52.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.01 -40.6 67.35 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.733 1.622 . . . . 0.0 111.235 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.1 m -66.96 -39.84 87.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -64.5 -52.82 55.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.5 p -77.12 -20.41 55.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.194 -170.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.72 67.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.159 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 66.7 p -90.83 -29.73 17.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.19 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 68.5 mtt -59.31 133.74 56.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.206 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.63 88.41 0.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.213 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -50.7 -43.39 57.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.64 -13.25 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.184 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.5 mmt -107.87 27.32 9.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.16 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.45 124.23 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.23 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 98.9 mt -84.62 -25.94 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 179.41 158.9 22.52 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -108.68 148.59 30.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -155.97 150.37 25.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 171.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 t -162.27 -177.65 5.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.222 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.55 -27.48 8.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.231 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.27 126.09 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.201 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -81.0 166.33 48.42 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 89.78 -7.75 81.17 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -106.76 9.88 30.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 111.206 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 93.4 m -65.31 -44.77 86.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 92.9 p -71.63 -41.43 68.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -61.29 -48.01 83.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.221 174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -57.96 -43.97 86.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.217 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.02 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.218 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.36 -47.64 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.6 mtm -61.56 -51.76 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.257 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.33 -46.77 87.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.241 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -68.35 -31.48 70.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.7 p -69.56 -18.03 63.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' HB2' HG12 ' A' ' 199' ' ' ILE . 93.9 mt -107.08 -0.12 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 57.09 45.16 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.239 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 197' ' ' LEU . 38.9 pt -128.65 158.19 72.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.7 161.77 33.4 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.725 1.617 . . . . 0.0 111.167 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.27 136.67 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.205 174.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 52.1 t -134.47 126.49 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.8 m -119.29 152.67 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.183 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.43 46.39 6.92 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.47 11.4 14.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.252 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.32 -89.72 1.42 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -137.58 45.42 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.196 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.36 -25.78 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.5 p -72.35 -6.63 44.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -112.3 5.42 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.215 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -118.06 -5.16 10.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.37 145.2 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.72 158.25 40.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.195 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -55.82 117.9 4.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 102.58 2.48 50.1 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -75.1 150.62 38.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.232 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.45 123.66 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.234 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.94 142.79 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.197 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.409 HG12 HG12 ' A' ' 13' ' ' ILE . 79.3 mt -116.16 125.81 73.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.225 171.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 67.9 t -113.1 99.34 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.165 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -90.89 91.65 8.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.216 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.25 -35.36 76.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.35 -47.13 85.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.241 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -73.57 -36.8 65.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.202 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.65 34.71 6.47 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.3 pt -131.4 154.45 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 111.172 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.7 t -133.3 136.4 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.61 118.41 57.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.172 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.31 130.62 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.192 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.92 57.79 3.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.205 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.41 154.97 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.695 1.596 . . . . 0.0 111.256 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 159.61 33.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.156 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -53.85 -49.15 69.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.14 -47.34 83.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.204 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 94.0 m -51.48 -46.86 63.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.217 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.57 -48.83 82.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -67.99 -32.56 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.01 -46.08 90.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.201 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -70.68 -26.51 63.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.194 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.11 -45.35 95.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 79.3 p -71.76 -29.24 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.2 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -66.88 -42.32 85.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.16 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.34 -42.14 81.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.47 -48.03 77.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.224 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 64.4 p -69.94 -23.23 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -71.12 -38.44 72.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 173.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -79.37 -34.36 42.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.2 -1.507 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.199 -177.243 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -98.74 107.53 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.186 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -103.82 135.68 44.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.46 -138.69 2.55 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.19 122.59 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 0.0 111.23 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.76 87.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.199 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.3 -37.54 87.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -148.97 135.85 10.58 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.193 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 161.68 36.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.719 1.613 . . . . 0.0 111.209 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.6 -176.18 16.32 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.41 125.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.858 0.361 . . . . 0.0 111.191 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 177' ' ' LEU . . . -116.48 126.24 53.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.218 178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.5 mt -123.91 117.83 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.68 -157.59 13.04 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.53 167.69 13.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.23 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' HB2' HG23 ' A' ' 218' ' ' VAL . . . -99.25 144.78 27.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.193 175.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -141.26 111.44 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 164.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 62.8 tp -87.47 115.08 24.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.209 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -108.74 97.01 6.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -86.59 164.17 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.224 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -115.56 106.88 14.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.172 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.41 128.33 36.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.171 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.78 127.03 29.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -87.22 111.96 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -87.72 124.88 34.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.204 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.98 118.93 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.158 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -81.53 102.93 10.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.209 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -87.4 -5.25 10.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.91 139.25 52.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.05 158.74 32.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 pt -119.02 172.5 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -76.19 157.75 32.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.78 -32.53 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.1 p -72.57 -14.84 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -96.48 -0.34 49.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.193 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.1 -51.08 77.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.07 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.204 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.33 -51.19 71.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -71.11 -34.12 70.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.85 -43.92 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.221 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.25 89.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.92 -45.18 90.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.216 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.16 -47.7 84.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.177 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.08 -36.21 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -40.51 94.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -33.81 76.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.95 -42.6 99.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.183 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.99 -43.43 98.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.71 -40.71 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.233 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.4 m -67.04 -43.63 82.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.186 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -63.98 -42.87 97.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -59.0 -49.17 78.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -52.09 -58.76 5.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.34 -42.05 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.196 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.98 -45.91 82.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.202 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -67.41 -34.59 77.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.201 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.27 -49.26 79.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -68.21 -27.06 66.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.19 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.39 -51.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.242 170.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.8 -37.02 83.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.24 93.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.204 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.4 tt -60.15 -46.76 88.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.213 173.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.94 -34.32 77.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.148 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -87.65 -45.13 10.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.218 -174.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.73 -36.42 3.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.47 -172.08 14.09 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.86 -26.29 68.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 111.207 -175.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -43.53 -45.77 6.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 176.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -97.22 -31.25 12.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.196 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.71 91.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.42 -30.99 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.183 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.41 -45.78 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -76.01 -27.52 57.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.206 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.58 -44.27 89.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.138 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.92 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -61.68 -38.37 87.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.202 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.18 -44.14 89.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.21 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.4 mtm -62.61 -38.02 88.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.234 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.11 -39.87 95.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.218 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.56 -23.31 66.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.254 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.1 p -98.38 -3.75 36.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.197 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -66.11 113.71 13.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.211 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.29 -32.89 82.94 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.71 1.607 . . . . 0.0 111.239 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -67.4 -43.71 80.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.262 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.97 -36.58 69.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.35 -52.29 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.49 -34.48 77.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.48 -47.06 90.93 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.44 -44.87 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.218 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -62.85 -39.59 94.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.66 -33.83 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.0 tpp -65.32 -41.54 93.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.29 -47.75 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.21 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.29 -46.53 49.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.235 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.2 m -65.14 -48.43 73.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.216 -172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.32 -9.82 34.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.8 mt 57.48 64.08 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.79 179.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.9 p -80.3 163.37 24.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.198 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.84 -37.96 86.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -59.85 -50.71 72.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.17 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -67.31 -40.24 86.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.211 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.65 85.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.34 -45.8 97.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.201 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -58.48 -43.81 89.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -67.48 -49.67 62.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.192 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.64 -46.31 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.195 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.4 mm -65.93 -42.54 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.178 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -67.0 -38.2 85.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.201 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -65.75 -44.85 84.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.186 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -66.7 -40.45 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.194 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.08 97.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.186 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.3 m -59.24 -42.98 92.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.77 -52.91 56.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 56.9 mtt -54.74 -42.09 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.205 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -69.66 -39.53 77.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.211 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.3 p -70.39 -19.86 62.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.184 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.11 -7.14 56.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 60.44 37.45 19.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -115.05 112.54 22.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.06 -30.35 70.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -62.12 -50.3 72.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.255 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.44 -28.78 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.6 -42.96 99.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.228 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -60.5 -42.03 95.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.209 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -65.98 -34.04 77.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.204 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.97 94.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.2 175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.46 -41.81 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.197 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -57.07 -43.33 81.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.195 174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.25 -42.3 99.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -62.48 -41.19 98.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.223 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.84 -50.32 72.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.189 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.87 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -58.83 -44.64 95.82 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.21 -43.22 99.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.07 -38.03 89.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.35 -48.43 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.205 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.23 -41.24 90.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.245 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.9 -38.42 88.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.07 -28.26 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.206 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.3 mt -68.67 -48.31 64.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.1 tp -74.7 -52.46 11.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 120.59 35.76 0.83 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.76 127.59 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.234 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.13 155.47 25.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.182 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 85.1 p -156.79 169.67 24.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 84.3 t -119.6 128.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -86.66 106.15 17.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 97.4 mt -90.77 10.82 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.3 p -90.91 -7.46 52.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -106.71 27.53 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.69 137.3 51.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -124.0 27.99 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -169.56 138.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.167 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.18 123.14 17.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.197 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.84 144.36 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.198 -167.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.96 121.49 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.208 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.1 t -93.66 118.3 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.185 -174.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.401 HG22 HG22 ' A' ' 209' ' ' THR . 48.5 mm -112.13 126.79 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.219 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 148.06 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.225 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.87 -41.56 82.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.22 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -112.91 151.65 30.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 56.4 tp -154.24 122.24 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 52.8 p -112.48 161.65 25.25 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.214 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -54.23 -35.86 84.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.691 1.594 . . . . 0.0 111.235 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.5 p -74.6 -10.08 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.204 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.99 -40.85 12.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.18 171.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 -22.93 64.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.52 -9.29 58.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.6 p -111.91 -28.47 8.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 95.6 mtp -57.29 94.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.203 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -41.73 105.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.185 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -64.43 -22.03 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.199 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -72.15 -27.92 62.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.19 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.1 -39.66 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.25 119.0 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.423 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 94.7 mt -96.18 -15.56 22.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.99 178.4 43.89 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -158.49 137.05 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.777 0.322 . . . . 0.0 111.18 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -115.71 139.24 50.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.216 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 91.3 m -120.43 138.36 53.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.09 -42.95 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.227 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.58 137.61 51.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.225 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 100.85 177.75 29.4 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.32 54.02 0.66 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -131.9 26.84 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.8 p -74.21 -30.58 62.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.196 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 97.2 p -77.24 -30.83 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -61.2 -48.78 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 172.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.2 m -55.77 -42.43 75.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.225 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -61.25 -44.19 97.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.45 -45.73 96.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 ttp -58.11 -53.07 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.26 99.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -70.84 -33.11 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.18 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.6 m -69.96 -37.47 75.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.7 -7.44 57.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 61.33 48.98 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 200' ' ' PRO . 47.6 pt -126.82 149.32 68.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.22 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 199' ' ' ILE . 49.3 Cg_exo -60.76 146.41 97.4 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.744 1.629 . . . . 0.0 111.201 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -160.44 138.87 10.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.196 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 76.9 t -129.81 127.81 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.6 164.93 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 -173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.65 26.1 59.48 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 90.9 mt -78.33 -31.65 48.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.22 -61.9 4.57 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 170.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -100.27 2.81 43.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 111.247 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.07 -27.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.184 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 159' ' ' ILE . 29.7 p -81.84 -6.92 59.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 96.3 p -106.07 -29.35 9.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.216 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -91.59 -24.48 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.212 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 68.0 t -111.88 119.14 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.227 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.6 157.75 33.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.241 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -56.39 128.36 35.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.223 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 108.18 -20.91 30.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -71.15 165.11 24.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.21 138.32 34.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 171.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 16' ' ' ALA . 86.1 t -127.29 131.06 70.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.171 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.8 mt -114.92 112.54 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.46 96.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -93.39 88.11 5.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.246 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 -20.86 79.63 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.83 -38.46 88.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 111.22 175.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -94.07 -31.09 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.186 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.32 34.85 7.27 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 pt -131.8 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 94.3 t -128.42 135.09 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.237 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.46 127.47 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.186 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.23 133.66 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.404 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 95.7 m-20 50.67 56.56 17.34 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.211 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 70.7 Cg_endo -70.49 156.81 60.66 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.697 1.598 . . . . 0.0 111.192 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.03 161.01 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.185 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -52.46 -48.97 65.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -57.89 -46.43 84.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.186 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 93.8 m -55.65 -43.6 76.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 64.1 t -60.12 -46.05 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.22 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.99 -34.38 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.244 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.92 -48.26 79.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.51 -26.21 60.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.229 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.11 -46.71 86.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 83.9 p -69.27 -31.83 70.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -68.99 -38.56 79.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.207 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -61.05 -43.27 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.55 -40.73 95.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.22 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 75.2 m -63.35 -39.58 94.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.221 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -59.83 -49.29 78.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.208 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.52 -36.09 82.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.219 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.2 -1.52 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.781 0.324 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 227' ' ' VAL . 87.7 mt -80.18 80.3 6.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.227 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.54 130.91 41.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.21 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.96 -150.52 5.23 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.1 114.92 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.5 87.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.07 73.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.189 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 t -151.32 141.51 14.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 174.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.07 160.75 29.96 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.699 1.6 . . . . 0.0 111.204 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.06 -177.17 18.65 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.9 mt -134.41 122.87 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 111.216 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.88 123.48 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.18 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.31 112.75 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.73 -160.86 20.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -83.41 150.55 25.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.198 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.37 128.37 38.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.21 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -126.8 139.05 53.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.3 tp -105.85 131.92 52.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -113.09 116.79 30.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.149 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.1 p -125.46 169.7 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.243 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -150.8 136.59 18.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.402 ' HB3' HG13 ' A' ' 144' ' ' VAL . 88.5 tt0 -58.78 136.01 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.247 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.86 137.37 58.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.223 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -86.7 113.88 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.3 m -120.34 117.08 26.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.35 127.21 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.211 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -80.65 107.29 13.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.22 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.24 22.97 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.206 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.778 ' O ' ' CB ' ' A' ' 30' ' ' LYS . 88.8 tt0 -59.51 -61.57 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.178 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.778 ' CB ' ' O ' ' A' ' 29' ' ' GLU . 87.1 tttt 124.9 140.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.201 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 31' ' ' ILE . 2.9 pp -121.17 166.23 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -90.93 165.9 13.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.212 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -52.23 -41.21 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.198 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.8 p -69.88 -18.17 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.92 2.5 49.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.256 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.88 -52.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.04 -32.6 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -59.1 -50.84 72.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.25 -33.77 72.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.196 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.0 mt -61.64 -44.83 99.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.223 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.51 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.38 -46.67 88.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.179 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -60.0 -51.14 70.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.31 -39.7 80.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.179 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.63 -58.8 6.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.199 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -28.8 69.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.201 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.3 tm? -65.32 -50.46 65.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.199 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.93 -38.91 90.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.21 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.02 -41.3 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.19 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.6 m -60.49 -41.95 95.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.217 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -57.23 -49.89 74.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -58.81 -46.18 88.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.255 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -52.65 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.06 -40.87 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.42 -43.14 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.178 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -34.46 72.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.8 mt -63.81 -47.97 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -72.08 -27.47 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.222 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.47 -46.31 90.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.201 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.35 -40.14 67.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.92 78.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 62' ' ' LEU . 10.0 tt -52.33 -45.38 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.07 -33.17 24.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.22 -174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.71 -44.16 24.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.233 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -118.13 -35.64 3.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.192 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 129.17 170.33 12.74 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.5 -26.89 68.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.205 -174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.8 -44.88 39.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.98 -33.91 39.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.194 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.03 83.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.251 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.35 -38.13 86.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.219 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.3 mt -60.34 -44.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.158 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -78.27 -24.57 46.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.01 -41.26 96.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 170.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.77 87.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.39 -39.72 94.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.206 174.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.68 -43.61 96.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.2 ttp -52.49 -48.12 66.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.202 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.9 -35.14 79.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.234 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -28.32 67.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.211 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.8 p -92.14 -14.58 28.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -64.87 118.94 53.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -52.95 -32.29 56.88 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.71 1.607 . . . . 0.0 111.213 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -50.54 -39.27 48.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.16 -47.69 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.39 -56.77 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.229 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -75.09 -31.31 61.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.187 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -57.18 -48.27 81.25 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.22 -42.34 84.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.203 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -53.71 -47.22 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.47 -35.44 79.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.7 tpp -63.78 -41.88 97.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.87 -47.97 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.58 -44.55 64.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.239 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -65.83 -48.22 72.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.198 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -94.65 -10.95 30.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.201 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 91.2 mt 57.95 63.84 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.224 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.79 169.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.8 p -70.57 163.09 27.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.182 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.29 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.12 -42.73 99.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.187 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.86 96.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.6 t -55.91 -48.45 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.226 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -57.87 -44.19 86.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -63.5 -45.42 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.55 -44.08 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.209 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 131' ' ' ARG . 38.6 mm -65.57 -45.54 92.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.217 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.03 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.168 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -59.85 -54.86 41.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -67.72 -39.01 84.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.212 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.29 99.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 m -61.17 -42.86 99.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.202 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.3 -49.78 83.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.215 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 59.4 mtt -56.4 -41.15 75.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.202 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.78 -38.83 73.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.203 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.8 p -69.37 -20.58 63.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.0 -9.6 59.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.202 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.24 32.82 20.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -104.36 106.99 17.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.42 -33.16 74.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.231 -170.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.32 -50.01 75.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.4 mt -68.53 -30.09 68.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.74 -42.04 98.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.64 -40.94 96.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.192 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -66.03 -33.63 76.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.177 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.99 -39.53 92.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.07 -42.65 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -57.37 -42.94 83.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.226 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.36 -42.55 96.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.197 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.406 ' HA ' HG21 ' A' ' 108' ' ' ILE . 91.3 mtt180 -63.8 -39.65 94.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.243 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.3 -47.59 83.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.17 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.53 -44.62 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.192 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.53 -42.97 97.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -61.38 -41.87 97.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.198 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 68.3 mtt85 -59.97 -42.47 94.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.19 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.68 -47.23 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.217 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.05 -43.61 96.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.17 -38.25 88.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -71.55 -30.71 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.173 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -69.94 -40.39 75.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.13 -28.99 42.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.201 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.19 35.8 9.4 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 22' ' ' GLU . 82.6 t -71.19 123.66 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.232 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.23 165.83 14.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.162 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 88.1 p -143.69 171.29 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.5 t -71.74 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -84.56 78.55 9.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.245 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.11 -6.28 59.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.4 p -74.29 -9.25 58.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -88.13 0.65 55.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.56 145.35 41.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.175 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.54 32.54 5.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -143.92 140.88 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.59 99.28 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.19 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.74 -179.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 97.6 t -94.8 122.95 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.58 117.75 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.76 125.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.218 175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.09 49.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.232 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -63.14 -56.47 16.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.232 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -146.34 176.76 9.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.227 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.69 145.12 51.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.6 p -129.6 155.69 79.89 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.195 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -52.34 -38.34 72.95 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.714 1.609 . . . . 0.0 111.215 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -43.85 75.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.28 -46.28 64.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.175 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 65.0 p -67.89 -29.71 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.85 -29.37 70.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.1 p -108.46 14.55 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.22 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 63.1 tpp -71.65 115.58 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.55 77.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.2 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HB2' HD11 ' A' ' 197' ' ' LEU . 63.7 pttt -63.16 -20.7 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.241 -172.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.11 -31.02 68.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.3 mmt -112.47 32.27 5.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.43 106.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.1 tp -80.52 -40.04 26.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.43 176.81 27.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -154.89 139.59 17.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 111.185 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -152.54 147.02 25.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.6 t -143.65 154.42 43.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -171.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.63 -53.31 57.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.14 124.78 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.11 74.22 0.84 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.5 -31.69 81.02 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.51 60.11 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.806 0.336 . . . . 0.0 111.19 174.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 96.6 m -59.21 -37.36 77.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.211 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t -58.31 -56.46 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -59.37 -40.14 85.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.3 -46.87 88.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.35 -38.84 92.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.09 -48.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.236 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.85 -35.71 81.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.19 98.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.184 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.55 -38.62 84.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.174 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 t -61.53 -43.03 99.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.2 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 173' ' ' LYS . 90.3 mt -88.24 -16.09 34.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.194 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 61.69 51.26 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.174 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 44.4 pt -127.68 159.67 64.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 199' ' ' ILE . 92.3 Cg_endo -76.68 163.35 31.76 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.666 1.577 . . . . 0.0 111.251 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -157.55 135.73 11.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.186 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.18 122.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.181 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.95 160.35 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.91 38.64 35.42 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.17 -6.41 57.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.327 . . . . 0.0 111.201 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 85.28 -64.73 4.14 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 171.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -141.38 44.33 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.69 -22.67 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.7 p -70.44 -22.29 62.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 83.0 p -90.29 -27.08 19.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -90.69 -27.94 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.242 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 61.8 t -125.6 116.6 46.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.243 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.15 166.4 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -58.52 125.6 24.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 106.11 -18.06 40.09 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -73.83 165.27 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.23 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 62.4 tp -100.26 125.98 46.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.172 171.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.58 138.71 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.203 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.38 126.01 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.2 171.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.08 100.77 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -99.68 93.61 5.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.34 -22.51 73.08 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.25 -39.22 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -103.23 -15.3 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.226 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.71 37.33 26.81 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.96 155.73 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 2' ' ' LEU . 73.6 t -120.27 135.31 60.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.214 172.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.4 mp -109.21 129.44 63.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.214 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.65 117.53 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.177 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 53.76 60.4 11.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.223 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.0 153.18 68.07 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.714 1.609 . . . . 0.0 111.209 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -88.78 -176.52 5.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -55.76 -53.95 50.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.198 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -59.27 -48.87 80.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 92.9 m -53.99 -47.37 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 54.9 t -60.63 -45.82 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.203 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -65.72 -34.22 77.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.32 -41.73 98.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.215 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -75.96 -29.62 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -63.23 -41.62 99.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 47.8 t -62.67 -46.56 87.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.199 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.61 -42.83 93.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.222 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.62 -47.16 85.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.17 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -61.01 -47.07 88.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.229 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.5 p -61.94 -28.32 69.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -78.57 -53.65 6.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -77.45 -42.41 36.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.529 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.179 -176.531 . . . . . . . . 0 0 . 1 stop_ save_